data_1aci_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1aci _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.519 ' HG2' ' CG2' ' A' ' 12' ' ' VAL . 34.5 Cg_endo . . . . . 0 C--O 1.215 -0.658 0 N-CA-C 110.311 -0.688 . . . . 0.0 110.311 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -72.07 -61.18 1.88 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 109.828 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -39.64 -54.5 2.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.507 -0.746 . . . . 0.0 110.031 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.519 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 89.6 t -59.82 -41.59 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.106 -0.996 . . . . 0.0 109.668 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 9' ' ' PRO . 0.8 OUTLIER -55.35 -65.05 0.65 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.931 . . . . 0.0 109.62 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.527 ' CD1' HG23 ' A' ' 66' ' ' THR . 2.1 mt -46.25 -27.12 0.93 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.163 -0.96 . . . . 0.0 109.209 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.5 -47.54 66.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.867 . . . . 0.0 109.39 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -67.74 -13.45 62.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.338 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 14' ' ' LEU . . . -68.22 -42.04 80.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.381 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.196 -0.94 . . . . 0.0 109.51 179.966 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.98 148.08 25.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 109.403 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.418 HG13 HG11 ' A' ' 74' ' ' VAL . 38.9 pt -107.19 -174.28 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.213 -0.929 . . . . 0.0 109.536 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.48 ' HG2' ' OD2' ' A' ' 38' ' ' ASP . 20.3 tptt -96.44 167.01 11.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.253 -0.904 . . . . 0.0 109.757 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.64 -24.77 31.25 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.282 -0.887 . . . . 0.0 109.726 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.48 ' OD2' ' HG2' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -48.77 -38.11 20.93 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.135 -0.978 . . . . 0.0 109.417 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -59.48 -45.58 91.27 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.317 -0.864 . . . . 0.0 109.441 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.47 ' HA ' HG23 ' A' ' 63' ' ' ILE . 39.4 t -58.3 -23.48 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.354 -0.841 . . . . 0.0 109.734 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 3.4 ttm180 -83.7 -42.07 17.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.179 -0.95 . . . . 0.0 109.507 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -62.75 -59.39 4.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.332 -0.855 . . . . 0.0 109.93 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.466 ' HB ' HD12 ' A' ' 63' ' ' ILE . 16.3 mt -56.54 -50.75 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.925 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.501 ' N ' HD13 ' A' ' 63' ' ' ILE . . . -59.17 -21.43 59.38 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 109.931 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -78.61 -37.67 41.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.145 -0.972 . . . . 0.0 109.68 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.5 mt -82.82 -17.29 44.54 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.19 -0.944 . . . . 0.0 109.623 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.411 ' C ' ' HD2' ' A' ' 49' ' ' PRO . 0.2 OUTLIER -121.4 8.9 10.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.437 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.575 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -44.41 -51.41 20.18 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 0.0 109.893 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 48' ' ' MET . 35.2 Cg_endo -78.48 97.7 1.15 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.338 2.026 . . . . 0.0 110.436 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -170.15 -46.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.29 -0.881 . . . . 0.0 109.594 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' A' ' 52' ' ' ASN . 0.9 OUTLIER -115.57 39.43 2.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -0.95 . . . . 0.0 109.584 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 51' ' ' LEU . 32.5 t30 41.98 57.85 3.07 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.396 -0.815 . . . . 0.0 109.747 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.94 173.6 3.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.228 -0.92 . . . . 0.0 109.446 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -86.66 -45.92 10.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.905 . . . . 0.0 109.263 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.462 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -174.57 -39.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.303 -0.873 . . . . 0.0 109.3 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -172.93 -32.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -63.55 -59.98 3.93 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.411 -0.806 . . . . 0.0 109.995 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.97 -44.35 74.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 109.657 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.85 -24.22 66.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.227 -0.921 . . . . 0.0 109.656 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.85 -29.76 56.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 109.855 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -77.74 -23.35 49.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.9 . . . . 0.0 109.721 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.11 -56.05 5.01 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.19 -0.944 . . . . 0.0 109.892 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.501 HD13 ' N ' ' A' ' 44' ' ' ALA . 6.4 mt -56.0 -38.06 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.111 -0.993 . . . . 0.0 109.857 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 15.9 mt-10 -60.34 -55.03 38.56 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.106 -0.996 . . . . 0.0 109.474 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -52.94 -17.43 4.99 Favored Glycine 0 N--CA 1.482 1.754 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.527 HG23 ' CD1' ' A' ' 14' ' ' LEU . 61.1 m -84.57 -50.01 8.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.118 -1.225 . . . . 0.0 110.267 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.41 3.68 42.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.079 -1.013 . . . . 0.0 110.058 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 10.4 mtp180 -104.32 -36.3 7.66 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.058 -1.026 . . . . 0.0 109.415 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.96 -8.36 37.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 110.038 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.466 ' HG3' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -77.55 -62.94 1.5 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.074 -1.016 . . . . 0.0 109.544 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -159.19 -86.54 0.06 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.515 ' CD1' ' C ' ' A' ' 72' ' ' ILE . 2.5 pp -59.88 174.21 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -1.124 . . . . 0.0 109.665 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.432 ' N ' HD11 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -114.5 157.76 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.37 -0.831 . . . . 0.0 109.211 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.418 HG11 HG13 ' A' ' 35' ' ' ILE . 2.3 t -115.8 142.79 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.443 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 13.0 pt-20 -105.1 97.38 7.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.268 -0.895 . . . . 0.0 109.491 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.414 ' HB2' ' OE2' ' A' ' 64' ' ' GLU . 51.2 t0 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.507 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.553 ' HA ' ' CD2' ' A' ' 13' ' ' LEU . 36.7 Cg_endo . . . . . 0 CA--C 1.54 0.785 0 CA-C-O 121.899 0.708 . . . . 0.0 112.698 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.507 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . 32.0 -121.12 0.06 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.209 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.507 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -24.0 -61.78 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.831 -0.543 . . . . 0.0 112.273 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.6 t -62.85 -47.47 92.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.004 -1.06 . . . . 0.0 110.849 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.579 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 1.3 mm? -60.97 -18.0 54.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.794 -1.191 . . . . 0.0 109.977 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 15' ' ' LYS . 17.7 mt -86.38 -53.74 4.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.088 -1.007 . . . . 0.0 109.717 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -45.5 -44.89 12.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -0.967 . . . . 0.0 109.181 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -40.47 86.47 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.335 -0.853 . . . . 0.0 109.416 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.09 -37.64 46.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.432 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.895 . . . . 0.0 109.588 -179.889 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.16 179.34 6.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 109.321 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 73' ' ' VAL . 8.9 pt -120.04 -175.19 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.913 . . . . 0.0 109.552 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -109.04 156.91 19.21 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.262 -0.899 . . . . 0.0 109.653 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.98 -16.31 64.27 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.3 -0.875 . . . . 0.0 109.628 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.441 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 11.7 t70 -48.25 -44.51 33.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 109.449 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.441 ' NZ ' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -55.0 -61.68 2.15 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.285 -0.884 . . . . 0.0 109.258 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.541 ' O ' ' CB ' ' A' ' 44' ' ' ALA . 46.0 t -46.94 -23.42 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.277 -0.89 . . . . 0.0 109.893 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.423 ' HB3' ' O ' ' A' ' 38' ' ' ASP . 4.0 ttt85 -75.12 -61.29 1.94 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.073 -1.017 . . . . 0.0 109.851 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -58.17 -52.64 64.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.233 -0.917 . . . . 0.0 110.032 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 82.8 mt -61.13 -43.06 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.205 -0.935 . . . . 0.0 110.082 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 40' ' ' VAL . . . -52.96 -49.59 65.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.045 -1.034 . . . . 0.0 109.72 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -49.22 78.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.505 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.505 ' N ' HD21 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -65.07 -15.02 61.9 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.256 -0.903 . . . . 0.0 110.094 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -102.89 21.46 15.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.139 -0.975 . . . . 0.0 109.919 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.562 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -57.21 -53.83 61.2 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.085 -1.009 . . . . 0.0 109.325 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.562 ' HD3' ' CB ' ' A' ' 48' ' ' MET . 36.5 Cg_endo -79.54 74.49 5.52 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.52 2.146 . . . . 0.0 110.296 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -150.26 -65.35 0.2 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.18 -0.95 . . . . 0.0 109.418 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 52' ' ' ASN . 1.5 pp -117.3 18.85 14.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.37 -0.831 . . . . 0.0 109.368 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 51' ' ' LEU . 1.2 p-10 39.73 68.16 0.4 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.483 -0.761 . . . . 0.0 109.915 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.422 ' O ' ' C ' ' A' ' 54' ' ' ALA . . . -63.5 168.35 4.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.171 -0.956 . . . . 0.0 109.501 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 53' ' ' ALA . . . -44.0 -36.54 2.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.893 . . . . 0.0 109.061 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 54' ' ' ALA . 1.6 m 174.3 -40.06 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.343 -0.848 . . . . 0.0 108.842 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.7 tt -171.34 -33.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 121.321 -0.862 . . . . 0.0 109.028 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.6 -67.42 0.46 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.297 -0.877 . . . . 0.0 110.331 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -44.67 -39.82 5.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.28 -0.887 . . . . 0.0 110.217 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.26 -44.38 97.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.065 -1.022 . . . . 0.0 110.041 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -40.14 94.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 110.347 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -70.38 -21.05 62.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -0.965 . . . . 0.0 110.151 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -56.45 5.09 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.097 -1.002 . . . . 0.0 109.605 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.518 ' HB ' ' CG1' ' A' ' 40' ' ' VAL . 15.3 mt -54.37 -35.74 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.256 -0.903 . . . . 0.0 109.423 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 1.2 tt0 -59.21 -56.83 17.09 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.225 -0.922 . . . . 0.0 109.378 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.88 -20.13 2.83 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.522 ' O ' ' CG ' ' A' ' 70' ' ' MET . 12.0 m -79.86 -57.5 3.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.397 -1.061 . . . . 0.0 109.921 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.452 ' HB3' HD12 ' A' ' 72' ' ' ILE . . . -78.15 10.62 2.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.961 . . . . 0.0 110.345 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -105.17 -55.48 2.32 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.993 -1.067 . . . . 0.0 110.476 -179.554 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.87 -25.7 12.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.078 -1.014 . . . . 0.0 111.899 -178.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.541 ' HG3' ' N ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -70.36 -30.81 67.83 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.543 -1.348 . . . . 0.0 110.901 -178.356 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.541 ' N ' ' HG3' ' A' ' 70' ' ' MET . . . -160.83 -123.09 0.66 Allowed Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.206 -1.473 . . . . 0.0 110.744 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.516 HD13 ' N ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -48.99 -178.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.491 -1.005 . . . . 0.0 110.527 -179.025 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.451 ' O ' HG12 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -110.99 -168.61 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.539 -0.725 . . . . 0.0 109.421 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.429 ' CG2' ' C ' ' A' ' 73' ' ' VAL . 2.1 t -151.34 155.53 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 109.659 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -115.79 135.29 54.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 109.384 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.493 -179.934 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.499 ' O ' ' CG ' ' A' ' 13' ' ' LEU . 34.0 Cg_endo . . . . . 0 C--O 1.215 -0.63 0 N-CA-C 110.403 -0.653 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . -73.3 -55.78 5.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 109.843 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -42.92 -65.25 0.5 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.882 . . . . 0.0 109.884 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.468 ' HB ' ' HG2' ' A' ' 9' ' ' PRO . 92.9 t -61.21 -38.08 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.791 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.499 ' CG ' ' O ' ' A' ' 9' ' ' PRO . 5.3 mt -44.67 -42.48 7.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 109.698 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.448 ' CD1' HG23 ' A' ' 66' ' ' THR . 0.8 OUTLIER -74.12 -40.35 62.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.087 -1.008 . . . . 0.0 109.553 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -50.06 -37.24 32.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.885 . . . . 0.0 109.296 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -79.6 -33.45 41.56 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.323 -0.861 . . . . 0.0 109.435 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.04 -25.33 58.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.564 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 109.379 179.836 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.453 ' OG1' ' N ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -157.66 176.16 12.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.199 -0.938 . . . . 0.0 109.691 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.458 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 27.3 pt -126.26 160.11 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.438 -0.789 . . . . 0.0 109.37 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.89 122.52 26.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.293 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -57.47 -15.69 7.6 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.231 -0.918 . . . . 0.0 110.083 -179.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 37' ' ' ARG . 31.2 t0 -43.9 -37.27 2.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.048 -1.032 . . . . 0.0 109.351 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.464 ' O ' HG13 ' A' ' 43' ' ' ILE . 13.4 mmtt -65.96 -56.31 12.32 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.155 -0.965 . . . . 0.0 109.11 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.498 ' CG2' HG23 ' A' ' 63' ' ' ILE . 37.9 t -42.06 -28.28 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 109.453 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -69.47 -54.74 12.79 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.305 -0.872 . . . . 0.0 109.375 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.21 -9.77 56.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.265 -0.897 . . . . 0.0 109.912 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 39' ' ' LYS . 11.9 mt -105.07 -8.73 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.098 -1.001 . . . . 0.0 109.855 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 40' ' ' VAL . . . -101.87 -19.12 15.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.971 . . . . 0.0 110.047 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -105.57 -32.34 8.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.384 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.6 mt -95.49 11.17 33.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.092 -1.005 . . . . 0.0 110.454 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.438 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -134.47 -53.2 0.83 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.049 -1.032 . . . . 0.0 109.496 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.427 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 19.4 mmt -58.86 111.49 3.74 Favored Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 121.31 -0.869 . . . . 0.0 109.733 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.548 ' HD2' ' CD2' ' A' ' 51' ' ' LEU . 34.9 Cg_endo -76.32 -30.7 5.14 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.366 2.044 . . . . 0.0 110.927 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 52' ' ' ASN . 12.4 t70 -173.14 -53.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.803 -1.186 . . . . 0.0 110.857 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.548 ' CD2' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER 27.04 38.77 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.927 -0.483 . . . . 0.0 111.089 -179.068 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.555 ' N ' ' O ' ' A' ' 50' ' ' ASP . 26.6 t-20 37.63 59.8 1.21 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.498 -0.751 . . . . 0.0 109.928 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -107.68 134.98 49.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.958 . . . . 0.0 109.798 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.19 -59.33 5.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.276 -0.89 . . . . 0.0 109.22 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.436 ' C ' HG13 ' A' ' 56' ' ' ILE . 3.1 p 178.51 -48.82 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.35 -0.844 . . . . 0.0 109.32 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.483 ' O ' ' HB2' ' A' ' 60' ' ' MET . 3.3 mt -137.35 5.14 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 O-C-N 121.175 -0.953 . . . . 0.0 109.345 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 61' ' ' ARG . 0.8 OUTLIER -100.32 -54.24 2.91 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.162 -0.962 . . . . 0.0 110.031 -179.249 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.38 -61.86 1.85 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.325 -0.859 . . . . 0.0 109.959 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.08 -37.78 55.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 109.791 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.483 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -75.91 -41.15 52.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.152 -0.967 . . . . 0.0 110.032 -179.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 57' ' ' GLU . 16.8 mtp180 -74.65 -7.36 52.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.105 -0.997 . . . . 0.0 109.534 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.446 ' HE3' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -83.71 -54.85 4.62 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.275 -0.891 . . . . 0.0 109.38 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.498 HG23 ' CG2' ' A' ' 40' ' ' VAL . 10.8 mt -63.69 -36.35 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.625 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -64.49 -50.97 65.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.103 -0.998 . . . . 0.0 109.125 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.07 -12.44 30.13 Favored Glycine 0 N--CA 1.481 1.693 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 13.7 m -84.23 -51.55 6.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -1.147 . . . . 0.0 109.425 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.492 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -79.78 -5.03 54.53 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.254 -0.904 . . . . 0.0 109.638 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 1.5 ttp180 -87.77 -48.09 8.11 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.946 -1.096 . . . . 0.0 109.505 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.59 -49.21 16.89 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.353 -0.842 . . . . 0.0 110.459 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.466 ' HG3' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -100.92 -30.49 11.63 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.127 -0.983 . . . . 0.0 110.496 -178.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.466 ' N ' ' HG3' ' A' ' 70' ' ' MET . . . -89.31 -147.95 17.19 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.96 -1.114 . . . . 0.0 110.674 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.501 ' CD1' ' C ' ' A' ' 72' ' ' ILE . 1.1 pp -105.87 -170.26 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.517 -0.99 . . . . 0.0 109.995 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.3 t -84.77 111.15 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.145 -0.972 . . . . 0.0 109.676 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.0 t -80.19 153.46 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 0.0 109.378 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 35' ' ' ILE . 14.8 pt-20 -113.63 -176.17 2.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.899 . . . . 0.0 109.458 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.6 t70 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.464 179.983 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 12' ' ' VAL . 35.5 Cg_endo . . . . . 0 C--O 1.215 -0.654 0 N-CA-C 110.543 -0.599 . . . . 0.0 110.543 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -70.66 -68.63 0.42 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.208 -0.932 . . . . 0.0 109.862 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -37.29 -45.03 0.63 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.507 -0.746 . . . . 0.0 110.683 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.459 ' HB ' ' HD2' ' A' ' 9' ' ' PRO . 49.0 t -65.96 -47.32 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.101 -1.0 . . . . 0.0 109.815 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 14' ' ' LEU . 19.8 mt -57.9 -63.04 1.39 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.669 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.451 HD23 ' HE2' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -44.39 -30.68 0.88 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.263 -0.898 . . . . 0.0 109.744 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -69.52 -46.45 66.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.73 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.1 9.89 9.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.634 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.06 -23.03 31.01 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.183 -0.948 . . . . 0.0 109.478 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.942 . . . . 0.0 109.386 179.844 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.01 162.29 14.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 109.616 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.458 HD13 ' O ' ' A' ' 36' ' ' LYS . 1.2 pp -136.92 172.9 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -0.844 . . . . 0.0 109.517 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.458 ' O ' HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -86.31 173.95 9.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.747 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -88.34 15.21 8.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.438 -0.789 . . . . 0.0 109.607 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 6.2 t70 -50.09 -39.95 44.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.599 -0.688 . . . . 0.0 110.194 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.451 ' HE2' HD23 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -71.9 -31.25 66.22 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.178 -0.951 . . . . 0.0 110.594 -179.177 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.527 ' CG2' HG21 ' A' ' 63' ' ' ILE . 47.4 t -65.04 -29.1 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.976 -1.077 . . . . 0.0 110.056 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.453 ' CB ' ' CZ ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -82.78 -30.89 28.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.114 -0.991 . . . . 0.0 109.973 -179.524 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 38' ' ' ASP . 6.7 mm-40 -76.26 -58.24 3.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.954 . . . . 0.0 109.819 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.3 mt -61.26 -55.11 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 110.273 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' ' 40' ' ' VAL . . . -47.25 -50.73 20.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.225 -0.922 . . . . 0.0 110.504 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -71.64 -24.63 61.89 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.044 -1.035 . . . . 0.0 110.368 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 mt -80.38 -11.68 59.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.004 -1.06 . . . . 0.0 109.627 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.48 39.99 1.89 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.265 -0.897 . . . . 0.0 109.274 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.557 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -50.5 -53.21 48.08 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.178 -0.951 . . . . 0.0 109.218 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.557 ' HD3' ' CB ' ' A' ' 48' ' ' MET . 36.8 Cg_endo -80.99 41.54 1.17 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.612 2.208 . . . . 0.0 110.404 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -111.13 -14.55 13.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.097 -1.002 . . . . 0.0 109.819 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -127.63 -99.24 0.37 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.13 -0.981 . . . . 0.0 109.591 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 57.0 t30 177.78 34.56 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.187 -0.946 . . . . 0.0 109.454 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.74 164.45 1.11 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.23 -22.38 66.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.267 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.465 ' O ' ' SD ' ' A' ' 48' ' ' MET . 0.1 OUTLIER -172.34 -50.19 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.286 -0.884 . . . . 0.0 108.937 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.482 HG21 ' N ' ' A' ' 57' ' ' GLU . 1.8 tt -174.9 -34.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.482 ' N ' HG21 ' A' ' 56' ' ' ILE . 15.9 tt0 -57.85 -66.1 0.53 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.533 -0.73 . . . . 0.0 109.805 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 57' ' ' GLU . . . -42.63 -36.65 1.46 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.354 -0.841 . . . . 0.0 109.751 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.13 -47.95 75.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.135 -0.978 . . . . 0.0 109.772 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.7 -38.02 83.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.989 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.429 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 35.7 mtp180 -74.0 -18.26 60.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 0.0 109.769 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.42 ' O ' ' OG1' ' A' ' 66' ' ' THR . 0.0 OUTLIER -79.75 -39.77 30.29 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.125 -0.984 . . . . 0.0 109.672 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.527 HG21 ' CG2' ' A' ' 40' ' ' VAL . 7.4 mt -65.46 -42.39 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.143 -0.973 . . . . 0.0 109.874 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.495 ' CD ' ' N ' ' A' ' 65' ' ' GLY . 3.0 pp20? -63.35 -47.09 83.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.996 -1.065 . . . . 0.0 109.384 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.495 ' N ' ' CD ' ' A' ' 64' ' ' GLU . . . -65.4 -11.09 51.61 Favored Glycine 0 N--CA 1.478 1.485 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.478 ' O ' ' HB2' ' A' ' 70' ' ' MET . 86.2 m -81.57 -44.62 17.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.388 -1.066 . . . . 0.0 109.517 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -82.35 -16.09 50.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 108.777 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -40.78 65.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.459 -0.775 . . . . 0.0 109.38 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.81 -31.3 14.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.13 -0.981 . . . . 0.0 109.87 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.478 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -53.99 -72.95 0.05 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.211 -0.931 . . . . 0.0 109.19 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 72' ' ' ILE . . . -162.48 -87.74 0.07 OUTLIER Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -39.56 152.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.642 -0.916 . . . . 0.0 110.389 -179.526 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.64 135.52 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.443 ' CG2' ' HB2' ' A' ' 67' ' ' ALA . 2.1 t -108.63 155.39 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.982 -1.074 . . . . 0.0 110.176 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -110.35 -171.37 1.82 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.396 -0.815 . . . . 0.0 109.123 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.9 t70 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.637 -179.928 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.542 ' HG2' ' CG2' ' A' ' 12' ' ' VAL . 35.8 Cg_endo . . . . . 0 C--O 1.214 -0.682 0 N-CA-C 110.37 -0.666 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -52.52 -61.31 2.36 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.294 -0.879 . . . . 0.0 110.129 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -36.4 -40.73 0.25 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.619 -0.676 . . . . 0.0 110.49 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.542 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 72.8 t -74.94 -43.01 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.09 -1.006 . . . . 0.0 109.465 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' A' ' 10' ' ' ALA . 63.0 mt -56.04 -66.74 0.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.994 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.488 ' HG ' ' N ' ' A' ' 15' ' ' LYS . 1.8 pp -57.74 -28.18 63.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.176 -0.953 . . . . 0.0 109.658 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.488 ' N ' ' HG ' ' A' ' 14' ' ' LEU . 57.1 tttt -56.29 -50.81 70.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.546 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -25.54 65.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.686 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.425 ' HB2' ' HE3' ' A' ' 39' ' ' LYS . . . -74.44 -8.84 57.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.201 -0.937 . . . . 0.0 109.58 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.61 179.97 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.433 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.488 HG21 HG21 ' A' ' 73' ' ' VAL . 0.9 OUTLIER -101.83 140.04 36.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.419 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 pt -91.69 171.79 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.233 -0.917 . . . . 0.0 109.441 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 mtmt -89.75 151.49 21.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 109.357 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.16 -16.58 64.1 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.206 -0.933 . . . . 0.0 109.303 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -45.69 -41.64 10.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.365 -0.835 . . . . 0.0 109.608 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.465 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.7 OUTLIER -59.76 -64.19 1.04 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 109.367 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.528 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 56.1 t -45.74 -23.64 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 0.0 109.973 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -42.79 32.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.118 -0.989 . . . . 0.0 110.162 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -84.6 -6.57 59.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.11 -0.994 . . . . 0.0 110.026 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 39' ' ' LYS . 7.6 mt -93.51 -39.68 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.061 -1.024 . . . . 0.0 109.898 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 48' ' ' MET . . . -77.97 -39.68 41.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.148 -0.97 . . . . 0.0 109.525 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -53.87 -20.59 6.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.272 -0.892 . . . . 0.0 109.77 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.3 mt -96.01 -30.89 13.33 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.141 -0.975 . . . . 0.0 109.653 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 50' ' ' ASP . 33.3 mmtt -131.39 43.51 3.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.913 . . . . 0.0 109.264 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.552 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -64.03 -52.54 55.32 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.387 -0.821 . . . . 0.0 110.01 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 48' ' ' MET . 35.5 Cg_endo -78.21 -3.03 13.06 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.41 2.074 . . . . 0.0 110.575 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.449 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 18.3 t70 -62.26 -13.32 26.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.348 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -139.84 27.81 2.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.397 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 51' ' ' LEU . 20.6 t30 42.33 74.58 0.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.344 -0.848 . . . . 0.0 109.622 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.29 155.33 32.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 0.0 109.504 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -45.49 -35.31 3.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.467 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 m 174.87 -44.67 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.253 -0.904 . . . . 0.0 109.107 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.407 HG13 ' HE3' ' A' ' 48' ' ' MET . 1.5 tt -173.5 -33.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.278 -0.889 . . . . 0.0 109.011 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 58' ' ' ALA . 1.2 tt0 -75.23 -66.41 0.77 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.409 -0.807 . . . . 0.0 110.195 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 57' ' ' GLU . . . -42.49 -40.53 2.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.254 -0.904 . . . . 0.0 110.205 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 62' ' ' MET . . . -60.41 -47.87 84.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.958 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.6 mtm -59.2 -46.7 87.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 110.186 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.6 mtp-105 -66.58 -19.18 65.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 110.006 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.457 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -68.36 -50.84 50.34 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.083 -1.011 . . . . 0.0 109.341 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.528 ' HB ' ' CG1' ' A' ' 40' ' ' VAL . 6.0 mt -59.73 -35.47 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.219 -0.926 . . . . 0.0 109.607 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.91 -52.3 64.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.086 -1.009 . . . . 0.0 109.061 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -55.59 -16.82 11.88 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 75.7 m -82.29 -52.29 7.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.359 -1.083 . . . . 0.0 109.351 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.477 ' HB1' ' CG2' ' A' ' 74' ' ' VAL . . . -75.71 -3.73 36.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.308 -0.87 . . . . 0.0 109.322 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -86.87 -48.68 7.98 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.211 -0.931 . . . . 0.0 109.299 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.8 p -81.43 -33.2 32.27 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.265 -0.897 . . . . 0.0 109.65 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -70.5 0.09 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.184 -0.948 . . . . 0.0 109.657 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -160.12 -74.29 0.02 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.514 ' N ' ' CD1' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -66.74 -174.98 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -1.16 . . . . 0.0 109.939 -179.632 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.488 HG21 HG21 ' A' ' 34' ' ' THR . 0.1 OUTLIER -132.17 132.4 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.34 -0.85 . . . . 0.0 109.22 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.477 ' CG2' ' HB1' ' A' ' 67' ' ' ALA . 27.7 t -81.64 157.48 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.632 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.475 ' N ' HG11 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -115.08 95.06 5.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 109.449 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.518 -179.973 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.557 ' O ' ' C ' ' A' ' 10' ' ' ALA . 32.9 Cg_endo . . . . . 0 C--O 1.207 -1.07 0 N-CA-C 109.95 -0.827 . . . . 0.0 109.95 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.557 ' C ' ' O ' ' A' ' 9' ' ' PRO . . . -17.63 -66.55 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.191 0.519 . . . . 0.0 111.502 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.66 -51.06 70.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.069 -1.019 . . . . 0.0 109.551 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 9' ' ' PRO . 42.4 t -45.81 -53.36 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.335 -0.853 . . . . 0.0 109.783 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.553 ' CD1' ' HB2' ' A' ' 9' ' ' PRO . 8.9 mp -47.17 -70.56 0.09 Allowed 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.331 -0.855 . . . . 0.0 110.15 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.53 ' CD1' HG23 ' A' ' 66' ' ' THR . 5.4 mt -55.94 -17.23 6.1 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.289 -0.882 . . . . 0.0 110.18 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.83 -38.07 67.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.096 -1.002 . . . . 0.0 109.237 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -79.09 -22.29 45.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.266 -0.896 . . . . 0.0 109.229 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.8 -66.59 0.38 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.219 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.272 -0.892 . . . . 0.0 109.209 179.742 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.79 133.22 34.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 109.575 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.459 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 4.1 pt -107.93 170.88 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 0.0 109.386 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -79.83 147.27 31.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.768 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.18 -6.37 33.92 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.288 -0.882 . . . . 0.0 109.699 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -41.98 -39.88 2.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.33 -0.857 . . . . 0.0 109.945 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -58.25 7.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.148 -0.97 . . . . 0.0 109.693 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.521 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 86.1 t -46.73 -27.77 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.303 -0.873 . . . . 0.0 110.024 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -70.92 -46.59 62.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.105 -0.997 . . . . 0.0 109.791 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 43' ' ' ILE . 2.0 tt0 -78.26 -65.4 0.98 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.155 -0.966 . . . . 0.0 109.791 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.453 HG22 HD22 ' A' ' 13' ' ' LEU . 10.8 mt -43.12 -44.8 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.927 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 40' ' ' VAL . . . -64.86 -43.77 91.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.164 -0.96 . . . . 0.0 109.717 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -58.08 -16.49 13.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 109.5 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.42 23.88 2.42 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.29 -0.881 . . . . 0.0 109.499 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.495 ' HD3' ' CB ' ' A' ' 50' ' ' ASP . 0.1 OUTLIER -144.0 18.02 1.77 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.0 109.413 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.547 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -43.73 -54.14 11.18 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.278 -0.889 . . . . 0.0 109.648 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.547 ' HD3' ' CB ' ' A' ' 48' ' ' MET . 36.5 Cg_endo -78.61 73.17 6.03 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.411 2.074 . . . . 0.0 110.438 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.495 ' CB ' ' HD3' ' A' ' 47' ' ' LYS . 36.8 t0 -162.4 -67.89 0.05 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.113 -0.992 . . . . 0.0 109.897 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.472 ' O ' ' CD1' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -114.18 38.7 2.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.139 -0.976 . . . . 0.0 109.868 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 51' ' ' LEU . 4.2 p-10 40.21 28.15 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.479 -0.763 . . . . 0.0 109.916 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -51.81 124.6 12.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.19 -0.944 . . . . 0.0 109.531 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.458 ' O ' ' CB ' ' A' ' 55' ' ' SER . . . -45.11 -57.92 3.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.939 . . . . 0.0 109.205 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 0.5 OUTLIER 166.32 -45.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.406 -0.809 . . . . 0.0 108.859 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 60' ' ' MET . 82.5 mt -140.05 7.8 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -104.92 -67.11 0.93 Allowed 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.259 -0.9 . . . . 0.0 109.45 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.09 -37.06 58.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.501 -0.749 . . . . 0.0 109.879 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.08 -31.66 68.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.128 -0.982 . . . . 0.0 109.383 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -78.64 -39.79 36.05 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.233 -0.917 . . . . 0.0 109.516 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -20.32 62.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.374 -0.829 . . . . 0.0 109.767 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.2 -60.82 2.18 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.179 -0.951 . . . . 0.0 110.075 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.521 ' HB ' ' CG1' ' A' ' 40' ' ' VAL . 14.9 mt -63.75 -42.75 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.191 -0.943 . . . . 0.0 109.967 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.453 ' HG2' HG22 ' A' ' 74' ' ' VAL . 24.2 tt0 -64.06 -48.52 75.91 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.092 -1.005 . . . . 0.0 109.302 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -67.25 -7.22 43.99 Favored Glycine 0 N--CA 1.478 1.447 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.53 HG23 ' CD1' ' A' ' 14' ' ' LEU . 8.5 m -87.26 -49.53 7.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -1.13 . . . . 0.0 109.46 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -71.49 -36.73 71.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.165 -0.96 . . . . 0.0 109.373 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -64.61 -59.2 4.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.403 -0.811 . . . . 0.0 109.907 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.71 -51.84 68.07 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.244 -0.91 . . . . 0.0 110.045 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.0 -68.88 0.15 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.217 -0.927 . . . . 0.0 109.384 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 72' ' ' ILE . . . -161.96 -88.02 0.07 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.48 ' C ' HD12 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -36.39 152.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.884 -0.774 . . . . 0.0 110.279 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.467 ' N ' HD12 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -112.88 164.76 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.391 -0.818 . . . . 0.0 108.881 179.527 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.453 HG22 ' HG2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -111.82 -174.55 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.13 -0.981 . . . . 0.0 109.695 -179.583 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 35' ' ' ILE . 0.4 OUTLIER -143.1 151.0 40.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.907 . . . . 0.0 109.267 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.7 t70 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.443 -179.951 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.458 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 35.9 Cg_endo . . . . . 0 C--O 1.215 -0.654 0 N-CA-C 110.398 -0.655 . . . . 0.0 110.398 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.498 ' HA ' ' CD1' ' A' ' 13' ' ' LEU . . . -47.52 -48.73 27.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.787 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -41.51 -50.58 3.97 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.387 -0.821 . . . . 0.0 109.652 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.448 HG22 ' HG2' ' A' ' 9' ' ' PRO . 91.5 t -68.34 -36.53 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.69 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.498 ' CD1' ' HA ' ' A' ' 10' ' ' ALA . 38.4 mt -53.88 -65.85 0.5 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.939 . . . . 0.0 109.57 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 15' ' ' LYS . 1.1 mt -43.18 -48.28 6.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -0.841 . . . . 0.0 109.76 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 14' ' ' LEU . 7.7 ttpt -42.85 -55.18 3.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 109.666 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.33 -43.72 98.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.206 -0.934 . . . . 0.0 109.564 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.63 -35.66 6.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.226 -0.921 . . . . 0.0 109.583 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.184 -0.947 . . . . 0.0 109.422 179.95 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.469 ' HA ' HG11 ' A' ' 73' ' ' VAL . 1.8 p -112.96 142.39 45.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 109.738 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.452 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 2.8 pt -98.31 -170.13 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.333 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.445 ' HE2' ' OE2' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -95.1 167.4 11.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.898 . . . . 0.0 109.712 -179.791 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.535 ' O ' ' CG1' ' A' ' 40' ' ' VAL . 5.5 mtm180 -97.29 -19.25 18.67 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.236 -0.915 . . . . 0.0 109.681 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.466 ' C ' ' O ' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -37.81 -34.9 0.12 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.67 -0.644 . . . . 0.0 109.929 -179.753 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 37' ' ' ARG . 8.5 mttm -72.93 -48.87 33.23 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.344 -0.848 . . . . 0.0 109.623 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.535 ' CG1' ' O ' ' A' ' 37' ' ' ARG . 9.8 p -51.29 -20.07 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 110.174 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.466 ' N ' HG11 ' A' ' 40' ' ' VAL . 0.7 OUTLIER -85.94 -62.39 1.53 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.085 -1.01 . . . . 0.0 109.778 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -50.19 -27.29 5.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.248 -0.908 . . . . 0.0 110.024 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.452 HG23 ' HB2' ' A' ' 47' ' ' LYS . 20.9 mt -96.75 -34.54 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.061 -1.025 . . . . 0.0 109.635 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 40' ' ' VAL . . . -47.43 -33.58 6.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.324 -0.86 . . . . 0.0 109.415 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.456 ' HA ' ' SD ' ' A' ' 48' ' ' MET . 2.6 mt-10 -88.46 -35.85 16.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.848 . . . . 0.0 109.268 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.4 mt -91.78 25.11 2.85 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.346 -0.846 . . . . 0.0 109.412 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.468 ' C ' ' HD3' ' A' ' 49' ' ' PRO . 14.2 tppt? -143.35 21.47 1.88 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.135 -0.978 . . . . 0.0 109.841 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.456 ' SD ' ' HA ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -114.32 78.49 4.67 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.024 -1.047 . . . . 0.0 109.733 179.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.468 ' HD3' ' C ' ' A' ' 47' ' ' LYS . 36.1 Cg_endo -78.53 -44.55 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.594 2.196 . . . . 0.0 110.126 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -120.36 1.62 10.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.41 -0.807 . . . . 0.0 109.343 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.544 ' O ' ' CG ' ' A' ' 51' ' ' LEU . 0.7 OUTLIER -116.39 64.99 0.71 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.253 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 53' ' ' ALA . 42.3 t-20 -41.16 -28.69 0.1 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.867 . . . . 0.0 109.673 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 52' ' ' ASN . . . 60.66 142.15 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.457 -0.777 . . . . 0.0 109.556 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -46.51 -61.86 1.62 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.282 -0.886 . . . . 0.0 109.315 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.469 ' O ' HG12 ' A' ' 56' ' ' ILE . 41.1 p -152.19 -49.96 0.11 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.245 -0.91 . . . . 0.0 109.625 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 55' ' ' SER . 8.5 mm -154.48 -33.08 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.253 -0.904 . . . . 0.0 109.202 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.74 -59.39 5.29 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.186 -0.946 . . . . 0.0 110.233 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.16 -58.39 5.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.337 -0.852 . . . . 0.0 110.126 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.97 -21.0 63.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.195 -0.941 . . . . 0.0 109.994 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.46 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -77.4 -33.06 55.14 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.171 -0.956 . . . . 0.0 109.83 -179.673 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.14 -13.32 55.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.63 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -80.81 -57.24 3.64 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.249 -0.907 . . . . 0.0 109.956 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.523 ' HB ' ' CG2' ' A' ' 40' ' ' VAL . 6.5 mt -63.34 -42.17 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.343 -0.848 . . . . 0.0 109.753 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -63.88 -48.39 76.89 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.975 -1.078 . . . . 0.0 108.93 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.39 -12.88 34.28 Favored Glycine 0 N--CA 1.48 1.621 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 54.2 m -83.78 -51.68 7.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -1.131 . . . . 0.0 109.017 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -68.56 -17.92 64.24 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.328 -0.858 . . . . 0.0 109.193 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.02 -46.59 34.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.339 -0.851 . . . . 0.0 109.682 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.26 -6.14 53.71 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.166 -0.959 . . . . 0.0 109.802 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -99.23 -49.71 4.38 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.078 -1.014 . . . . 0.0 110.361 -179.45 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.1 -134.58 2.21 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.356 -1.402 . . . . 0.0 111.073 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.516 ' CD1' ' C ' ' A' ' 72' ' ' ILE . 0.9 OUTLIER -52.81 -171.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.589 -0.948 . . . . 0.0 111.114 -178.785 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.469 HG11 ' HA ' ' A' ' 34' ' ' THR . 3.5 p -110.56 -175.89 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.41 HG12 ' HG2' ' A' ' 37' ' ' ARG . 2.0 t -130.68 156.85 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.991 -1.068 . . . . 0.0 109.559 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 35' ' ' ILE . 16.0 pt-20 -131.05 145.33 51.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 0.0 109.505 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 43.9 t0 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.393 -179.996 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.483 ' O ' HG21 ' A' ' 12' ' ' VAL . 34.4 Cg_endo . . . . . 0 C--O 1.215 -0.658 0 N-CA-C 110.501 -0.615 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.47 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -62.96 -41.75 99.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.232 -0.917 . . . . 0.0 109.826 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -36.85 -50.04 0.83 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.55 -0.719 . . . . 0.0 110.427 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 9' ' ' PRO . 2.4 m -72.02 -38.89 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.037 -1.039 . . . . 0.0 109.444 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 10' ' ' ALA . 65.1 mt -54.39 -66.81 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.403 -0.81 . . . . 0.0 109.934 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 18' ' ' ALA . 3.5 pp -52.76 -30.19 31.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 110.294 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.514 ' N ' HD13 ' A' ' 14' ' ' LEU . 19.4 tttt -53.11 -62.38 1.69 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.035 -1.041 . . . . 0.0 110.022 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -69.1 -28.76 66.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.055 -1.028 . . . . 0.0 109.666 -179.732 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.434 ' O ' ' CB ' ' A' ' 18' ' ' ALA . . . -89.97 5.86 44.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.954 . . . . 0.0 109.701 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 14' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.099 -1.0 . . . . 0.0 109.643 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.429 ' O ' HG21 ' A' ' 34' ' ' THR . . . . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.488 ' HA ' HG11 ' A' ' 73' ' ' VAL . 11.9 p -142.72 164.37 30.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.561 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.467 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 3.4 pt -150.88 167.03 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 109.522 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -79.71 131.52 35.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.139 -0.976 . . . . 0.0 109.355 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -74.17 -8.01 54.66 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.133 -0.98 . . . . 0.0 109.554 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 37' ' ' ARG . 48.6 t0 -42.78 -33.08 0.69 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.302 -0.874 . . . . 0.0 109.716 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -71.87 -52.82 15.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 109.338 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.524 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 57.8 t -48.37 -23.43 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.393 -0.817 . . . . 0.0 109.681 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.81 -44.13 17.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 0.0 109.661 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.42 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 7.4 mm-40 -72.71 -13.55 61.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.222 -0.924 . . . . 0.0 109.849 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.411 HD11 HG23 ' A' ' 43' ' ' ILE . 8.0 mt -105.2 -18.5 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.104 -0.997 . . . . 0.0 109.47 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.459 ' O ' ' HG3' ' A' ' 48' ' ' MET . . . -82.31 -34.98 28.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 109.544 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.27 -22.08 35.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.445 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.8 mt -73.4 -44.8 57.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.9 . . . . 0.0 109.445 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -119.58 32.32 6.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.307 -0.87 . . . . 0.0 109.177 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.57 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -48.08 -51.29 49.73 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.384 -0.822 . . . . 0.0 110.007 -179.73 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 48' ' ' MET . 36.4 Cg_endo -80.68 57.62 6.61 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.657 2.238 . . . . 0.0 110.76 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -136.68 4.45 2.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.171 -0.956 . . . . 0.0 109.672 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.71 -91.58 0.14 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.071 -1.018 . . . . 0.0 109.464 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -176.63 87.09 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.301 -0.875 . . . . 0.0 109.757 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.37 178.69 4.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -0.909 . . . . 0.0 109.303 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -128.99 -38.35 1.65 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.295 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.424 ' O ' HG12 ' A' ' 56' ' ' ILE . 13.6 m -127.61 -63.82 1.01 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.257 -0.902 . . . . 0.0 109.108 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -175.96 -31.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.385 -0.822 . . . . 0.0 108.8 179.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.524 ' HA ' ' CG ' ' A' ' 60' ' ' MET . 1.1 tt0 -56.89 -47.94 79.34 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.321 -0.862 . . . . 0.0 109.883 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.63 -43.23 62.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.389 -0.819 . . . . 0.0 110.148 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.01 -61.49 1.76 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.069 -1.019 . . . . 0.0 110.08 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.524 ' CG ' ' HA ' ' A' ' 57' ' ' GLU . 1.7 ppp? -52.86 -19.55 2.61 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.197 -0.94 . . . . 0.0 109.961 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -83.72 -34.88 24.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.175 -0.953 . . . . 0.0 109.599 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -47.41 72.88 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.283 -0.885 . . . . 0.0 109.713 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.524 ' HB ' ' CG1' ' A' ' 40' ' ' VAL . 8.9 mt -62.99 -40.4 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.938 . . . . 0.0 109.881 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.05 -49.65 73.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.88 -1.137 . . . . 0.0 109.383 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.12 -13.64 28.64 Favored Glycine 0 N--CA 1.479 1.562 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.5 ' O ' ' HB2' ' A' ' 70' ' ' MET . 50.4 m -86.14 -47.42 9.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.389 -1.065 . . . . 0.0 109.918 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -70.21 -19.04 63.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 109.775 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.461 ' HG3' HG21 ' A' ' 73' ' ' VAL . 1.9 ttp180 -79.35 -58.8 3.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.237 -0.914 . . . . 0.0 109.814 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.03 -25.0 63.37 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.23 -0.919 . . . . 0.0 110.329 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.5 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -96.24 -21.86 17.6 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.997 -1.065 . . . . 0.0 110.741 -179.114 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -154.8 -141.97 3.35 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.27 -1.443 . . . . 0.0 110.751 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.524 HD13 ' N ' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -70.81 -174.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.568 -0.96 . . . . 0.0 110.308 -179.315 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.488 HG11 ' HA ' ' A' ' 34' ' ' THR . 1.4 p -90.45 -172.46 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.474 -0.766 . . . . 0.0 108.984 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.3 t -132.76 135.17 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.079 -1.013 . . . . 0.0 109.729 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 35' ' ' ILE . 22.4 pt-20 -98.65 160.6 14.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 109.26 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 43.6 t0 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.986 -1.006 . . . . 0.0 109.495 -179.957 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' A' ' 12' ' ' VAL . 36.0 Cg_endo . . . . . 0 C--O 1.215 -0.626 0 N-CA-C 110.559 -0.593 . . . . 0.0 110.559 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -84.02 -68.09 0.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.194 -0.942 . . . . 0.0 109.656 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -40.18 -53.8 2.42 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.422 -0.799 . . . . 0.0 109.973 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.45 ' HB ' ' HD2' ' A' ' 9' ' ' PRO . 48.8 t -60.14 -43.04 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 109.616 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.9 mt -51.46 -48.13 62.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.214 -0.929 . . . . 0.0 109.789 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.452 HD13 HG23 ' A' ' 66' ' ' THR . 8.5 mt -67.4 -27.28 66.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.622 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -69.8 -30.84 68.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.481 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -76.56 -48.3 19.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 0.0 109.489 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.491 ' HB2' ' CD ' ' A' ' 39' ' ' LYS . . . -91.71 37.5 0.96 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.906 . . . . 0.0 109.465 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.419 ' O ' HG22 ' A' ' 35' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.427 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.2 p -125.81 176.76 6.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.312 -0.867 . . . . 0.0 109.373 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.457 HD11 ' HE2' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -141.1 168.76 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.166 179.77 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.46 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 15.8 ttmt -85.64 171.06 11.96 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.222 -0.924 . . . . 0.0 109.702 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.449 ' NH2' ' OE2' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -72.51 -14.37 61.64 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.34 -0.85 . . . . 0.0 109.474 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 37' ' ' ARG . 4.6 t0 -41.71 -33.64 0.52 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.492 -0.755 . . . . 0.0 109.674 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.491 ' CD ' ' HB2' ' A' ' 17' ' ' ALA . 1.8 ttpt -69.24 -61.86 1.61 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.191 -0.943 . . . . 0.0 109.442 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.48 ' CG2' HG23 ' A' ' 63' ' ' ILE . 84.8 t -49.69 -20.58 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.885 . . . . 0.0 110.053 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -72.96 -51.34 18.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.023 -1.048 . . . . 0.0 110.369 -179.438 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 43' ' ' ILE . 16.8 pt-20 -73.78 -39.2 64.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.02 -1.05 . . . . 0.0 110.476 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.469 ' N ' ' HG3' ' A' ' 42' ' ' GLU . 9.6 mt -73.05 -14.44 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.101 -0.999 . . . . 0.0 109.917 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 40' ' ' VAL . . . -92.88 -26.52 17.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.096 -1.002 . . . . 0.0 109.748 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 2.4 pt-20 -96.39 -2.64 45.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.12 -0.987 . . . . 0.0 109.664 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 43' ' ' ILE . 0.3 OUTLIER -73.34 -24.82 60.41 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.235 -0.915 . . . . 0.0 109.744 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.425 ' N ' ' HG ' ' A' ' 46' ' ' LEU . 5.2 ttmt -159.07 58.4 0.42 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.144 -0.972 . . . . 0.0 109.394 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.536 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 1.3 mtp -43.87 -52.87 14.01 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.416 -0.803 . . . . 0.0 110.349 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 48' ' ' MET . 34.0 Cg_endo -77.04 96.26 1.1 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.417 2.078 . . . . 0.0 110.591 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 24.4 t0 178.7 -40.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.366 -0.834 . . . . 0.0 109.38 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.443 ' O ' ' C ' ' A' ' 52' ' ' ASN . 0.5 OUTLIER -107.34 35.84 2.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 109.594 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER 40.56 76.45 0.07 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.459 -0.776 . . . . 0.0 109.755 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.75 139.98 33.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.23 -0.919 . . . . 0.0 109.353 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.94 -47.85 64.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 109.497 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.52 -52.56 0.09 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.245 -0.91 . . . . 0.0 108.851 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.7 tt -175.41 -31.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.303 -0.873 . . . . 0.0 109.242 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -60.2 -53.65 55.22 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.279 -0.888 . . . . 0.0 109.448 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.04 -53.22 44.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.427 -0.795 . . . . 0.0 109.842 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.62 -42.32 61.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.795 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.46 -38.22 90.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.19 -0.943 . . . . 0.0 110.121 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -76.1 -15.99 59.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 109.656 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.61 -59.95 2.57 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.229 -0.92 . . . . 0.0 109.586 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.48 HG23 ' CG2' ' A' ' 40' ' ' VAL . 24.1 mt -57.38 -35.26 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.248 -0.908 . . . . 0.0 109.987 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.449 ' OE2' ' NH2' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -62.29 -51.53 67.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.091 -1.006 . . . . 0.0 109.326 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.81 -9.67 27.99 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.49 ' O ' ' HB2' ' A' ' 70' ' ' MET . 87.6 m -87.29 -51.17 6.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -1.114 . . . . 0.0 110.026 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -76.69 -14.97 59.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 109.736 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.66 -57.11 3.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.67 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.0 -21.84 62.24 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.284 -0.885 . . . . 0.0 110.172 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.49 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -65.08 -65.89 0.61 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.079 -1.013 . . . . 0.0 109.609 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -161.13 -65.96 0.02 OUTLIER Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.267 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.537 ' CD1' ' N ' ' A' ' 73' ' ' VAL . 1.7 pp -72.62 -179.37 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -1.117 . . . . 0.0 110.513 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.537 ' N ' ' CD1' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -126.33 151.59 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.583 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.31 168.53 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.146 -0.972 . . . . 0.0 109.588 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.46 ' HG3' ' HA ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -123.75 125.66 45.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.308 -0.87 . . . . 0.0 109.582 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.1 t0 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.52 179.931 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.465 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 35.4 Cg_endo . . . . . 0 C--O 1.214 -0.695 0 N-CA-C 110.431 -0.642 . . . . 0.0 110.431 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -73.74 -65.04 0.88 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.963 . . . . 0.0 109.822 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.51 ' HA ' ' CE ' ' A' ' 70' ' ' MET . . . -36.69 -39.27 0.2 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.565 -0.709 . . . . 0.0 110.703 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.452 HG22 ' HG2' ' A' ' 9' ' ' PRO . 38.8 t -75.35 -51.43 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.022 -1.049 . . . . 0.0 109.865 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 9' ' ' PRO . 21.5 mt -51.37 -60.96 2.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.054 -1.028 . . . . 0.0 109.366 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.444 HD12 HG23 ' A' ' 66' ' ' THR . 0.2 OUTLIER -50.06 -40.39 45.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.599 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' LYS . 14.4 mttt -52.89 -65.89 0.48 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 109.196 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -44.46 -26.37 0.34 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 108.944 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.589 ' O ' ' CB ' ' A' ' 18' ' ' ALA . . . -105.22 51.89 0.75 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.454 -0.779 . . . . 0.0 109.34 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.589 ' CB ' ' O ' ' A' ' 17' ' ' ALA . . . . . . . . 0 N--CA 1.497 1.901 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.312 0.577 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.445 ' OG1' ' HA ' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -95.95 171.08 8.85 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.294 -0.879 . . . . 0.0 109.733 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.436 HG23 ' HB3' ' A' ' 18' ' ' ALA . 6.9 pt -85.01 -173.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.374 -0.829 . . . . 0.0 109.91 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -99.3 147.81 24.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 0.0 109.572 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -73.99 -10.13 59.33 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.277 -0.889 . . . . 0.0 109.604 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 37' ' ' ARG . 0.4 OUTLIER -42.6 -51.73 5.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.334 -0.854 . . . . 0.0 109.837 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.473 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -57.32 -45.03 84.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.701 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.57 ' CG1' ' CG2' ' A' ' 63' ' ' ILE . 75.4 t -56.0 -28.06 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -0.846 . . . . 0.0 110.474 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -75.59 -51.62 12.46 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.986 -1.071 . . . . 0.0 110.072 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -60.97 -29.87 69.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 0.0 110.044 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 39' ' ' LYS . 45.3 mt -83.02 -34.37 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.006 -1.059 . . . . 0.0 109.981 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.03 -9.4 58.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.088 -1.008 . . . . 0.0 109.793 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -99.35 -33.67 10.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.148 -0.97 . . . . 0.0 109.525 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.402 ' CD1' ' C ' ' A' ' 46' ' ' LEU . 0.7 OUTLIER -77.47 -11.43 59.85 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.225 -0.922 . . . . 0.0 109.998 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -132.08 34.88 3.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 109.673 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.58 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 4.3 ttp -50.57 -48.41 82.18 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.163 -0.961 . . . . 0.0 109.808 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 48' ' ' MET . 35.9 Cg_endo -78.84 82.01 2.62 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.059 1.839 . . . . 0.0 110.168 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -144.57 -46.63 0.25 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -0.945 . . . . 0.0 109.794 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 52' ' ' ASN . 0.5 OUTLIER -117.41 22.29 12.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.212 -0.93 . . . . 0.0 109.681 -179.813 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 51' ' ' LEU . 3.5 t-20 44.14 72.62 0.18 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.157 -0.964 . . . . 0.0 109.556 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.87 174.05 6.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -0.942 . . . . 0.0 109.325 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.85 -57.69 9.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 0.0 109.521 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.1 m -162.9 -56.6 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.627 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -157.23 -32.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.251 -0.906 . . . . 0.0 109.064 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -49.55 -65.0 0.64 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.164 -0.96 . . . . 0.0 110.085 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.6 -43.22 68.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.393 -0.817 . . . . 0.0 110.383 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.58 -28.94 68.87 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.024 -1.047 . . . . 0.0 110.15 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -31.3 49.52 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.127 -0.983 . . . . 0.0 109.311 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.426 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -77.32 -16.25 59.02 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.434 -0.791 . . . . 0.0 109.01 179.581 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.407 ' O ' ' OG1' ' A' ' 66' ' ' THR . 3.2 mtp -77.41 -52.06 9.76 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.4 -0.813 . . . . 0.0 109.461 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.57 ' CG2' ' CG1' ' A' ' 40' ' ' VAL . 2.3 mt -66.07 -45.88 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.762 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.523 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 7.8 pt-20 -64.01 -47.36 80.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.914 -1.116 . . . . 0.0 109.432 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.523 ' N ' ' HG3' ' A' ' 64' ' ' GLU . . . -61.43 -14.78 43.25 Favored Glycine 0 N--CA 1.479 1.53 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.499 ' O ' ' HG2' ' A' ' 70' ' ' MET . 61.0 m -98.02 -20.98 17.06 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.41 -1.053 . . . . 0.0 109.393 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -92.07 -9.39 42.87 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.218 -0.926 . . . . 0.0 109.048 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.516 ' CG ' HG11 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -105.36 -49.08 3.53 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.49 -0.757 . . . . 0.0 110.6 -179.362 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 p -75.54 -39.0 58.89 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.215 -0.928 . . . . 0.0 111.729 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.51 ' CE ' ' HA ' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -81.62 -27.49 34.15 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 120.636 -1.29 . . . . 0.0 111.628 -177.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.508 ' N ' ' HG3' ' A' ' 70' ' ' MET . . . -149.21 -141.24 3.41 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 118.76 -1.686 . . . . 0.0 111.59 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.51 ' CD1' ' C ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -52.25 -166.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.869 -0.783 . . . . 0.0 110.717 -178.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.516 HG11 ' CG ' ' A' ' 68' ' ' ARG . 22.4 t -112.14 165.44 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.349 -0.845 . . . . 0.0 109.951 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.465 HG22 ' CB ' ' A' ' 67' ' ' ALA . 98.1 t -124.55 156.66 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.337 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.492 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 14.4 pt-20 -115.59 110.19 18.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -0.943 . . . . 0.0 109.587 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.7 t0 . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.342 179.842 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.551 ' HG2' ' CG2' ' A' ' 12' ' ' VAL . 32.8 Cg_endo . . . . . 0 C--O 1.216 -0.578 0 CA-C-O 121.652 0.605 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 12' ' ' VAL . . . -54.17 -54.91 33.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.474 -0.766 . . . . 0.0 110.669 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -30.99 -36.84 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.695 -0.628 . . . . 0.0 111.079 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.551 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 1.2 t -81.33 -53.22 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.964 -1.085 . . . . 0.0 109.706 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.459 HD11 ' HA ' ' A' ' 10' ' ' ALA . 2.1 mp -46.42 -45.3 17.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.267 -0.896 . . . . 0.0 109.981 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.3 mt -67.24 -37.57 83.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.906 . . . . 0.0 110.015 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.99 -33.93 76.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.275 -0.89 . . . . 0.0 110.387 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -92.96 -8.28 43.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.965 -1.084 . . . . 0.0 109.676 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.27 -37.74 57.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 109.643 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.899 . . . . 0.0 109.675 -179.841 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.476 ' O ' ' CG2' ' A' ' 34' ' ' THR . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.253 0.549 . . . . 0.0 109.893 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.498 ' CG2' HG13 ' A' ' 73' ' ' VAL . 16.6 p -160.32 126.35 4.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.395 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.415 ' CG1' HG11 ' A' ' 74' ' ' VAL . 41.5 pt -86.35 175.18 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.962 . . . . 0.0 109.413 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.74 138.62 45.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.204 -0.935 . . . . 0.0 109.699 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.483 ' NH1' ' OD1' ' A' ' 76' ' ' ASP . 4.6 mtp180 -53.4 -35.7 60.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.34 -0.85 . . . . 0.0 109.457 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.32 -54.54 8.77 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.257 -0.902 . . . . 0.0 109.381 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 40' ' ' VAL . 2.5 mttt -56.9 -55.63 32.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.29 -0.881 . . . . 0.0 109.355 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.447 HG12 ' CG2' ' A' ' 63' ' ' ILE . 99.2 t -42.32 -29.61 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -0.848 . . . . 0.0 110.171 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -77.66 -44.96 26.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.109 -0.994 . . . . 0.0 110.13 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.403 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 2.7 tp10 -63.48 -61.58 2.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.102 -0.999 . . . . 0.0 109.998 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 19.3 mt -57.47 -31.37 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.321 -0.862 . . . . 0.0 110.242 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 48' ' ' MET . . . -63.6 -31.65 72.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.112 -0.993 . . . . 0.0 110.024 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -92.68 -65.15 1.02 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.096 -1.003 . . . . 0.0 109.965 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 33.8 mt -53.35 -19.33 3.26 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.24 -0.912 . . . . 0.0 110.204 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.488 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -116.14 -11.21 11.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.071 -1.018 . . . . 0.0 109.871 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.466 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 0.9 OUTLIER -39.23 99.14 0.19 Allowed Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.6 -0.687 . . . . 0.0 109.927 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 47' ' ' LYS . 36.4 Cg_endo -79.84 -82.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.55 2.167 . . . . 0.0 110.127 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -144.0 -72.96 0.27 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.361 -0.837 . . . . 0.0 109.342 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.484 ' O ' ' ND2' ' A' ' 52' ' ' ASN . 3.6 mt 54.34 18.19 1.79 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.191 -0.943 . . . . 0.0 109.505 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER 40.34 33.8 0.19 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.449 -0.782 . . . . 0.0 109.792 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.53 154.37 42.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 0.0 109.452 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.23 -26.55 42.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 109.589 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m -158.41 -58.41 0.07 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.165 -0.959 . . . . 0.0 108.88 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 tt -172.51 -33.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.256 -0.903 . . . . 0.0 109.201 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -47.97 -60.18 2.8 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.268 -0.895 . . . . 0.0 109.33 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.97 -49.86 29.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.454 -0.779 . . . . 0.0 109.339 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 62' ' ' MET . . . -49.06 -42.09 37.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 109.177 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -37.75 88.47 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.228 -0.92 . . . . 0.0 109.329 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.99 -13.16 62.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 108.914 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -82.63 -51.07 8.09 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.333 -0.855 . . . . 0.0 109.329 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.489 ' O ' ' HB ' ' A' ' 66' ' ' THR . 4.8 mt -56.35 -42.6 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.895 . . . . 0.0 109.619 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.518 ' CG ' HG22 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -61.55 -53.83 51.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.898 -1.126 . . . . 0.0 109.43 -179.737 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -56.4 -15.57 12.0 Favored Glycine 0 N--CA 1.48 1.618 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 90.5 m -81.71 -59.99 2.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.3 -1.118 . . . . 0.0 109.546 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.496 ' CB ' HD13 ' A' ' 72' ' ' ILE . . . -73.41 -2.78 23.74 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.238 -0.914 . . . . 0.0 109.528 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.512 ' HG3' ' NH1' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -86.56 -50.24 6.98 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.19 -0.944 . . . . 0.0 109.725 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.47 -8.75 34.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.106 -0.996 . . . . 0.0 109.894 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.486 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -71.06 -69.16 0.39 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.064 -1.022 . . . . 0.0 109.086 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -161.44 -79.9 0.03 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.522 ' N ' ' CD1' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -57.88 -169.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.464 -1.021 . . . . 0.0 109.995 -179.631 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.498 HG13 ' CG2' ' A' ' 34' ' ' THR . 0.4 OUTLIER -138.64 169.97 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.4 -0.812 . . . . 0.0 108.884 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.518 HG22 ' CG ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -106.69 151.48 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.027 -1.046 . . . . 0.0 109.425 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -125.22 145.47 49.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.901 . . . . 0.0 109.494 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.483 ' OD1' ' NH1' ' A' ' 37' ' ' ARG . 14.2 t70 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.452 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 12' ' ' VAL . 35.3 Cg_endo . . . . . 0 C--O 1.214 -0.691 0 N-CA-C 110.528 -0.605 . . . . 0.0 110.528 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -79.38 -66.99 0.8 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.252 -0.905 . . . . 0.0 110.052 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -37.25 -46.24 0.72 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.51 -0.744 . . . . 0.0 110.187 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.406 ' HB ' ' HD2' ' A' ' 9' ' ' PRO . 88.7 t -67.67 -46.78 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.213 -0.929 . . . . 0.0 109.423 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 mt -46.85 -48.93 20.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.433 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.45 HD23 ' HB1' ' A' ' 67' ' ' ALA . 0.4 OUTLIER -68.71 -38.48 80.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.594 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.6 -66.02 0.46 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 109.669 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -59.11 -32.93 70.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.152 -0.968 . . . . 0.0 109.739 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 14' ' ' LEU . . . -50.05 -65.1 0.62 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.141 -0.975 . . . . 0.0 109.548 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 109.406 179.914 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.195 0.521 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.1 p -118.6 148.93 42.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.188 -0.945 . . . . 0.0 109.425 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.422 HG13 HG11 ' A' ' 74' ' ' VAL . 11.6 pt -105.74 -179.09 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.297 -0.877 . . . . 0.0 109.618 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -95.61 146.96 24.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.294 -0.879 . . . . 0.0 109.487 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.9 ppt_? -60.42 -15.44 26.43 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.235 -0.916 . . . . 0.0 109.517 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -47.92 -39.25 18.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.325 -0.859 . . . . 0.0 109.561 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.43 -45.99 90.57 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.314 -0.866 . . . . 0.0 109.52 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.471 ' O ' ' CB ' ' A' ' 44' ' ' ALA . 30.4 t -61.79 -12.89 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 0.0 109.48 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.9 -55.15 5.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 109.912 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -72.44 -51.07 21.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.228 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 63.2 mt -57.44 -45.92 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 110.094 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' A' ' 40' ' ' VAL . . . -57.28 -39.18 75.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -0.959 . . . . 0.0 109.981 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.35 -36.78 77.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.125 -0.985 . . . . 0.0 109.831 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mt -87.49 14.89 7.32 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.171 -0.956 . . . . 0.0 109.596 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.48 24.38 3.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 0.0 109.264 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.572 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -69.8 -51.01 16.16 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.389 -0.819 . . . . 0.0 109.942 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 48' ' ' MET . 34.1 Cg_endo -77.34 89.1 1.35 Allowed 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.336 2.024 . . . . 0.0 110.647 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -176.69 -62.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.402 HD21 ' SD ' ' A' ' 62' ' ' MET . 1.5 pp -103.02 -0.75 30.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.387 -0.82 . . . . 0.0 109.22 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 45.95 81.11 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.273 -0.892 . . . . 0.0 109.713 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.62 163.13 16.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.0 109.277 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -46.45 -56.09 6.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 109.132 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.427 ' O ' ' HE2' ' A' ' 48' ' ' MET . 1.6 m -160.07 -69.4 0.07 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.276 -0.89 . . . . 0.0 108.678 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.465 ' O ' ' CG2' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -147.0 8.26 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.355 -0.84 . . . . 0.0 109.584 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -92.95 -51.98 4.81 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.111 -0.993 . . . . 0.0 109.483 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.21 -27.81 61.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.361 -0.837 . . . . 0.0 109.543 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.73 -37.61 70.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 109.354 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.444 ' HG2' HG13 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -72.64 -50.73 23.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.694 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -61.18 -17.5 53.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.624 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.441 ' O ' ' OG1' ' A' ' 66' ' ' THR . 0.0 OUTLIER -75.64 -54.75 6.47 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.251 -0.906 . . . . 0.0 110.087 -179.653 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.487 ' O ' ' HB ' ' A' ' 66' ' ' THR . 12.3 mt -56.16 -38.87 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 110.482 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.4 ' C ' ' N ' ' A' ' 66' ' ' THR . 1.7 tt0 -63.11 -60.95 2.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.712 -1.242 . . . . 0.0 109.303 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.74 -16.6 7.71 Favored Glycine 0 N--CA 1.479 1.501 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.5 ' O ' ' HB2' ' A' ' 70' ' ' MET . 33.2 m -74.14 -55.1 6.49 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.234 -1.156 . . . . 0.0 109.272 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -67.76 -14.25 62.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.181 -0.949 . . . . 0.0 109.249 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -52.29 40.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 0.0 109.803 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.17 -9.92 29.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.206 -0.934 . . . . 0.0 110.49 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.5 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -97.15 -49.85 4.82 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.097 -1.002 . . . . 0.0 110.109 -179.264 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -138.64 -127.02 2.46 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.654 -1.26 . . . . 0.0 110.167 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.51 ' CD1' ' C ' ' A' ' 72' ' ' ILE . 0.5 OUTLIER -85.69 179.28 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.361 -1.082 . . . . 0.0 109.973 -179.446 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.41 -169.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.917 . . . . 0.0 109.545 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.422 HG11 HG13 ' A' ' 35' ' ' ILE . 8.8 t -135.6 167.56 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 0.0 109.525 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -122.01 152.44 39.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.451 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.4 t70 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.455 -179.935 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.452 ' HD2' HG22 ' A' ' 12' ' ' VAL . 35.8 Cg_endo . . . . . 0 C--O 1.215 -0.671 0 N-CA-C 110.332 -0.68 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.478 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -72.49 -67.25 0.57 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.21 -0.931 . . . . 0.0 110.11 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -33.93 -53.8 0.46 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.761 -0.587 . . . . 0.0 110.663 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 99.4 t -57.31 -50.39 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.089 -1.007 . . . . 0.0 109.783 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.5 mt -48.18 -68.52 0.18 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.117 -0.99 . . . . 0.0 109.767 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.444 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 6.0 mt -55.67 -20.72 15.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.198 -0.939 . . . . 0.0 109.6 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -61.34 -57.32 12.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.501 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 17' ' ' ALA . 47.0 mmtm -60.22 -25.55 65.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 0.0 109.319 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 14' ' ' LEU . . . -42.92 -35.91 1.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.39 -0.819 . . . . 0.0 109.408 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.269 -0.894 . . . . 0.0 109.565 179.937 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.441 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.283 0.563 . . . . 0.0 109.584 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.1 p -126.54 143.5 51.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 109.378 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.597 ' CD1' ' N ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -112.53 -171.63 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.172 -0.955 . . . . 0.0 109.615 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -100.17 168.69 9.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.386 -0.821 . . . . 0.0 109.931 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.04 -11.22 57.07 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.379 -0.826 . . . . 0.0 110.046 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -51.09 -44.9 61.33 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.135 -0.978 . . . . 0.0 109.776 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.432 ' NZ ' HD22 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -59.77 -34.62 73.23 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.319 -0.863 . . . . 0.0 109.852 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.423 ' HA ' HD11 ' A' ' 63' ' ' ILE . 68.1 t -63.06 -30.59 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 110.017 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -80.73 -23.33 39.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.112 -0.992 . . . . 0.0 110.008 -179.673 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -80.67 -52.6 7.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.971 . . . . 0.0 109.62 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.472 ' HB ' HD12 ' A' ' 63' ' ' ILE . 43.4 mt -65.99 -36.47 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.663 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.7 -38.71 80.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.212 -0.93 . . . . 0.0 109.636 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -74.52 -27.22 60.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 0.0 109.698 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.03 -0.06 54.61 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.093 -1.005 . . . . 0.0 109.595 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -149.44 47.92 0.96 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.325 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.582 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -62.7 -50.37 78.25 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.273 -0.892 . . . . 0.0 110.033 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 48' ' ' MET . 36.4 Cg_endo -80.7 49.43 3.22 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.711 2.274 . . . . 0.0 110.815 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -123.2 -33.65 3.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.095 -1.003 . . . . 0.0 109.233 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 52' ' ' ASN . 0.8 OUTLIER -123.86 34.87 4.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -0.885 . . . . 0.0 109.334 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' A' ' 52' ' ' ASN . 29.1 t-20 42.95 38.16 1.33 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.357 -0.84 . . . . 0.0 109.537 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.54 135.64 57.73 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.187 -0.946 . . . . 0.0 109.318 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.9 -73.41 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.891 . . . . 0.0 109.536 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.475 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -139.08 -51.21 0.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 109.635 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 55' ' ' SER . 10.4 mm -157.31 -32.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.385 -0.822 . . . . 0.0 109.371 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.42 -59.12 5.91 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.24 -0.912 . . . . 0.0 110.578 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.9 -50.25 66.79 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.379 -0.826 . . . . 0.0 110.831 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.23 -24.76 66.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.983 -1.073 . . . . 0.0 110.089 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.444 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -74.24 -38.06 63.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 109.771 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.08 -13.18 57.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.341 -0.849 . . . . 0.0 109.871 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.05 -53.96 7.56 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.19 -0.944 . . . . 0.0 109.398 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.472 HD12 ' HB ' ' A' ' 43' ' ' ILE . 12.2 mt -64.98 -41.12 91.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.91 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.417 ' HG2' ' CZ ' ' A' ' 68' ' ' ARG . 18.1 tt0 -61.66 -53.35 57.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.04 -1.038 . . . . 0.0 109.722 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.67 -10.66 32.0 Favored Glycine 0 N--CA 1.479 1.537 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.481 ' O ' ' HB2' ' A' ' 70' ' ' MET . 5.0 m -85.12 -44.25 13.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.272 -1.134 . . . . 0.0 109.667 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -72.38 -32.88 66.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -0.932 . . . . 0.0 109.584 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.417 ' CZ ' ' HG2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -65.35 -55.49 17.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.239 -0.913 . . . . 0.0 110.073 -179.629 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 70' ' ' MET . 0.1 OUTLIER -67.9 -46.45 71.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.965 . . . . 0.0 110.48 -179.275 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -44.9 -72.02 0.07 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.05 -1.031 . . . . 0.0 109.458 -179.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -162.18 -93.2 0.09 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.497 HD11 ' O ' ' A' ' 73' ' ' VAL . 2.2 pp -48.19 178.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.52 -0.988 . . . . 0.0 109.935 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.497 ' O ' HD11 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -122.09 -175.8 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.221 -0.924 . . . . 0.0 109.817 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.492 HG11 ' N ' ' A' ' 75' ' ' GLU . 92.8 t -146.53 145.57 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.617 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.492 ' N ' HG11 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -94.68 178.58 5.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 109.376 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.3 t0 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.483 -179.924 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.413 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 34.5 Cg_endo . . . . . 0 C--O 1.215 -0.653 0 N-CA-C 110.222 -0.722 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.06 -65.76 0.49 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.337 -0.852 . . . . 0.0 110.837 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.526 ' CA ' ' HE2' ' A' ' 70' ' ' MET . . . -45.35 -65.66 0.51 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.26 -0.9 . . . . 0.0 111.415 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 80.4 t -55.99 -20.62 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.954 -1.091 . . . . 0.0 111.354 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.469 HD11 ' O ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -87.83 -24.8 23.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.766 -1.209 . . . . 0.0 110.002 -179.418 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.3 mt -71.26 -50.73 29.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.011 -1.056 . . . . 0.0 109.237 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.511 ' CD ' ' N ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -66.6 -41.43 88.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.207 -0.933 . . . . 0.0 109.169 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.511 ' N ' ' CD ' ' A' ' 15' ' ' LYS . 9.4 tttp -49.93 -36.95 29.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -0.927 . . . . 0.0 109.114 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.434 ' HB2' ' HD3' ' A' ' 39' ' ' LYS . . . -99.81 -75.33 0.57 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.325 -0.859 . . . . 0.0 109.186 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.359 -0.838 . . . . 0.0 109.497 179.892 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.434 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.257 0.551 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.458 ' OG1' ' N ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -106.16 176.39 5.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 109.472 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.458 ' N ' ' OG1' ' A' ' 34' ' ' THR . 12.8 pt -125.94 165.78 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.295 -0.878 . . . . 0.0 109.434 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.8 mtpt -89.53 144.95 25.62 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.336 -0.852 . . . . 0.0 109.293 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -60.77 -13.47 15.33 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.269 -0.894 . . . . 0.0 109.619 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 37' ' ' ARG . 2.5 t0 -42.76 -41.07 3.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.295 -0.878 . . . . 0.0 109.549 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.434 ' HD3' ' HB2' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -71.48 -47.53 54.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -0.857 . . . . 0.0 109.501 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.463 HG13 ' CG ' ' A' ' 60' ' ' MET . 75.0 t -53.03 -20.51 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.799 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -81.16 -62.07 1.77 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.94 . . . . 0.0 109.694 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.65 -55.69 23.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.352 -0.842 . . . . 0.0 110.032 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.455 ' CG2' HD12 ' A' ' 63' ' ' ILE . 74.3 mt -54.24 -58.41 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.916 . . . . 0.0 110.178 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 43' ' ' ILE . . . -42.19 -28.82 0.21 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.223 -0.923 . . . . 0.0 109.77 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -67.03 -51.29 56.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.186 -0.947 . . . . 0.0 109.49 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.5 mt -77.49 -2.24 34.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.875 . . . . 0.0 109.702 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.27 23.15 6.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.119 -0.988 . . . . 0.0 109.529 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.617 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 5.5 ttp -69.32 -43.12 23.04 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 110.755 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 48' ' ' MET . 36.2 Cg_endo -79.51 13.7 2.01 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 122.055 1.837 . . . . 0.0 111.194 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.53 -35.46 79.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.97 -1.081 . . . . 0.0 109.412 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.421 HD22 ' SD ' ' A' ' 62' ' ' MET . 0.3 OUTLIER -143.99 23.81 1.69 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -0.87 . . . . 0.0 109.595 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 51' ' ' LEU . 35.3 t-20 44.99 56.69 5.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -0.894 . . . . 0.0 109.626 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.458 ' HB3' ' HB2' ' A' ' 58' ' ' ALA . . . -52.56 170.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 109.396 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.27 -44.35 68.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.923 . . . . 0.0 109.367 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.55 -50.81 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.218 -0.926 . . . . 0.0 108.841 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.51 HG21 ' N ' ' A' ' 57' ' ' GLU . 8.1 tt -172.53 -31.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 121.207 -0.933 . . . . 0.0 109.518 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.51 ' N ' HG21 ' A' ' 56' ' ' ILE . 6.2 tp10 -57.2 -45.53 83.69 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.208 -0.932 . . . . 0.0 109.806 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.458 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . . . -60.04 -35.84 75.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.337 -0.852 . . . . 0.0 109.813 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.5 ' HA ' ' CG ' ' A' ' 62' ' ' MET . . . -63.21 -25.56 68.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.975 . . . . 0.0 109.396 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.463 ' CG ' HG13 ' A' ' 40' ' ' VAL . 1.3 mtt -81.06 -23.54 38.45 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.113 -0.992 . . . . 0.0 108.395 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.05 -22.42 36.39 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.605 -0.685 . . . . 0.0 109.847 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.5 ' CG ' ' HA ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -82.47 -50.34 8.96 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.894 -1.129 . . . . 0.0 109.425 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.474 ' O ' ' HB ' ' A' ' 66' ' ' THR . 8.0 mt -57.68 -37.92 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.418 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.39 -50.72 70.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.102 -0.999 . . . . 0.0 109.21 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.77 -12.99 23.11 Favored Glycine 0 N--CA 1.481 1.635 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 54.0 m -82.54 -54.16 5.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -1.15 . . . . 0.0 109.089 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -79.21 3.27 18.33 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.374 -0.829 . . . . 0.0 109.261 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.44 -49.91 5.9 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.173 -0.955 . . . . 0.0 109.384 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -21.53 24.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.878 . . . . 0.0 109.877 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.526 ' HE2' ' CA ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -60.18 -64.34 0.98 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.057 -1.027 . . . . 0.0 109.478 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -159.08 -98.54 0.14 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.523 ' CD1' ' C ' ' A' ' 72' ' ' ILE . 2.5 pp -53.14 -172.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -1.115 . . . . 0.0 109.692 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.54 176.85 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 109.276 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.98 151.36 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.337 -0.852 . . . . 0.0 109.476 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.505 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -113.93 65.41 0.66 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.934 . . . . 0.0 109.519 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.6 t0 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.456 179.993 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.53 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 34.7 Cg_endo . . . . . 0 C--O 1.216 -0.592 0 N-CA-C 110.535 -0.602 . . . . 0.0 110.535 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -64.46 -43.56 93.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.867 . . . . 0.0 109.956 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 14' ' ' LEU . . . -37.5 -51.66 1.15 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.507 -0.746 . . . . 0.0 110.269 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 9' ' ' PRO . 3.1 m -66.8 -41.04 87.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 121.018 -1.051 . . . . 0.0 109.105 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.431 HD22 ' NZ ' ' A' ' 16' ' ' LYS . 9.4 mt -61.86 -15.62 43.85 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.019 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.491 ' CD1' HG23 ' A' ' 66' ' ' THR . 4.9 mt -77.65 -51.4 10.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 108.778 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -50.43 -34.86 26.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.86 . . . . 0.0 108.968 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.431 ' NZ ' HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -64.32 -51.33 63.98 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.316 -0.865 . . . . 0.0 109.286 179.808 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 18' ' ' ALA . . . -61.7 -69.23 0.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 0.0 109.411 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 17' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.165 -0.959 . . . . 0.0 109.326 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.445 ' O ' HG21 ' A' ' 34' ' ' THR . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.314 0.578 . . . . 0.0 109.641 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.445 HG21 ' O ' ' A' ' 33' ' ' ALA . 14.6 p -144.73 133.91 22.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.314 -0.866 . . . . 0.0 109.212 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.417 ' O ' HG11 ' A' ' 74' ' ' VAL . 6.0 pt -90.88 -171.47 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.109 -0.994 . . . . 0.0 109.493 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.456 ' HA ' ' HE3' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -97.56 148.21 23.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 109.373 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 38' ' ' ASP . 1.6 mtt180 -75.03 -16.46 60.6 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.278 -0.889 . . . . 0.0 109.458 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 37' ' ' ARG . 5.9 t0 -43.73 -54.33 5.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.453 -0.779 . . . . 0.0 109.468 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.436 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -53.7 -41.18 66.68 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.177 -0.952 . . . . 0.0 109.656 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.508 HG23 ' CG2' ' A' ' 63' ' ' ILE . 75.1 t -57.35 -36.45 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.313 -0.867 . . . . 0.0 109.927 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -29.56 65.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.157 -0.964 . . . . 0.0 110.052 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -80.92 -24.5 38.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.064 -1.022 . . . . 0.0 109.808 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.459 ' HB ' HD12 ' A' ' 63' ' ' ILE . 29.6 mt -95.63 -14.59 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.811 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.406 ' HB1' HD13 ' A' ' 63' ' ' ILE . . . -105.29 -22.21 13.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.114 -0.991 . . . . 0.0 110.022 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -96.13 -41.12 8.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.096 -1.002 . . . . 0.0 109.759 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.431 ' C ' ' HG2' ' A' ' 47' ' ' LYS . 5.4 mt -84.09 2.8 37.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.15 -0.969 . . . . 0.0 109.662 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.431 ' HG2' ' C ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -139.09 41.43 2.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.151 -0.968 . . . . 0.0 109.458 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.565 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.2 OUTLIER -45.37 -51.57 25.7 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.215 -0.928 . . . . 0.0 109.806 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 48' ' ' MET . 35.4 Cg_endo -78.5 75.66 4.83 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.442 2.095 . . . . 0.0 110.447 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.71 -59.7 0.89 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -0.895 . . . . 0.0 109.678 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.495 ' O ' ' HB2' ' A' ' 52' ' ' ASN . 2.3 pp -120.13 -32.88 4.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.143 -0.973 . . . . 0.0 109.991 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.496 ' O ' ' CB ' ' A' ' 53' ' ' ALA . 1.1 t-20 162.41 -90.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.471 -0.768 . . . . 0.0 109.121 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 52' ' ' ASN . . . 76.0 128.82 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.473 -0.767 . . . . 0.0 109.73 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -89.47 -41.45 12.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 109.228 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -158.16 -48.84 0.06 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.417 -0.802 . . . . 0.0 108.854 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.512 HG21 ' N ' ' A' ' 57' ' ' GLU . 4.2 tt -177.14 -31.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.317 -0.865 . . . . 0.0 108.985 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.512 ' N ' HG21 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -65.46 -59.87 3.55 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.332 -0.855 . . . . 0.0 110.049 -179.873 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.94 -30.0 68.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.272 -0.893 . . . . 0.0 110.43 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.457 ' HB1' ' HB3' ' A' ' 53' ' ' ALA . . . -72.55 -33.32 66.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.152 -0.968 . . . . 0.0 109.97 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -50.04 13.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.175 -0.953 . . . . 0.0 110.138 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.7 -17.89 61.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.319 -0.863 . . . . 0.0 109.81 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.429 ' SD ' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -80.92 -55.62 4.67 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.165 -0.959 . . . . 0.0 110.072 -179.467 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.508 ' CG2' HG23 ' A' ' 40' ' ' VAL . 3.1 mt -51.24 -43.08 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.05 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.463 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 12.3 pt-20 -64.81 -45.62 85.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.869 -1.144 . . . . 0.0 108.867 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.463 ' N ' ' HG3' ' A' ' 64' ' ' GLU . . . -60.26 -14.41 33.16 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.491 HG23 ' CD1' ' A' ' 14' ' ' LEU . 86.7 m -85.73 -60.36 2.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.388 -1.066 . . . . 0.0 109.265 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.463 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -61.86 -13.8 27.76 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.166 -0.959 . . . . 0.0 109.061 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.589 ' CG ' ' CG1' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -77.67 -62.3 1.71 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.329 -0.857 . . . . 0.0 109.269 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.01 -15.48 63.62 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.315 -0.866 . . . . 0.0 109.261 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.422 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.1 OUTLIER -88.4 -34.35 17.58 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.328 -0.858 . . . . 0.0 109.885 -179.754 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -159.64 -102.16 0.18 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.505 ' CD1' ' C ' ' A' ' 72' ' ' ILE . 1.1 pp -108.16 -169.63 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -1.197 . . . . 0.0 110.103 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.589 ' CG1' ' CG ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -103.92 -176.8 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.392 -0.818 . . . . 0.0 109.517 179.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.417 HG11 ' O ' ' A' ' 35' ' ' ILE . 1.5 t -109.54 -170.15 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.363 -0.836 . . . . 0.0 109.216 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -124.55 177.16 6.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 109.545 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.5 t70 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.461 179.935 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.524 ' HG2' ' CG2' ' A' ' 12' ' ' VAL . 35.5 Cg_endo . . . . . 0 C--O 1.214 -0.703 0 N-CA-C 110.081 -0.776 . . . . 0.0 110.081 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -91.7 -65.66 0.99 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.13 -0.981 . . . . 0.0 109.793 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -41.78 -30.01 0.22 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.014 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.524 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 70.1 t -84.54 -46.46 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.137 -0.977 . . . . 0.0 109.603 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.52 ' CD1' ' O ' ' A' ' 9' ' ' PRO . 6.3 mt -52.62 -54.72 29.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.586 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.411 ' O ' ' HB1' ' A' ' 18' ' ' ALA . 0.9 OUTLIER -60.38 -43.98 96.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.312 -0.867 . . . . 0.0 109.531 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 7.9 ttpt -54.18 -30.07 48.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 0.0 109.534 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -45.45 35.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.145 -0.972 . . . . 0.0 109.627 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -102.04 47.5 0.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 109.773 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 14' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.206 -0.934 . . . . 0.0 109.535 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.3 p -145.53 152.51 39.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.003 . . . . 0.0 109.689 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.409 HD11 ' HB3' ' A' ' 18' ' ' ALA . 39.8 pt -115.54 -175.38 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 109.223 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.76 127.6 45.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.0 109.621 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.531 ' CG ' HG13 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -56.1 -35.86 67.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.957 . . . . 0.0 109.121 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -49.07 -38.68 25.02 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.471 -0.768 . . . . 0.0 109.61 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -63.96 -45.77 87.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.119 -0.988 . . . . 0.0 109.665 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.459 HG11 ' HB ' ' A' ' 63' ' ' ILE . 1.8 t -68.55 -11.08 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.039 -1.038 . . . . 0.0 109.132 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.45 -47.49 10.59 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.275 -0.89 . . . . 0.0 108.895 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.47 ' O ' HD21 ' A' ' 46' ' ' LEU . 3.1 tt0 -55.44 -33.97 64.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.266 -0.896 . . . . 0.0 109.226 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 12.7 mt -83.36 -22.9 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.379 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.37 -24.54 61.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.913 . . . . 0.0 109.375 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.45 ' HA ' ' SD ' ' A' ' 48' ' ' MET . 31.2 mt-10 -93.47 -35.8 12.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 109.171 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.506 ' CD2' ' N ' ' A' ' 46' ' ' LEU . 0.5 OUTLIER -66.93 -8.58 30.47 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.332 -0.855 . . . . 0.0 109.795 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.458 ' HD2' ' O ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -140.86 48.67 1.7 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.206 -0.934 . . . . 0.0 109.61 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.549 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 3.7 tpp -43.42 -52.97 12.35 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.297 -0.877 . . . . 0.0 109.42 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.549 ' HD3' ' CB ' ' A' ' 48' ' ' MET . 36.2 Cg_endo -79.46 86.3 1.7 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.498 2.132 . . . . 0.0 110.131 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -134.66 -60.23 0.79 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.135 -0.978 . . . . 0.0 109.815 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.49 ' O ' ' HB2' ' A' ' 52' ' ' ASN . 3.9 pp -127.16 -10.69 5.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 110.091 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 10.5 t30 164.35 -89.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.318 -0.864 . . . . 0.0 109.024 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.438 ' HB3' ' HB1' ' A' ' 59' ' ' ALA . . . 63.37 72.4 0.48 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.515 -0.74 . . . . 0.0 109.592 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.81 -30.51 57.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.176 -0.953 . . . . 0.0 108.983 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.489 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -164.17 -61.43 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.364 -0.835 . . . . 0.0 109.247 179.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -165.8 -34.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -65.54 -62.82 1.3 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.273 -0.892 . . . . 0.0 110.519 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.95 -38.98 71.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.319 -0.863 . . . . 0.0 110.297 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.438 ' HB1' ' HB3' ' A' ' 53' ' ' ALA . . . -66.3 -70.13 0.26 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.161 -0.962 . . . . 0.0 110.033 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.525 ' HA ' HG12 ' A' ' 63' ' ' ILE . 0.7 OUTLIER -46.68 -28.37 1.47 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.181 -0.949 . . . . 0.0 110.405 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.457 ' HA ' ' OE2' ' A' ' 64' ' ' GLU . 2.3 mmm180 -74.63 -41.28 60.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.975 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.465 ' SD ' HD23 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -69.49 -47.21 64.61 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.233 -0.917 . . . . 0.0 110.258 -179.3 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.535 ' O ' ' HB ' ' A' ' 66' ' ' THR . 1.0 OUTLIER -52.08 -57.95 3.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.246 -0.909 . . . . 0.0 111.159 -179.421 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.457 ' OE2' ' HA ' ' A' ' 61' ' ' ARG . 9.9 pt-20 -56.44 -55.14 37.34 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 120.946 -1.097 . . . . 0.0 109.519 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.57 -19.41 13.28 Favored Glycine 0 N--CA 1.483 1.778 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.535 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 63.8 m -77.95 -42.82 31.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.473 -1.016 . . . . 0.0 109.119 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -80.72 -1.38 42.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.24 -0.913 . . . . 0.0 108.946 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.441 ' HG2' HG21 ' A' ' 73' ' ' VAL . 0.1 OUTLIER -83.98 -55.0 4.46 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.323 -0.861 . . . . 0.0 109.94 -179.731 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.67 -11.05 43.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.13 -0.981 . . . . 0.0 110.597 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.423 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -65.71 -50.35 65.16 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.935 -1.103 . . . . 0.0 110.122 -179.65 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -156.79 -71.56 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.092 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.51 ' CD1' ' C ' ' A' ' 72' ' ' ILE . 1.0 OUTLIER -98.04 -174.27 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.148 -1.207 . . . . 0.0 109.848 -179.557 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.441 HG21 ' HG2' ' A' ' 68' ' ' ARG . 2.3 p -107.98 -179.26 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.465 -0.772 . . . . 0.0 109.043 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.531 HG13 ' CG ' ' A' ' 37' ' ' ARG . 0.1 OUTLIER -127.16 159.11 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.989 . . . . 0.0 109.308 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 1.9 pp20? -133.81 157.59 45.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.9 t0 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.5 -179.893 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.478 ' O ' HD11 ' A' ' 13' ' ' LEU . 35.9 Cg_endo . . . . . 0 C--O 1.214 -0.678 0 N-CA-C 110.308 -0.689 . . . . 0.0 110.308 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.475 ' HA ' HD11 ' A' ' 13' ' ' LEU . . . -51.88 -50.65 60.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.305 -0.872 . . . . 0.0 109.995 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -42.57 -50.87 5.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.22 -0.925 . . . . 0.0 109.87 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.443 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 42.8 t -56.28 -48.83 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 109.973 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.478 HD11 ' O ' ' A' ' 9' ' ' PRO . 4.9 mp -53.25 -58.08 8.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.145 -0.972 . . . . 0.0 109.835 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.407 ' HA ' ' HB1' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -49.06 -33.5 11.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.907 . . . . 0.0 109.604 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -60.9 -62.89 1.53 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 0.0 110.112 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.86 -3.56 29.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.104 -0.997 . . . . 0.0 109.818 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.407 ' HB1' ' HA ' ' A' ' 14' ' ' LEU . . . -84.57 -25.16 28.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.079 -1.013 . . . . 0.0 109.426 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.483 -179.931 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -159.16 150.24 20.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -0.883 . . . . 0.0 109.682 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.473 HG22 HD11 ' A' ' 35' ' ' ILE . 6.5 pt -145.3 170.3 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.213 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -82.2 142.88 31.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -0.963 . . . . 0.0 109.808 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.456 ' HA ' HG22 ' A' ' 40' ' ' VAL . 30.0 mtt180 -70.33 -10.41 58.91 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.442 -0.786 . . . . 0.0 109.77 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 37' ' ' ARG . 66.3 t0 -39.5 -50.24 2.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.69 -0.631 . . . . 0.0 109.955 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -48.24 82.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 0.0 109.726 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.462 ' O ' HD11 ' A' ' 63' ' ' ILE . 46.2 t -45.1 -25.94 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.096 -1.002 . . . . 0.0 109.856 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -84.54 -39.36 18.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.199 -0.938 . . . . 0.0 109.922 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 3.5 tt0 -66.56 -27.87 68.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 0.0 109.924 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.7 mt -90.81 -42.41 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.077 -1.015 . . . . 0.0 109.775 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.506 ' HA ' ' CD ' ' A' ' 47' ' ' LYS . . . -56.26 -21.57 24.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.073 -1.017 . . . . 0.0 109.114 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.34 -44.75 12.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.624 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mt -72.21 -10.94 60.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 109.753 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.506 ' CD ' ' HA ' ' A' ' 44' ' ' ALA . 14.9 ptmt -111.0 29.19 8.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -0.963 . . . . 0.0 110.085 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.58 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -64.88 -51.31 57.87 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.1 -1.0 . . . . 0.0 109.551 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 48' ' ' MET . 36.7 Cg_endo -80.96 57.5 6.56 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.734 2.29 . . . . 0.0 110.605 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.95 -76.67 0.23 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.995 -1.066 . . . . 0.0 109.719 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.418 HD21 ' SD ' ' A' ' 62' ' ' MET . 1.6 pp -89.27 17.99 5.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 109.934 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 52' ' ' ASN . 8.5 t30 45.23 73.08 0.17 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.152 -0.968 . . . . 0.0 109.464 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.512 ' CB ' ' HB1' ' A' ' 59' ' ' ALA . . . -73.88 138.07 44.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.19 -0.944 . . . . 0.0 109.564 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.41 -68.14 0.2 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.951 . . . . 0.0 109.334 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.478 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -143.25 -52.5 0.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.348 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -165.13 -32.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.319 -0.863 . . . . 0.0 108.971 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -60.57 -70.29 0.18 Allowed 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.102 -0.998 . . . . 0.0 110.323 -179.45 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 57' ' ' GLU . . . -42.8 -58.65 2.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 110.007 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.512 ' HB1' ' CB ' ' A' ' 53' ' ' ALA . . . -49.36 -40.02 34.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.215 -0.928 . . . . 0.0 110.186 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.56 -35.67 81.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.168 -0.957 . . . . 0.0 110.207 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -14.81 58.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.12 -0.988 . . . . 0.0 109.677 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.418 ' SD ' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -76.79 -57.46 3.84 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.177 -0.952 . . . . 0.0 109.644 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.462 HD11 ' O ' ' A' ' 40' ' ' VAL . 9.1 mt -61.31 -36.82 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.063 -1.023 . . . . 0.0 109.585 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -63.95 -48.13 77.72 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.076 -1.015 . . . . 0.0 108.972 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.0 -9.39 34.19 Favored Glycine 0 N--CA 1.48 1.601 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 70' ' ' MET . 85.5 m -87.89 -48.2 7.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -1.13 . . . . 0.0 109.752 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.409 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -80.92 -12.13 59.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.127 -0.983 . . . . 0.0 109.622 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.569 ' NH2' ' CG1' ' A' ' 73' ' ' VAL . 0.1 OUTLIER -88.99 -46.0 9.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.176 -0.952 . . . . 0.0 109.435 179.814 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.59 -23.51 42.66 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.362 -0.837 . . . . 0.0 109.91 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -65.98 -66.01 0.6 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.195 -0.941 . . . . 0.0 109.354 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -161.62 -92.19 0.09 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.5 HD11 ' O ' ' A' ' 73' ' ' VAL . 2.8 pp -48.96 177.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.441 -1.035 . . . . 0.0 110.298 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.569 ' CG1' ' NH2' ' A' ' 68' ' ' ARG . 0.5 OUTLIER -112.26 -171.19 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.394 -0.816 . . . . 0.0 110.014 -179.525 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.7 t -134.03 163.78 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.076 -1.015 . . . . 0.0 109.767 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -129.76 176.86 7.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.228 -0.92 . . . . 0.0 109.689 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 t70 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.443 179.97 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.53 ' O ' ' CG ' ' A' ' 13' ' ' LEU . 34.4 Cg_endo . . . . . 0 C--O 1.213 -0.758 0 N-CA-C 110.32 -0.684 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . -75.76 -64.55 1.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 110.213 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -41.36 -61.46 1.04 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.313 -0.867 . . . . 0.0 110.141 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.51 ' HB ' ' HG2' ' A' ' 9' ' ' PRO . 17.5 t -65.48 -30.01 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 109.852 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.53 ' CG ' ' O ' ' A' ' 9' ' ' PRO . 1.1 mt -50.31 -60.54 2.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.078 -1.013 . . . . 0.0 109.581 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.91 -35.43 74.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 109.726 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -50.32 -63.26 1.17 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.879 . . . . 0.0 109.792 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -21.38 60.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 0.0 109.808 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.84 -45.15 74.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 109.798 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 0.0 109.453 -179.941 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.23 0.538 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.43 ' HA ' ' CG1' ' A' ' 73' ' ' VAL . 5.6 p -81.22 -171.66 3.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -0.914 . . . . 0.0 109.55 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.541 HG22 ' CD1' ' A' ' 72' ' ' ILE . 3.3 pt -140.1 -170.08 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.888 . . . . 0.0 109.588 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.4 ptpt -95.11 130.32 41.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.352 -0.843 . . . . 0.0 109.641 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.404 ' O ' ' C ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -67.35 -8.5 33.04 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.223 -0.923 . . . . 0.0 109.655 179.896 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 37' ' ' ARG . 31.9 t70 -42.5 -54.64 3.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.363 -0.836 . . . . 0.0 109.912 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -42.34 90.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 109.809 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 40' ' ' VAL . 68.2 t -57.38 -21.59 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.193 -0.942 . . . . 0.0 109.717 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.7 ttp85 -84.87 -59.02 2.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.442 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -48.61 -58.18 5.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 109.509 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.469 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 92.2 mt -56.69 -56.21 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 109.571 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.447 ' N ' HD13 ' A' ' 63' ' ' ILE . . . -45.59 -25.27 0.44 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.962 . . . . 0.0 109.564 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -75.44 -57.34 3.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.944 . . . . 0.0 109.663 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 43' ' ' ILE . 4.4 pp -70.46 -4.64 23.67 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.122 -0.986 . . . . 0.0 109.867 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.34 5.26 49.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.146 -0.971 . . . . 0.0 109.572 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.577 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -48.39 -50.06 59.63 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 110.199 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 48' ' ' MET . 34.8 Cg_endo -77.47 77.49 3.83 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.258 1.972 . . . . 0.0 110.575 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -172.34 -35.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.388 -0.82 . . . . 0.0 109.412 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.463 ' O ' ' OD1' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -143.74 16.56 1.79 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.441 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 52' ' ' ASN . 7.3 p-10 40.58 67.7 0.48 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.506 -0.746 . . . . 0.0 109.833 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.46 ' HB3' HD13 ' A' ' 51' ' ' LEU . . . -85.37 154.6 21.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 109.549 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -47.65 -51.44 21.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.17 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.12 -52.1 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.368 -0.833 . . . . 0.0 108.931 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.552 ' CG2' ' O ' ' A' ' 56' ' ' ILE . 20.8 mm -149.99 9.44 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.453 -0.779 . . . . 0.0 109.612 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -97.61 -52.7 3.68 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 120.899 -1.125 . . . . 0.0 109.717 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.51 -43.41 73.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.365 -0.834 . . . . 0.0 109.352 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.67 -24.33 64.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.355 -0.841 . . . . 0.0 109.438 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.431 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -70.66 -38.69 73.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.311 -0.868 . . . . 0.0 109.63 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.51 -14.85 58.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.276 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.37 -60.65 2.28 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.367 -0.833 . . . . 0.0 109.57 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.483 ' O ' ' HB ' ' A' ' 66' ' ' THR . 15.3 mt -59.34 -36.27 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 109.787 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -62.85 -60.02 4.06 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.083 -1.011 . . . . 0.0 109.498 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 68' ' ' ARG . . . -56.52 -15.85 13.5 Favored Glycine 0 N--CA 1.479 1.547 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.524 ' CG2' ' SD ' ' A' ' 70' ' ' MET . 60.8 m -74.1 -55.86 5.6 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.243 -1.151 . . . . 0.0 109.153 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.473 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -62.2 -27.2 68.81 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.403 ' HB2' ' HA2' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -47.77 -61.81 1.76 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.525 -0.735 . . . . 0.0 109.17 179.302 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.55 -68.58 0.78 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.332 -0.855 . . . . 0.0 110.312 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.524 ' SD ' ' CG2' ' A' ' 66' ' ' THR . 1.1 mpt? -45.49 -21.02 0.08 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.177 -0.952 . . . . 0.0 111.615 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' A' ' 67' ' ' ALA . . . -150.1 -133.13 2.09 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 118.898 -1.62 . . . . 0.0 110.764 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.541 ' CD1' HG22 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -102.81 -170.26 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.529 -0.983 . . . . 0.0 110.215 -179.354 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.484 ' O ' HD11 ' A' ' 72' ' ' ILE . 9.1 p -84.08 165.06 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -0.869 . . . . 0.0 109.85 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 75' ' ' GLU . 54.5 t -124.7 161.95 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.218 -0.926 . . . . 0.0 109.578 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.47 ' N ' HG13 ' A' ' 74' ' ' VAL . 2.3 pp20? -114.51 135.14 54.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 109.38 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.4 179.929 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo . . . . . 0 C--O 1.214 -0.682 0 N-CA-C 110.441 -0.638 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.471 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -67.51 -66.16 0.6 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.244 -0.91 . . . . 0.0 109.883 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.517 ' CB ' ' SD ' ' A' ' 70' ' ' MET . . . -34.51 -67.73 0.13 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.677 -0.639 . . . . 0.0 110.705 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.1 t -49.55 -44.19 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.07 -1.019 . . . . 0.0 109.906 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 14.8 mt -54.13 -69.41 0.12 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.148 -0.97 . . . . 0.0 109.752 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.509 ' O ' ' CB ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -48.48 -26.91 2.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.77 -179.801 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -64.58 0.89 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 0.0 109.717 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.4 tptp -56.68 -32.59 65.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -0.942 . . . . 0.0 109.326 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -105.01 48.62 0.83 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.569 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 14' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.14 -0.975 . . . . 0.0 109.532 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.41 0.624 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -161.05 179.62 8.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.409 -0.807 . . . . 0.0 109.678 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -159.7 164.0 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.299 -0.876 . . . . 0.0 109.301 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.5 146.32 31.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 109.707 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.453 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 3.3 ppt_? -64.04 -17.12 63.06 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.353 -0.842 . . . . 0.0 109.791 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 37' ' ' ARG . 11.9 t70 -46.04 -47.87 16.9 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.112 -0.993 . . . . 0.0 109.258 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.435 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -62.71 -44.78 95.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 0.0 109.322 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.474 HG12 ' HB ' ' A' ' 63' ' ' ILE . 47.9 t -53.09 -20.43 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.299 -0.876 . . . . 0.0 109.585 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.24 -52.6 5.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.301 -0.874 . . . . 0.0 109.546 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -59.21 -21.38 59.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.244 -0.91 . . . . 0.0 109.664 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.47 ' HB ' HD12 ' A' ' 63' ' ' ILE . 14.2 mt -101.36 -22.0 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.269 -0.895 . . . . 0.0 109.388 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.473 ' CB ' ' O ' ' A' ' 40' ' ' VAL . . . -83.49 -4.66 58.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.436 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -97.77 -39.65 8.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.156 -0.965 . . . . 0.0 109.529 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.4 mt -91.91 -29.42 16.69 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.158 -0.964 . . . . 0.0 109.5 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.429 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -81.37 -2.44 49.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -0.867 . . . . 0.0 109.542 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.6 ttp -45.22 105.66 0.48 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.199 -0.938 . . . . 0.0 109.321 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 47' ' ' LYS . 35.2 Cg_endo -76.85 -69.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.397 2.065 . . . . 0.0 110.66 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -169.11 34.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.638 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.535 ' CD1' ' HG3' ' A' ' 62' ' ' MET . 0.2 OUTLIER -102.23 -16.44 16.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.171 -0.956 . . . . 0.0 109.773 -179.734 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 53' ' ' ALA . 10.7 t-20 48.31 69.38 0.55 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.095 -1.003 . . . . 0.0 109.047 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 52' ' ' ASN . . . -43.0 100.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.344 -0.847 . . . . 0.0 109.495 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 52' ' ' ASN . . . -50.35 -31.12 13.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.233 -0.917 . . . . 0.0 109.385 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.514 ' O ' HG12 ' A' ' 56' ' ' ILE . 16.4 m -145.87 -67.71 0.29 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.199 -0.938 . . . . 0.0 109.219 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -168.28 -30.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.391 -0.818 . . . . 0.0 109.167 -179.814 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.63 -54.98 30.02 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 120.952 -1.093 . . . . 0.0 109.955 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -43.8 -72.7 0.05 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.612 -0.68 . . . . 0.0 110.972 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.94 -54.91 27.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.337 -0.852 . . . . 0.0 111.111 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.474 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -50.63 -25.83 4.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.077 -1.014 . . . . 0.0 110.815 -178.946 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -81.56 -32.93 31.98 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.015 -1.053 . . . . 0.0 109.643 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.535 ' HG3' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -70.57 -54.93 10.15 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.218 -0.927 . . . . 0.0 109.534 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.474 ' HB ' HG12 ' A' ' 40' ' ' VAL . 7.5 mt -67.56 -42.36 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.211 -0.931 . . . . 0.0 109.974 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 60' ' ' MET . 2.9 tm-20 -60.11 -54.29 47.73 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.083 -1.011 . . . . 0.0 109.61 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.21 -15.87 31.93 Favored Glycine 0 N--CA 1.479 1.548 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 70' ' ' MET . 29.9 m -75.0 -55.05 6.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.282 -1.128 . . . . 0.0 109.001 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.487 ' O ' ' C ' ' A' ' 71' ' ' GLY . . . -64.91 -23.84 67.35 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.003 -1.06 . . . . 0.0 108.493 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.44 -51.53 68.07 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.009 -1.057 . . . . 0.0 109.371 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.46 -53.18 3.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.19 -0.944 . . . . 0.0 110.169 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.517 ' SD ' ' CB ' ' A' ' 11' ' ' ALA . 2.5 mmt -62.64 -23.63 67.18 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.233 -0.917 . . . . 0.0 111.12 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.487 ' C ' ' O ' ' A' ' 67' ' ' ALA . . . -142.85 -123.53 1.82 Allowed Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.586 -1.293 . . . . 0.0 110.372 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.48 ' O ' ' O ' ' A' ' 67' ' ' ALA . 1.2 pp -115.4 -174.55 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.188 -1.184 . . . . 0.0 109.894 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.468 ' O ' HD11 ' A' ' 72' ' ' ILE . 3.8 t -79.53 157.47 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 109.751 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.9 t -127.61 170.45 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.936 . . . . 0.0 109.594 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.453 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 2.0 pt-20 -130.21 149.28 51.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.398 -0.814 . . . . 0.0 109.419 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 t70 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.921 -1.038 . . . . 0.0 109.525 -179.939 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo . . . . . 0 C--O 1.215 -0.633 0 N-CA-C 110.152 -0.749 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -54.6 -45.16 73.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -0.872 . . . . 0.0 109.911 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -41.3 -44.52 2.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.008 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.1 t -75.55 -36.91 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.179 -0.951 . . . . 0.0 110.014 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 10' ' ' ALA . 90.6 mt -57.77 -33.09 68.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.92 . . . . 0.0 110.093 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.432 HD12 HG23 ' A' ' 66' ' ' THR . 0.5 OUTLIER -79.1 -36.27 40.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.052 -1.03 . . . . 0.0 109.802 -179.687 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.68 -13.54 60.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.214 -0.929 . . . . 0.0 109.964 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -92.58 -29.35 16.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.079 -1.013 . . . . 0.0 109.594 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.13 -47.54 79.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.193 -0.942 . . . . 0.0 109.356 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 109.351 179.823 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.35 0.595 . . . . 0.0 109.978 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.5 p -125.91 169.18 12.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.379 -0.826 . . . . 0.0 109.265 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.475 HG22 HD12 ' A' ' 72' ' ' ILE . 27.3 pt -107.75 169.91 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 109.41 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt -109.9 164.77 12.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.185 -0.947 . . . . 0.0 109.524 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.469 ' HD2' ' CE ' ' A' ' 60' ' ' MET . 0.3 OUTLIER -60.8 -15.52 30.77 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.285 -0.885 . . . . 0.0 109.694 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 37' ' ' ARG . 37.1 t0 -43.63 -55.29 4.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 0.0 109.655 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -61.05 -57.42 12.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.221 -0.925 . . . . 0.0 109.692 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.524 ' O ' ' CB ' ' A' ' 44' ' ' ALA . 60.8 t -41.68 -28.68 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.89 . . . . 0.0 110.407 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -74.66 -49.91 19.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.078 -1.014 . . . . 0.0 110.216 -179.447 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -67.73 -21.08 65.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.078 -1.014 . . . . 0.0 110.109 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.48 HG22 HD11 ' A' ' 43' ' ' ILE . 19.7 mt -101.33 -13.62 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.457 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 40' ' ' VAL . . . -88.15 -14.25 39.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.317 -0.865 . . . . 0.0 109.252 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.67 -52.86 4.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.345 -0.847 . . . . 0.0 109.624 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.2 mt -88.11 32.03 0.77 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -0.944 . . . . 0.0 109.695 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -159.43 23.55 0.19 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.211 -0.931 . . . . 0.0 109.407 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.474 ' HE3' HD12 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -121.97 85.28 45.47 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.312 -0.867 . . . . 0.0 109.623 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -80.42 43.61 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.865 2.376 . . . . 0.0 110.755 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.439 ' O ' ' CG ' ' A' ' 50' ' ' ASP . 18.9 t0 53.99 25.63 5.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.062 -1.024 . . . . 0.0 109.23 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.508 ' O ' ' CB ' ' A' ' 52' ' ' ASN . 1.9 pp -44.44 -39.29 4.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.616 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 51' ' ' LEU . 7.1 t-20 161.47 95.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.636 -0.665 . . . . 0.0 109.21 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.497 ' HB3' ' N ' ' A' ' 59' ' ' ALA . . . -171.31 139.31 1.3 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.946 . . . . 0.0 109.425 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 53' ' ' ALA . . . -45.09 -59.6 2.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.202 -0.936 . . . . 0.0 109.127 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.8 -65.43 0.1 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.342 -0.849 . . . . 0.0 108.959 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.539 ' CG2' ' O ' ' A' ' 56' ' ' ILE . 2.7 mm -137.82 1.84 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.385 -0.822 . . . . 0.0 108.99 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.32 -57.07 3.22 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.039 -1.038 . . . . 0.0 109.681 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.473 ' CB ' ' HB3' ' A' ' 53' ' ' ALA . . . -64.26 -52.23 59.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.387 -0.821 . . . . 0.0 109.532 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.497 ' N ' ' HB3' ' A' ' 53' ' ' ALA . . . -51.3 -40.96 60.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 109.4 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.469 ' CE ' ' HD2' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -62.56 -37.94 88.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.867 . . . . 0.0 109.671 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.515 ' HA ' ' CG ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -68.05 -16.75 64.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.581 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.4 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -78.56 -53.7 6.93 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.287 -0.883 . . . . 0.0 109.835 -179.724 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.511 HG22 ' HA ' ' A' ' 40' ' ' VAL . 7.8 mt -60.57 -42.3 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.179 -0.951 . . . . 0.0 109.714 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.515 ' CG ' ' HA ' ' A' ' 61' ' ' ARG . 2.0 pp20? -64.25 -44.62 91.23 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.961 -1.087 . . . . 0.0 109.602 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.49 -12.38 55.89 Favored Glycine 0 C--N 1.298 -1.568 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 70' ' ' MET . 14.7 m -84.8 -56.11 3.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.401 -1.058 . . . . 0.0 109.644 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -64.46 -31.07 72.13 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.93 -1.106 . . . . 0.0 108.75 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -60.13 4.15 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.331 -0.856 . . . . 0.0 109.433 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.51 -56.25 3.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.092 -1.005 . . . . 0.0 109.876 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 66' ' ' THR . 9.5 mtp -64.49 -10.01 22.66 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.321 -0.862 . . . . 0.0 111.009 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 67' ' ' ALA . . . -142.94 -130.73 2.48 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.272 -1.442 . . . . 0.0 110.839 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.496 ' CD1' ' C ' ' A' ' 72' ' ' ILE . 0.9 OUTLIER -101.31 -169.83 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.491 -1.005 . . . . 0.0 110.301 -179.217 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.4 t -81.94 145.76 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -0.846 . . . . 0.0 109.69 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.6 t -120.36 147.28 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.407 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 12.4 pt-20 -95.27 139.82 31.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.302 -0.874 . . . . 0.0 109.477 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.9 t0 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.438 179.917 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.224 0.535 . . . . 0.0 109.58 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.09 92.51 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 0.0 109.462 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.33 65.87 1.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 109.463 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.502 HG13 ' N ' ' A' ' 5' ' ' THR . 5.2 tp -162.23 153.53 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.906 . . . . 0.0 109.571 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.502 ' N ' HG13 ' A' ' 4' ' ' ILE . 1.5 t -47.62 172.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.276 -0.89 . . . . 0.0 109.388 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 7' ' ' THR . 0.1 OUTLIER -59.35 169.29 1.24 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.202 -0.936 . . . . 0.0 109.527 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.451 ' CB ' ' O ' ' A' ' 6' ' ' LYS . 0.2 OUTLIER 70.83 122.08 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.878 . . . . 0.0 109.46 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.31 170.44 18.54 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.394 2.063 . . . . 0.0 110.383 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.519 ' HG2' ' CG2' ' A' ' 12' ' ' VAL . 34.5 Cg_endo -77.12 162.63 31.46 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.53 2.154 . . . . 0.0 110.311 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -72.07 -61.18 1.88 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 109.828 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -39.64 -54.5 2.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.507 -0.746 . . . . 0.0 110.031 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.519 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 89.6 t -59.82 -41.59 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.106 -0.996 . . . . 0.0 109.668 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 9' ' ' PRO . 0.8 OUTLIER -55.35 -65.05 0.65 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.931 . . . . 0.0 109.62 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.527 ' CD1' HG23 ' A' ' 66' ' ' THR . 2.1 mt -46.25 -27.12 0.93 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.163 -0.96 . . . . 0.0 109.209 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.469 ' HD3' ' CD1' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -68.5 -47.54 66.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.867 . . . . 0.0 109.39 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -67.74 -13.45 62.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.338 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 14' ' ' LEU . . . -68.22 -42.04 80.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.381 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.81 -23.36 4.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.196 -0.94 . . . . 0.0 109.51 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.01 24.72 7.88 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.469 ' CD1' ' HD3' ' A' ' 15' ' ' LYS . 57.4 mt -48.26 -38.52 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.214 -1.168 . . . . 0.0 109.837 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -97.85 70.68 2.17 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.539 -0.726 . . . . 0.0 109.339 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.8 m -147.58 163.67 35.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -0.89 . . . . 0.0 109.434 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 25' ' ' GLY . . . -73.33 -65.27 2.29 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.7 m 49.28 -94.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.131 -1.217 . . . . 0.0 109.578 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . 131.07 -95.35 0.32 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -46.85 158.43 0.42 Allowed Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 121.318 -1.107 . . . . 0.0 109.872 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.37 114.05 3.46 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.625 2.217 . . . . 0.0 110.242 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.467 ' O ' ' HD2' ' A' ' 29' ' ' ARG . 3.7 m-20 -96.41 43.11 1.08 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.245 -0.909 . . . . 0.0 109.628 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.467 ' HD2' ' O ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -146.22 113.44 6.22 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 109.532 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -166.98 -66.11 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.327 -0.858 . . . . 0.0 109.501 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.9 -172.48 2.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.259 -0.901 . . . . 0.0 109.283 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.5 t -65.96 104.37 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.934 . . . . 0.0 109.606 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.96 176.5 6.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 0.0 109.344 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.98 148.08 25.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 109.403 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.418 HG13 HG11 ' A' ' 74' ' ' VAL . 38.9 pt -107.19 -174.28 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.213 -0.929 . . . . 0.0 109.536 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.48 ' HG2' ' OD2' ' A' ' 38' ' ' ASP . 20.3 tptt -96.44 167.01 11.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.253 -0.904 . . . . 0.0 109.757 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.64 -24.77 31.25 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.282 -0.887 . . . . 0.0 109.726 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.48 ' OD2' ' HG2' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -48.77 -38.11 20.93 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.135 -0.978 . . . . 0.0 109.417 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -59.48 -45.58 91.27 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.317 -0.864 . . . . 0.0 109.441 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.47 ' HA ' HG23 ' A' ' 63' ' ' ILE . 39.4 t -58.3 -23.48 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.354 -0.841 . . . . 0.0 109.734 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 3.4 ttm180 -83.7 -42.07 17.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.179 -0.95 . . . . 0.0 109.507 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -62.75 -59.39 4.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.332 -0.855 . . . . 0.0 109.93 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.466 ' HB ' HD12 ' A' ' 63' ' ' ILE . 16.3 mt -56.54 -50.75 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.925 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.501 ' N ' HD13 ' A' ' 63' ' ' ILE . . . -59.17 -21.43 59.38 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 109.931 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -78.61 -37.67 41.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.145 -0.972 . . . . 0.0 109.68 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.5 mt -82.82 -17.29 44.54 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.19 -0.944 . . . . 0.0 109.623 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.411 ' C ' ' HD2' ' A' ' 49' ' ' PRO . 0.2 OUTLIER -121.4 8.9 10.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.437 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.575 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -44.41 -51.41 20.18 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 0.0 109.893 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 48' ' ' MET . 35.2 Cg_endo -78.48 97.7 1.15 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.338 2.026 . . . . 0.0 110.436 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -170.15 -46.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.29 -0.881 . . . . 0.0 109.594 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' A' ' 52' ' ' ASN . 0.9 OUTLIER -115.57 39.43 2.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -0.95 . . . . 0.0 109.584 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 51' ' ' LEU . 32.5 t30 41.98 57.85 3.07 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.396 -0.815 . . . . 0.0 109.747 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.94 173.6 3.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.228 -0.92 . . . . 0.0 109.446 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -86.66 -45.92 10.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.905 . . . . 0.0 109.263 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.462 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -174.57 -39.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.303 -0.873 . . . . 0.0 109.3 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -172.93 -32.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -63.55 -59.98 3.93 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.411 -0.806 . . . . 0.0 109.995 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.97 -44.35 74.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 109.657 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.85 -24.22 66.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.227 -0.921 . . . . 0.0 109.656 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.85 -29.76 56.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 109.855 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -77.74 -23.35 49.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.9 . . . . 0.0 109.721 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.11 -56.05 5.01 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.19 -0.944 . . . . 0.0 109.892 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.501 HD13 ' N ' ' A' ' 44' ' ' ALA . 6.4 mt -56.0 -38.06 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.111 -0.993 . . . . 0.0 109.857 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 15.9 mt-10 -60.34 -55.03 38.56 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.106 -0.996 . . . . 0.0 109.474 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -52.94 -17.43 4.99 Favored Glycine 0 N--CA 1.482 1.754 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.527 HG23 ' CD1' ' A' ' 14' ' ' LEU . 61.1 m -84.57 -50.01 8.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.118 -1.225 . . . . 0.0 110.267 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.41 3.68 42.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.079 -1.013 . . . . 0.0 110.058 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 10.4 mtp180 -104.32 -36.3 7.66 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.058 -1.026 . . . . 0.0 109.415 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.96 -8.36 37.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 110.038 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.466 ' HG3' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -77.55 -62.94 1.5 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.074 -1.016 . . . . 0.0 109.544 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -159.19 -86.54 0.06 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.515 ' CD1' ' C ' ' A' ' 72' ' ' ILE . 2.5 pp -59.88 174.21 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -1.124 . . . . 0.0 109.665 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.432 ' N ' HD11 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -114.5 157.76 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.37 -0.831 . . . . 0.0 109.211 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.418 HG11 HG13 ' A' ' 35' ' ' ILE . 2.3 t -115.8 142.79 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.443 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 13.0 pt-20 -105.1 97.38 7.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.268 -0.895 . . . . 0.0 109.491 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.414 ' HB2' ' OE2' ' A' ' 64' ' ' GLU . 51.2 t0 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.507 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.515 ' HE2' ' CD ' ' A' ' 6' ' ' LYS . 26.5 ttp . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.9 p -92.79 -173.28 3.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.336 -0.853 . . . . 0.0 109.624 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 56.76 28.1 13.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 109.363 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.4 ' O ' ' C ' ' A' ' 5' ' ' THR . 6.5 mm -137.92 113.68 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.906 . . . . 0.0 109.087 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -42.61 113.59 0.48 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.869 . . . . 0.0 109.691 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.515 ' CD ' ' HE2' ' A' ' 1' ' ' MET . 0.1 OUTLIER -149.69 163.92 36.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 0.0 109.342 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.5 m -115.76 85.47 14.32 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.3 -0.875 . . . . 0.0 109.756 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.581 ' HG2' ' CG2' ' A' ' 12' ' ' VAL . 30.1 Cg_endo -75.16 168.33 24.96 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.208 1.939 . . . . 0.0 109.845 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.553 ' HA ' ' CD2' ' A' ' 13' ' ' LEU . 36.7 Cg_endo -80.96 -156.05 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 123.298 2.665 . . . . 0.0 112.698 -177.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.507 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . 32.0 -121.12 0.06 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.209 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.507 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -24.0 -61.78 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.831 -0.543 . . . . 0.0 112.273 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.581 ' CG2' ' HG2' ' A' ' 8' ' ' PRO . 19.6 t -62.85 -47.47 92.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.004 -1.06 . . . . 0.0 110.849 -178.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.579 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 1.3 mm? -60.97 -18.0 54.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.794 -1.191 . . . . 0.0 109.977 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 15' ' ' LYS . 17.7 mt -86.38 -53.74 4.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.088 -1.007 . . . . 0.0 109.717 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.464 ' CG ' HD13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -45.5 -44.89 12.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -0.967 . . . . 0.0 109.181 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -40.47 86.47 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.335 -0.853 . . . . 0.0 109.416 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.09 -37.64 46.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.432 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.01 -66.55 0.74 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.895 . . . . 0.0 109.588 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 20' ' ' ILE . . . 115.32 41.2 0.82 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.478 HG22 HD11 ' A' ' 20' ' ' ILE . 46.8 mt -43.49 100.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.26 -1.141 . . . . 0.0 109.774 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 19' ' ' GLY . 5.7 mt-10 -106.81 -90.74 0.42 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.171 -0.956 . . . . 0.0 109.246 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.5 m -81.14 179.36 7.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.345 -0.847 . . . . 0.0 109.23 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 24' ' ' SER . . . 179.48 -115.9 0.5 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER 75.5 -176.12 0.13 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -1.116 . . . . 0.0 109.57 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 26' ' ' GLU . . . -67.41 -15.33 65.75 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 25' ' ' GLY . 18.1 tt0 -43.24 111.68 1.1 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.249 -1.147 . . . . 0.0 109.686 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.87 128.95 9.56 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.44 2.094 . . . . 0.0 110.369 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -141.88 41.14 1.68 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.176 -0.953 . . . . 0.0 109.716 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.04 9.75 7.85 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.151 -0.968 . . . . 0.0 109.855 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -95.9 -18.62 20.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.066 -1.021 . . . . 0.0 109.845 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.7 mtpt -96.88 -172.95 2.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.139 -0.976 . . . . 0.0 109.458 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 80.8 t -92.57 122.24 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.189 -0.945 . . . . 0.0 109.304 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.07 58.46 1.52 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.203 -0.936 . . . . 0.0 109.527 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.16 179.34 6.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 109.321 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 73' ' ' VAL . 8.9 pt -120.04 -175.19 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.913 . . . . 0.0 109.552 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -109.04 156.91 19.21 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.262 -0.899 . . . . 0.0 109.653 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.98 -16.31 64.27 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.3 -0.875 . . . . 0.0 109.628 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.441 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 11.7 t70 -48.25 -44.51 33.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 109.449 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.441 ' NZ ' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -55.0 -61.68 2.15 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.285 -0.884 . . . . 0.0 109.258 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.541 ' O ' ' CB ' ' A' ' 44' ' ' ALA . 46.0 t -46.94 -23.42 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.277 -0.89 . . . . 0.0 109.893 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.423 ' HB3' ' O ' ' A' ' 38' ' ' ASP . 4.0 ttt85 -75.12 -61.29 1.94 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.073 -1.017 . . . . 0.0 109.851 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -58.17 -52.64 64.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.233 -0.917 . . . . 0.0 110.032 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 82.8 mt -61.13 -43.06 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.205 -0.935 . . . . 0.0 110.082 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 40' ' ' VAL . . . -52.96 -49.59 65.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.045 -1.034 . . . . 0.0 109.72 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -49.22 78.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.505 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.505 ' N ' HD21 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -65.07 -15.02 61.9 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.256 -0.903 . . . . 0.0 110.094 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -102.89 21.46 15.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.139 -0.975 . . . . 0.0 109.919 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.562 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -57.21 -53.83 61.2 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.085 -1.009 . . . . 0.0 109.325 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.562 ' HD3' ' CB ' ' A' ' 48' ' ' MET . 36.5 Cg_endo -79.54 74.49 5.52 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.52 2.146 . . . . 0.0 110.296 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -150.26 -65.35 0.2 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.18 -0.95 . . . . 0.0 109.418 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 52' ' ' ASN . 1.5 pp -117.3 18.85 14.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.37 -0.831 . . . . 0.0 109.368 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 51' ' ' LEU . 1.2 p-10 39.73 68.16 0.4 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.483 -0.761 . . . . 0.0 109.915 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.422 ' O ' ' C ' ' A' ' 54' ' ' ALA . . . -63.5 168.35 4.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.171 -0.956 . . . . 0.0 109.501 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 53' ' ' ALA . . . -44.0 -36.54 2.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.893 . . . . 0.0 109.061 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 54' ' ' ALA . 1.6 m 174.3 -40.06 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.343 -0.848 . . . . 0.0 108.842 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.7 tt -171.34 -33.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 121.321 -0.862 . . . . 0.0 109.028 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.6 -67.42 0.46 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.297 -0.877 . . . . 0.0 110.331 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -44.67 -39.82 5.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.28 -0.887 . . . . 0.0 110.217 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.26 -44.38 97.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.065 -1.022 . . . . 0.0 110.041 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -40.14 94.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 110.347 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -70.38 -21.05 62.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -0.965 . . . . 0.0 110.151 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -56.45 5.09 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.097 -1.002 . . . . 0.0 109.605 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.518 ' HB ' ' CG1' ' A' ' 40' ' ' VAL . 15.3 mt -54.37 -35.74 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.256 -0.903 . . . . 0.0 109.423 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 1.2 tt0 -59.21 -56.83 17.09 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.225 -0.922 . . . . 0.0 109.378 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.88 -20.13 2.83 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.522 ' O ' ' CG ' ' A' ' 70' ' ' MET . 12.0 m -79.86 -57.5 3.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.397 -1.061 . . . . 0.0 109.921 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.452 ' HB3' HD12 ' A' ' 72' ' ' ILE . . . -78.15 10.62 2.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.961 . . . . 0.0 110.345 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -105.17 -55.48 2.32 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.993 -1.067 . . . . 0.0 110.476 -179.554 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.87 -25.7 12.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.078 -1.014 . . . . 0.0 111.899 -178.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.541 ' HG3' ' N ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -70.36 -30.81 67.83 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.543 -1.348 . . . . 0.0 110.901 -178.356 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.541 ' N ' ' HG3' ' A' ' 70' ' ' MET . . . -160.83 -123.09 0.66 Allowed Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.206 -1.473 . . . . 0.0 110.744 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.516 HD13 ' N ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -48.99 -178.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.491 -1.005 . . . . 0.0 110.527 -179.025 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.451 ' O ' HG12 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -110.99 -168.61 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.539 -0.725 . . . . 0.0 109.421 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.429 ' CG2' ' C ' ' A' ' 73' ' ' VAL . 2.1 t -151.34 155.53 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 109.659 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -115.79 135.29 54.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 109.384 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.493 -179.934 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ttt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.4 m 60.81 52.58 4.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.932 . . . . 0.0 109.286 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.13 62.77 1.46 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 109.464 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.456 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 1.2 tt -160.41 116.15 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.898 . . . . 0.0 109.518 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 4' ' ' ILE . 45.5 m 43.71 80.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 109.524 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 7' ' ' THR . 0.3 OUTLIER -79.76 87.43 5.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.306 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER 44.83 90.72 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.321 -0.862 . . . . 0.0 109.618 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.457 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 35.5 Cg_endo -77.3 174.87 12.07 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.612 2.208 . . . . 0.0 110.091 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.499 ' O ' ' CG ' ' A' ' 13' ' ' LEU . 34.0 Cg_endo -77.04 142.56 22.03 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.46 2.107 . . . . 0.0 110.403 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . -73.3 -55.78 5.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 109.843 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -42.92 -65.25 0.5 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.882 . . . . 0.0 109.884 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.468 ' HB ' ' HG2' ' A' ' 9' ' ' PRO . 92.9 t -61.21 -38.08 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.791 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.499 ' CG ' ' O ' ' A' ' 9' ' ' PRO . 5.3 mt -44.67 -42.48 7.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 109.698 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.448 ' CD1' HG23 ' A' ' 66' ' ' THR . 0.8 OUTLIER -74.12 -40.35 62.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.087 -1.008 . . . . 0.0 109.553 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -50.06 -37.24 32.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.885 . . . . 0.0 109.296 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -79.6 -33.45 41.56 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.323 -0.861 . . . . 0.0 109.435 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.04 -25.33 58.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.564 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.99 -73.68 0.17 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 109.379 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.75 49.72 0.83 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.401 ' O ' ' C ' ' A' ' 21' ' ' GLU . 20.4 mt -68.63 -4.67 3.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.303 -1.116 . . . . 0.0 110.022 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 20' ' ' ILE . 20.0 tp10 -45.48 116.4 1.15 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.139 -0.976 . . . . 0.0 109.447 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 t -175.2 -76.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 109.413 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.61 -96.74 0.03 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.98 160.1 15.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.306 -1.114 . . . . 0.0 109.679 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 26' ' ' GLU . . . 96.06 95.46 1.79 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 0.4 OUTLIER -44.43 143.85 1.89 Allowed Pre-proline 0 C--N 1.306 -1.312 0 O-C-N 121.202 -1.175 . . . . 0.0 109.4 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.53 119.83 5.01 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.598 2.199 . . . . 0.0 110.683 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -110.57 -79.61 0.58 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.91 . . . . 0.0 109.466 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.8 82.68 5.85 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.176 -0.952 . . . . 0.0 109.558 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.409 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 38.7 p30 -96.94 145.9 25.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.178 -0.951 . . . . 0.0 109.402 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.81 -171.65 2.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.167 -0.958 . . . . 0.0 109.742 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.493 ' O ' ' CG2' ' A' ' 34' ' ' THR . 38.6 t -60.31 130.89 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.375 -0.828 . . . . 0.0 109.434 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.87 93.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.128 -0.983 . . . . 0.0 109.175 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.493 ' CG2' ' O ' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -157.66 176.16 12.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.199 -0.938 . . . . 0.0 109.691 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.458 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 27.3 pt -126.26 160.11 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.438 -0.789 . . . . 0.0 109.37 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.89 122.52 26.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.293 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -57.47 -15.69 7.6 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.231 -0.918 . . . . 0.0 110.083 -179.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 37' ' ' ARG . 31.2 t0 -43.9 -37.27 2.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.048 -1.032 . . . . 0.0 109.351 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.464 ' O ' HG13 ' A' ' 43' ' ' ILE . 13.4 mmtt -65.96 -56.31 12.32 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.155 -0.965 . . . . 0.0 109.11 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.498 ' CG2' HG23 ' A' ' 63' ' ' ILE . 37.9 t -42.06 -28.28 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 109.453 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -69.47 -54.74 12.79 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.305 -0.872 . . . . 0.0 109.375 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.21 -9.77 56.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.265 -0.897 . . . . 0.0 109.912 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 39' ' ' LYS . 11.9 mt -105.07 -8.73 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.098 -1.001 . . . . 0.0 109.855 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 40' ' ' VAL . . . -101.87 -19.12 15.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.971 . . . . 0.0 110.047 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -105.57 -32.34 8.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.384 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.6 mt -95.49 11.17 33.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.092 -1.005 . . . . 0.0 110.454 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.438 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -134.47 -53.2 0.83 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.049 -1.032 . . . . 0.0 109.496 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.427 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 19.4 mmt -58.86 111.49 3.74 Favored Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 121.31 -0.869 . . . . 0.0 109.733 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.548 ' HD2' ' CD2' ' A' ' 51' ' ' LEU . 34.9 Cg_endo -76.32 -30.7 5.14 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.366 2.044 . . . . 0.0 110.927 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 52' ' ' ASN . 12.4 t70 -173.14 -53.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.803 -1.186 . . . . 0.0 110.857 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.548 ' CD2' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER 27.04 38.77 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.927 -0.483 . . . . 0.0 111.089 -179.068 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.555 ' N ' ' O ' ' A' ' 50' ' ' ASP . 26.6 t-20 37.63 59.8 1.21 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.498 -0.751 . . . . 0.0 109.928 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -107.68 134.98 49.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.958 . . . . 0.0 109.798 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.19 -59.33 5.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.276 -0.89 . . . . 0.0 109.22 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.436 ' C ' HG13 ' A' ' 56' ' ' ILE . 3.1 p 178.51 -48.82 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.35 -0.844 . . . . 0.0 109.32 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.483 ' O ' ' HB2' ' A' ' 60' ' ' MET . 3.3 mt -137.35 5.14 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 O-C-N 121.175 -0.953 . . . . 0.0 109.345 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 61' ' ' ARG . 0.8 OUTLIER -100.32 -54.24 2.91 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.162 -0.962 . . . . 0.0 110.031 -179.249 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.38 -61.86 1.85 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.325 -0.859 . . . . 0.0 109.959 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.08 -37.78 55.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 109.791 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.483 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -75.91 -41.15 52.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.152 -0.967 . . . . 0.0 110.032 -179.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 57' ' ' GLU . 16.8 mtp180 -74.65 -7.36 52.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.105 -0.997 . . . . 0.0 109.534 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.446 ' HE3' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -83.71 -54.85 4.62 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.275 -0.891 . . . . 0.0 109.38 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.498 HG23 ' CG2' ' A' ' 40' ' ' VAL . 10.8 mt -63.69 -36.35 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.625 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -64.49 -50.97 65.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.103 -0.998 . . . . 0.0 109.125 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.07 -12.44 30.13 Favored Glycine 0 N--CA 1.481 1.693 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 13.7 m -84.23 -51.55 6.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -1.147 . . . . 0.0 109.425 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.492 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -79.78 -5.03 54.53 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.254 -0.904 . . . . 0.0 109.638 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 1.5 ttp180 -87.77 -48.09 8.11 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.946 -1.096 . . . . 0.0 109.505 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.59 -49.21 16.89 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.353 -0.842 . . . . 0.0 110.459 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.466 ' HG3' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -100.92 -30.49 11.63 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.127 -0.983 . . . . 0.0 110.496 -178.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.466 ' N ' ' HG3' ' A' ' 70' ' ' MET . . . -89.31 -147.95 17.19 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.96 -1.114 . . . . 0.0 110.674 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.501 ' CD1' ' C ' ' A' ' 72' ' ' ILE . 1.1 pp -105.87 -170.26 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.517 -0.99 . . . . 0.0 109.995 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.3 t -84.77 111.15 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.145 -0.972 . . . . 0.0 109.676 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.0 t -80.19 153.46 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 0.0 109.378 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 35' ' ' ILE . 14.8 pt-20 -113.63 -176.17 2.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.899 . . . . 0.0 109.458 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.6 t70 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.464 179.983 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.1 t -115.14 165.96 12.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -0.931 . . . . 0.0 109.421 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.573 ' CG ' ' O ' ' A' ' 3' ' ' PHE . 1.0 OUTLIER -61.46 119.34 8.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.956 . . . . 0.0 109.787 -179.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.05 17.83 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.168 -0.957 . . . . 0.0 109.464 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.9 t -165.45 27.85 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 0.0 109.325 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.19 124.12 25.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.349 -0.845 . . . . 0.0 109.959 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.34 135.67 21.71 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.287 -0.883 . . . . 0.0 109.417 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.422 ' HG2' HD22 ' A' ' 13' ' ' LEU . 36.2 Cg_endo -79.76 156.48 24.23 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.412 2.075 . . . . 0.0 109.972 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 12' ' ' VAL . 35.5 Cg_endo -77.4 -170.27 0.9 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.557 2.172 . . . . 0.0 110.543 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -70.66 -68.63 0.42 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.208 -0.932 . . . . 0.0 109.862 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -37.29 -45.03 0.63 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.507 -0.746 . . . . 0.0 110.683 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.459 ' HB ' ' HD2' ' A' ' 9' ' ' PRO . 49.0 t -65.96 -47.32 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.101 -1.0 . . . . 0.0 109.815 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.422 HD22 ' HG2' ' A' ' 8' ' ' PRO . 19.8 mt -57.9 -63.04 1.39 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.669 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.451 HD23 ' HE2' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -44.39 -30.68 0.88 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.263 -0.898 . . . . 0.0 109.744 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -69.52 -46.45 66.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.73 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.1 9.89 9.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.634 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.06 -23.03 31.01 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.183 -0.948 . . . . 0.0 109.478 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.65 -50.82 10.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.942 . . . . 0.0 109.386 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.43 64.58 0.45 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.4 mt -62.29 94.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.21 -1.171 . . . . 0.0 109.522 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -80.36 131.53 35.64 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.262 -0.899 . . . . 0.0 109.379 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.34 133.39 35.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.194 -0.941 . . . . 0.0 109.621 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.03 67.89 0.01 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.478 ' OG ' ' N ' ' A' ' 25' ' ' GLY . 0.8 OUTLIER -87.21 176.34 7.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -1.142 . . . . 0.0 109.593 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.478 ' N ' ' OG ' ' A' ' 24' ' ' SER . . . 152.85 40.03 0.02 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 0.7 OUTLIER 175.6 104.49 0.09 OUTLIER Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 121.589 -0.948 . . . . 0.0 108.721 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -76.82 105.57 2.1 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.351 2.034 . . . . 0.0 110.64 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -101.12 -161.21 0.84 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.38 -0.825 . . . . 0.0 109.411 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.48 -93.13 0.45 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.219 -0.926 . . . . 0.0 109.425 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -77.06 108.42 10.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -0.869 . . . . 0.0 109.521 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.96 83.87 5.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.436 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.29 144.39 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.703 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -161.45 85.49 0.65 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.327 -0.858 . . . . 0.0 109.301 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.01 162.29 14.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 109.616 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.458 HD13 ' O ' ' A' ' 36' ' ' LYS . 1.2 pp -136.92 172.9 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -0.844 . . . . 0.0 109.517 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.458 ' O ' HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -86.31 173.95 9.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.747 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -88.34 15.21 8.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.438 -0.789 . . . . 0.0 109.607 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 6.2 t70 -50.09 -39.95 44.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.599 -0.688 . . . . 0.0 110.194 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.451 ' HE2' HD23 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -71.9 -31.25 66.22 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.178 -0.951 . . . . 0.0 110.594 -179.177 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.527 ' CG2' HG21 ' A' ' 63' ' ' ILE . 47.4 t -65.04 -29.1 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.976 -1.077 . . . . 0.0 110.056 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.453 ' CB ' ' CZ ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -82.78 -30.89 28.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.114 -0.991 . . . . 0.0 109.973 -179.524 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 38' ' ' ASP . 6.7 mm-40 -76.26 -58.24 3.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.954 . . . . 0.0 109.819 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.3 mt -61.26 -55.11 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 110.273 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' ' 40' ' ' VAL . . . -47.25 -50.73 20.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.225 -0.922 . . . . 0.0 110.504 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -71.64 -24.63 61.89 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.044 -1.035 . . . . 0.0 110.368 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 mt -80.38 -11.68 59.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.004 -1.06 . . . . 0.0 109.627 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.48 39.99 1.89 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.265 -0.897 . . . . 0.0 109.274 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.557 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -50.5 -53.21 48.08 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.178 -0.951 . . . . 0.0 109.218 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.557 ' HD3' ' CB ' ' A' ' 48' ' ' MET . 36.8 Cg_endo -80.99 41.54 1.17 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.612 2.208 . . . . 0.0 110.404 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -111.13 -14.55 13.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.097 -1.002 . . . . 0.0 109.819 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -127.63 -99.24 0.37 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.13 -0.981 . . . . 0.0 109.591 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 57.0 t30 177.78 34.56 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.187 -0.946 . . . . 0.0 109.454 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.74 164.45 1.11 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.23 -22.38 66.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.267 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.465 ' O ' ' SD ' ' A' ' 48' ' ' MET . 0.1 OUTLIER -172.34 -50.19 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.286 -0.884 . . . . 0.0 108.937 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.482 HG21 ' N ' ' A' ' 57' ' ' GLU . 1.8 tt -174.9 -34.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.482 ' N ' HG21 ' A' ' 56' ' ' ILE . 15.9 tt0 -57.85 -66.1 0.53 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.533 -0.73 . . . . 0.0 109.805 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 57' ' ' GLU . . . -42.63 -36.65 1.46 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.354 -0.841 . . . . 0.0 109.751 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.13 -47.95 75.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.135 -0.978 . . . . 0.0 109.772 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.7 -38.02 83.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.989 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.429 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 35.7 mtp180 -74.0 -18.26 60.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 0.0 109.769 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.42 ' O ' ' OG1' ' A' ' 66' ' ' THR . 0.0 OUTLIER -79.75 -39.77 30.29 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.125 -0.984 . . . . 0.0 109.672 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.527 HG21 ' CG2' ' A' ' 40' ' ' VAL . 7.4 mt -65.46 -42.39 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.143 -0.973 . . . . 0.0 109.874 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.495 ' CD ' ' N ' ' A' ' 65' ' ' GLY . 3.0 pp20? -63.35 -47.09 83.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.996 -1.065 . . . . 0.0 109.384 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.495 ' N ' ' CD ' ' A' ' 64' ' ' GLU . . . -65.4 -11.09 51.61 Favored Glycine 0 N--CA 1.478 1.485 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.478 ' O ' ' HB2' ' A' ' 70' ' ' MET . 86.2 m -81.57 -44.62 17.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.388 -1.066 . . . . 0.0 109.517 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -82.35 -16.09 50.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 108.777 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -40.78 65.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.459 -0.775 . . . . 0.0 109.38 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.81 -31.3 14.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.13 -0.981 . . . . 0.0 109.87 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.478 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -53.99 -72.95 0.05 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.211 -0.931 . . . . 0.0 109.19 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 72' ' ' ILE . . . -162.48 -87.74 0.07 OUTLIER Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -39.56 152.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.642 -0.916 . . . . 0.0 110.389 -179.526 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.64 135.52 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.443 ' CG2' ' HB2' ' A' ' 67' ' ' ALA . 2.1 t -108.63 155.39 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.982 -1.074 . . . . 0.0 110.176 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -110.35 -171.37 1.82 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.396 -0.815 . . . . 0.0 109.123 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.9 t70 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.637 -179.928 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.461 ' HG3' ' N ' ' A' ' 2' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.504 ' C ' ' CG ' ' A' ' 3' ' ' PHE . 60.2 p -95.49 85.81 4.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.438 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.529 ' O ' ' CB ' ' A' ' 4' ' ' ILE . 0.8 OUTLIER 64.71 113.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.924 . . . . 0.0 109.132 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.529 ' CB ' ' O ' ' A' ' 3' ' ' PHE . 0.5 OUTLIER 80.46 133.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.455 -0.778 . . . . 0.0 109.176 -179.821 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.0 m -86.17 -20.5 28.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.906 . . . . 0.0 109.536 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.415 ' O ' ' CB ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -68.18 169.28 10.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.181 -0.949 . . . . 0.0 109.351 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.465 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 0.2 OUTLIER 70.5 63.69 0.47 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.209 -0.932 . . . . 0.0 109.713 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.465 ' HD3' ' N ' ' A' ' 7' ' ' THR . 35.2 Cg_endo -77.7 148.12 25.4 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.568 2.179 . . . . 0.0 110.48 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.542 ' HG2' ' CG2' ' A' ' 12' ' ' VAL . 35.8 Cg_endo -77.52 147.76 25.59 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.73 2.286 . . . . 0.0 110.37 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -52.52 -61.31 2.36 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.294 -0.879 . . . . 0.0 110.129 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -36.4 -40.73 0.25 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.619 -0.676 . . . . 0.0 110.49 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.542 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 72.8 t -74.94 -43.01 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.09 -1.006 . . . . 0.0 109.465 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' A' ' 10' ' ' ALA . 63.0 mt -56.04 -66.74 0.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.994 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.488 ' HG ' ' N ' ' A' ' 15' ' ' LYS . 1.8 pp -57.74 -28.18 63.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.176 -0.953 . . . . 0.0 109.658 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.488 ' N ' ' HG ' ' A' ' 14' ' ' LEU . 57.1 tttt -56.29 -50.81 70.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.546 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -25.54 65.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.686 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.425 ' HB2' ' HE3' ' A' ' 39' ' ' LYS . . . -74.44 -8.84 57.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.201 -0.937 . . . . 0.0 109.58 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.54 -36.54 12.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.61 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.65 51.61 19.61 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.0 mt -60.97 -22.74 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.29 -1.123 . . . . 0.0 109.823 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -82.05 121.87 27.1 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.318 -0.864 . . . . 0.0 109.413 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 77.6 p -125.75 179.1 5.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.131 -0.98 . . . . 0.0 109.61 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.38 -105.7 0.78 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 t -112.58 142.68 44.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -1.148 . . . . 0.0 109.378 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 26' ' ' GLU . . . 101.77 170.39 27.64 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 25' ' ' GLY . 61.6 tt0 45.2 85.79 0.16 Allowed Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.225 -1.162 . . . . 0.0 109.073 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.62 163.2 32.09 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.562 2.174 . . . . 0.0 110.423 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -59.85 106.14 0.46 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.309 -0.869 . . . . 0.0 109.465 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -73.23 -166.51 0.33 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.241 -0.912 . . . . 0.0 109.766 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.1 -48.51 17.56 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.272 -0.892 . . . . 0.0 109.709 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.42 129.93 45.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 109.522 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.569 ' CG1' ' CG2' ' A' ' 73' ' ' VAL . 6.3 p -48.74 161.47 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.232 -0.918 . . . . 0.0 109.503 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.433 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . -66.58 124.09 21.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.477 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.488 HG21 HG21 ' A' ' 73' ' ' VAL . 0.9 OUTLIER -101.83 140.04 36.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.419 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 pt -91.69 171.79 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.233 -0.917 . . . . 0.0 109.441 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 mtmt -89.75 151.49 21.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 109.357 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.16 -16.58 64.1 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.206 -0.933 . . . . 0.0 109.303 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -45.69 -41.64 10.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.365 -0.835 . . . . 0.0 109.608 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.465 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.7 OUTLIER -59.76 -64.19 1.04 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 109.367 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.528 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 56.1 t -45.74 -23.64 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 0.0 109.973 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -42.79 32.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.118 -0.989 . . . . 0.0 110.162 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -84.6 -6.57 59.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.11 -0.994 . . . . 0.0 110.026 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 39' ' ' LYS . 7.6 mt -93.51 -39.68 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.061 -1.024 . . . . 0.0 109.898 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 48' ' ' MET . . . -77.97 -39.68 41.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.148 -0.97 . . . . 0.0 109.525 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -53.87 -20.59 6.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.272 -0.892 . . . . 0.0 109.77 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.3 mt -96.01 -30.89 13.33 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.141 -0.975 . . . . 0.0 109.653 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 50' ' ' ASP . 33.3 mmtt -131.39 43.51 3.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.913 . . . . 0.0 109.264 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.552 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -64.03 -52.54 55.32 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.387 -0.821 . . . . 0.0 110.01 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 48' ' ' MET . 35.5 Cg_endo -78.21 -3.03 13.06 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.41 2.074 . . . . 0.0 110.575 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.449 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 18.3 t70 -62.26 -13.32 26.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.348 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -139.84 27.81 2.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.397 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 51' ' ' LEU . 20.6 t30 42.33 74.58 0.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.344 -0.848 . . . . 0.0 109.622 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.29 155.33 32.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 0.0 109.504 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -45.49 -35.31 3.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.467 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 m 174.87 -44.67 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.253 -0.904 . . . . 0.0 109.107 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.407 HG13 ' HE3' ' A' ' 48' ' ' MET . 1.5 tt -173.5 -33.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.278 -0.889 . . . . 0.0 109.011 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 58' ' ' ALA . 1.2 tt0 -75.23 -66.41 0.77 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.409 -0.807 . . . . 0.0 110.195 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 57' ' ' GLU . . . -42.49 -40.53 2.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.254 -0.904 . . . . 0.0 110.205 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 62' ' ' MET . . . -60.41 -47.87 84.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.958 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.6 mtm -59.2 -46.7 87.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 110.186 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.6 mtp-105 -66.58 -19.18 65.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 110.006 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.457 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -68.36 -50.84 50.34 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.083 -1.011 . . . . 0.0 109.341 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.528 ' HB ' ' CG1' ' A' ' 40' ' ' VAL . 6.0 mt -59.73 -35.47 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.219 -0.926 . . . . 0.0 109.607 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.91 -52.3 64.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.086 -1.009 . . . . 0.0 109.061 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -55.59 -16.82 11.88 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 75.7 m -82.29 -52.29 7.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.359 -1.083 . . . . 0.0 109.351 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.477 ' HB1' ' CG2' ' A' ' 74' ' ' VAL . . . -75.71 -3.73 36.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.308 -0.87 . . . . 0.0 109.322 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -86.87 -48.68 7.98 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.211 -0.931 . . . . 0.0 109.299 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.8 p -81.43 -33.2 32.27 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.265 -0.897 . . . . 0.0 109.65 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -70.5 0.09 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.184 -0.948 . . . . 0.0 109.657 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -160.12 -74.29 0.02 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.514 ' N ' ' CD1' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -66.74 -174.98 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -1.16 . . . . 0.0 109.939 -179.632 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.569 ' CG2' ' CG1' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -132.17 132.4 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.34 -0.85 . . . . 0.0 109.22 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.477 ' CG2' ' HB1' ' A' ' 67' ' ' ALA . 27.7 t -81.64 157.48 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.632 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.475 ' N ' HG11 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -115.08 95.06 5.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 109.449 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.518 -179.973 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.294 0.569 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.09 32.25 6.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 109.572 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -111.58 95.57 5.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 109.637 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.52 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 0.6 OUTLIER -97.12 115.49 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.917 . . . . 0.0 109.332 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.71 88.03 0.52 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.517 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.22 74.03 1.16 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.253 -0.904 . . . . 0.0 109.421 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.541 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 53.83 56.39 13.08 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.038 -1.039 . . . . 0.0 109.459 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.637 ' N ' ' CD ' ' A' ' 9' ' ' PRO . 26.0 Cg_endo -69.27 -33.78 17.68 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.1 1.866 . . . . 0.0 111.981 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 8' ' ' PRO . 32.9 Cg_endo -74.29 -41.3 0.93 Allowed 'Trans proline' 0 C--O 1.207 -1.07 0 C-N-CA 121.363 1.375 . . . . 0.0 109.95 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.557 ' C ' ' O ' ' A' ' 9' ' ' PRO . . . -17.63 -66.55 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.191 0.519 . . . . 0.0 111.502 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.66 -51.06 70.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.069 -1.019 . . . . 0.0 109.551 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 9' ' ' PRO . 42.4 t -45.81 -53.36 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.335 -0.853 . . . . 0.0 109.783 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.553 ' CD1' ' HB2' ' A' ' 9' ' ' PRO . 8.9 mp -47.17 -70.56 0.09 Allowed 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.331 -0.855 . . . . 0.0 110.15 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.53 ' CD1' HG23 ' A' ' 66' ' ' THR . 5.4 mt -55.94 -17.23 6.1 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.289 -0.882 . . . . 0.0 110.18 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.83 -38.07 67.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.096 -1.002 . . . . 0.0 109.237 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -79.09 -22.29 45.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.266 -0.896 . . . . 0.0 109.229 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.8 -66.59 0.38 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.219 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.5 -87.53 0.08 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.272 -0.892 . . . . 0.0 109.209 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.08 43.58 0.04 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.0 mm -50.51 -72.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.214 -1.168 . . . . 0.0 109.348 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.461 ' OE1' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -80.74 123.66 28.39 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.63 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.3 m -107.89 -174.18 2.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.212 -0.93 . . . . 0.0 109.787 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' ' 24' ' ' SER . . . -67.93 -8.76 54.69 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 2.6 m 73.28 172.51 0.3 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -1.139 . . . . 0.0 109.507 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.481 ' O ' ' HD3' ' A' ' 27' ' ' PRO . . . 90.06 -90.19 1.59 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -112.14 91.83 16.96 Favored Pre-proline 0 C--N 1.306 -1.297 0 O-C-N 121.257 -1.143 . . . . 0.0 109.774 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 25' ' ' GLY . 36.6 Cg_endo -78.4 122.73 5.71 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.583 2.189 . . . . 0.0 110.413 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.422 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 30.4 t-20 -56.5 120.05 7.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.187 -0.946 . . . . 0.0 109.363 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -56.15 99.74 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.282 -0.886 . . . . 0.0 109.704 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 28' ' ' ASN . 5.5 p-10 -178.66 145.31 0.3 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.866 . . . . 0.0 109.408 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.51 -171.93 2.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.153 -0.967 . . . . 0.0 109.647 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 m -65.26 174.21 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.34 -0.85 . . . . 0.0 110.145 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -156.82 171.28 20.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.453 -0.779 . . . . 0.0 109.394 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.79 133.22 34.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 109.575 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.459 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 4.1 pt -107.93 170.88 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 0.0 109.386 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -79.83 147.27 31.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.768 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.18 -6.37 33.92 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.288 -0.882 . . . . 0.0 109.699 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -41.98 -39.88 2.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.33 -0.857 . . . . 0.0 109.945 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -58.25 7.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.148 -0.97 . . . . 0.0 109.693 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.521 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 86.1 t -46.73 -27.77 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.303 -0.873 . . . . 0.0 110.024 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -70.92 -46.59 62.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.105 -0.997 . . . . 0.0 109.791 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 43' ' ' ILE . 2.0 tt0 -78.26 -65.4 0.98 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.155 -0.966 . . . . 0.0 109.791 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.453 HG22 HD22 ' A' ' 13' ' ' LEU . 10.8 mt -43.12 -44.8 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.927 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 40' ' ' VAL . . . -64.86 -43.77 91.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.164 -0.96 . . . . 0.0 109.717 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -58.08 -16.49 13.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 109.5 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.42 23.88 2.42 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.29 -0.881 . . . . 0.0 109.499 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.495 ' HD3' ' CB ' ' A' ' 50' ' ' ASP . 0.1 OUTLIER -144.0 18.02 1.77 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.0 109.413 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.547 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -43.73 -54.14 11.18 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.278 -0.889 . . . . 0.0 109.648 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.547 ' HD3' ' CB ' ' A' ' 48' ' ' MET . 36.5 Cg_endo -78.61 73.17 6.03 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.411 2.074 . . . . 0.0 110.438 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.495 ' CB ' ' HD3' ' A' ' 47' ' ' LYS . 36.8 t0 -162.4 -67.89 0.05 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.113 -0.992 . . . . 0.0 109.897 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.472 ' O ' ' CD1' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -114.18 38.7 2.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.139 -0.976 . . . . 0.0 109.868 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 51' ' ' LEU . 4.2 p-10 40.21 28.15 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.479 -0.763 . . . . 0.0 109.916 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -51.81 124.6 12.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.19 -0.944 . . . . 0.0 109.531 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.458 ' O ' ' CB ' ' A' ' 55' ' ' SER . . . -45.11 -57.92 3.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.939 . . . . 0.0 109.205 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 0.5 OUTLIER 166.32 -45.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.406 -0.809 . . . . 0.0 108.859 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 60' ' ' MET . 82.5 mt -140.05 7.8 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -104.92 -67.11 0.93 Allowed 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.259 -0.9 . . . . 0.0 109.45 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.09 -37.06 58.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.501 -0.749 . . . . 0.0 109.879 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.08 -31.66 68.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.128 -0.982 . . . . 0.0 109.383 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -78.64 -39.79 36.05 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.233 -0.917 . . . . 0.0 109.516 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -20.32 62.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.374 -0.829 . . . . 0.0 109.767 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.2 -60.82 2.18 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.179 -0.951 . . . . 0.0 110.075 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.521 ' HB ' ' CG1' ' A' ' 40' ' ' VAL . 14.9 mt -63.75 -42.75 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.191 -0.943 . . . . 0.0 109.967 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.453 ' HG2' HG22 ' A' ' 74' ' ' VAL . 24.2 tt0 -64.06 -48.52 75.91 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.092 -1.005 . . . . 0.0 109.302 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -67.25 -7.22 43.99 Favored Glycine 0 N--CA 1.478 1.447 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.53 HG23 ' CD1' ' A' ' 14' ' ' LEU . 8.5 m -87.26 -49.53 7.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -1.13 . . . . 0.0 109.46 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -71.49 -36.73 71.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.165 -0.96 . . . . 0.0 109.373 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -64.61 -59.2 4.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.403 -0.811 . . . . 0.0 109.907 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.71 -51.84 68.07 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.244 -0.91 . . . . 0.0 110.045 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.0 -68.88 0.15 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.217 -0.927 . . . . 0.0 109.384 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 72' ' ' ILE . . . -161.96 -88.02 0.07 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.48 ' C ' HD12 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -36.39 152.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.884 -0.774 . . . . 0.0 110.279 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.467 ' N ' HD12 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -112.88 164.76 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.391 -0.818 . . . . 0.0 108.881 179.527 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.453 HG22 ' HG2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -111.82 -174.55 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.13 -0.981 . . . . 0.0 109.695 -179.583 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 35' ' ' ILE . 0.4 OUTLIER -143.1 151.0 40.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.907 . . . . 0.0 109.267 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.7 t70 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.443 -179.951 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mtt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.9 t -100.41 -22.46 15.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.875 . . . . 0.0 109.573 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.553 ' CG ' ' O ' ' A' ' 3' ' ' PHE . 8.0 p90 -45.47 118.73 1.85 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 0.0 109.631 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.8 tp -54.05 135.05 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.926 . . . . 0.0 109.359 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -64.81 95.74 0.16 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.26 -0.9 . . . . 0.0 109.492 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.467 ' O ' ' O ' ' A' ' 5' ' ' THR . 0.1 OUTLIER 60.78 132.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.296 -0.878 . . . . 0.0 109.493 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.486 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -49.56 173.72 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.31 -0.869 . . . . 0.0 109.669 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.486 ' HD2' ' CB ' ' A' ' 7' ' ' THR . 35.7 Cg_endo -78.48 173.72 13.35 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.669 2.246 . . . . 0.0 110.562 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.458 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 35.9 Cg_endo -78.12 115.44 3.75 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.728 2.286 . . . . 0.0 110.398 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.498 ' HA ' ' CD1' ' A' ' 13' ' ' LEU . . . -47.52 -48.73 27.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.787 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -41.51 -50.58 3.97 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.387 -0.821 . . . . 0.0 109.652 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.448 HG22 ' HG2' ' A' ' 9' ' ' PRO . 91.5 t -68.34 -36.53 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.69 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.498 ' CD1' ' HA ' ' A' ' 10' ' ' ALA . 38.4 mt -53.88 -65.85 0.5 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.939 . . . . 0.0 109.57 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 15' ' ' LYS . 1.1 mt -43.18 -48.28 6.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -0.841 . . . . 0.0 109.76 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 14' ' ' LEU . 7.7 ttpt -42.85 -55.18 3.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 109.666 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.33 -43.72 98.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.206 -0.934 . . . . 0.0 109.564 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.63 -35.66 6.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.226 -0.921 . . . . 0.0 109.583 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.63 -66.5 0.86 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.184 -0.947 . . . . 0.0 109.422 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 20' ' ' ILE . . . 114.02 31.55 2.24 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.441 ' C ' ' O ' ' A' ' 19' ' ' GLY . 20.1 mt -42.5 100.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.252 -1.146 . . . . 0.0 109.558 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -91.65 -0.44 57.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.333 -0.854 . . . . 0.0 109.608 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 m -148.66 134.08 18.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.393 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -116.43 -15.36 7.06 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.73 177.24 4.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -1.12 . . . . 0.0 109.545 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 26' ' ' GLU . . . 141.47 -155.94 25.49 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.462 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 25.4 tp10 179.47 65.16 0.13 Allowed Pre-proline 0 N--CA 1.485 1.314 0 O-C-N 121.235 -1.156 . . . . 0.0 109.634 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.462 ' HD3' ' N ' ' A' ' 26' ' ' GLU . 35.2 Cg_endo -78.28 144.67 20.83 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.679 2.252 . . . . 0.0 110.332 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -58.79 -23.55 60.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.153 -0.967 . . . . 0.0 109.515 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' LYS . 6.5 ptp180 -90.43 27.07 1.78 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.214 -0.929 . . . . 0.0 109.881 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.443 ' O ' ' HG2' ' A' ' 27' ' ' PRO . 17.3 t-20 42.2 -93.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.277 -0.889 . . . . 0.0 110.046 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -141.6 105.87 4.81 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.133 -0.979 . . . . 0.0 109.402 -179.662 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.2 t -140.92 109.35 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.162 -0.961 . . . . 0.0 109.524 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -171.29 128.23 0.69 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 0.0 109.296 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.469 ' HA ' HG11 ' A' ' 73' ' ' VAL . 1.8 p -112.96 142.39 45.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 109.738 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.452 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 2.8 pt -98.31 -170.13 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.333 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.445 ' HE2' ' OE2' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -95.1 167.4 11.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.898 . . . . 0.0 109.712 -179.791 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.535 ' O ' ' CG1' ' A' ' 40' ' ' VAL . 5.5 mtm180 -97.29 -19.25 18.67 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.236 -0.915 . . . . 0.0 109.681 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.466 ' C ' ' O ' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -37.81 -34.9 0.12 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.67 -0.644 . . . . 0.0 109.929 -179.753 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 37' ' ' ARG . 8.5 mttm -72.93 -48.87 33.23 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.344 -0.848 . . . . 0.0 109.623 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.535 ' CG1' ' O ' ' A' ' 37' ' ' ARG . 9.8 p -51.29 -20.07 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 110.174 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.466 ' N ' HG11 ' A' ' 40' ' ' VAL . 0.7 OUTLIER -85.94 -62.39 1.53 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.085 -1.01 . . . . 0.0 109.778 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -50.19 -27.29 5.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.248 -0.908 . . . . 0.0 110.024 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.452 HG23 ' HB2' ' A' ' 47' ' ' LYS . 20.9 mt -96.75 -34.54 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.061 -1.025 . . . . 0.0 109.635 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 40' ' ' VAL . . . -47.43 -33.58 6.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.324 -0.86 . . . . 0.0 109.415 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.456 ' HA ' ' SD ' ' A' ' 48' ' ' MET . 2.6 mt-10 -88.46 -35.85 16.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.848 . . . . 0.0 109.268 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.4 mt -91.78 25.11 2.85 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.346 -0.846 . . . . 0.0 109.412 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.468 ' C ' ' HD3' ' A' ' 49' ' ' PRO . 14.2 tppt? -143.35 21.47 1.88 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.135 -0.978 . . . . 0.0 109.841 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.456 ' SD ' ' HA ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -114.32 78.49 4.67 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.024 -1.047 . . . . 0.0 109.733 179.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.468 ' HD3' ' C ' ' A' ' 47' ' ' LYS . 36.1 Cg_endo -78.53 -44.55 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.594 2.196 . . . . 0.0 110.126 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -120.36 1.62 10.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.41 -0.807 . . . . 0.0 109.343 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.544 ' O ' ' CG ' ' A' ' 51' ' ' LEU . 0.7 OUTLIER -116.39 64.99 0.71 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.253 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 53' ' ' ALA . 42.3 t-20 -41.16 -28.69 0.1 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.867 . . . . 0.0 109.673 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 52' ' ' ASN . . . 60.66 142.15 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.457 -0.777 . . . . 0.0 109.556 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -46.51 -61.86 1.62 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.282 -0.886 . . . . 0.0 109.315 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.469 ' O ' HG12 ' A' ' 56' ' ' ILE . 41.1 p -152.19 -49.96 0.11 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.245 -0.91 . . . . 0.0 109.625 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 55' ' ' SER . 8.5 mm -154.48 -33.08 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.253 -0.904 . . . . 0.0 109.202 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.74 -59.39 5.29 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.186 -0.946 . . . . 0.0 110.233 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.16 -58.39 5.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.337 -0.852 . . . . 0.0 110.126 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.97 -21.0 63.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.195 -0.941 . . . . 0.0 109.994 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.46 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -77.4 -33.06 55.14 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.171 -0.956 . . . . 0.0 109.83 -179.673 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.14 -13.32 55.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.63 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -80.81 -57.24 3.64 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.249 -0.907 . . . . 0.0 109.956 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.523 ' HB ' ' CG2' ' A' ' 40' ' ' VAL . 6.5 mt -63.34 -42.17 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.343 -0.848 . . . . 0.0 109.753 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -63.88 -48.39 76.89 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.975 -1.078 . . . . 0.0 108.93 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.39 -12.88 34.28 Favored Glycine 0 N--CA 1.48 1.621 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 54.2 m -83.78 -51.68 7.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -1.131 . . . . 0.0 109.017 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -68.56 -17.92 64.24 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.328 -0.858 . . . . 0.0 109.193 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.02 -46.59 34.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.339 -0.851 . . . . 0.0 109.682 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.26 -6.14 53.71 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.166 -0.959 . . . . 0.0 109.802 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -99.23 -49.71 4.38 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.078 -1.014 . . . . 0.0 110.361 -179.45 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.1 -134.58 2.21 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.356 -1.402 . . . . 0.0 111.073 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.516 ' CD1' ' C ' ' A' ' 72' ' ' ILE . 0.9 OUTLIER -52.81 -171.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.589 -0.948 . . . . 0.0 111.114 -178.785 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.469 HG11 ' HA ' ' A' ' 34' ' ' THR . 3.5 p -110.56 -175.89 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.41 HG12 ' HG2' ' A' ' 37' ' ' ARG . 2.0 t -130.68 156.85 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.991 -1.068 . . . . 0.0 109.559 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 35' ' ' ILE . 16.0 pt-20 -131.05 145.33 51.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 0.0 109.505 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 43.9 t0 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.393 -179.996 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.4 m 64.67 39.79 6.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.448 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -162.12 141.45 9.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 109.568 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.498 ' C ' ' CD1' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -117.57 -14.55 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 109.28 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.52 32.82 3.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.282 -0.886 . . . . 0.0 109.313 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.419 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -96.62 151.01 20.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.308 -0.87 . . . . 0.0 109.639 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.46 ' C ' ' HD2' ' A' ' 9' ' ' PRO . 6.7 m -132.44 67.24 78.41 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.886 . . . . 0.0 109.379 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.627 ' N ' ' CD ' ' A' ' 9' ' ' PRO . 30.2 Cg_endo -72.74 -30.36 11.72 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.832 2.355 . . . . 0.0 113.929 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 8' ' ' PRO . 34.4 Cg_endo -75.02 122.8 7.43 Favored 'Trans proline' 0 C--N 1.321 -0.869 0 C-N-CA 121.143 1.229 . . . . 0.0 110.501 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.47 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -62.96 -41.75 99.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.232 -0.917 . . . . 0.0 109.826 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -36.85 -50.04 0.83 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.55 -0.719 . . . . 0.0 110.427 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 9' ' ' PRO . 2.4 m -72.02 -38.89 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.037 -1.039 . . . . 0.0 109.444 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 10' ' ' ALA . 65.1 mt -54.39 -66.81 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.403 -0.81 . . . . 0.0 109.934 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 18' ' ' ALA . 3.5 pp -52.76 -30.19 31.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 110.294 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.514 ' N ' HD13 ' A' ' 14' ' ' LEU . 19.4 tttt -53.11 -62.38 1.69 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.035 -1.041 . . . . 0.0 110.022 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -69.1 -28.76 66.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.055 -1.028 . . . . 0.0 109.666 -179.732 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.434 ' O ' ' CB ' ' A' ' 18' ' ' ALA . . . -89.97 5.86 44.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.954 . . . . 0.0 109.701 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 14' ' ' LEU . . . 169.9 62.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.099 -1.0 . . . . 0.0 109.643 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.85 -82.66 0.05 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.1 mm -51.08 -89.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.318 -1.107 . . . . 0.0 109.542 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -71.58 132.24 44.38 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.148 -0.97 . . . . 0.0 109.45 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.9 m -59.48 -49.04 79.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.19 -0.944 . . . . 0.0 109.68 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.15 -77.84 0.35 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 m -44.65 -85.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.209 -1.171 . . . . 0.0 109.331 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 26' ' ' GLU . . . -165.63 99.94 0.17 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 25' ' ' GLY . 23.3 tt0 -43.53 110.53 0.95 Allowed Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.208 -1.172 . . . . 0.0 109.411 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -75.47 168.53 24.31 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.24 1.96 . . . . 0.0 110.113 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -104.34 44.67 1.01 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 109.879 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 30' ' ' ASN . 0.3 OUTLIER -124.36 -160.92 0.96 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.324 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 29' ' ' ARG . 5.7 p30 -44.33 129.44 6.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.16 -0.962 . . . . 0.0 109.455 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.93 160.86 3.26 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.228 -0.92 . . . . 0.0 109.39 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 63.7 t -129.51 131.46 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.579 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.429 ' O ' HG21 ' A' ' 34' ' ' THR . . . -115.8 51.88 0.92 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.192 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.488 ' HA ' HG11 ' A' ' 73' ' ' VAL . 11.9 p -142.72 164.37 30.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.561 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.467 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 3.4 pt -150.88 167.03 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 109.522 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -79.71 131.52 35.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.139 -0.976 . . . . 0.0 109.355 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -74.17 -8.01 54.66 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.133 -0.98 . . . . 0.0 109.554 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 37' ' ' ARG . 48.6 t0 -42.78 -33.08 0.69 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.302 -0.874 . . . . 0.0 109.716 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -71.87 -52.82 15.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 109.338 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.524 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 57.8 t -48.37 -23.43 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.393 -0.817 . . . . 0.0 109.681 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.81 -44.13 17.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 0.0 109.661 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.42 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 7.4 mm-40 -72.71 -13.55 61.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.222 -0.924 . . . . 0.0 109.849 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.411 HD11 HG23 ' A' ' 43' ' ' ILE . 8.0 mt -105.2 -18.5 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.104 -0.997 . . . . 0.0 109.47 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.459 ' O ' ' HG3' ' A' ' 48' ' ' MET . . . -82.31 -34.98 28.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 109.544 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.27 -22.08 35.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.445 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.8 mt -73.4 -44.8 57.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.9 . . . . 0.0 109.445 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -119.58 32.32 6.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.307 -0.87 . . . . 0.0 109.177 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.57 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -48.08 -51.29 49.73 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.384 -0.822 . . . . 0.0 110.007 -179.73 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 48' ' ' MET . 36.4 Cg_endo -80.68 57.62 6.61 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.657 2.238 . . . . 0.0 110.76 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -136.68 4.45 2.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.171 -0.956 . . . . 0.0 109.672 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.71 -91.58 0.14 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.071 -1.018 . . . . 0.0 109.464 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -176.63 87.09 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.301 -0.875 . . . . 0.0 109.757 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.37 178.69 4.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -0.909 . . . . 0.0 109.303 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -128.99 -38.35 1.65 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.295 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.424 ' O ' HG12 ' A' ' 56' ' ' ILE . 13.6 m -127.61 -63.82 1.01 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.257 -0.902 . . . . 0.0 109.108 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -175.96 -31.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.385 -0.822 . . . . 0.0 108.8 179.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.524 ' HA ' ' CG ' ' A' ' 60' ' ' MET . 1.1 tt0 -56.89 -47.94 79.34 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.321 -0.862 . . . . 0.0 109.883 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.63 -43.23 62.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.389 -0.819 . . . . 0.0 110.148 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.01 -61.49 1.76 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.069 -1.019 . . . . 0.0 110.08 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.524 ' CG ' ' HA ' ' A' ' 57' ' ' GLU . 1.7 ppp? -52.86 -19.55 2.61 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.197 -0.94 . . . . 0.0 109.961 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -83.72 -34.88 24.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.175 -0.953 . . . . 0.0 109.599 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -47.41 72.88 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.283 -0.885 . . . . 0.0 109.713 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.524 ' HB ' ' CG1' ' A' ' 40' ' ' VAL . 8.9 mt -62.99 -40.4 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.938 . . . . 0.0 109.881 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.05 -49.65 73.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.88 -1.137 . . . . 0.0 109.383 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.12 -13.64 28.64 Favored Glycine 0 N--CA 1.479 1.562 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.5 ' O ' ' HB2' ' A' ' 70' ' ' MET . 50.4 m -86.14 -47.42 9.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.389 -1.065 . . . . 0.0 109.918 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -70.21 -19.04 63.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 109.775 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.461 ' HG3' HG21 ' A' ' 73' ' ' VAL . 1.9 ttp180 -79.35 -58.8 3.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.237 -0.914 . . . . 0.0 109.814 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.03 -25.0 63.37 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.23 -0.919 . . . . 0.0 110.329 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.5 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -96.24 -21.86 17.6 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.997 -1.065 . . . . 0.0 110.741 -179.114 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -154.8 -141.97 3.35 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.27 -1.443 . . . . 0.0 110.751 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.524 HD13 ' N ' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -70.81 -174.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.568 -0.96 . . . . 0.0 110.308 -179.315 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.488 HG11 ' HA ' ' A' ' 34' ' ' THR . 1.4 p -90.45 -172.46 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.474 -0.766 . . . . 0.0 108.984 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.3 t -132.76 135.17 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.079 -1.013 . . . . 0.0 109.729 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 35' ' ' ILE . 22.4 pt-20 -98.65 160.6 14.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 109.26 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 43.6 t0 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.986 -1.006 . . . . 0.0 109.495 -179.957 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.81 38.76 1.66 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 109.4 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -124.66 78.08 1.65 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.298 -0.876 . . . . 0.0 109.396 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.503 ' O ' ' N ' ' A' ' 6' ' ' LYS . 2.9 tp -51.49 -24.15 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.574 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.96 93.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.266 -0.896 . . . . 0.0 109.43 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -135.46 -173.53 3.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 109.471 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.9 m -99.75 115.5 65.54 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.908 . . . . 0.0 109.365 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.71 170.31 19.33 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.34 2.027 . . . . 0.0 110.357 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' A' ' 12' ' ' VAL . 36.0 Cg_endo -77.77 -162.62 0.18 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.582 2.188 . . . . 0.0 110.559 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -84.02 -68.09 0.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.194 -0.942 . . . . 0.0 109.656 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -40.18 -53.8 2.42 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.422 -0.799 . . . . 0.0 109.973 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.45 ' HB ' ' HD2' ' A' ' 9' ' ' PRO . 48.8 t -60.14 -43.04 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 109.616 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.9 mt -51.46 -48.13 62.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.214 -0.929 . . . . 0.0 109.789 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.452 HD13 HG23 ' A' ' 66' ' ' THR . 8.5 mt -67.4 -27.28 66.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.622 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -69.8 -30.84 68.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.481 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -76.56 -48.3 19.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 0.0 109.489 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.491 ' HB2' ' CD ' ' A' ' 39' ' ' LYS . . . -91.71 37.5 0.96 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.906 . . . . 0.0 109.465 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.419 ' O ' HG22 ' A' ' 35' ' ' ILE . . . -90.8 -53.24 4.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.427 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 21' ' ' GLU . . . 140.84 -18.49 2.76 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.3 mt -46.86 96.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.318 -1.107 . . . . 0.0 109.532 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.484 ' HG2' ' N ' ' A' ' 22' ' ' SER . 22.9 tt0 -141.97 149.5 40.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.393 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.484 ' N ' ' HG2' ' A' ' 21' ' ' GLU . 39.8 m -54.24 156.59 3.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 109.592 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.24 47.49 0.1 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.35 -159.99 0.63 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -1.139 . . . . 0.0 109.306 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 26' ' ' GLU . . . -179.01 153.63 12.75 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 25' ' ' GLY . 3.6 tt0 45.47 94.23 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.407 -1.055 . . . . 0.0 109.865 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.09 143.52 20.36 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.61 2.207 . . . . 0.0 110.302 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.53 -76.05 0.52 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.205 -0.934 . . . . 0.0 109.62 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.11 -168.09 1.42 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.485 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.2 p-10 -52.88 137.19 32.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.393 -0.817 . . . . 0.0 109.418 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.89 97.46 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.231 -0.918 . . . . 0.0 109.589 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.1 t -58.71 102.73 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.214 -0.929 . . . . 0.0 109.242 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -151.75 125.57 9.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.178 -0.951 . . . . 0.0 109.455 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.2 p -125.81 176.76 6.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.312 -0.867 . . . . 0.0 109.373 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.457 HD11 ' HE2' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -141.1 168.76 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.166 179.77 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.46 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 15.8 ttmt -85.64 171.06 11.96 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.222 -0.924 . . . . 0.0 109.702 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.449 ' NH2' ' OE2' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -72.51 -14.37 61.64 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.34 -0.85 . . . . 0.0 109.474 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 37' ' ' ARG . 4.6 t0 -41.71 -33.64 0.52 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.492 -0.755 . . . . 0.0 109.674 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.491 ' CD ' ' HB2' ' A' ' 17' ' ' ALA . 1.8 ttpt -69.24 -61.86 1.61 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.191 -0.943 . . . . 0.0 109.442 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.48 ' CG2' HG23 ' A' ' 63' ' ' ILE . 84.8 t -49.69 -20.58 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.885 . . . . 0.0 110.053 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -72.96 -51.34 18.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.023 -1.048 . . . . 0.0 110.369 -179.438 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 43' ' ' ILE . 16.8 pt-20 -73.78 -39.2 64.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.02 -1.05 . . . . 0.0 110.476 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.469 ' N ' ' HG3' ' A' ' 42' ' ' GLU . 9.6 mt -73.05 -14.44 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.101 -0.999 . . . . 0.0 109.917 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 40' ' ' VAL . . . -92.88 -26.52 17.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.096 -1.002 . . . . 0.0 109.748 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 2.4 pt-20 -96.39 -2.64 45.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.12 -0.987 . . . . 0.0 109.664 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 43' ' ' ILE . 0.3 OUTLIER -73.34 -24.82 60.41 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.235 -0.915 . . . . 0.0 109.744 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.425 ' N ' ' HG ' ' A' ' 46' ' ' LEU . 5.2 ttmt -159.07 58.4 0.42 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.144 -0.972 . . . . 0.0 109.394 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.536 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 1.3 mtp -43.87 -52.87 14.01 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.416 -0.803 . . . . 0.0 110.349 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 48' ' ' MET . 34.0 Cg_endo -77.04 96.26 1.1 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.417 2.078 . . . . 0.0 110.591 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 24.4 t0 178.7 -40.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.366 -0.834 . . . . 0.0 109.38 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.443 ' O ' ' C ' ' A' ' 52' ' ' ASN . 0.5 OUTLIER -107.34 35.84 2.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 109.594 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER 40.56 76.45 0.07 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.459 -0.776 . . . . 0.0 109.755 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.75 139.98 33.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.23 -0.919 . . . . 0.0 109.353 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.94 -47.85 64.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 109.497 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.52 -52.56 0.09 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.245 -0.91 . . . . 0.0 108.851 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.7 tt -175.41 -31.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.303 -0.873 . . . . 0.0 109.242 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -60.2 -53.65 55.22 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.279 -0.888 . . . . 0.0 109.448 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.04 -53.22 44.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.427 -0.795 . . . . 0.0 109.842 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.62 -42.32 61.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.795 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.46 -38.22 90.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.19 -0.943 . . . . 0.0 110.121 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -76.1 -15.99 59.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 109.656 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.61 -59.95 2.57 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.229 -0.92 . . . . 0.0 109.586 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.48 HG23 ' CG2' ' A' ' 40' ' ' VAL . 24.1 mt -57.38 -35.26 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.248 -0.908 . . . . 0.0 109.987 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.449 ' OE2' ' NH2' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -62.29 -51.53 67.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.091 -1.006 . . . . 0.0 109.326 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.81 -9.67 27.99 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.49 ' O ' ' HB2' ' A' ' 70' ' ' MET . 87.6 m -87.29 -51.17 6.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -1.114 . . . . 0.0 110.026 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -76.69 -14.97 59.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 109.736 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.66 -57.11 3.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.67 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.0 -21.84 62.24 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.284 -0.885 . . . . 0.0 110.172 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.49 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -65.08 -65.89 0.61 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.079 -1.013 . . . . 0.0 109.609 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -161.13 -65.96 0.02 OUTLIER Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.267 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.537 ' CD1' ' N ' ' A' ' 73' ' ' VAL . 1.7 pp -72.62 -179.37 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -1.117 . . . . 0.0 110.513 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.537 ' N ' ' CD1' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -126.33 151.59 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.583 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.31 168.53 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.146 -0.972 . . . . 0.0 109.588 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.46 ' HG3' ' HA ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -123.75 125.66 45.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.308 -0.87 . . . . 0.0 109.582 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.1 t0 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.52 179.931 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.311 0.577 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.9 m -137.31 -49.39 0.61 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.281 -0.887 . . . . 0.0 109.313 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.64 134.83 54.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 109.353 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.2 mp -137.23 130.97 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.207 -0.933 . . . . 0.0 109.498 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.33 130.95 35.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 109.405 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.73 149.31 41.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.634 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.6 m 63.71 79.02 0.26 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 109.548 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.27 151.44 26.46 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.571 2.18 . . . . 0.0 110.331 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.465 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 35.4 Cg_endo -77.34 174.1 13.27 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.643 2.229 . . . . 0.0 110.431 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -73.74 -65.04 0.88 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.963 . . . . 0.0 109.822 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.51 ' HA ' ' CE ' ' A' ' 70' ' ' MET . . . -36.69 -39.27 0.2 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.565 -0.709 . . . . 0.0 110.703 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.452 HG22 ' HG2' ' A' ' 9' ' ' PRO . 38.8 t -75.35 -51.43 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.022 -1.049 . . . . 0.0 109.865 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 9' ' ' PRO . 21.5 mt -51.37 -60.96 2.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.054 -1.028 . . . . 0.0 109.366 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.444 HD12 HG23 ' A' ' 66' ' ' THR . 0.2 OUTLIER -50.06 -40.39 45.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.599 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' LYS . 14.4 mttt -52.89 -65.89 0.48 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 109.196 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -44.46 -26.37 0.34 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 108.944 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.589 ' O ' ' CB ' ' A' ' 18' ' ' ALA . . . -105.22 51.89 0.75 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.454 -0.779 . . . . 0.0 109.34 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.589 ' CB ' ' O ' ' A' ' 17' ' ' ALA . . . 88.75 102.33 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 20' ' ' ILE . . . 168.77 -47.67 0.22 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.476 ' O ' ' O ' ' A' ' 19' ' ' GLY . 1.8 mt -58.7 -120.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.391 -1.064 . . . . 0.0 109.726 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 2.6 pt-20 -89.34 88.64 7.57 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 120.7 -1.25 . . . . 0.0 109.442 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.1 m -98.53 8.79 44.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.148 -0.97 . . . . 0.0 109.642 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.1 129.14 1.16 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.0 p 50.94 -168.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.234 -1.156 . . . . 0.0 109.229 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 26' ' ' GLU . . . -158.19 -66.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 25' ' ' GLY . 1.6 pt-20 -43.66 130.48 3.94 Favored Pre-proline 0 C--N 1.305 -1.338 0 O-C-N 121.279 -1.13 . . . . 0.0 109.458 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.75 133.46 11.45 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.491 2.128 . . . . 0.0 110.719 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.67 153.39 35.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.329 -0.857 . . . . 0.0 109.399 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -71.21 -13.13 61.82 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.239 -0.913 . . . . 0.0 109.893 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -110.4 -15.7 13.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.158 -0.963 . . . . 0.0 109.603 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.72 -174.89 5.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.438 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.6 p -46.47 144.03 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 109.576 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.56 -169.43 2.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 0.0 109.656 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.445 ' OG1' ' HA ' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -95.95 171.08 8.85 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.294 -0.879 . . . . 0.0 109.733 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.436 HG23 ' HB3' ' A' ' 18' ' ' ALA . 6.9 pt -85.01 -173.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.374 -0.829 . . . . 0.0 109.91 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -99.3 147.81 24.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 0.0 109.572 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -73.99 -10.13 59.33 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.277 -0.889 . . . . 0.0 109.604 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 37' ' ' ARG . 0.4 OUTLIER -42.6 -51.73 5.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.334 -0.854 . . . . 0.0 109.837 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.473 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -57.32 -45.03 84.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.701 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.57 ' CG1' ' CG2' ' A' ' 63' ' ' ILE . 75.4 t -56.0 -28.06 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -0.846 . . . . 0.0 110.474 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -75.59 -51.62 12.46 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.986 -1.071 . . . . 0.0 110.072 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -60.97 -29.87 69.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 0.0 110.044 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 39' ' ' LYS . 45.3 mt -83.02 -34.37 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.006 -1.059 . . . . 0.0 109.981 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.03 -9.4 58.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.088 -1.008 . . . . 0.0 109.793 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -99.35 -33.67 10.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.148 -0.97 . . . . 0.0 109.525 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.402 ' CD1' ' C ' ' A' ' 46' ' ' LEU . 0.7 OUTLIER -77.47 -11.43 59.85 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.225 -0.922 . . . . 0.0 109.998 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -132.08 34.88 3.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 109.673 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.58 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 4.3 ttp -50.57 -48.41 82.18 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.163 -0.961 . . . . 0.0 109.808 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 48' ' ' MET . 35.9 Cg_endo -78.84 82.01 2.62 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.059 1.839 . . . . 0.0 110.168 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -144.57 -46.63 0.25 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -0.945 . . . . 0.0 109.794 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 52' ' ' ASN . 0.5 OUTLIER -117.41 22.29 12.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.212 -0.93 . . . . 0.0 109.681 -179.813 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 51' ' ' LEU . 3.5 t-20 44.14 72.62 0.18 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.157 -0.964 . . . . 0.0 109.556 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.87 174.05 6.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -0.942 . . . . 0.0 109.325 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.85 -57.69 9.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 0.0 109.521 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.1 m -162.9 -56.6 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.627 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -157.23 -32.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.251 -0.906 . . . . 0.0 109.064 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -49.55 -65.0 0.64 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.164 -0.96 . . . . 0.0 110.085 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.6 -43.22 68.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.393 -0.817 . . . . 0.0 110.383 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.58 -28.94 68.87 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.024 -1.047 . . . . 0.0 110.15 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -31.3 49.52 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.127 -0.983 . . . . 0.0 109.311 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.426 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -77.32 -16.25 59.02 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.434 -0.791 . . . . 0.0 109.01 179.581 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.407 ' O ' ' OG1' ' A' ' 66' ' ' THR . 3.2 mtp -77.41 -52.06 9.76 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.4 -0.813 . . . . 0.0 109.461 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.57 ' CG2' ' CG1' ' A' ' 40' ' ' VAL . 2.3 mt -66.07 -45.88 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.762 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.523 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 7.8 pt-20 -64.01 -47.36 80.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.914 -1.116 . . . . 0.0 109.432 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.523 ' N ' ' HG3' ' A' ' 64' ' ' GLU . . . -61.43 -14.78 43.25 Favored Glycine 0 N--CA 1.479 1.53 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.499 ' O ' ' HG2' ' A' ' 70' ' ' MET . 61.0 m -98.02 -20.98 17.06 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.41 -1.053 . . . . 0.0 109.393 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -92.07 -9.39 42.87 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.218 -0.926 . . . . 0.0 109.048 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.516 ' CG ' HG11 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -105.36 -49.08 3.53 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.49 -0.757 . . . . 0.0 110.6 -179.362 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 p -75.54 -39.0 58.89 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.215 -0.928 . . . . 0.0 111.729 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.51 ' CE ' ' HA ' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -81.62 -27.49 34.15 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 120.636 -1.29 . . . . 0.0 111.628 -177.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.508 ' N ' ' HG3' ' A' ' 70' ' ' MET . . . -149.21 -141.24 3.41 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 118.76 -1.686 . . . . 0.0 111.59 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.51 ' CD1' ' C ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -52.25 -166.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.869 -0.783 . . . . 0.0 110.717 -178.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.516 HG11 ' CG ' ' A' ' 68' ' ' ARG . 22.4 t -112.14 165.44 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.349 -0.845 . . . . 0.0 109.951 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.465 HG22 ' CB ' ' A' ' 67' ' ' ALA . 98.1 t -124.55 156.66 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.337 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.492 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 14.4 pt-20 -115.59 110.19 18.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -0.943 . . . . 0.0 109.587 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.7 t0 . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.342 179.842 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.449 ' CG2' ' N ' ' A' ' 3' ' ' PHE . 18.9 m -118.58 -93.42 0.52 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 109.573 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.449 ' N ' ' CG2' ' A' ' 2' ' ' THR . 0.1 OUTLIER -107.34 124.24 49.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.18 -0.95 . . . . 0.0 109.68 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.48 HD11 ' N ' ' A' ' 4' ' ' ILE . 3.7 mp -136.69 158.3 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.292 -0.88 . . . . 0.0 109.271 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.518 ' CG2' ' O ' ' A' ' 5' ' ' THR . 14.2 t -102.66 107.41 18.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.698 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.471 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -80.95 -161.41 0.39 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.211 -0.931 . . . . 0.0 108.856 179.601 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.579 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -129.66 52.09 8.68 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 120.989 -1.07 . . . . 0.0 110.15 179.731 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.623 ' N ' ' CD ' ' A' ' 9' ' ' PRO . 28.2 Cg_endo -71.15 -32.07 13.64 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.284 1.99 . . . . 0.0 113.643 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 8' ' ' PRO . 32.8 Cg_endo -75.89 136.13 18.29 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 C-N-CA 121.321 1.347 . . . . 0.0 110.596 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 12' ' ' VAL . . . -54.17 -54.91 33.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.474 -0.766 . . . . 0.0 110.669 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -30.99 -36.84 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.695 -0.628 . . . . 0.0 111.079 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.551 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 1.2 t -81.33 -53.22 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.964 -1.085 . . . . 0.0 109.706 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.459 HD11 ' HA ' ' A' ' 10' ' ' ALA . 2.1 mp -46.42 -45.3 17.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.267 -0.896 . . . . 0.0 109.981 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.3 mt -67.24 -37.57 83.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.906 . . . . 0.0 110.015 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.99 -33.93 76.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.275 -0.89 . . . . 0.0 110.387 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -92.96 -8.28 43.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.965 -1.084 . . . . 0.0 109.676 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.27 -37.74 57.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 109.643 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.72 -36.53 25.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.899 . . . . 0.0 109.675 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.52 44.11 1.27 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.8 mm -63.73 -10.39 7.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 121.312 -1.111 . . . . 0.0 110.15 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -104.99 -33.07 8.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.033 -1.042 . . . . 0.0 109.807 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.05 -83.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.393 -0.817 . . . . 0.0 109.493 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.56 138.9 8.22 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.19 166.45 10.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -1.154 . . . . 0.0 109.365 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.54 -173.92 0.48 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -46.31 129.79 7.75 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.151 -1.205 . . . . 0.0 109.335 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.89 117.3 4.17 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.443 2.095 . . . . 0.0 110.341 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -151.39 46.28 0.81 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.145 -0.972 . . . . 0.0 109.922 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.44 ' O ' ' C ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -169.45 55.46 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.013 -1.054 . . . . 0.0 110.441 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 29' ' ' ARG . 1.9 p-10 39.69 50.96 2.31 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.36 -0.837 . . . . 0.0 110.3 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.54 104.34 4.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.129 -0.982 . . . . 0.0 109.309 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -171.56 143.21 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.148 -0.97 . . . . 0.0 110.032 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.476 ' O ' ' CG2' ' A' ' 34' ' ' THR . . . 48.17 74.95 0.15 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.378 -0.826 . . . . 0.0 109.893 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.498 ' CG2' HG13 ' A' ' 73' ' ' VAL . 16.6 p -160.32 126.35 4.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.395 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.415 ' CG1' HG11 ' A' ' 74' ' ' VAL . 41.5 pt -86.35 175.18 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.962 . . . . 0.0 109.413 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.74 138.62 45.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.204 -0.935 . . . . 0.0 109.699 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.483 ' NH1' ' OD1' ' A' ' 76' ' ' ASP . 4.6 mtp180 -53.4 -35.7 60.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.34 -0.85 . . . . 0.0 109.457 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.32 -54.54 8.77 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.257 -0.902 . . . . 0.0 109.381 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 40' ' ' VAL . 2.5 mttt -56.9 -55.63 32.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.29 -0.881 . . . . 0.0 109.355 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.447 HG12 ' CG2' ' A' ' 63' ' ' ILE . 99.2 t -42.32 -29.61 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -0.848 . . . . 0.0 110.171 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -77.66 -44.96 26.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.109 -0.994 . . . . 0.0 110.13 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.403 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 2.7 tp10 -63.48 -61.58 2.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.102 -0.999 . . . . 0.0 109.998 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 19.3 mt -57.47 -31.37 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.321 -0.862 . . . . 0.0 110.242 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 48' ' ' MET . . . -63.6 -31.65 72.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.112 -0.993 . . . . 0.0 110.024 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -92.68 -65.15 1.02 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.096 -1.003 . . . . 0.0 109.965 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 33.8 mt -53.35 -19.33 3.26 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.24 -0.912 . . . . 0.0 110.204 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.488 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -116.14 -11.21 11.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.071 -1.018 . . . . 0.0 109.871 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.466 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 0.9 OUTLIER -39.23 99.14 0.19 Allowed Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.6 -0.687 . . . . 0.0 109.927 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 47' ' ' LYS . 36.4 Cg_endo -79.84 -82.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.55 2.167 . . . . 0.0 110.127 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -144.0 -72.96 0.27 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.361 -0.837 . . . . 0.0 109.342 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.484 ' O ' ' ND2' ' A' ' 52' ' ' ASN . 3.6 mt 54.34 18.19 1.79 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.191 -0.943 . . . . 0.0 109.505 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER 40.34 33.8 0.19 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.449 -0.782 . . . . 0.0 109.792 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.53 154.37 42.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 0.0 109.452 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.23 -26.55 42.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 109.589 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m -158.41 -58.41 0.07 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.165 -0.959 . . . . 0.0 108.88 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 tt -172.51 -33.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.256 -0.903 . . . . 0.0 109.201 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -47.97 -60.18 2.8 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.268 -0.895 . . . . 0.0 109.33 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.97 -49.86 29.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.454 -0.779 . . . . 0.0 109.339 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 62' ' ' MET . . . -49.06 -42.09 37.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 109.177 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -37.75 88.47 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.228 -0.92 . . . . 0.0 109.329 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.99 -13.16 62.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 108.914 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -82.63 -51.07 8.09 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.333 -0.855 . . . . 0.0 109.329 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.489 ' O ' ' HB ' ' A' ' 66' ' ' THR . 4.8 mt -56.35 -42.6 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.895 . . . . 0.0 109.619 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.518 ' CG ' HG22 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -61.55 -53.83 51.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.898 -1.126 . . . . 0.0 109.43 -179.737 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -56.4 -15.57 12.0 Favored Glycine 0 N--CA 1.48 1.618 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 90.5 m -81.71 -59.99 2.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.3 -1.118 . . . . 0.0 109.546 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.496 ' CB ' HD13 ' A' ' 72' ' ' ILE . . . -73.41 -2.78 23.74 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.238 -0.914 . . . . 0.0 109.528 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.512 ' HG3' ' NH1' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -86.56 -50.24 6.98 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.19 -0.944 . . . . 0.0 109.725 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.47 -8.75 34.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.106 -0.996 . . . . 0.0 109.894 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.486 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -71.06 -69.16 0.39 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.064 -1.022 . . . . 0.0 109.086 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -161.44 -79.9 0.03 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.522 ' N ' ' CD1' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -57.88 -169.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.464 -1.021 . . . . 0.0 109.995 -179.631 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.498 HG13 ' CG2' ' A' ' 34' ' ' THR . 0.4 OUTLIER -138.64 169.97 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.4 -0.812 . . . . 0.0 108.884 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.518 HG22 ' CG ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -106.69 151.48 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.027 -1.046 . . . . 0.0 109.425 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -125.22 145.47 49.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.901 . . . . 0.0 109.494 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.483 ' OD1' ' NH1' ' A' ' 37' ' ' ARG . 14.2 t70 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.452 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 71.1 p -69.9 -142.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.27 -0.893 . . . . 0.0 109.246 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -127.76 72.59 1.41 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.959 -1.088 . . . . 0.0 109.641 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.9 tp -98.0 148.88 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.226 -0.921 . . . . 0.0 109.417 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.87 41.74 3.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 109.624 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.95 -171.35 3.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.191 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 44.08 81.21 0.26 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 109.406 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.75 159.66 31.4 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.643 2.229 . . . . 0.0 110.314 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 12' ' ' VAL . 35.3 Cg_endo -77.68 -159.98 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.591 2.194 . . . . 0.0 110.528 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -79.38 -66.99 0.8 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.252 -0.905 . . . . 0.0 110.052 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -37.25 -46.24 0.72 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.51 -0.744 . . . . 0.0 110.187 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.406 ' HB ' ' HD2' ' A' ' 9' ' ' PRO . 88.7 t -67.67 -46.78 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.213 -0.929 . . . . 0.0 109.423 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 mt -46.85 -48.93 20.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.433 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.45 HD23 ' HB1' ' A' ' 67' ' ' ALA . 0.4 OUTLIER -68.71 -38.48 80.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.594 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.6 -66.02 0.46 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 109.669 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -59.11 -32.93 70.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.152 -0.968 . . . . 0.0 109.739 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 14' ' ' LEU . . . -50.05 -65.1 0.62 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.141 -0.975 . . . . 0.0 109.548 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.48 -29.49 36.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 109.406 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 21' ' ' GLU . . . 81.2 31.82 33.45 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.46 HD13 HG22 ' A' ' 20' ' ' ILE . 44.4 mm -53.55 94.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.196 -1.179 . . . . 0.0 109.769 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 19' ' ' GLY . 40.4 tt0 -121.52 109.23 14.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 109.266 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.3 m -137.12 57.14 1.77 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.328 -0.857 . . . . 0.0 109.536 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.27 -61.13 3.53 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 59.0 m -128.75 -2.08 5.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -1.149 . . . . 0.0 109.583 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.12 67.67 1.21 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -44.7 107.89 0.68 Allowed Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.31 -1.112 . . . . 0.0 109.736 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.96 124.56 7.45 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.439 2.093 . . . . 0.0 110.271 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -129.82 4.26 4.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.322 -0.861 . . . . 0.0 109.56 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.54 113.04 6.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.267 -0.895 . . . . 0.0 109.495 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -153.91 39.56 0.48 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.253 -0.905 . . . . 0.0 109.68 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -55.07 138.94 43.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.177 -0.952 . . . . 0.0 109.153 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.3 t 57.23 99.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.206 -0.933 . . . . 0.0 109.186 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.32 94.37 4.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 0.0 109.616 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.1 p -118.6 148.93 42.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.188 -0.945 . . . . 0.0 109.425 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.422 HG13 HG11 ' A' ' 74' ' ' VAL . 11.6 pt -105.74 -179.09 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.297 -0.877 . . . . 0.0 109.618 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -95.61 146.96 24.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.294 -0.879 . . . . 0.0 109.487 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.9 ppt_? -60.42 -15.44 26.43 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.235 -0.916 . . . . 0.0 109.517 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -47.92 -39.25 18.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.325 -0.859 . . . . 0.0 109.561 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.43 -45.99 90.57 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.314 -0.866 . . . . 0.0 109.52 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.471 ' O ' ' CB ' ' A' ' 44' ' ' ALA . 30.4 t -61.79 -12.89 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 0.0 109.48 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.9 -55.15 5.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 109.912 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -72.44 -51.07 21.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.228 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 63.2 mt -57.44 -45.92 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 110.094 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' A' ' 40' ' ' VAL . . . -57.28 -39.18 75.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -0.959 . . . . 0.0 109.981 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.35 -36.78 77.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.125 -0.985 . . . . 0.0 109.831 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mt -87.49 14.89 7.32 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.171 -0.956 . . . . 0.0 109.596 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.48 24.38 3.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 0.0 109.264 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.572 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -69.8 -51.01 16.16 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.389 -0.819 . . . . 0.0 109.942 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 48' ' ' MET . 34.1 Cg_endo -77.34 89.1 1.35 Allowed 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.336 2.024 . . . . 0.0 110.647 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -176.69 -62.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.402 HD21 ' SD ' ' A' ' 62' ' ' MET . 1.5 pp -103.02 -0.75 30.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.387 -0.82 . . . . 0.0 109.22 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 45.95 81.11 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.273 -0.892 . . . . 0.0 109.713 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.62 163.13 16.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.0 109.277 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -46.45 -56.09 6.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 109.132 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.427 ' O ' ' HE2' ' A' ' 48' ' ' MET . 1.6 m -160.07 -69.4 0.07 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.276 -0.89 . . . . 0.0 108.678 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.465 ' O ' ' CG2' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -147.0 8.26 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.355 -0.84 . . . . 0.0 109.584 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -92.95 -51.98 4.81 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.111 -0.993 . . . . 0.0 109.483 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.21 -27.81 61.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.361 -0.837 . . . . 0.0 109.543 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.73 -37.61 70.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 109.354 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.444 ' HG2' HG13 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -72.64 -50.73 23.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.694 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -61.18 -17.5 53.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.624 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.441 ' O ' ' OG1' ' A' ' 66' ' ' THR . 0.0 OUTLIER -75.64 -54.75 6.47 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.251 -0.906 . . . . 0.0 110.087 -179.653 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.487 ' O ' ' HB ' ' A' ' 66' ' ' THR . 12.3 mt -56.16 -38.87 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 110.482 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.4 ' C ' ' N ' ' A' ' 66' ' ' THR . 1.7 tt0 -63.11 -60.95 2.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.712 -1.242 . . . . 0.0 109.303 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.74 -16.6 7.71 Favored Glycine 0 N--CA 1.479 1.501 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.5 ' O ' ' HB2' ' A' ' 70' ' ' MET . 33.2 m -74.14 -55.1 6.49 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.234 -1.156 . . . . 0.0 109.272 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -67.76 -14.25 62.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.181 -0.949 . . . . 0.0 109.249 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -52.29 40.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 0.0 109.803 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.17 -9.92 29.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.206 -0.934 . . . . 0.0 110.49 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.5 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -97.15 -49.85 4.82 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.097 -1.002 . . . . 0.0 110.109 -179.264 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -138.64 -127.02 2.46 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.654 -1.26 . . . . 0.0 110.167 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.51 ' CD1' ' C ' ' A' ' 72' ' ' ILE . 0.5 OUTLIER -85.69 179.28 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.361 -1.082 . . . . 0.0 109.973 -179.446 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.41 -169.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.917 . . . . 0.0 109.545 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.422 HG11 HG13 ' A' ' 35' ' ' ILE . 8.8 t -135.6 167.56 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 0.0 109.525 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -122.01 152.44 39.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.451 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.4 t70 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.455 -179.935 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.74 -35.27 20.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.656 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.484 ' O ' HG13 ' A' ' 4' ' ' ILE . 1.2 t80 59.46 104.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.153 -0.967 . . . . 0.0 109.346 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 3' ' ' PHE . 18.2 mt -146.45 -75.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.281 -0.887 . . . . 0.0 109.412 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.476 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 2.8 t -90.18 178.29 6.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.401 -0.812 . . . . 0.0 109.695 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 5' ' ' THR . 13.2 ttmt 62.77 124.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.407 -0.808 . . . . 0.0 109.513 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 m 66.34 81.71 0.21 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.325 -0.859 . . . . 0.0 109.42 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.27 159.85 32.94 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.562 2.175 . . . . 0.0 110.189 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.452 ' HD2' HG22 ' A' ' 12' ' ' VAL . 35.8 Cg_endo -76.9 -162.11 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.538 2.159 . . . . 0.0 110.332 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.478 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -72.49 -67.25 0.57 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.21 -0.931 . . . . 0.0 110.11 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -33.93 -53.8 0.46 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.761 -0.587 . . . . 0.0 110.663 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 99.4 t -57.31 -50.39 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.089 -1.007 . . . . 0.0 109.783 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.5 mt -48.18 -68.52 0.18 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.117 -0.99 . . . . 0.0 109.767 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.444 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 6.0 mt -55.67 -20.72 15.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.198 -0.939 . . . . 0.0 109.6 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -61.34 -57.32 12.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.501 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 17' ' ' ALA . 47.0 mmtm -60.22 -25.55 65.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 0.0 109.319 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 14' ' ' LEU . . . -42.92 -35.91 1.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.39 -0.819 . . . . 0.0 109.408 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -102.83 -24.34 13.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.269 -0.894 . . . . 0.0 109.565 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.75 34.95 7.04 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.402 HG22 HD11 ' A' ' 20' ' ' ILE . 36.0 mm -54.43 100.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.249 -1.148 . . . . 0.0 109.746 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -51.23 163.42 0.24 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.872 . . . . 0.0 109.519 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.82 125.33 17.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 109.68 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 163.2 -175.53 39.49 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.1 t -62.09 170.64 2.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -1.118 . . . . 0.0 109.484 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.75 76.89 1.07 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -46.1 127.0 7.29 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.29 -1.124 . . . . 0.0 109.7 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.38 131.46 10.62 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.532 2.155 . . . . 0.0 110.286 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -118.96 -29.16 5.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.117 -0.989 . . . . 0.0 109.539 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.409 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -57.83 138.96 55.15 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.22 -0.925 . . . . 0.0 109.627 -179.895 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -119.63 21.01 12.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.134 -0.979 . . . . 0.0 109.374 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.95 173.55 3.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.295 -0.878 . . . . 0.0 109.757 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.5 t -126.15 159.61 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.397 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.441 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . -133.22 157.3 45.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.212 -0.93 . . . . 0.0 109.584 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.1 p -126.54 143.5 51.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 109.378 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.597 ' CD1' ' N ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -112.53 -171.63 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.172 -0.955 . . . . 0.0 109.615 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -100.17 168.69 9.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.386 -0.821 . . . . 0.0 109.931 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.04 -11.22 57.07 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.379 -0.826 . . . . 0.0 110.046 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -51.09 -44.9 61.33 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.135 -0.978 . . . . 0.0 109.776 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.432 ' NZ ' HD22 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -59.77 -34.62 73.23 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.319 -0.863 . . . . 0.0 109.852 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.423 ' HA ' HD11 ' A' ' 63' ' ' ILE . 68.1 t -63.06 -30.59 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 110.017 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -80.73 -23.33 39.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.112 -0.992 . . . . 0.0 110.008 -179.673 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -80.67 -52.6 7.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.971 . . . . 0.0 109.62 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.472 ' HB ' HD12 ' A' ' 63' ' ' ILE . 43.4 mt -65.99 -36.47 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.663 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.7 -38.71 80.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.212 -0.93 . . . . 0.0 109.636 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -74.52 -27.22 60.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 0.0 109.698 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.03 -0.06 54.61 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.093 -1.005 . . . . 0.0 109.595 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -149.44 47.92 0.96 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.325 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.582 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -62.7 -50.37 78.25 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.273 -0.892 . . . . 0.0 110.033 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 48' ' ' MET . 36.4 Cg_endo -80.7 49.43 3.22 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.711 2.274 . . . . 0.0 110.815 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -123.2 -33.65 3.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.095 -1.003 . . . . 0.0 109.233 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 52' ' ' ASN . 0.8 OUTLIER -123.86 34.87 4.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -0.885 . . . . 0.0 109.334 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' A' ' 52' ' ' ASN . 29.1 t-20 42.95 38.16 1.33 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.357 -0.84 . . . . 0.0 109.537 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.54 135.64 57.73 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.187 -0.946 . . . . 0.0 109.318 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.9 -73.41 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.891 . . . . 0.0 109.536 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.475 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -139.08 -51.21 0.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 109.635 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 55' ' ' SER . 10.4 mm -157.31 -32.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.385 -0.822 . . . . 0.0 109.371 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.42 -59.12 5.91 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.24 -0.912 . . . . 0.0 110.578 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.9 -50.25 66.79 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.379 -0.826 . . . . 0.0 110.831 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.23 -24.76 66.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.983 -1.073 . . . . 0.0 110.089 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.444 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -74.24 -38.06 63.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 109.771 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.08 -13.18 57.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.341 -0.849 . . . . 0.0 109.871 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.05 -53.96 7.56 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.19 -0.944 . . . . 0.0 109.398 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.472 HD12 ' HB ' ' A' ' 43' ' ' ILE . 12.2 mt -64.98 -41.12 91.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.91 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.417 ' HG2' ' CZ ' ' A' ' 68' ' ' ARG . 18.1 tt0 -61.66 -53.35 57.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.04 -1.038 . . . . 0.0 109.722 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.67 -10.66 32.0 Favored Glycine 0 N--CA 1.479 1.537 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.481 ' O ' ' HB2' ' A' ' 70' ' ' MET . 5.0 m -85.12 -44.25 13.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.272 -1.134 . . . . 0.0 109.667 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -72.38 -32.88 66.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -0.932 . . . . 0.0 109.584 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.417 ' CZ ' ' HG2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -65.35 -55.49 17.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.239 -0.913 . . . . 0.0 110.073 -179.629 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 70' ' ' MET . 0.1 OUTLIER -67.9 -46.45 71.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.965 . . . . 0.0 110.48 -179.275 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -44.9 -72.02 0.07 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.05 -1.031 . . . . 0.0 109.458 -179.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -162.18 -93.2 0.09 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.497 HD11 ' O ' ' A' ' 73' ' ' VAL . 2.2 pp -48.19 178.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.52 -0.988 . . . . 0.0 109.935 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.497 ' O ' HD11 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -122.09 -175.8 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.221 -0.924 . . . . 0.0 109.817 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.492 HG11 ' N ' ' A' ' 75' ' ' GLU . 92.8 t -146.53 145.57 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.617 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.492 ' N ' HG11 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -94.68 178.58 5.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 109.376 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.3 t0 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.483 -179.924 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.268 0.556 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.7 t -156.7 24.3 0.33 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.246 -0.909 . . . . 0.0 109.356 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 57.09 92.86 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.332 -0.855 . . . . 0.0 109.685 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.419 ' O ' ' C ' ' A' ' 5' ' ' THR . 1.5 tp -113.02 57.24 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.256 -0.902 . . . . 0.0 109.299 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 4' ' ' ILE . 10.9 t -44.05 161.18 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 109.571 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.8 -152.86 0.46 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.373 -0.829 . . . . 0.0 109.509 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.445 ' O ' HG21 ' A' ' 7' ' ' THR . 3.1 t -63.64 119.33 53.09 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.201 -0.937 . . . . 0.0 109.648 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.486 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 35.1 Cg_endo -78.09 175.18 11.45 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.448 2.099 . . . . 0.0 110.266 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 8' ' ' PRO . 34.5 Cg_endo -76.42 154.58 36.06 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.455 2.103 . . . . 0.0 110.222 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.06 -65.76 0.49 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.337 -0.852 . . . . 0.0 110.837 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.526 ' CA ' ' HE2' ' A' ' 70' ' ' MET . . . -45.35 -65.66 0.51 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.26 -0.9 . . . . 0.0 111.415 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 80.4 t -55.99 -20.62 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.954 -1.091 . . . . 0.0 111.354 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.469 HD11 ' O ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -87.83 -24.8 23.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.766 -1.209 . . . . 0.0 110.002 -179.418 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.3 mt -71.26 -50.73 29.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.011 -1.056 . . . . 0.0 109.237 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.511 ' CD ' ' N ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -66.6 -41.43 88.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.207 -0.933 . . . . 0.0 109.169 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.511 ' N ' ' CD ' ' A' ' 15' ' ' LYS . 9.4 tttp -49.93 -36.95 29.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -0.927 . . . . 0.0 109.114 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.434 ' HB2' ' HD3' ' A' ' 39' ' ' LYS . . . -99.81 -75.33 0.57 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.325 -0.859 . . . . 0.0 109.186 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -158.8 85.53 0.83 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.359 -0.838 . . . . 0.0 109.497 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -147.15 -105.84 0.43 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 15' ' ' LYS . 11.7 mt -53.51 -19.18 2.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.29 -1.124 . . . . 0.0 109.479 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.44 ' HB3' ' O ' ' A' ' 20' ' ' ILE . 3.2 tt0 60.81 111.02 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.296 -0.877 . . . . 0.0 109.32 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.68 135.97 40.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.923 . . . . 0.0 109.433 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 24' ' ' SER . . . 133.12 41.96 0.17 Allowed Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' GLY . 9.5 m -43.89 136.62 3.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.286 -1.126 . . . . 0.0 109.459 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 26' ' ' GLU . . . -162.79 43.9 0.34 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 25' ' ' GLY . 15.0 tt0 49.1 97.21 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.349 -1.089 . . . . 0.0 109.465 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.26 165.68 27.42 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.54 2.16 . . . . 0.0 110.379 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -147.95 -161.79 1.41 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 109.571 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.41 41.52 1.13 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.365 -0.834 . . . . 0.0 108.898 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 31' ' ' LYS . 16.5 p30 -94.82 -145.64 0.26 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.435 -0.791 . . . . 0.0 109.586 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.487 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -71.08 141.65 50.84 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.147 -0.971 . . . . 0.0 110.01 -179.633 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 t -114.59 141.66 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.0 109.309 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.434 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . -97.4 143.26 28.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -0.929 . . . . 0.0 109.608 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.458 ' OG1' ' N ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -106.16 176.39 5.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 109.472 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.458 ' N ' ' OG1' ' A' ' 34' ' ' THR . 12.8 pt -125.94 165.78 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.295 -0.878 . . . . 0.0 109.434 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.8 mtpt -89.53 144.95 25.62 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.336 -0.852 . . . . 0.0 109.293 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -60.77 -13.47 15.33 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.269 -0.894 . . . . 0.0 109.619 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 37' ' ' ARG . 2.5 t0 -42.76 -41.07 3.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.295 -0.878 . . . . 0.0 109.549 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.434 ' HD3' ' HB2' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -71.48 -47.53 54.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -0.857 . . . . 0.0 109.501 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.463 HG13 ' CG ' ' A' ' 60' ' ' MET . 75.0 t -53.03 -20.51 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.799 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -81.16 -62.07 1.77 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.94 . . . . 0.0 109.694 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.65 -55.69 23.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.352 -0.842 . . . . 0.0 110.032 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.455 ' CG2' HD12 ' A' ' 63' ' ' ILE . 74.3 mt -54.24 -58.41 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.916 . . . . 0.0 110.178 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 43' ' ' ILE . . . -42.19 -28.82 0.21 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.223 -0.923 . . . . 0.0 109.77 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -67.03 -51.29 56.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.186 -0.947 . . . . 0.0 109.49 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.5 mt -77.49 -2.24 34.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.875 . . . . 0.0 109.702 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.27 23.15 6.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.119 -0.988 . . . . 0.0 109.529 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.617 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 5.5 ttp -69.32 -43.12 23.04 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 110.755 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 48' ' ' MET . 36.2 Cg_endo -79.51 13.7 2.01 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 122.055 1.837 . . . . 0.0 111.194 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.53 -35.46 79.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.97 -1.081 . . . . 0.0 109.412 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.421 HD22 ' SD ' ' A' ' 62' ' ' MET . 0.3 OUTLIER -143.99 23.81 1.69 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -0.87 . . . . 0.0 109.595 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 51' ' ' LEU . 35.3 t-20 44.99 56.69 5.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -0.894 . . . . 0.0 109.626 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.458 ' HB3' ' HB2' ' A' ' 58' ' ' ALA . . . -52.56 170.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 109.396 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.27 -44.35 68.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.923 . . . . 0.0 109.367 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.55 -50.81 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.218 -0.926 . . . . 0.0 108.841 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.51 HG21 ' N ' ' A' ' 57' ' ' GLU . 8.1 tt -172.53 -31.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 121.207 -0.933 . . . . 0.0 109.518 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.51 ' N ' HG21 ' A' ' 56' ' ' ILE . 6.2 tp10 -57.2 -45.53 83.69 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.208 -0.932 . . . . 0.0 109.806 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.458 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . . . -60.04 -35.84 75.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.337 -0.852 . . . . 0.0 109.813 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.5 ' HA ' ' CG ' ' A' ' 62' ' ' MET . . . -63.21 -25.56 68.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.975 . . . . 0.0 109.396 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.463 ' CG ' HG13 ' A' ' 40' ' ' VAL . 1.3 mtt -81.06 -23.54 38.45 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.113 -0.992 . . . . 0.0 108.395 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.05 -22.42 36.39 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.605 -0.685 . . . . 0.0 109.847 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.5 ' CG ' ' HA ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -82.47 -50.34 8.96 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.894 -1.129 . . . . 0.0 109.425 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.474 ' O ' ' HB ' ' A' ' 66' ' ' THR . 8.0 mt -57.68 -37.92 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.418 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.39 -50.72 70.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.102 -0.999 . . . . 0.0 109.21 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.77 -12.99 23.11 Favored Glycine 0 N--CA 1.481 1.635 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 54.0 m -82.54 -54.16 5.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -1.15 . . . . 0.0 109.089 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -79.21 3.27 18.33 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.374 -0.829 . . . . 0.0 109.261 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.44 -49.91 5.9 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.173 -0.955 . . . . 0.0 109.384 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -21.53 24.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.878 . . . . 0.0 109.877 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.526 ' HE2' ' CA ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -60.18 -64.34 0.98 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.057 -1.027 . . . . 0.0 109.478 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -159.08 -98.54 0.14 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.523 ' CD1' ' C ' ' A' ' 72' ' ' ILE . 2.5 pp -53.14 -172.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -1.115 . . . . 0.0 109.692 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.54 176.85 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 109.276 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.98 151.36 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.337 -0.852 . . . . 0.0 109.476 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.505 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -113.93 65.41 0.66 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.934 . . . . 0.0 109.519 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.6 t0 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.456 179.993 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.401 ' O ' ' HB ' ' A' ' 2' ' ' THR . 9.7 ptt? . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.281 0.562 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.401 ' HB ' ' O ' ' A' ' 1' ' ' MET . 8.5 m 66.02 171.53 0.23 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 109.6 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.54 ' N ' ' CD1' ' A' ' 3' ' ' PHE . 0.5 OUTLIER -130.44 97.04 4.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -0.935 . . . . 0.0 109.696 -179.879 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.557 ' CG2' ' N ' ' A' ' 5' ' ' THR . 2.0 mp 60.58 168.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 109.047 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.557 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 3.5 m 63.21 125.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 0.0 109.415 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.488 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -104.32 -160.45 0.77 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.428 -179.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.45 ' C ' ' HD2' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -112.05 86.02 7.21 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.247 -0.908 . . . . 0.0 109.523 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.628 ' N ' ' CD ' ' A' ' 9' ' ' PRO . 30.1 Cg_endo -72.18 -30.97 12.56 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.593 2.195 . . . . 0.0 113.647 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 8' ' ' PRO . 34.7 Cg_endo -75.64 127.47 10.28 Favored 'Trans proline' 0 C--N 1.323 -0.816 0 C-N-CA 121.243 1.295 . . . . 0.0 110.535 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -64.46 -43.56 93.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.867 . . . . 0.0 109.956 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 14' ' ' LEU . . . -37.5 -51.66 1.15 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.507 -0.746 . . . . 0.0 110.269 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 9' ' ' PRO . 3.1 m -66.8 -41.04 87.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 121.018 -1.051 . . . . 0.0 109.105 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.431 HD22 ' NZ ' ' A' ' 16' ' ' LYS . 9.4 mt -61.86 -15.62 43.85 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.019 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.491 ' CD1' HG23 ' A' ' 66' ' ' THR . 4.9 mt -77.65 -51.4 10.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 108.778 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -50.43 -34.86 26.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.86 . . . . 0.0 108.968 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.431 ' NZ ' HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -64.32 -51.33 63.98 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.316 -0.865 . . . . 0.0 109.286 179.808 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 18' ' ' ALA . . . -61.7 -69.23 0.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 0.0 109.411 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 17' ' ' ALA . . . -45.29 -68.95 0.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.165 -0.959 . . . . 0.0 109.326 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 21' ' ' GLU . . . 61.71 56.91 20.21 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.6 mt -50.01 91.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.24 -1.153 . . . . 0.0 109.594 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.8 tt0 -167.55 69.45 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.905 . . . . 0.0 109.487 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.12 47.68 2.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.167 -0.958 . . . . 0.0 109.297 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.01 -84.34 0.26 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 t -93.44 -165.11 1.27 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -1.162 . . . . 0.0 109.762 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 26' ' ' GLU . . . -134.73 95.58 0.27 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.462 ' HG3' ' HD2' ' A' ' 27' ' ' PRO . 0.5 OUTLIER -43.69 159.19 0.23 Allowed Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.338 -1.095 . . . . 0.0 109.782 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.462 ' HD2' ' HG3' ' A' ' 26' ' ' GLU . 34.8 Cg_endo -78.21 -163.86 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.686 2.258 . . . . 0.0 110.377 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.49 -22.98 15.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.413 -0.805 . . . . 0.0 109.803 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.517 ' CD ' ' OD1' ' A' ' 30' ' ' ASN . 7.1 ptp180 -66.99 -148.74 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.243 -0.911 . . . . 0.0 109.975 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.517 ' OD1' ' CD ' ' A' ' 29' ' ' ARG . 25.3 p-10 -46.64 157.95 0.13 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.27 -0.894 . . . . 0.0 109.786 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.32 106.16 16.18 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.272 -0.893 . . . . 0.0 109.475 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.464 HG23 HG22 ' A' ' 34' ' ' THR . 11.6 p -120.43 166.92 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.911 . . . . 0.0 109.418 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.445 ' O ' HG21 ' A' ' 34' ' ' THR . . . -127.84 103.56 7.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.641 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.464 HG22 HG23 ' A' ' 32' ' ' VAL . 14.6 p -144.73 133.91 22.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.314 -0.866 . . . . 0.0 109.212 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.417 ' O ' HG11 ' A' ' 74' ' ' VAL . 6.0 pt -90.88 -171.47 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.109 -0.994 . . . . 0.0 109.493 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.456 ' HA ' ' HE3' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -97.56 148.21 23.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 109.373 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 38' ' ' ASP . 1.6 mtt180 -75.03 -16.46 60.6 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.278 -0.889 . . . . 0.0 109.458 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 37' ' ' ARG . 5.9 t0 -43.73 -54.33 5.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.453 -0.779 . . . . 0.0 109.468 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.436 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -53.7 -41.18 66.68 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.177 -0.952 . . . . 0.0 109.656 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.508 HG23 ' CG2' ' A' ' 63' ' ' ILE . 75.1 t -57.35 -36.45 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.313 -0.867 . . . . 0.0 109.927 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -29.56 65.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.157 -0.964 . . . . 0.0 110.052 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -80.92 -24.5 38.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.064 -1.022 . . . . 0.0 109.808 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.459 ' HB ' HD12 ' A' ' 63' ' ' ILE . 29.6 mt -95.63 -14.59 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.811 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.406 ' HB1' HD13 ' A' ' 63' ' ' ILE . . . -105.29 -22.21 13.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.114 -0.991 . . . . 0.0 110.022 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -96.13 -41.12 8.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.096 -1.002 . . . . 0.0 109.759 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.431 ' C ' ' HG2' ' A' ' 47' ' ' LYS . 5.4 mt -84.09 2.8 37.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.15 -0.969 . . . . 0.0 109.662 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.431 ' HG2' ' C ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -139.09 41.43 2.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.151 -0.968 . . . . 0.0 109.458 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.565 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.2 OUTLIER -45.37 -51.57 25.7 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.215 -0.928 . . . . 0.0 109.806 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 48' ' ' MET . 35.4 Cg_endo -78.5 75.66 4.83 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.442 2.095 . . . . 0.0 110.447 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.71 -59.7 0.89 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -0.895 . . . . 0.0 109.678 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.495 ' O ' ' HB2' ' A' ' 52' ' ' ASN . 2.3 pp -120.13 -32.88 4.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.143 -0.973 . . . . 0.0 109.991 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.496 ' O ' ' CB ' ' A' ' 53' ' ' ALA . 1.1 t-20 162.41 -90.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.471 -0.768 . . . . 0.0 109.121 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 52' ' ' ASN . . . 76.0 128.82 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.473 -0.767 . . . . 0.0 109.73 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -89.47 -41.45 12.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 109.228 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -158.16 -48.84 0.06 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.417 -0.802 . . . . 0.0 108.854 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.512 HG21 ' N ' ' A' ' 57' ' ' GLU . 4.2 tt -177.14 -31.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.317 -0.865 . . . . 0.0 108.985 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.512 ' N ' HG21 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -65.46 -59.87 3.55 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.332 -0.855 . . . . 0.0 110.049 -179.873 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.94 -30.0 68.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.272 -0.893 . . . . 0.0 110.43 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.457 ' HB1' ' HB3' ' A' ' 53' ' ' ALA . . . -72.55 -33.32 66.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.152 -0.968 . . . . 0.0 109.97 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -50.04 13.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.175 -0.953 . . . . 0.0 110.138 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.7 -17.89 61.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.319 -0.863 . . . . 0.0 109.81 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.429 ' SD ' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -80.92 -55.62 4.67 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.165 -0.959 . . . . 0.0 110.072 -179.467 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.508 ' CG2' HG23 ' A' ' 40' ' ' VAL . 3.1 mt -51.24 -43.08 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.05 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.463 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 12.3 pt-20 -64.81 -45.62 85.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.869 -1.144 . . . . 0.0 108.867 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.463 ' N ' ' HG3' ' A' ' 64' ' ' GLU . . . -60.26 -14.41 33.16 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.491 HG23 ' CD1' ' A' ' 14' ' ' LEU . 86.7 m -85.73 -60.36 2.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.388 -1.066 . . . . 0.0 109.265 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.463 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -61.86 -13.8 27.76 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.166 -0.959 . . . . 0.0 109.061 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.589 ' CG ' ' CG1' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -77.67 -62.3 1.71 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.329 -0.857 . . . . 0.0 109.269 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.01 -15.48 63.62 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.315 -0.866 . . . . 0.0 109.261 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.422 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.1 OUTLIER -88.4 -34.35 17.58 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.328 -0.858 . . . . 0.0 109.885 -179.754 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -159.64 -102.16 0.18 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.505 ' CD1' ' C ' ' A' ' 72' ' ' ILE . 1.1 pp -108.16 -169.63 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -1.197 . . . . 0.0 110.103 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.589 ' CG1' ' CG ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -103.92 -176.8 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.392 -0.818 . . . . 0.0 109.517 179.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.417 HG11 ' O ' ' A' ' 35' ' ' ILE . 1.5 t -109.54 -170.15 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.363 -0.836 . . . . 0.0 109.216 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -124.55 177.16 6.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 109.545 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.5 t70 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.461 179.935 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.59 -33.68 2.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.933 . . . . 0.0 109.401 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -158.12 99.85 1.67 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 0.0 109.482 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.432 HG12 ' N ' ' A' ' 5' ' ' THR . 19.2 tt -62.31 164.6 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.198 -0.939 . . . . 0.0 109.534 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.432 ' N ' HG12 ' A' ' 4' ' ' ILE . 6.3 t -85.48 137.24 33.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 109.335 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -137.67 104.05 5.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.236 -0.915 . . . . 0.0 109.379 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.0 p -99.64 136.8 20.21 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.125 -0.985 . . . . 0.0 109.195 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.75 152.14 25.28 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.416 2.077 . . . . 0.0 110.515 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.524 ' HG2' ' CG2' ' A' ' 12' ' ' VAL . 35.5 Cg_endo -77.97 -165.26 0.32 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.623 2.215 . . . . 0.0 110.081 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -91.7 -65.66 0.99 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.13 -0.981 . . . . 0.0 109.793 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -41.78 -30.01 0.22 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.014 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.524 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 70.1 t -84.54 -46.46 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.137 -0.977 . . . . 0.0 109.603 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.52 ' CD1' ' O ' ' A' ' 9' ' ' PRO . 6.3 mt -52.62 -54.72 29.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.586 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.411 ' O ' ' HB1' ' A' ' 18' ' ' ALA . 0.9 OUTLIER -60.38 -43.98 96.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.312 -0.867 . . . . 0.0 109.531 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 7.9 ttpt -54.18 -30.07 48.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 0.0 109.534 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -45.45 35.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.145 -0.972 . . . . 0.0 109.627 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -102.04 47.5 0.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 109.773 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 14' ' ' LEU . . . 172.17 -42.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.206 -0.934 . . . . 0.0 109.535 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 21' ' ' GLU . . . -48.42 -79.19 0.07 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.422 ' C ' ' O ' ' A' ' 19' ' ' GLY . 3.1 mp -42.75 94.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.28 -1.129 . . . . 0.0 109.867 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.1 pt-20 -88.38 -22.28 23.86 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.239 -0.913 . . . . 0.0 109.439 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.7 163.27 13.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -0.81 . . . . 0.0 109.316 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -151.11 -45.91 0.02 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 p -159.49 -176.95 6.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -1.156 . . . . 0.0 109.671 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.97 116.36 0.01 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -47.21 160.23 0.36 Allowed Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 121.23 -1.159 . . . . 0.0 109.489 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.47 167.53 22.69 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.579 2.186 . . . . 0.0 110.449 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -157.03 -61.27 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.378 -0.826 . . . . 0.0 109.209 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -146.97 38.85 1.0 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.297 -0.877 . . . . 0.0 109.567 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -50.12 112.39 0.67 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -0.912 . . . . 0.0 109.13 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -118.88 115.24 23.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.757 -179.629 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 31' ' ' LYS . 52.7 t 58.94 117.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -0.891 . . . . 0.0 109.727 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.81 156.49 17.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 109.237 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.3 p -145.53 152.51 39.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.003 . . . . 0.0 109.689 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.409 HD11 ' HB3' ' A' ' 18' ' ' ALA . 39.8 pt -115.54 -175.38 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 109.223 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.76 127.6 45.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.0 109.621 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.531 ' CG ' HG13 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -56.1 -35.86 67.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.957 . . . . 0.0 109.121 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -49.07 -38.68 25.02 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.471 -0.768 . . . . 0.0 109.61 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -63.96 -45.77 87.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.119 -0.988 . . . . 0.0 109.665 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.459 HG11 ' HB ' ' A' ' 63' ' ' ILE . 1.8 t -68.55 -11.08 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.039 -1.038 . . . . 0.0 109.132 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.45 -47.49 10.59 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.275 -0.89 . . . . 0.0 108.895 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.47 ' O ' HD21 ' A' ' 46' ' ' LEU . 3.1 tt0 -55.44 -33.97 64.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.266 -0.896 . . . . 0.0 109.226 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 12.7 mt -83.36 -22.9 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.379 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.37 -24.54 61.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.913 . . . . 0.0 109.375 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.45 ' HA ' ' SD ' ' A' ' 48' ' ' MET . 31.2 mt-10 -93.47 -35.8 12.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 109.171 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.506 ' CD2' ' N ' ' A' ' 46' ' ' LEU . 0.5 OUTLIER -66.93 -8.58 30.47 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.332 -0.855 . . . . 0.0 109.795 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.458 ' HD2' ' O ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -140.86 48.67 1.7 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.206 -0.934 . . . . 0.0 109.61 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.549 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 3.7 tpp -43.42 -52.97 12.35 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.297 -0.877 . . . . 0.0 109.42 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.549 ' HD3' ' CB ' ' A' ' 48' ' ' MET . 36.2 Cg_endo -79.46 86.3 1.7 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.498 2.132 . . . . 0.0 110.131 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -134.66 -60.23 0.79 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.135 -0.978 . . . . 0.0 109.815 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.49 ' O ' ' HB2' ' A' ' 52' ' ' ASN . 3.9 pp -127.16 -10.69 5.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 110.091 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 10.5 t30 164.35 -89.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.318 -0.864 . . . . 0.0 109.024 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.438 ' HB3' ' HB1' ' A' ' 59' ' ' ALA . . . 63.37 72.4 0.48 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.515 -0.74 . . . . 0.0 109.592 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.81 -30.51 57.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.176 -0.953 . . . . 0.0 108.983 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.489 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -164.17 -61.43 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.364 -0.835 . . . . 0.0 109.247 179.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -165.8 -34.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -65.54 -62.82 1.3 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.273 -0.892 . . . . 0.0 110.519 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.95 -38.98 71.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.319 -0.863 . . . . 0.0 110.297 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.438 ' HB1' ' HB3' ' A' ' 53' ' ' ALA . . . -66.3 -70.13 0.26 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.161 -0.962 . . . . 0.0 110.033 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.525 ' HA ' HG12 ' A' ' 63' ' ' ILE . 0.7 OUTLIER -46.68 -28.37 1.47 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.181 -0.949 . . . . 0.0 110.405 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.457 ' HA ' ' OE2' ' A' ' 64' ' ' GLU . 2.3 mmm180 -74.63 -41.28 60.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.975 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.465 ' SD ' HD23 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -69.49 -47.21 64.61 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.233 -0.917 . . . . 0.0 110.258 -179.3 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.535 ' O ' ' HB ' ' A' ' 66' ' ' THR . 1.0 OUTLIER -52.08 -57.95 3.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.246 -0.909 . . . . 0.0 111.159 -179.421 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.457 ' OE2' ' HA ' ' A' ' 61' ' ' ARG . 9.9 pt-20 -56.44 -55.14 37.34 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 120.946 -1.097 . . . . 0.0 109.519 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.57 -19.41 13.28 Favored Glycine 0 N--CA 1.483 1.778 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.535 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 63.8 m -77.95 -42.82 31.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.473 -1.016 . . . . 0.0 109.119 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -80.72 -1.38 42.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.24 -0.913 . . . . 0.0 108.946 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.441 ' HG2' HG21 ' A' ' 73' ' ' VAL . 0.1 OUTLIER -83.98 -55.0 4.46 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.323 -0.861 . . . . 0.0 109.94 -179.731 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.67 -11.05 43.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.13 -0.981 . . . . 0.0 110.597 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.423 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -65.71 -50.35 65.16 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.935 -1.103 . . . . 0.0 110.122 -179.65 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -156.79 -71.56 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.092 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.51 ' CD1' ' C ' ' A' ' 72' ' ' ILE . 1.0 OUTLIER -98.04 -174.27 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.148 -1.207 . . . . 0.0 109.848 -179.557 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.441 HG21 ' HG2' ' A' ' 68' ' ' ARG . 2.3 p -107.98 -179.26 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.465 -0.772 . . . . 0.0 109.043 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.531 HG13 ' CG ' ' A' ' 37' ' ' ARG . 0.1 OUTLIER -127.16 159.11 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.989 . . . . 0.0 109.308 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 1.9 pp20? -133.81 157.59 45.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.9 t0 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.5 -179.893 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.28 155.72 50.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 109.52 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.544 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 62.9 m-85 -81.82 113.89 20.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.193 -0.942 . . . . 0.0 109.39 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.544 ' CG2' ' O ' ' A' ' 3' ' ' PHE . 1.5 tp 81.03 149.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.547 -0.721 . . . . 0.0 109.411 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 t -156.3 161.9 40.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.227 -0.92 . . . . 0.0 109.708 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.72 178.39 7.96 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.313 -0.867 . . . . 0.0 109.389 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 47.5 88.35 0.11 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 109.518 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.465 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 35.9 Cg_endo -78.65 174.43 12.31 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.665 2.243 . . . . 0.0 110.412 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.478 ' O ' HD11 ' A' ' 13' ' ' LEU . 35.9 Cg_endo -77.36 117.65 4.41 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.555 2.17 . . . . 0.0 110.308 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.475 ' HA ' HD11 ' A' ' 13' ' ' LEU . . . -51.88 -50.65 60.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.305 -0.872 . . . . 0.0 109.995 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -42.57 -50.87 5.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.22 -0.925 . . . . 0.0 109.87 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.443 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 42.8 t -56.28 -48.83 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 109.973 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.478 HD11 ' O ' ' A' ' 9' ' ' PRO . 4.9 mp -53.25 -58.08 8.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.145 -0.972 . . . . 0.0 109.835 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.407 ' HA ' ' HB1' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -49.06 -33.5 11.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.907 . . . . 0.0 109.604 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -60.9 -62.89 1.53 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 0.0 110.112 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.86 -3.56 29.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.104 -0.997 . . . . 0.0 109.818 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.407 ' HB1' ' HA ' ' A' ' 14' ' ' LEU . . . -84.57 -25.16 28.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.079 -1.013 . . . . 0.0 109.426 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.82 -73.55 0.1 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.483 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.88 47.89 0.26 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 mt -51.91 -20.77 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.193 -1.18 . . . . 0.0 109.727 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -100.26 136.93 39.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.225 -0.922 . . . . 0.0 109.519 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 p -135.12 -166.88 1.9 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.927 . . . . 0.0 109.72 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.15 -149.39 0.13 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -122.35 -12.55 8.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.335 -1.097 . . . . 0.0 109.517 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 26' ' ' GLU . . . -154.45 55.76 0.42 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.471 ' CG ' ' HD2' ' A' ' 27' ' ' PRO . 27.9 tt0 -44.1 138.97 3.27 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.248 -1.149 . . . . 0.0 109.532 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.471 ' HD2' ' CG ' ' A' ' 26' ' ' GLU . 36.3 Cg_endo -78.41 135.41 13.29 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.596 2.197 . . . . 0.0 110.369 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.418 ' O ' ' O ' ' A' ' 27' ' ' PRO . 27.1 t30 43.69 89.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.22 -0.925 . . . . 0.0 109.336 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.7 ptt-85 -62.11 146.74 49.61 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.281 -0.887 . . . . 0.0 109.713 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.19 -174.45 4.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.366 -0.833 . . . . 0.0 109.245 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.88 118.61 2.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.217 -0.927 . . . . 0.0 109.257 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.2 p -107.16 38.4 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 109.393 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -132.11 58.69 1.73 Allowed 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.632 -0.668 . . . . 0.0 109.351 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -159.16 150.24 20.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -0.883 . . . . 0.0 109.682 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.473 HG22 HD11 ' A' ' 35' ' ' ILE . 6.5 pt -145.3 170.3 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.213 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -82.2 142.88 31.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -0.963 . . . . 0.0 109.808 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.456 ' HA ' HG22 ' A' ' 40' ' ' VAL . 30.0 mtt180 -70.33 -10.41 58.91 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.442 -0.786 . . . . 0.0 109.77 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 37' ' ' ARG . 66.3 t0 -39.5 -50.24 2.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.69 -0.631 . . . . 0.0 109.955 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -48.24 82.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 0.0 109.726 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.462 ' O ' HD11 ' A' ' 63' ' ' ILE . 46.2 t -45.1 -25.94 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.096 -1.002 . . . . 0.0 109.856 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -84.54 -39.36 18.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.199 -0.938 . . . . 0.0 109.922 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 3.5 tt0 -66.56 -27.87 68.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 0.0 109.924 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.7 mt -90.81 -42.41 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.077 -1.015 . . . . 0.0 109.775 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.506 ' HA ' ' CD ' ' A' ' 47' ' ' LYS . . . -56.26 -21.57 24.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.073 -1.017 . . . . 0.0 109.114 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.34 -44.75 12.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.624 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mt -72.21 -10.94 60.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 109.753 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.506 ' CD ' ' HA ' ' A' ' 44' ' ' ALA . 14.9 ptmt -111.0 29.19 8.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -0.963 . . . . 0.0 110.085 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.58 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -64.88 -51.31 57.87 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.1 -1.0 . . . . 0.0 109.551 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 48' ' ' MET . 36.7 Cg_endo -80.96 57.5 6.56 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.734 2.29 . . . . 0.0 110.605 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.95 -76.67 0.23 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.995 -1.066 . . . . 0.0 109.719 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.418 HD21 ' SD ' ' A' ' 62' ' ' MET . 1.6 pp -89.27 17.99 5.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 109.934 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 52' ' ' ASN . 8.5 t30 45.23 73.08 0.17 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.152 -0.968 . . . . 0.0 109.464 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.512 ' CB ' ' HB1' ' A' ' 59' ' ' ALA . . . -73.88 138.07 44.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.19 -0.944 . . . . 0.0 109.564 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.41 -68.14 0.2 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.951 . . . . 0.0 109.334 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.478 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -143.25 -52.5 0.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.348 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -165.13 -32.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.319 -0.863 . . . . 0.0 108.971 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -60.57 -70.29 0.18 Allowed 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.102 -0.998 . . . . 0.0 110.323 -179.45 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 57' ' ' GLU . . . -42.8 -58.65 2.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 110.007 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.512 ' HB1' ' CB ' ' A' ' 53' ' ' ALA . . . -49.36 -40.02 34.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.215 -0.928 . . . . 0.0 110.186 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.56 -35.67 81.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.168 -0.957 . . . . 0.0 110.207 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -14.81 58.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.12 -0.988 . . . . 0.0 109.677 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.418 ' SD ' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -76.79 -57.46 3.84 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.177 -0.952 . . . . 0.0 109.644 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.462 HD11 ' O ' ' A' ' 40' ' ' VAL . 9.1 mt -61.31 -36.82 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.063 -1.023 . . . . 0.0 109.585 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -63.95 -48.13 77.72 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.076 -1.015 . . . . 0.0 108.972 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.0 -9.39 34.19 Favored Glycine 0 N--CA 1.48 1.601 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 70' ' ' MET . 85.5 m -87.89 -48.2 7.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -1.13 . . . . 0.0 109.752 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.409 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -80.92 -12.13 59.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.127 -0.983 . . . . 0.0 109.622 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.569 ' NH2' ' CG1' ' A' ' 73' ' ' VAL . 0.1 OUTLIER -88.99 -46.0 9.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.176 -0.952 . . . . 0.0 109.435 179.814 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.59 -23.51 42.66 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.362 -0.837 . . . . 0.0 109.91 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -65.98 -66.01 0.6 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.195 -0.941 . . . . 0.0 109.354 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -161.62 -92.19 0.09 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.5 HD11 ' O ' ' A' ' 73' ' ' VAL . 2.8 pp -48.96 177.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.441 -1.035 . . . . 0.0 110.298 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.569 ' CG1' ' NH2' ' A' ' 68' ' ' ARG . 0.5 OUTLIER -112.26 -171.19 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.394 -0.816 . . . . 0.0 110.014 -179.525 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.7 t -134.03 163.78 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.076 -1.015 . . . . 0.0 109.767 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -129.76 176.86 7.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.228 -0.92 . . . . 0.0 109.689 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 t70 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.443 179.97 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.452 ' O ' ' CB ' ' A' ' 2' ' ' THR . 24.6 mtt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.26 0.552 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.452 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.2 OUTLIER 72.16 99.22 0.07 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 109.367 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -74.79 84.82 2.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.642 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.3 tt -163.39 152.39 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.352 -0.842 . . . . 0.0 109.306 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.41 99.41 0.41 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.919 . . . . 0.0 109.768 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -137.99 -156.57 0.7 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.882 . . . . 0.0 109.391 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.6 p -98.45 139.66 21.31 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.226 -0.921 . . . . 0.0 109.515 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.453 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 35.8 Cg_endo -79.12 173.72 13.04 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.607 2.205 . . . . 0.0 110.454 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.53 ' O ' ' CG ' ' A' ' 13' ' ' LEU . 34.4 Cg_endo -76.64 151.07 32.0 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.726 2.284 . . . . 0.0 110.32 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . -75.76 -64.55 1.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 110.213 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -41.36 -61.46 1.04 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.313 -0.867 . . . . 0.0 110.141 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.51 ' HB ' ' HG2' ' A' ' 9' ' ' PRO . 17.5 t -65.48 -30.01 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 109.852 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.53 ' CG ' ' O ' ' A' ' 9' ' ' PRO . 1.1 mt -50.31 -60.54 2.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.078 -1.013 . . . . 0.0 109.581 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.91 -35.43 74.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 109.726 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -50.32 -63.26 1.17 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.879 . . . . 0.0 109.792 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -21.38 60.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 0.0 109.808 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.84 -45.15 74.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 109.798 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.07 -51.05 5.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 0.0 109.453 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.22 46.55 0.86 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.8 mt -56.11 97.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 O-C-N 121.27 -1.135 . . . . 0.0 109.738 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -150.07 -62.1 0.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.287 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 65.22 59.2 0.83 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.547 -0.721 . . . . 0.0 109.677 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.31 -23.89 7.42 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.14 161.59 37.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -1.134 . . . . 0.0 109.426 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.469 ' O ' ' HD3' ' A' ' 27' ' ' PRO . . . 67.84 -113.22 5.29 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -39.76 100.59 0.22 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.552 -0.969 . . . . 0.0 109.95 -179.767 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 25' ' ' GLY . 36.2 Cg_endo -79.04 155.8 26.22 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.479 2.119 . . . . 0.0 110.076 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.446 ' O ' ' O ' ' A' ' 27' ' ' PRO . 3.5 t-20 60.54 150.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.275 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.94 137.19 32.55 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.292 -0.88 . . . . 0.0 109.602 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -169.2 29.44 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.927 . . . . 0.0 109.588 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.18 110.06 0.87 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.178 -0.951 . . . . 0.0 109.265 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.6 p -162.34 39.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 0.0 109.518 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -124.22 177.28 5.92 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.668 -0.645 . . . . 0.0 109.589 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.43 ' HA ' ' CG1' ' A' ' 73' ' ' VAL . 5.6 p -81.22 -171.66 3.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -0.914 . . . . 0.0 109.55 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.541 HG22 ' CD1' ' A' ' 72' ' ' ILE . 3.3 pt -140.1 -170.08 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.888 . . . . 0.0 109.588 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.4 ptpt -95.11 130.32 41.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.352 -0.843 . . . . 0.0 109.641 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.404 ' O ' ' C ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -67.35 -8.5 33.04 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.223 -0.923 . . . . 0.0 109.655 179.896 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 37' ' ' ARG . 31.9 t70 -42.5 -54.64 3.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.363 -0.836 . . . . 0.0 109.912 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -42.34 90.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 109.809 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 40' ' ' VAL . 68.2 t -57.38 -21.59 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.193 -0.942 . . . . 0.0 109.717 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.7 ttp85 -84.87 -59.02 2.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.442 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -48.61 -58.18 5.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 109.509 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.469 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 92.2 mt -56.69 -56.21 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 109.571 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.447 ' N ' HD13 ' A' ' 63' ' ' ILE . . . -45.59 -25.27 0.44 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.962 . . . . 0.0 109.564 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -75.44 -57.34 3.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.944 . . . . 0.0 109.663 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 43' ' ' ILE . 4.4 pp -70.46 -4.64 23.67 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.122 -0.986 . . . . 0.0 109.867 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.34 5.26 49.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.146 -0.971 . . . . 0.0 109.572 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.577 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -48.39 -50.06 59.63 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 110.199 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 48' ' ' MET . 34.8 Cg_endo -77.47 77.49 3.83 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.258 1.972 . . . . 0.0 110.575 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -172.34 -35.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.388 -0.82 . . . . 0.0 109.412 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.463 ' O ' ' OD1' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -143.74 16.56 1.79 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.441 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 52' ' ' ASN . 7.3 p-10 40.58 67.7 0.48 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.506 -0.746 . . . . 0.0 109.833 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.46 ' HB3' HD13 ' A' ' 51' ' ' LEU . . . -85.37 154.6 21.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 109.549 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -47.65 -51.44 21.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.17 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.12 -52.1 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.368 -0.833 . . . . 0.0 108.931 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.552 ' CG2' ' O ' ' A' ' 56' ' ' ILE . 20.8 mm -149.99 9.44 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.453 -0.779 . . . . 0.0 109.612 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -97.61 -52.7 3.68 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 120.899 -1.125 . . . . 0.0 109.717 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.51 -43.41 73.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.365 -0.834 . . . . 0.0 109.352 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.67 -24.33 64.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.355 -0.841 . . . . 0.0 109.438 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.431 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -70.66 -38.69 73.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.311 -0.868 . . . . 0.0 109.63 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.51 -14.85 58.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.276 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.37 -60.65 2.28 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.367 -0.833 . . . . 0.0 109.57 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.483 ' O ' ' HB ' ' A' ' 66' ' ' THR . 15.3 mt -59.34 -36.27 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 109.787 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -62.85 -60.02 4.06 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.083 -1.011 . . . . 0.0 109.498 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 68' ' ' ARG . . . -56.52 -15.85 13.5 Favored Glycine 0 N--CA 1.479 1.547 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.524 ' CG2' ' SD ' ' A' ' 70' ' ' MET . 60.8 m -74.1 -55.86 5.6 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.243 -1.151 . . . . 0.0 109.153 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.473 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -62.2 -27.2 68.81 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.403 ' HB2' ' HA2' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -47.77 -61.81 1.76 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.525 -0.735 . . . . 0.0 109.17 179.302 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.55 -68.58 0.78 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.332 -0.855 . . . . 0.0 110.312 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.524 ' SD ' ' CG2' ' A' ' 66' ' ' THR . 1.1 mpt? -45.49 -21.02 0.08 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.177 -0.952 . . . . 0.0 111.615 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' A' ' 67' ' ' ALA . . . -150.1 -133.13 2.09 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 118.898 -1.62 . . . . 0.0 110.764 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.541 ' CD1' HG22 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -102.81 -170.26 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.529 -0.983 . . . . 0.0 110.215 -179.354 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.484 ' O ' HD11 ' A' ' 72' ' ' ILE . 9.1 p -84.08 165.06 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -0.869 . . . . 0.0 109.85 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 75' ' ' GLU . 54.5 t -124.7 161.95 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.218 -0.926 . . . . 0.0 109.578 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.47 ' N ' HG13 ' A' ' 74' ' ' VAL . 2.3 pp20? -114.51 135.14 54.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 109.38 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.4 179.929 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.6 mtm . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.2 t -157.13 -42.24 0.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.89 . . . . 0.0 109.63 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -173.88 46.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -0.92 . . . . 0.0 109.342 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 4' ' ' ILE . 2.6 tp -119.69 71.25 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 109.494 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.08 146.76 47.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.221 -0.925 . . . . 0.0 109.564 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.9 tptp -60.35 -178.71 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.501 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.449 ' OG1' ' HD2' ' A' ' 8' ' ' PRO . 8.4 t -179.87 146.98 0.45 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.858 . . . . 0.0 109.448 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.449 ' HD2' ' OG1' ' A' ' 7' ' ' THR . 34.8 Cg_endo -77.28 171.47 17.69 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.61 2.207 . . . . 0.0 110.327 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.56 174.47 12.62 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.622 2.215 . . . . 0.0 110.441 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.471 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -67.51 -66.16 0.6 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.244 -0.91 . . . . 0.0 109.883 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.517 ' CB ' ' SD ' ' A' ' 70' ' ' MET . . . -34.51 -67.73 0.13 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.677 -0.639 . . . . 0.0 110.705 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.1 t -49.55 -44.19 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.07 -1.019 . . . . 0.0 109.906 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 14.8 mt -54.13 -69.41 0.12 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.148 -0.97 . . . . 0.0 109.752 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.509 ' O ' ' CB ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -48.48 -26.91 2.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.77 -179.801 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -64.58 0.89 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 0.0 109.717 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.4 tptp -56.68 -32.59 65.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -0.942 . . . . 0.0 109.326 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -105.01 48.62 0.83 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.569 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 14' ' ' LEU . . . -133.13 -36.7 1.0 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.14 -0.975 . . . . 0.0 109.532 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.01 63.19 1.91 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.481 HG22 HD11 ' A' ' 20' ' ' ILE . 19.8 mm -70.23 -15.28 19.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 O-C-N 121.24 -1.153 . . . . 0.0 109.748 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -97.83 75.38 2.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -0.908 . . . . 0.0 109.817 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 51.09 -157.22 0.11 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.763 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' A' ' 24' ' ' SER . . . -89.18 -82.04 1.31 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 3.6 t 73.78 141.0 0.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.249 -1.148 . . . . 0.0 109.455 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 26' ' ' GLU . . . 101.99 -150.01 18.15 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 25' ' ' GLY . 19.3 tt0 -44.42 136.49 4.19 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.206 -1.173 . . . . 0.0 109.215 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.49 135.12 12.95 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.522 2.148 . . . . 0.0 110.776 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.89 -173.75 2.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.357 -0.839 . . . . 0.0 109.277 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.15 -36.18 14.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.737 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -156.76 81.14 0.95 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.483 -0.76 . . . . 0.0 109.224 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.47 101.07 8.09 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 109.814 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.8 p -152.23 133.36 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.305 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 51.29 43.51 29.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.856 . . . . 0.0 109.625 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -161.05 179.62 8.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.409 -0.807 . . . . 0.0 109.678 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -159.7 164.0 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.299 -0.876 . . . . 0.0 109.301 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.5 146.32 31.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 109.707 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.453 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 3.3 ppt_? -64.04 -17.12 63.06 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.353 -0.842 . . . . 0.0 109.791 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 37' ' ' ARG . 11.9 t70 -46.04 -47.87 16.9 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.112 -0.993 . . . . 0.0 109.258 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.435 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -62.71 -44.78 95.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 0.0 109.322 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.474 HG12 ' HB ' ' A' ' 63' ' ' ILE . 47.9 t -53.09 -20.43 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.299 -0.876 . . . . 0.0 109.585 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.24 -52.6 5.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.301 -0.874 . . . . 0.0 109.546 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -59.21 -21.38 59.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.244 -0.91 . . . . 0.0 109.664 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.47 ' HB ' HD12 ' A' ' 63' ' ' ILE . 14.2 mt -101.36 -22.0 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.269 -0.895 . . . . 0.0 109.388 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.473 ' CB ' ' O ' ' A' ' 40' ' ' VAL . . . -83.49 -4.66 58.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.436 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -97.77 -39.65 8.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.156 -0.965 . . . . 0.0 109.529 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.4 mt -91.91 -29.42 16.69 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.158 -0.964 . . . . 0.0 109.5 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.429 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -81.37 -2.44 49.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -0.867 . . . . 0.0 109.542 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.6 ttp -45.22 105.66 0.48 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.199 -0.938 . . . . 0.0 109.321 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 47' ' ' LYS . 35.2 Cg_endo -76.85 -69.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.397 2.065 . . . . 0.0 110.66 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -169.11 34.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.638 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.535 ' CD1' ' HG3' ' A' ' 62' ' ' MET . 0.2 OUTLIER -102.23 -16.44 16.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.171 -0.956 . . . . 0.0 109.773 -179.734 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 53' ' ' ALA . 10.7 t-20 48.31 69.38 0.55 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.095 -1.003 . . . . 0.0 109.047 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 52' ' ' ASN . . . -43.0 100.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.344 -0.847 . . . . 0.0 109.495 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 52' ' ' ASN . . . -50.35 -31.12 13.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.233 -0.917 . . . . 0.0 109.385 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.514 ' O ' HG12 ' A' ' 56' ' ' ILE . 16.4 m -145.87 -67.71 0.29 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.199 -0.938 . . . . 0.0 109.219 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -168.28 -30.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.391 -0.818 . . . . 0.0 109.167 -179.814 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.63 -54.98 30.02 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 120.952 -1.093 . . . . 0.0 109.955 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -43.8 -72.7 0.05 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.612 -0.68 . . . . 0.0 110.972 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.94 -54.91 27.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.337 -0.852 . . . . 0.0 111.111 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.474 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -50.63 -25.83 4.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.077 -1.014 . . . . 0.0 110.815 -178.946 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -81.56 -32.93 31.98 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.015 -1.053 . . . . 0.0 109.643 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.535 ' HG3' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -70.57 -54.93 10.15 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.218 -0.927 . . . . 0.0 109.534 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.474 ' HB ' HG12 ' A' ' 40' ' ' VAL . 7.5 mt -67.56 -42.36 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.211 -0.931 . . . . 0.0 109.974 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 60' ' ' MET . 2.9 tm-20 -60.11 -54.29 47.73 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.083 -1.011 . . . . 0.0 109.61 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.21 -15.87 31.93 Favored Glycine 0 N--CA 1.479 1.548 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 70' ' ' MET . 29.9 m -75.0 -55.05 6.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.282 -1.128 . . . . 0.0 109.001 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.487 ' O ' ' C ' ' A' ' 71' ' ' GLY . . . -64.91 -23.84 67.35 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.003 -1.06 . . . . 0.0 108.493 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.44 -51.53 68.07 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.009 -1.057 . . . . 0.0 109.371 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.46 -53.18 3.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.19 -0.944 . . . . 0.0 110.169 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.517 ' SD ' ' CB ' ' A' ' 11' ' ' ALA . 2.5 mmt -62.64 -23.63 67.18 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.233 -0.917 . . . . 0.0 111.12 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.487 ' C ' ' O ' ' A' ' 67' ' ' ALA . . . -142.85 -123.53 1.82 Allowed Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.586 -1.293 . . . . 0.0 110.372 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.48 ' O ' ' O ' ' A' ' 67' ' ' ALA . 1.2 pp -115.4 -174.55 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.188 -1.184 . . . . 0.0 109.894 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.468 ' O ' HD11 ' A' ' 72' ' ' ILE . 3.8 t -79.53 157.47 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 109.751 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.9 t -127.61 170.45 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.936 . . . . 0.0 109.594 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.453 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 2.0 pt-20 -130.21 149.28 51.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.398 -0.814 . . . . 0.0 109.419 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 t70 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.921 -1.038 . . . . 0.0 109.525 -179.939 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttp . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.415 ' O ' ' CB ' ' A' ' 3' ' ' PHE . 2.5 t -169.56 121.83 0.73 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.19 -0.944 . . . . 0.0 109.398 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.415 ' CB ' ' O ' ' A' ' 2' ' ' THR . 0.3 OUTLIER 68.91 62.36 0.32 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.356 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 3' ' ' PHE . 26.9 mt -155.61 -66.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.392 -0.818 . . . . 0.0 109.122 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 m -119.62 44.25 2.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.342 -0.849 . . . . 0.0 109.046 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.46 ' O ' ' HB ' ' A' ' 7' ' ' THR . 4.6 mmtt -100.42 163.24 12.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.333 -0.854 . . . . 0.0 109.656 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 6' ' ' LYS . 8.4 m 70.24 123.12 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.336 -0.853 . . . . 0.0 109.62 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.509 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 34.8 Cg_endo -79.38 176.16 9.96 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.621 2.214 . . . . 0.0 110.187 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.509 ' HD2' ' HB2' ' A' ' 8' ' ' PRO . 34.1 Cg_endo -76.48 118.12 4.79 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.419 2.08 . . . . 0.0 110.152 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -54.6 -45.16 73.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -0.872 . . . . 0.0 109.911 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -41.3 -44.52 2.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.008 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.1 t -75.55 -36.91 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.179 -0.951 . . . . 0.0 110.014 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.481 HD12 ' HG2' ' A' ' 8' ' ' PRO . 90.6 mt -57.77 -33.09 68.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.92 . . . . 0.0 110.093 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.432 HD12 HG23 ' A' ' 66' ' ' THR . 0.5 OUTLIER -79.1 -36.27 40.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.052 -1.03 . . . . 0.0 109.802 -179.687 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.406 ' CG ' HD13 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -75.68 -13.54 60.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.214 -0.929 . . . . 0.0 109.964 -179.509 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -92.58 -29.35 16.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.079 -1.013 . . . . 0.0 109.594 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.13 -47.54 79.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.193 -0.942 . . . . 0.0 109.356 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.23 -49.74 8.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 109.351 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.89 81.81 1.24 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.447 ' O ' HG21 ' A' ' 20' ' ' ILE . 95.5 mt -56.61 -20.13 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.197 -1.178 . . . . 0.0 109.714 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -96.81 36.94 1.34 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 109.629 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 47.15 -149.11 0.14 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.94 . . . . 0.0 109.428 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.3 -149.88 1.83 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.48 15.54 15.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.244 -1.151 . . . . 0.0 109.497 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.478 ' O ' ' HD3' ' A' ' 27' ' ' PRO . . . 163.49 -92.98 0.11 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -40.89 100.89 0.23 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.474 -1.015 . . . . 0.0 109.543 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 25' ' ' GLY . 36.1 Cg_endo -77.95 128.64 9.31 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.483 2.122 . . . . 0.0 110.787 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -94.58 110.93 22.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.326 -0.859 . . . . 0.0 109.163 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.07 120.94 31.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.158 -0.964 . . . . 0.0 110.037 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -166.52 -159.69 0.38 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.339 -0.851 . . . . 0.0 109.252 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -66.08 156.13 34.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.191 -0.943 . . . . 0.0 109.346 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.2 t -52.12 123.18 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.116 -0.99 . . . . 0.0 109.022 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.62 145.69 32.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 109.978 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.5 p -125.91 169.18 12.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.379 -0.826 . . . . 0.0 109.265 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.475 HG22 HD12 ' A' ' 72' ' ' ILE . 27.3 pt -107.75 169.91 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 109.41 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt -109.9 164.77 12.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.185 -0.947 . . . . 0.0 109.524 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.469 ' HD2' ' CE ' ' A' ' 60' ' ' MET . 0.3 OUTLIER -60.8 -15.52 30.77 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.285 -0.885 . . . . 0.0 109.694 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 37' ' ' ARG . 37.1 t0 -43.63 -55.29 4.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 0.0 109.655 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -61.05 -57.42 12.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.221 -0.925 . . . . 0.0 109.692 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.524 ' O ' ' CB ' ' A' ' 44' ' ' ALA . 60.8 t -41.68 -28.68 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.89 . . . . 0.0 110.407 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -74.66 -49.91 19.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.078 -1.014 . . . . 0.0 110.216 -179.447 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -67.73 -21.08 65.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.078 -1.014 . . . . 0.0 110.109 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.48 HG22 HD11 ' A' ' 43' ' ' ILE . 19.7 mt -101.33 -13.62 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.457 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 40' ' ' VAL . . . -88.15 -14.25 39.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.317 -0.865 . . . . 0.0 109.252 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.67 -52.86 4.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.345 -0.847 . . . . 0.0 109.624 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.2 mt -88.11 32.03 0.77 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -0.944 . . . . 0.0 109.695 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -159.43 23.55 0.19 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.211 -0.931 . . . . 0.0 109.407 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.474 ' HE3' HD12 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -121.97 85.28 45.47 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.312 -0.867 . . . . 0.0 109.623 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -80.42 43.61 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.865 2.376 . . . . 0.0 110.755 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.439 ' O ' ' CG ' ' A' ' 50' ' ' ASP . 18.9 t0 53.99 25.63 5.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.062 -1.024 . . . . 0.0 109.23 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.508 ' O ' ' CB ' ' A' ' 52' ' ' ASN . 1.9 pp -44.44 -39.29 4.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.616 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 51' ' ' LEU . 7.1 t-20 161.47 95.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.636 -0.665 . . . . 0.0 109.21 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.497 ' HB3' ' N ' ' A' ' 59' ' ' ALA . . . -171.31 139.31 1.3 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.946 . . . . 0.0 109.425 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 53' ' ' ALA . . . -45.09 -59.6 2.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.202 -0.936 . . . . 0.0 109.127 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.8 -65.43 0.1 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.342 -0.849 . . . . 0.0 108.959 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.539 ' CG2' ' O ' ' A' ' 56' ' ' ILE . 2.7 mm -137.82 1.84 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.385 -0.822 . . . . 0.0 108.99 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.32 -57.07 3.22 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.039 -1.038 . . . . 0.0 109.681 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.473 ' CB ' ' HB3' ' A' ' 53' ' ' ALA . . . -64.26 -52.23 59.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.387 -0.821 . . . . 0.0 109.532 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.497 ' N ' ' HB3' ' A' ' 53' ' ' ALA . . . -51.3 -40.96 60.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 109.4 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.469 ' CE ' ' HD2' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -62.56 -37.94 88.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.867 . . . . 0.0 109.671 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.515 ' HA ' ' CG ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -68.05 -16.75 64.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.581 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.4 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -78.56 -53.7 6.93 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.287 -0.883 . . . . 0.0 109.835 -179.724 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.511 HG22 ' HA ' ' A' ' 40' ' ' VAL . 7.8 mt -60.57 -42.3 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.179 -0.951 . . . . 0.0 109.714 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.515 ' CG ' ' HA ' ' A' ' 61' ' ' ARG . 2.0 pp20? -64.25 -44.62 91.23 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.961 -1.087 . . . . 0.0 109.602 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.49 -12.38 55.89 Favored Glycine 0 C--N 1.298 -1.568 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 70' ' ' MET . 14.7 m -84.8 -56.11 3.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.401 -1.058 . . . . 0.0 109.644 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -64.46 -31.07 72.13 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.93 -1.106 . . . . 0.0 108.75 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -60.13 4.15 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.331 -0.856 . . . . 0.0 109.433 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.51 -56.25 3.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.092 -1.005 . . . . 0.0 109.876 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 66' ' ' THR . 9.5 mtp -64.49 -10.01 22.66 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.321 -0.862 . . . . 0.0 111.009 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 67' ' ' ALA . . . -142.94 -130.73 2.48 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.272 -1.442 . . . . 0.0 110.839 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.496 ' CD1' ' C ' ' A' ' 72' ' ' ILE . 0.9 OUTLIER -101.31 -169.83 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.491 -1.005 . . . . 0.0 110.301 -179.217 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.4 t -81.94 145.76 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -0.846 . . . . 0.0 109.69 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.6 t -120.36 147.28 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.407 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 12.4 pt-20 -95.27 139.82 31.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.302 -0.874 . . . . 0.0 109.477 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.9 t0 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.438 179.917 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.537 ' HG2' ' CG2' ' A' ' 12' ' ' VAL . 34.5 Cg_endo . . . . . 0 C--O 1.215 -0.658 0 N-CA-C 110.311 -0.688 . . . . 0.0 110.311 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -72.07 -61.18 1.88 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 109.828 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -39.64 -54.5 2.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.507 -0.746 . . . . 0.0 110.031 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.537 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 89.6 t -59.82 -41.59 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.106 -0.996 . . . . 0.0 109.668 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 9' ' ' PRO . 0.8 OUTLIER -55.35 -65.05 0.65 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.931 . . . . 0.0 109.62 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.725 HD11 HG23 ' A' ' 63' ' ' ILE . 2.1 mt -46.25 -27.12 0.93 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.163 -0.96 . . . . 0.0 109.209 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.5 -47.54 66.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.867 . . . . 0.0 109.39 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -67.74 -13.45 62.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.338 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.22 -42.04 80.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.381 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.196 -0.94 . . . . 0.0 109.51 179.966 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.98 148.08 25.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 109.403 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.426 HG13 HG13 ' A' ' 74' ' ' VAL . 38.9 pt -107.19 -174.28 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.213 -0.929 . . . . 0.0 109.536 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.49 ' HB3' ' OD1' ' A' ' 38' ' ' ASP . 20.3 tptt -96.44 167.01 11.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.253 -0.904 . . . . 0.0 109.757 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.64 -24.77 31.25 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.282 -0.887 . . . . 0.0 109.726 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.49 ' OD1' ' HB3' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -48.77 -38.11 20.93 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.135 -0.978 . . . . 0.0 109.417 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.403 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 6.9 mmtp -59.48 -45.58 91.27 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.317 -0.864 . . . . 0.0 109.441 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.721 HG13 ' HB ' ' A' ' 63' ' ' ILE . 39.4 t -58.3 -23.48 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.354 -0.841 . . . . 0.0 109.734 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 3.4 ttm180 -83.7 -42.07 17.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.179 -0.95 . . . . 0.0 109.507 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -62.75 -59.39 4.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.332 -0.855 . . . . 0.0 109.93 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 16.3 mt -56.54 -50.75 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.925 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.423 ' N ' HD11 ' A' ' 63' ' ' ILE . . . -59.17 -21.43 59.38 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 109.931 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -78.61 -37.67 41.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.145 -0.972 . . . . 0.0 109.68 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.5 mt -82.82 -17.29 44.54 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.19 -0.944 . . . . 0.0 109.623 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.419 ' C ' ' HD2' ' A' ' 49' ' ' PRO . 0.2 OUTLIER -121.4 8.9 10.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.437 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.575 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -44.41 -51.41 20.18 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 0.0 109.893 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 48' ' ' MET . 35.2 Cg_endo -78.48 97.7 1.15 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.338 2.026 . . . . 0.0 110.436 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -170.15 -46.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.29 -0.881 . . . . 0.0 109.594 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' A' ' 52' ' ' ASN . 0.9 OUTLIER -115.57 39.43 2.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -0.95 . . . . 0.0 109.584 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 51' ' ' LEU . 32.5 t30 41.98 57.85 3.07 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.396 -0.815 . . . . 0.0 109.747 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.94 173.6 3.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.228 -0.92 . . . . 0.0 109.446 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -86.66 -45.92 10.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.905 . . . . 0.0 109.263 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.46 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -174.57 -39.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.303 -0.873 . . . . 0.0 109.3 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -172.93 -32.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -63.55 -59.98 3.93 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.411 -0.806 . . . . 0.0 109.995 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.97 -44.35 74.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 109.657 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.85 -24.22 66.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.227 -0.921 . . . . 0.0 109.656 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.85 -29.76 56.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 109.855 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -77.74 -23.35 49.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.9 . . . . 0.0 109.721 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.11 -56.05 5.01 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.19 -0.944 . . . . 0.0 109.892 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.725 HG23 HD11 ' A' ' 14' ' ' LEU . 6.4 mt -56.0 -38.06 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.111 -0.993 . . . . 0.0 109.857 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 15.9 mt-10 -60.34 -55.03 38.56 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.106 -0.996 . . . . 0.0 109.474 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -52.94 -17.43 4.99 Favored Glycine 0 N--CA 1.482 1.754 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.556 HG21 HD12 ' A' ' 14' ' ' LEU . 61.1 m -84.57 -50.01 8.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.118 -1.225 . . . . 0.0 110.267 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.704 ' HB3' HG21 ' A' ' 74' ' ' VAL . . . -86.41 3.68 42.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.079 -1.013 . . . . 0.0 110.058 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 10.4 mtp180 -104.32 -36.3 7.66 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.058 -1.026 . . . . 0.0 109.415 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.96 -8.36 37.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 110.038 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.473 ' HG3' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -77.55 -62.94 1.5 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.074 -1.016 . . . . 0.0 109.544 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -159.19 -86.54 0.06 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.796 ' C ' HD12 ' A' ' 72' ' ' ILE . 2.5 pp -59.88 174.21 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -1.124 . . . . 0.0 109.665 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.481 ' N ' HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -114.5 157.76 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.37 -0.831 . . . . 0.0 109.211 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.704 HG21 ' HB3' ' A' ' 67' ' ' ALA . 2.3 t -115.8 142.79 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.443 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 13.0 pt-20 -105.1 97.38 7.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.268 -0.895 . . . . 0.0 109.491 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.425 ' HB2' ' OE2' ' A' ' 64' ' ' GLU . 51.2 t0 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.507 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.632 ' HA ' ' CD2' ' A' ' 13' ' ' LEU . 36.7 Cg_endo . . . . . 0 CA--C 1.54 0.785 0 CA-C-O 121.899 0.708 . . . . 0.0 112.698 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.507 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . 32.0 -121.12 0.06 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.209 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.507 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -24.0 -61.78 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.831 -0.543 . . . . 0.0 112.273 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.6 t -62.85 -47.47 92.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.004 -1.06 . . . . 0.0 110.849 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.632 ' CD2' ' HA ' ' A' ' 9' ' ' PRO . 1.3 mm? -60.97 -18.0 54.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.794 -1.191 . . . . 0.0 109.977 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 15' ' ' LYS . 17.7 mt -86.38 -53.74 4.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.088 -1.007 . . . . 0.0 109.717 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -45.5 -44.89 12.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -0.967 . . . . 0.0 109.181 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -40.47 86.47 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.335 -0.853 . . . . 0.0 109.416 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.409 ' HB1' ' HG2' ' A' ' 39' ' ' LYS . . . -51.09 -37.64 46.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.432 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.895 . . . . 0.0 109.588 -179.889 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.456 HG22 ' CG2' ' A' ' 73' ' ' VAL . 1.0 OUTLIER -132.16 179.34 6.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 109.321 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.622 HD11 ' HB1' ' A' ' 67' ' ' ALA . 8.9 pt -120.04 -175.19 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.913 . . . . 0.0 109.552 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -109.04 156.91 19.21 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.262 -0.899 . . . . 0.0 109.653 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.98 -16.31 64.27 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.3 -0.875 . . . . 0.0 109.628 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.441 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 11.7 t70 -48.25 -44.51 33.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 109.449 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.441 ' NZ ' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -55.0 -61.68 2.15 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.285 -0.884 . . . . 0.0 109.258 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.946 HG13 ' HB ' ' A' ' 63' ' ' ILE . 46.0 t -46.94 -23.42 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.277 -0.89 . . . . 0.0 109.893 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.441 ' HB3' ' O ' ' A' ' 38' ' ' ASP . 4.0 ttt85 -75.12 -61.29 1.94 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.073 -1.017 . . . . 0.0 109.851 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -58.17 -52.64 64.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.233 -0.917 . . . . 0.0 110.032 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 82.8 mt -61.13 -43.06 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.205 -0.935 . . . . 0.0 110.082 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 40' ' ' VAL . . . -52.96 -49.59 65.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.045 -1.034 . . . . 0.0 109.72 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -49.22 78.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.505 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.423 ' N ' ' CD2' ' A' ' 46' ' ' LEU . 0.3 OUTLIER -65.07 -15.02 61.9 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.256 -0.903 . . . . 0.0 110.094 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -102.89 21.46 15.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.139 -0.975 . . . . 0.0 109.919 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.571 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -57.21 -53.83 61.2 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.085 -1.009 . . . . 0.0 109.325 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.571 ' HD3' ' CB ' ' A' ' 48' ' ' MET . 36.5 Cg_endo -79.54 74.49 5.52 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.52 2.146 . . . . 0.0 110.296 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -150.26 -65.35 0.2 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.18 -0.95 . . . . 0.0 109.418 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 52' ' ' ASN . 1.5 pp -117.3 18.85 14.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.37 -0.831 . . . . 0.0 109.368 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 51' ' ' LEU . 1.2 p-10 39.73 68.16 0.4 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.483 -0.761 . . . . 0.0 109.915 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.487 ' CB ' ' HB2' ' A' ' 59' ' ' ALA . . . -63.5 168.35 4.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.171 -0.956 . . . . 0.0 109.501 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 53' ' ' ALA . . . -44.0 -36.54 2.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.893 . . . . 0.0 109.061 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m 174.3 -40.06 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.343 -0.848 . . . . 0.0 108.842 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.7 tt -171.34 -33.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 121.321 -0.862 . . . . 0.0 109.028 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.6 -67.42 0.46 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.297 -0.877 . . . . 0.0 110.331 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -44.67 -39.82 5.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.28 -0.887 . . . . 0.0 110.217 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.487 ' HB2' ' CB ' ' A' ' 53' ' ' ALA . . . -61.26 -44.38 97.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.065 -1.022 . . . . 0.0 110.041 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -40.14 94.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 110.347 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -70.38 -21.05 62.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -0.965 . . . . 0.0 110.151 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -56.45 5.09 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.097 -1.002 . . . . 0.0 109.605 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.946 ' HB ' HG13 ' A' ' 40' ' ' VAL . 15.3 mt -54.37 -35.74 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.256 -0.903 . . . . 0.0 109.423 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 1.2 tt0 -59.21 -56.83 17.09 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.225 -0.922 . . . . 0.0 109.378 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.88 -20.13 2.83 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.522 ' O ' ' CG ' ' A' ' 70' ' ' MET . 12.0 m -79.86 -57.5 3.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.397 -1.061 . . . . 0.0 109.921 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.622 ' HB1' HD11 ' A' ' 35' ' ' ILE . . . -78.15 10.62 2.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.961 . . . . 0.0 110.345 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -105.17 -55.48 2.32 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.993 -1.067 . . . . 0.0 110.476 -179.554 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.87 -25.7 12.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.078 -1.014 . . . . 0.0 111.899 -178.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.547 ' HG3' ' N ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -70.36 -30.81 67.83 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.543 -1.348 . . . . 0.0 110.901 -178.356 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.547 ' N ' ' HG3' ' A' ' 70' ' ' MET . . . -160.83 -123.09 0.66 Allowed Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.206 -1.473 . . . . 0.0 110.744 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.606 ' N ' HD12 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -48.99 -178.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.491 -1.005 . . . . 0.0 110.527 -179.025 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.475 ' O ' HG12 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -110.99 -168.61 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.539 -0.725 . . . . 0.0 109.421 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.429 ' CG2' ' C ' ' A' ' 73' ' ' VAL . 2.1 t -151.34 155.53 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 109.659 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -115.79 135.29 54.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 109.384 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.493 -179.934 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.499 ' O ' ' CG ' ' A' ' 13' ' ' LEU . 34.0 Cg_endo . . . . . 0 C--O 1.215 -0.63 0 N-CA-C 110.403 -0.653 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . -73.3 -55.78 5.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 109.843 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -42.92 -65.25 0.5 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.882 . . . . 0.0 109.884 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.489 ' HB ' ' HG2' ' A' ' 9' ' ' PRO . 92.9 t -61.21 -38.08 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.791 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.499 ' CG ' ' O ' ' A' ' 9' ' ' PRO . 5.3 mt -44.67 -42.48 7.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 109.698 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.595 HD22 ' HB2' ' A' ' 67' ' ' ALA . 0.8 OUTLIER -74.12 -40.35 62.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.087 -1.008 . . . . 0.0 109.553 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -50.06 -37.24 32.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.885 . . . . 0.0 109.296 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -79.6 -33.45 41.56 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.323 -0.861 . . . . 0.0 109.435 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.04 -25.33 58.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.564 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 109.379 179.836 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.453 ' OG1' ' N ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -157.66 176.16 12.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.199 -0.938 . . . . 0.0 109.691 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.9 HG13 HG13 ' A' ' 74' ' ' VAL . 27.3 pt -126.26 160.11 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.438 -0.789 . . . . 0.0 109.37 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.89 122.52 26.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.293 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -57.47 -15.69 7.6 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.231 -0.918 . . . . 0.0 110.083 -179.589 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 37' ' ' ARG . 31.2 t0 -43.9 -37.27 2.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.048 -1.032 . . . . 0.0 109.351 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.471 ' O ' HG13 ' A' ' 43' ' ' ILE . 13.4 mmtt -65.96 -56.31 12.32 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.155 -0.965 . . . . 0.0 109.11 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.85 HG22 ' CG2' ' A' ' 63' ' ' ILE . 37.9 t -42.06 -28.28 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 109.453 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -69.47 -54.74 12.79 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.305 -0.872 . . . . 0.0 109.375 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.21 -9.77 56.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.265 -0.897 . . . . 0.0 109.912 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 39' ' ' LYS . 11.9 mt -105.07 -8.73 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.098 -1.001 . . . . 0.0 109.855 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.461 ' HA ' ' HG2' ' A' ' 48' ' ' MET . . . -101.87 -19.12 15.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.971 . . . . 0.0 110.047 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -105.57 -32.34 8.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.384 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.6 mt -95.49 11.17 33.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.092 -1.005 . . . . 0.0 110.454 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.423 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -134.47 -53.2 0.83 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.049 -1.032 . . . . 0.0 109.496 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.475 ' HB3' HD21 ' A' ' 51' ' ' LEU . 19.4 mmt -58.86 111.49 3.74 Favored Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 121.31 -0.869 . . . . 0.0 109.733 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.56 ' HD2' ' CD2' ' A' ' 51' ' ' LEU . 34.9 Cg_endo -76.32 -30.7 5.14 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.366 2.044 . . . . 0.0 110.927 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.561 ' C ' ' HG ' ' A' ' 51' ' ' LEU . 12.4 t70 -173.14 -53.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.803 -1.186 . . . . 0.0 110.857 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.85 HD13 ' CE ' ' A' ' 62' ' ' MET . 0.0 OUTLIER 27.04 38.77 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.927 -0.483 . . . . 0.0 111.089 -179.068 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.555 ' N ' ' O ' ' A' ' 50' ' ' ASP . 26.6 t-20 37.63 59.8 1.21 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.498 -0.751 . . . . 0.0 109.928 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.568 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . . . -107.68 134.98 49.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.958 . . . . 0.0 109.798 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.19 -59.33 5.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.276 -0.89 . . . . 0.0 109.22 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.43 ' C ' HG13 ' A' ' 56' ' ' ILE . 3.1 p 178.51 -48.82 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.35 -0.844 . . . . 0.0 109.32 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.588 HG22 ' O ' ' A' ' 56' ' ' ILE . 3.3 mt -137.35 5.14 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 O-C-N 121.175 -0.953 . . . . 0.0 109.345 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 61' ' ' ARG . 0.8 OUTLIER -100.32 -54.24 2.91 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.162 -0.962 . . . . 0.0 110.031 -179.249 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.568 ' HB3' ' HA ' ' A' ' 53' ' ' ALA . . . -80.38 -61.86 1.85 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.325 -0.859 . . . . 0.0 109.959 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.439 ' H ' ' HB1' ' A' ' 53' ' ' ALA . . . -52.08 -37.78 55.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 109.791 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.529 ' CE ' HG23 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -75.91 -41.15 52.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.152 -0.967 . . . . 0.0 110.032 -179.638 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 57' ' ' GLU . 16.8 mtp180 -74.65 -7.36 52.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.105 -0.997 . . . . 0.0 109.534 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.85 ' CE ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -83.71 -54.85 4.62 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.275 -0.891 . . . . 0.0 109.38 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.85 ' CG2' HG22 ' A' ' 40' ' ' VAL . 10.8 mt -63.69 -36.35 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.625 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -64.49 -50.97 65.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.103 -0.998 . . . . 0.0 109.125 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.07 -12.44 30.13 Favored Glycine 0 N--CA 1.481 1.693 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 13.7 m -84.23 -51.55 6.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -1.147 . . . . 0.0 109.425 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.595 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -79.78 -5.03 54.53 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.254 -0.904 . . . . 0.0 109.638 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 1.5 ttp180 -87.77 -48.09 8.11 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.946 -1.096 . . . . 0.0 109.505 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.59 -49.21 16.89 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.353 -0.842 . . . . 0.0 110.459 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.488 ' HG3' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -100.92 -30.49 11.63 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.127 -0.983 . . . . 0.0 110.496 -178.553 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.488 ' N ' ' HG3' ' A' ' 70' ' ' MET . . . -89.31 -147.95 17.19 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.96 -1.114 . . . . 0.0 110.674 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.559 ' C ' HD12 ' A' ' 72' ' ' ILE . 1.1 pp -105.87 -170.26 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.517 -0.99 . . . . 0.0 109.995 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.3 t -84.77 111.15 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.145 -0.972 . . . . 0.0 109.676 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.9 HG13 HG13 ' A' ' 35' ' ' ILE . 3.0 t -80.19 153.46 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 0.0 109.378 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 35' ' ' ILE . 14.8 pt-20 -113.63 -176.17 2.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.899 . . . . 0.0 109.458 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.6 t70 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.464 179.983 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.445 ' HD2' ' HB ' ' A' ' 12' ' ' VAL . 35.5 Cg_endo . . . . . 0 C--O 1.215 -0.654 0 N-CA-C 110.543 -0.599 . . . . 0.0 110.543 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -70.66 -68.63 0.42 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.208 -0.932 . . . . 0.0 109.862 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -37.29 -45.03 0.63 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.507 -0.746 . . . . 0.0 110.683 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.445 ' HB ' ' HD2' ' A' ' 9' ' ' PRO . 49.0 t -65.96 -47.32 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.101 -1.0 . . . . 0.0 109.815 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.454 ' HA ' HD23 ' A' ' 13' ' ' LEU . 19.8 mt -57.9 -63.04 1.39 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.669 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.454 HD21 ' HE2' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -44.39 -30.68 0.88 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.263 -0.898 . . . . 0.0 109.744 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 12' ' ' VAL . 10.6 tttt -69.52 -46.45 66.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.73 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.1 9.89 9.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.634 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.06 -23.03 31.01 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.183 -0.948 . . . . 0.0 109.478 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.942 . . . . 0.0 109.386 179.844 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.01 162.29 14.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 109.616 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.909 HD12 ' O ' ' A' ' 36' ' ' LYS . 1.2 pp -136.92 172.9 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -0.844 . . . . 0.0 109.517 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.909 ' O ' HD12 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -86.31 173.95 9.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.747 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -88.34 15.21 8.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.438 -0.789 . . . . 0.0 109.607 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.433 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 6.2 t70 -50.09 -39.95 44.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.599 -0.688 . . . . 0.0 110.194 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.483 ' HE3' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -71.9 -31.25 66.22 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.178 -0.951 . . . . 0.0 110.594 -179.177 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 1.012 HG22 HG22 ' A' ' 63' ' ' ILE . 47.4 t -65.04 -29.1 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.976 -1.077 . . . . 0.0 110.056 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.46 ' NH2' ' HB2' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -82.78 -30.89 28.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.114 -0.991 . . . . 0.0 109.973 -179.524 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 38' ' ' ASP . 6.7 mm-40 -76.26 -58.24 3.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.954 . . . . 0.0 109.819 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.3 mt -61.26 -55.11 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 110.273 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.603 ' HB2' HD12 ' A' ' 63' ' ' ILE . . . -47.25 -50.73 20.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.225 -0.922 . . . . 0.0 110.504 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -71.64 -24.63 61.89 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.044 -1.035 . . . . 0.0 110.368 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 mt -80.38 -11.68 59.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.004 -1.06 . . . . 0.0 109.627 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.48 39.99 1.89 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.265 -0.897 . . . . 0.0 109.274 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.569 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -50.5 -53.21 48.08 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.178 -0.951 . . . . 0.0 109.218 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.569 ' HD3' ' CB ' ' A' ' 48' ' ' MET . 36.8 Cg_endo -80.99 41.54 1.17 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.612 2.208 . . . . 0.0 110.404 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.44 ' HB3' HD23 ' A' ' 51' ' ' LEU . 33.8 t0 -111.13 -14.55 13.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.097 -1.002 . . . . 0.0 109.819 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -127.63 -99.24 0.37 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.13 -0.981 . . . . 0.0 109.591 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 57.0 t30 177.78 34.56 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.187 -0.946 . . . . 0.0 109.454 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.428 ' HB1' ' HB3' ' A' ' 58' ' ' ALA . . . -55.74 164.45 1.11 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.23 -22.38 66.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.267 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.465 ' O ' ' SD ' ' A' ' 48' ' ' MET . 0.1 OUTLIER -172.34 -50.19 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.286 -0.884 . . . . 0.0 108.937 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.439 HG23 ' N ' ' A' ' 57' ' ' GLU . 1.8 tt -174.9 -34.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.439 ' N ' HG23 ' A' ' 56' ' ' ILE . 15.9 tt0 -57.85 -66.1 0.53 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.533 -0.73 . . . . 0.0 109.805 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 57' ' ' GLU . . . -42.63 -36.65 1.46 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.354 -0.841 . . . . 0.0 109.751 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.13 -47.95 75.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.135 -0.978 . . . . 0.0 109.772 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.7 -38.02 83.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.989 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.439 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 35.7 mtp180 -74.0 -18.26 60.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 0.0 109.769 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.75 -39.77 30.29 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.125 -0.984 . . . . 0.0 109.672 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.012 HG22 HG22 ' A' ' 40' ' ' VAL . 7.4 mt -65.46 -42.39 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.143 -0.973 . . . . 0.0 109.874 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.495 ' CD ' ' N ' ' A' ' 65' ' ' GLY . 3.0 pp20? -63.35 -47.09 83.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.996 -1.065 . . . . 0.0 109.384 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.495 ' N ' ' CD ' ' A' ' 64' ' ' GLU . . . -65.4 -11.09 51.61 Favored Glycine 0 N--CA 1.478 1.485 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 70' ' ' MET . 86.2 m -81.57 -44.62 17.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.388 -1.066 . . . . 0.0 109.517 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.547 ' HB3' HG21 ' A' ' 74' ' ' VAL . . . -82.35 -16.09 50.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 108.777 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -40.78 65.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.459 -0.775 . . . . 0.0 109.38 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.81 -31.3 14.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.13 -0.981 . . . . 0.0 109.87 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -53.99 -72.95 0.05 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.211 -0.931 . . . . 0.0 109.19 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 72' ' ' ILE . . . -162.48 -87.74 0.07 OUTLIER Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.495 HD13 ' C ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -39.56 152.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.642 -0.916 . . . . 0.0 110.389 -179.526 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.64 135.52 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.547 HG21 ' HB3' ' A' ' 67' ' ' ALA . 2.1 t -108.63 155.39 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.982 -1.074 . . . . 0.0 110.176 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -110.35 -171.37 1.82 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.396 -0.815 . . . . 0.0 109.123 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.9 t70 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.637 -179.928 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.553 ' HG2' ' CG2' ' A' ' 12' ' ' VAL . 35.8 Cg_endo . . . . . 0 C--O 1.214 -0.682 0 N-CA-C 110.37 -0.666 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.517 ' HA ' HD12 ' A' ' 13' ' ' LEU . . . -52.52 -61.31 2.36 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.294 -0.879 . . . . 0.0 110.129 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -36.4 -40.73 0.25 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.619 -0.676 . . . . 0.0 110.49 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.553 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 72.8 t -74.94 -43.01 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.09 -1.006 . . . . 0.0 109.465 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 10' ' ' ALA . 63.0 mt -56.04 -66.74 0.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.994 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.596 HD13 ' HB2' ' A' ' 67' ' ' ALA . 1.8 pp -57.74 -28.18 63.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.176 -0.953 . . . . 0.0 109.658 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.488 ' N ' ' HG ' ' A' ' 14' ' ' LEU . 57.1 tttt -56.29 -50.81 70.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.546 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -25.54 65.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.686 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.423 ' HB1' ' HE3' ' A' ' 39' ' ' LYS . . . -74.44 -8.84 57.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.201 -0.937 . . . . 0.0 109.58 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.547 ' HB1' HG21 ' A' ' 72' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.61 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.866 HG22 ' O ' ' A' ' 73' ' ' VAL . 0.9 OUTLIER -101.83 140.04 36.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.419 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 pt -91.69 171.79 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.233 -0.917 . . . . 0.0 109.441 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 mtmt -89.75 151.49 21.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 109.357 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.16 -16.58 64.1 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.206 -0.933 . . . . 0.0 109.303 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -45.69 -41.64 10.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.365 -0.835 . . . . 0.0 109.608 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.471 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.7 OUTLIER -59.76 -64.19 1.04 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 109.367 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.893 HG22 ' CG2' ' A' ' 63' ' ' ILE . 56.1 t -45.74 -23.64 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 0.0 109.973 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -42.79 32.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.118 -0.989 . . . . 0.0 110.162 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -84.6 -6.57 59.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.11 -0.994 . . . . 0.0 110.026 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 39' ' ' LYS . 7.6 mt -93.51 -39.68 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.061 -1.024 . . . . 0.0 109.898 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 48' ' ' MET . . . -77.97 -39.68 41.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.148 -0.97 . . . . 0.0 109.525 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -53.87 -20.59 6.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.272 -0.892 . . . . 0.0 109.77 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 46' ' ' LEU . 9.3 mt -96.01 -30.89 13.33 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.141 -0.975 . . . . 0.0 109.653 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 50' ' ' ASP . 33.3 mmtt -131.39 43.51 3.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.913 . . . . 0.0 109.264 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.565 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -64.03 -52.54 55.32 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.387 -0.821 . . . . 0.0 110.01 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 48' ' ' MET . 35.5 Cg_endo -78.21 -3.03 13.06 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.41 2.074 . . . . 0.0 110.575 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.492 ' C ' HD23 ' A' ' 51' ' ' LEU . 18.3 t70 -62.26 -13.32 26.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.348 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.772 ' N ' HD23 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -139.84 27.81 2.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.397 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 51' ' ' LEU . 20.6 t30 42.33 74.58 0.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.344 -0.848 . . . . 0.0 109.622 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.852 ' CB ' ' HB2' ' A' ' 59' ' ' ALA . . . -77.29 155.33 32.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 0.0 109.504 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -45.49 -35.31 3.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.467 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 m 174.87 -44.67 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.253 -0.904 . . . . 0.0 109.107 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.404 HG23 ' N ' ' A' ' 57' ' ' GLU . 1.5 tt -173.5 -33.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.278 -0.889 . . . . 0.0 109.011 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 58' ' ' ALA . 1.2 tt0 -75.23 -66.41 0.77 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.409 -0.807 . . . . 0.0 110.195 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 57' ' ' GLU . . . -42.49 -40.53 2.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.254 -0.904 . . . . 0.0 110.205 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.852 ' HB2' ' CB ' ' A' ' 53' ' ' ALA . . . -60.41 -47.87 84.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.958 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.6 mtm -59.2 -46.7 87.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 110.186 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.6 mtp-105 -66.58 -19.18 65.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 110.006 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -68.36 -50.84 50.34 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.083 -1.011 . . . . 0.0 109.341 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.893 ' CG2' HG22 ' A' ' 40' ' ' VAL . 6.0 mt -59.73 -35.47 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.219 -0.926 . . . . 0.0 109.607 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.91 -52.3 64.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.086 -1.009 . . . . 0.0 109.061 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -55.59 -16.82 11.88 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 75.7 m -82.29 -52.29 7.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.359 -1.083 . . . . 0.0 109.351 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.596 ' HB2' HD13 ' A' ' 14' ' ' LEU . . . -75.71 -3.73 36.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.308 -0.87 . . . . 0.0 109.322 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -86.87 -48.68 7.98 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.211 -0.931 . . . . 0.0 109.299 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.8 p -81.43 -33.2 32.27 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.265 -0.897 . . . . 0.0 109.65 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -70.5 0.09 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.184 -0.948 . . . . 0.0 109.657 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -160.12 -74.29 0.02 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.547 HG21 ' HB1' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -66.74 -174.98 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -1.16 . . . . 0.0 109.939 -179.632 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.866 ' O ' HG22 ' A' ' 34' ' ' THR . 0.1 OUTLIER -132.17 132.4 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.34 -0.85 . . . . 0.0 109.22 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.528 ' CG2' ' HB3' ' A' ' 67' ' ' ALA . 27.7 t -81.64 157.48 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.632 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.411 ' N ' HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -115.08 95.06 5.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 109.449 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.518 -179.973 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.57 ' HB2' ' CD1' ' A' ' 13' ' ' LEU . 32.9 Cg_endo . . . . . 0 C--O 1.207 -1.07 0 N-CA-C 109.95 -0.827 . . . . 0.0 109.95 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.557 ' C ' ' O ' ' A' ' 9' ' ' PRO . . . -17.63 -66.55 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.191 0.519 . . . . 0.0 111.502 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.66 -51.06 70.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.069 -1.019 . . . . 0.0 109.551 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 9' ' ' PRO . 42.4 t -45.81 -53.36 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.335 -0.853 . . . . 0.0 109.783 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.572 HD23 HG23 ' A' ' 43' ' ' ILE . 8.9 mp -47.17 -70.56 0.09 Allowed 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.331 -0.855 . . . . 0.0 110.15 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.484 ' HA ' HD23 ' A' ' 14' ' ' LEU . 5.4 mt -55.94 -17.23 6.1 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.289 -0.882 . . . . 0.0 110.18 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.83 -38.07 67.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.096 -1.002 . . . . 0.0 109.237 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -79.09 -22.29 45.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.266 -0.896 . . . . 0.0 109.229 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.8 -66.59 0.38 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.219 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.272 -0.892 . . . . 0.0 109.209 179.742 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.79 133.22 34.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 109.575 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.484 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 4.1 pt -107.93 170.88 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 0.0 109.386 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -79.83 147.27 31.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.768 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.18 -6.37 33.92 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.288 -0.882 . . . . 0.0 109.699 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -41.98 -39.88 2.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.33 -0.857 . . . . 0.0 109.945 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -58.25 7.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.148 -0.97 . . . . 0.0 109.693 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.99 HG13 ' HB ' ' A' ' 63' ' ' ILE . 86.1 t -46.73 -27.77 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.303 -0.873 . . . . 0.0 110.024 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -70.92 -46.59 62.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.105 -0.997 . . . . 0.0 109.791 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 43' ' ' ILE . 2.0 tt0 -78.26 -65.4 0.98 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.155 -0.966 . . . . 0.0 109.791 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.572 HG23 HD23 ' A' ' 13' ' ' LEU . 10.8 mt -43.12 -44.8 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.927 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.733 ' HB1' ' HB1' ' A' ' 59' ' ' ALA . . . -64.86 -43.77 91.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.164 -0.96 . . . . 0.0 109.717 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -58.08 -16.49 13.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 109.5 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.42 23.88 2.42 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.29 -0.881 . . . . 0.0 109.499 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.512 ' HD3' ' CB ' ' A' ' 50' ' ' ASP . 0.1 OUTLIER -144.0 18.02 1.77 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.0 109.413 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.553 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -43.73 -54.14 11.18 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.278 -0.889 . . . . 0.0 109.648 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.553 ' HD3' ' CB ' ' A' ' 48' ' ' MET . 36.5 Cg_endo -78.61 73.17 6.03 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.411 2.074 . . . . 0.0 110.438 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.512 ' CB ' ' HD3' ' A' ' 47' ' ' LYS . 36.8 t0 -162.4 -67.89 0.05 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.113 -0.992 . . . . 0.0 109.897 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -114.18 38.7 2.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.139 -0.976 . . . . 0.0 109.868 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 51' ' ' LEU . 4.2 p-10 40.21 28.15 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.479 -0.763 . . . . 0.0 109.916 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.678 ' HB1' ' HB2' ' A' ' 59' ' ' ALA . . . -51.81 124.6 12.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.19 -0.944 . . . . 0.0 109.531 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.458 ' O ' ' CB ' ' A' ' 55' ' ' SER . . . -45.11 -57.92 3.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.939 . . . . 0.0 109.205 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 0.5 OUTLIER 166.32 -45.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.406 -0.809 . . . . 0.0 108.859 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.671 HG22 ' O ' ' A' ' 56' ' ' ILE . 82.5 mt -140.05 7.8 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -104.92 -67.11 0.93 Allowed 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.259 -0.9 . . . . 0.0 109.45 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.09 -37.06 58.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.501 -0.749 . . . . 0.0 109.879 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.733 ' HB1' ' HB1' ' A' ' 44' ' ' ALA . . . -71.08 -31.66 68.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.128 -0.982 . . . . 0.0 109.383 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.498 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -78.64 -39.79 36.05 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.233 -0.917 . . . . 0.0 109.516 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -20.32 62.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.374 -0.829 . . . . 0.0 109.767 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.2 -60.82 2.18 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.179 -0.951 . . . . 0.0 110.075 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.99 ' HB ' HG13 ' A' ' 40' ' ' VAL . 14.9 mt -63.75 -42.75 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.191 -0.943 . . . . 0.0 109.967 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.684 ' HG2' HG21 ' A' ' 74' ' ' VAL . 24.2 tt0 -64.06 -48.52 75.91 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.092 -1.005 . . . . 0.0 109.302 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -67.25 -7.22 43.99 Favored Glycine 0 N--CA 1.478 1.447 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 8.5 m -87.26 -49.53 7.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -1.13 . . . . 0.0 109.46 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -71.49 -36.73 71.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.165 -0.96 . . . . 0.0 109.373 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -64.61 -59.2 4.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.403 -0.811 . . . . 0.0 109.907 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.71 -51.84 68.07 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.244 -0.91 . . . . 0.0 110.045 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.0 -68.88 0.15 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.217 -0.927 . . . . 0.0 109.384 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 72' ' ' ILE . . . -161.96 -88.02 0.07 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.556 HD13 ' C ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -36.39 152.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.884 -0.774 . . . . 0.0 110.279 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.471 ' O ' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -112.88 164.76 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.391 -0.818 . . . . 0.0 108.881 179.527 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.684 HG21 ' HG2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -111.82 -174.55 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.13 -0.981 . . . . 0.0 109.695 -179.583 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 35' ' ' ILE . 0.4 OUTLIER -143.1 151.0 40.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.907 . . . . 0.0 109.267 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.7 t70 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.443 -179.951 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.469 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 35.9 Cg_endo . . . . . 0 C--O 1.215 -0.654 0 N-CA-C 110.398 -0.655 . . . . 0.0 110.398 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.609 ' HA ' HD12 ' A' ' 13' ' ' LEU . . . -47.52 -48.73 27.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.787 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -41.51 -50.58 3.97 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.387 -0.821 . . . . 0.0 109.652 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.408 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 91.5 t -68.34 -36.53 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.69 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.609 HD12 ' HA ' ' A' ' 10' ' ' ALA . 38.4 mt -53.88 -65.85 0.5 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.939 . . . . 0.0 109.57 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 15' ' ' LYS . 1.1 mt -43.18 -48.28 6.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -0.841 . . . . 0.0 109.76 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 14' ' ' LEU . 7.7 ttpt -42.85 -55.18 3.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 109.666 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.33 -43.72 98.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.206 -0.934 . . . . 0.0 109.564 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.592 ' HB1' ' HD3' ' A' ' 39' ' ' LYS . . . -46.63 -35.66 6.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.226 -0.921 . . . . 0.0 109.583 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.184 -0.947 . . . . 0.0 109.422 179.95 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.524 HG22 ' CG1' ' A' ' 73' ' ' VAL . 1.8 p -112.96 142.39 45.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 109.738 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.45 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 2.8 pt -98.31 -170.13 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.333 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.466 ' HE2' ' OE2' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -95.1 167.4 11.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.898 . . . . 0.0 109.712 -179.791 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 1.051 ' O ' HG12 ' A' ' 40' ' ' VAL . 5.5 mtm180 -97.29 -19.25 18.67 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.236 -0.915 . . . . 0.0 109.681 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.466 ' C ' ' O ' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -37.81 -34.9 0.12 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.67 -0.644 . . . . 0.0 109.929 -179.753 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.592 ' HD3' ' HB1' ' A' ' 17' ' ' ALA . 8.5 mttm -72.93 -48.87 33.23 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.344 -0.848 . . . . 0.0 109.623 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 1.051 HG12 ' O ' ' A' ' 37' ' ' ARG . 9.8 p -51.29 -20.07 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 110.174 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -85.94 -62.39 1.53 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.085 -1.01 . . . . 0.0 109.778 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 16.6 pt-20 -50.19 -27.29 5.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.248 -0.908 . . . . 0.0 110.024 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.677 HG22 ' HB2' ' A' ' 47' ' ' LYS . 20.9 mt -96.75 -34.54 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.061 -1.025 . . . . 0.0 109.635 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.829 ' HB2' ' O ' ' A' ' 40' ' ' VAL . . . -47.43 -33.58 6.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.324 -0.86 . . . . 0.0 109.415 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.467 ' HA ' ' SD ' ' A' ' 48' ' ' MET . 2.6 mt-10 -88.46 -35.85 16.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.848 . . . . 0.0 109.268 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.4 mt -91.78 25.11 2.85 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.346 -0.846 . . . . 0.0 109.412 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.677 ' HB2' HG22 ' A' ' 43' ' ' ILE . 14.2 tppt? -143.35 21.47 1.88 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.135 -0.978 . . . . 0.0 109.841 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.467 ' SD ' ' HA ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -114.32 78.49 4.67 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.024 -1.047 . . . . 0.0 109.733 179.775 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 47' ' ' LYS . 36.1 Cg_endo -78.53 -44.55 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.594 2.196 . . . . 0.0 110.126 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -120.36 1.62 10.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.41 -0.807 . . . . 0.0 109.343 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.544 ' CG ' ' O ' ' A' ' 51' ' ' LEU . 0.7 OUTLIER -116.39 64.99 0.71 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.253 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 53' ' ' ALA . 42.3 t-20 -41.16 -28.69 0.1 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.867 . . . . 0.0 109.673 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.658 ' HB1' ' HB3' ' A' ' 58' ' ' ALA . . . 60.66 142.15 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.457 -0.777 . . . . 0.0 109.556 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -46.51 -61.86 1.62 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.282 -0.886 . . . . 0.0 109.315 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.455 ' O ' HG12 ' A' ' 56' ' ' ILE . 41.1 p -152.19 -49.96 0.11 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.245 -0.91 . . . . 0.0 109.625 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.483 HD13 ' HA ' ' A' ' 56' ' ' ILE . 8.5 mm -154.48 -33.08 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.253 -0.904 . . . . 0.0 109.202 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.74 -59.39 5.29 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.186 -0.946 . . . . 0.0 110.233 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.658 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -50.16 -58.39 5.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.337 -0.852 . . . . 0.0 110.126 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.97 -21.0 63.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.195 -0.941 . . . . 0.0 109.994 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.449 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -77.4 -33.06 55.14 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.171 -0.956 . . . . 0.0 109.83 -179.673 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.14 -13.32 55.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.63 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -80.81 -57.24 3.64 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.249 -0.907 . . . . 0.0 109.956 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.824 ' CG2' HG23 ' A' ' 40' ' ' VAL . 6.5 mt -63.34 -42.17 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.343 -0.848 . . . . 0.0 109.753 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -63.88 -48.39 76.89 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.975 -1.078 . . . . 0.0 108.93 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.39 -12.88 34.28 Favored Glycine 0 N--CA 1.48 1.621 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.491 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 54.2 m -83.78 -51.68 7.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -1.131 . . . . 0.0 109.017 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -68.56 -17.92 64.24 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.328 -0.858 . . . . 0.0 109.193 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.02 -46.59 34.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.339 -0.851 . . . . 0.0 109.682 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.26 -6.14 53.71 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.166 -0.959 . . . . 0.0 109.802 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -99.23 -49.71 4.38 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.078 -1.014 . . . . 0.0 110.361 -179.45 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.1 -134.58 2.21 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.356 -1.402 . . . . 0.0 111.073 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.526 ' C ' HD12 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -52.81 -171.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.589 -0.948 . . . . 0.0 111.114 -178.785 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.729 HG22 ' H ' ' A' ' 74' ' ' VAL . 3.5 p -110.56 -175.89 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.729 ' H ' HG22 ' A' ' 73' ' ' VAL . 2.0 t -130.68 156.85 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.991 -1.068 . . . . 0.0 109.559 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.466 ' OE2' ' HE2' ' A' ' 36' ' ' LYS . 16.0 pt-20 -131.05 145.33 51.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 0.0 109.505 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 43.9 t0 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.393 -179.996 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.451 ' HG2' ' CG2' ' A' ' 12' ' ' VAL . 34.4 Cg_endo . . . . . 0 C--O 1.215 -0.658 0 N-CA-C 110.501 -0.615 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.482 ' HA ' HD12 ' A' ' 13' ' ' LEU . . . -62.96 -41.75 99.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.232 -0.917 . . . . 0.0 109.826 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -36.85 -50.04 0.83 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.55 -0.719 . . . . 0.0 110.427 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.455 ' H ' HG22 ' A' ' 12' ' ' VAL . 2.4 m -72.02 -38.89 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.037 -1.039 . . . . 0.0 109.444 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 10' ' ' ALA . 65.1 mt -54.39 -66.81 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.403 -0.81 . . . . 0.0 109.934 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 18' ' ' ALA . 3.5 pp -52.76 -30.19 31.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 110.294 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.455 ' N ' HD12 ' A' ' 14' ' ' LEU . 19.4 tttt -53.11 -62.38 1.69 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.035 -1.041 . . . . 0.0 110.022 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -69.1 -28.76 66.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.055 -1.028 . . . . 0.0 109.666 -179.732 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.616 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -89.97 5.86 44.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.954 . . . . 0.0 109.701 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.681 ' O ' HD13 ' A' ' 35' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.099 -1.0 . . . . 0.0 109.643 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.845 ' O ' HG12 ' A' ' 73' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.643 HG22 ' CG1' ' A' ' 73' ' ' VAL . 11.9 p -142.72 164.37 30.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.561 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.681 HD13 ' O ' ' A' ' 18' ' ' ALA . 3.4 pt -150.88 167.03 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 109.522 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -79.71 131.52 35.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.139 -0.976 . . . . 0.0 109.355 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -74.17 -8.01 54.66 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.133 -0.98 . . . . 0.0 109.554 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 37' ' ' ARG . 48.6 t0 -42.78 -33.08 0.69 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.302 -0.874 . . . . 0.0 109.716 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.434 ' HD2' HD11 ' A' ' 43' ' ' ILE . 1.4 mmtt -71.87 -52.82 15.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 109.338 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.937 HG13 ' HB ' ' A' ' 63' ' ' ILE . 57.8 t -48.37 -23.43 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.393 -0.817 . . . . 0.0 109.681 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.81 -44.13 17.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 0.0 109.661 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.42 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 7.4 mm-40 -72.71 -13.55 61.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.222 -0.924 . . . . 0.0 109.849 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.434 HD11 ' HD2' ' A' ' 39' ' ' LYS . 8.0 mt -105.2 -18.5 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.104 -0.997 . . . . 0.0 109.47 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 48' ' ' MET . . . -82.31 -34.98 28.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 109.544 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.27 -22.08 35.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.445 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.421 ' HA ' HD23 ' A' ' 46' ' ' LEU . 4.8 mt -73.4 -44.8 57.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.9 . . . . 0.0 109.445 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -119.58 32.32 6.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.307 -0.87 . . . . 0.0 109.177 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.57 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -48.08 -51.29 49.73 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.384 -0.822 . . . . 0.0 110.007 -179.73 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 48' ' ' MET . 36.4 Cg_endo -80.68 57.62 6.61 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.657 2.238 . . . . 0.0 110.76 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -136.68 4.45 2.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.171 -0.956 . . . . 0.0 109.672 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.616 HD12 ' H ' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -141.71 -91.58 0.14 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.071 -1.018 . . . . 0.0 109.464 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.616 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.4 t30 -176.63 87.09 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.301 -0.875 . . . . 0.0 109.757 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.457 ' CB ' ' HB3' ' A' ' 58' ' ' ALA . . . -120.37 178.69 4.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -0.909 . . . . 0.0 109.303 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -128.99 -38.35 1.65 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.295 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.425 ' O ' HG12 ' A' ' 56' ' ' ILE . 13.6 m -127.61 -63.82 1.01 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.257 -0.902 . . . . 0.0 109.108 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -175.96 -31.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.385 -0.822 . . . . 0.0 108.8 179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.543 ' HA ' ' CG ' ' A' ' 60' ' ' MET . 1.1 tt0 -56.89 -47.94 79.34 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.321 -0.862 . . . . 0.0 109.883 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.457 ' HB3' ' CB ' ' A' ' 53' ' ' ALA . . . -51.63 -43.23 62.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.389 -0.819 . . . . 0.0 110.148 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.01 -61.49 1.76 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.069 -1.019 . . . . 0.0 110.08 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.543 ' CG ' ' HA ' ' A' ' 57' ' ' GLU . 1.7 ppp? -52.86 -19.55 2.61 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.197 -0.94 . . . . 0.0 109.961 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -83.72 -34.88 24.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.175 -0.953 . . . . 0.0 109.599 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -47.41 72.88 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.283 -0.885 . . . . 0.0 109.713 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.937 ' HB ' HG13 ' A' ' 40' ' ' VAL . 8.9 mt -62.99 -40.4 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.938 . . . . 0.0 109.881 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.05 -49.65 73.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.88 -1.137 . . . . 0.0 109.383 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.12 -13.64 28.64 Favored Glycine 0 N--CA 1.479 1.562 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.497 ' O ' ' HB2' ' A' ' 70' ' ' MET . 50.4 m -86.14 -47.42 9.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.389 -1.065 . . . . 0.0 109.918 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -70.21 -19.04 63.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 109.775 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.462 ' CG ' HG23 ' A' ' 73' ' ' VAL . 1.9 ttp180 -79.35 -58.8 3.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.237 -0.914 . . . . 0.0 109.814 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.03 -25.0 63.37 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.23 -0.919 . . . . 0.0 110.329 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.497 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -96.24 -21.86 17.6 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.997 -1.065 . . . . 0.0 110.741 -179.114 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -154.8 -141.97 3.35 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.27 -1.443 . . . . 0.0 110.751 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.587 ' N ' HD12 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -70.81 -174.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.568 -0.96 . . . . 0.0 110.308 -179.315 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.845 HG12 ' O ' ' A' ' 33' ' ' ALA . 1.4 p -90.45 -172.46 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.474 -0.766 . . . . 0.0 108.984 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.667 ' H ' HG22 ' A' ' 73' ' ' VAL . 84.3 t -132.76 135.17 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.079 -1.013 . . . . 0.0 109.729 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 35' ' ' ILE . 22.4 pt-20 -98.65 160.6 14.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 109.26 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 43.6 t0 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.986 -1.006 . . . . 0.0 109.495 -179.957 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.441 ' HD2' ' HB ' ' A' ' 12' ' ' VAL . 36.0 Cg_endo . . . . . 0 C--O 1.215 -0.626 0 N-CA-C 110.559 -0.593 . . . . 0.0 110.559 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -84.02 -68.09 0.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.194 -0.942 . . . . 0.0 109.656 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -40.18 -53.8 2.42 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.422 -0.799 . . . . 0.0 109.973 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.441 ' HB ' ' HD2' ' A' ' 9' ' ' PRO . 48.8 t -60.14 -43.04 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 109.616 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 13' ' ' LEU . 7.9 mt -51.46 -48.13 62.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.214 -0.929 . . . . 0.0 109.789 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.445 ' CD1' HG22 ' A' ' 66' ' ' THR . 8.5 mt -67.4 -27.28 66.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.622 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -69.8 -30.84 68.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.481 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -76.56 -48.3 19.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 0.0 109.489 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.71 37.5 0.96 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.906 . . . . 0.0 109.465 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.768 ' HB1' HG21 ' A' ' 72' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.427 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.2 p -125.81 176.76 6.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.312 -0.867 . . . . 0.0 109.373 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.766 HD12 ' HE2' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -141.1 168.76 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.166 179.77 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.484 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 15.8 ttmt -85.64 171.06 11.96 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.222 -0.924 . . . . 0.0 109.702 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.458 ' HD3' ' OE1' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -72.51 -14.37 61.64 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.34 -0.85 . . . . 0.0 109.474 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 37' ' ' ARG . 4.6 t0 -41.71 -33.64 0.52 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.492 -0.755 . . . . 0.0 109.674 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.766 ' HE2' HD12 ' A' ' 35' ' ' ILE . 1.8 ttpt -69.24 -61.86 1.61 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.191 -0.943 . . . . 0.0 109.442 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.896 HG13 ' HB ' ' A' ' 63' ' ' ILE . 84.8 t -49.69 -20.58 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.885 . . . . 0.0 110.053 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -72.96 -51.34 18.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.023 -1.048 . . . . 0.0 110.369 -179.438 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.478 ' HG3' ' N ' ' A' ' 43' ' ' ILE . 16.8 pt-20 -73.78 -39.2 64.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.02 -1.05 . . . . 0.0 110.476 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.518 ' HB ' HD13 ' A' ' 63' ' ' ILE . 9.6 mt -73.05 -14.44 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.101 -0.999 . . . . 0.0 109.917 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 40' ' ' VAL . . . -92.88 -26.52 17.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.096 -1.002 . . . . 0.0 109.748 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 2.4 pt-20 -96.39 -2.64 45.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.12 -0.987 . . . . 0.0 109.664 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 43' ' ' ILE . 0.3 OUTLIER -73.34 -24.82 60.41 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.235 -0.915 . . . . 0.0 109.744 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.429 ' N ' ' HG ' ' A' ' 46' ' ' LEU . 5.2 ttmt -159.07 58.4 0.42 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.144 -0.972 . . . . 0.0 109.394 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.559 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 1.3 mtp -43.87 -52.87 14.01 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.416 -0.803 . . . . 0.0 110.349 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 48' ' ' MET . 34.0 Cg_endo -77.04 96.26 1.1 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.417 2.078 . . . . 0.0 110.591 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 24.4 t0 178.7 -40.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.366 -0.834 . . . . 0.0 109.38 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.443 ' O ' ' C ' ' A' ' 52' ' ' ASN . 0.5 OUTLIER -107.34 35.84 2.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 109.594 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER 40.56 76.45 0.07 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.459 -0.776 . . . . 0.0 109.755 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.75 139.98 33.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.23 -0.919 . . . . 0.0 109.353 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.94 -47.85 64.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 109.497 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.52 -52.56 0.09 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.245 -0.91 . . . . 0.0 108.851 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.7 tt -175.41 -31.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.303 -0.873 . . . . 0.0 109.242 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -60.2 -53.65 55.22 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.279 -0.888 . . . . 0.0 109.448 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.04 -53.22 44.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.427 -0.795 . . . . 0.0 109.842 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.62 -42.32 61.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.795 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.46 -38.22 90.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.19 -0.943 . . . . 0.0 110.121 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -76.1 -15.99 59.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 109.656 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.61 -59.95 2.57 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.229 -0.92 . . . . 0.0 109.586 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.896 ' HB ' HG13 ' A' ' 40' ' ' VAL . 24.1 mt -57.38 -35.26 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.248 -0.908 . . . . 0.0 109.987 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.458 ' OE1' ' HD3' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -62.29 -51.53 67.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.091 -1.006 . . . . 0.0 109.326 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.81 -9.67 27.99 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 70' ' ' MET . 87.6 m -87.29 -51.17 6.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -1.114 . . . . 0.0 110.026 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -76.69 -14.97 59.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 109.736 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.66 -57.11 3.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.67 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.0 -21.84 62.24 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.284 -0.885 . . . . 0.0 110.172 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -65.08 -65.89 0.61 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.079 -1.013 . . . . 0.0 109.609 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -161.13 -65.96 0.02 OUTLIER Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.267 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.877 HD12 ' N ' ' A' ' 73' ' ' VAL . 1.7 pp -72.62 -179.37 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -1.117 . . . . 0.0 110.513 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.877 ' N ' HD12 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -126.33 151.59 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.583 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.31 168.53 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.146 -0.972 . . . . 0.0 109.588 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.484 ' HG3' ' HA ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -123.75 125.66 45.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.308 -0.87 . . . . 0.0 109.582 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.1 t0 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.52 179.931 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.473 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 35.4 Cg_endo . . . . . 0 C--O 1.214 -0.695 0 N-CA-C 110.431 -0.642 . . . . 0.0 110.431 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -73.74 -65.04 0.88 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.963 . . . . 0.0 109.822 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.506 ' HA ' ' CE ' ' A' ' 70' ' ' MET . . . -36.69 -39.27 0.2 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.565 -0.709 . . . . 0.0 110.703 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.433 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 38.8 t -75.35 -51.43 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.022 -1.049 . . . . 0.0 109.865 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 13' ' ' LEU . 21.5 mt -51.37 -60.96 2.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.054 -1.028 . . . . 0.0 109.366 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.512 HD13 HG22 ' A' ' 66' ' ' THR . 0.2 OUTLIER -50.06 -40.39 45.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.599 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' LYS . 14.4 mttt -52.89 -65.89 0.48 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 109.196 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -44.46 -26.37 0.34 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 108.944 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.726 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -105.22 51.89 0.75 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.454 -0.779 . . . . 0.0 109.34 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' A' ' 17' ' ' ALA . . . . . . . . 0 N--CA 1.497 1.901 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.312 0.577 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.445 ' OG1' ' HA ' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -95.95 171.08 8.85 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.294 -0.879 . . . . 0.0 109.733 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.6 HG21 ' CB ' ' A' ' 18' ' ' ALA . 6.9 pt -85.01 -173.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.374 -0.829 . . . . 0.0 109.91 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -99.3 147.81 24.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 0.0 109.572 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -73.99 -10.13 59.33 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.277 -0.889 . . . . 0.0 109.604 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 37' ' ' ARG . 0.4 OUTLIER -42.6 -51.73 5.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.334 -0.854 . . . . 0.0 109.837 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.465 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -57.32 -45.03 84.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.701 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.942 HG13 ' CG2' ' A' ' 63' ' ' ILE . 75.4 t -56.0 -28.06 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -0.846 . . . . 0.0 110.474 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -75.59 -51.62 12.46 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.986 -1.071 . . . . 0.0 110.072 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -60.97 -29.87 69.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 0.0 110.044 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 39' ' ' LYS . 45.3 mt -83.02 -34.37 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.006 -1.059 . . . . 0.0 109.981 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.03 -9.4 58.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.088 -1.008 . . . . 0.0 109.793 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -99.35 -33.67 10.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.148 -0.97 . . . . 0.0 109.525 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.815 ' O ' HD12 ' A' ' 46' ' ' LEU . 0.7 OUTLIER -77.47 -11.43 59.85 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.225 -0.922 . . . . 0.0 109.998 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -132.08 34.88 3.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 109.673 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.58 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 4.3 ttp -50.57 -48.41 82.18 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.163 -0.961 . . . . 0.0 109.808 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 48' ' ' MET . 35.9 Cg_endo -78.84 82.01 2.62 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.059 1.839 . . . . 0.0 110.168 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -144.57 -46.63 0.25 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -0.945 . . . . 0.0 109.794 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.416 HD13 ' SD ' ' A' ' 62' ' ' MET . 0.5 OUTLIER -117.41 22.29 12.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.212 -0.93 . . . . 0.0 109.681 -179.813 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 51' ' ' LEU . 3.5 t-20 44.14 72.62 0.18 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.157 -0.964 . . . . 0.0 109.556 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.414 ' HB1' ' HB3' ' A' ' 58' ' ' ALA . . . -100.87 174.05 6.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -0.942 . . . . 0.0 109.325 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.85 -57.69 9.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 0.0 109.521 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.1 m -162.9 -56.6 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.627 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.515 HD13 ' HA ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -157.23 -32.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.251 -0.906 . . . . 0.0 109.064 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -49.55 -65.0 0.64 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.164 -0.96 . . . . 0.0 110.085 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.414 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -53.6 -43.22 68.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.393 -0.817 . . . . 0.0 110.383 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.58 -28.94 68.87 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.024 -1.047 . . . . 0.0 110.15 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -31.3 49.52 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.127 -0.983 . . . . 0.0 109.311 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.429 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -77.32 -16.25 59.02 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.434 -0.791 . . . . 0.0 109.01 179.581 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.416 ' SD ' HD13 ' A' ' 51' ' ' LEU . 3.2 mtp -77.41 -52.06 9.76 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.4 -0.813 . . . . 0.0 109.461 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.942 ' CG2' HG13 ' A' ' 40' ' ' VAL . 2.3 mt -66.07 -45.88 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.762 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.543 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 7.8 pt-20 -64.01 -47.36 80.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.914 -1.116 . . . . 0.0 109.432 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.543 ' N ' ' HG3' ' A' ' 64' ' ' GLU . . . -61.43 -14.78 43.25 Favored Glycine 0 N--CA 1.479 1.53 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.52 ' O ' ' HG2' ' A' ' 70' ' ' MET . 61.0 m -98.02 -20.98 17.06 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.41 -1.053 . . . . 0.0 109.393 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.557 ' HB3' HG21 ' A' ' 74' ' ' VAL . . . -92.07 -9.39 42.87 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.218 -0.926 . . . . 0.0 109.048 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.788 ' CD ' HG13 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -105.36 -49.08 3.53 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.49 -0.757 . . . . 0.0 110.6 -179.362 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 p -75.54 -39.0 58.89 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.215 -0.928 . . . . 0.0 111.729 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.52 ' HG2' ' O ' ' A' ' 66' ' ' THR . 0.2 OUTLIER -81.62 -27.49 34.15 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 120.636 -1.29 . . . . 0.0 111.628 -177.88 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.504 ' N ' ' HG3' ' A' ' 70' ' ' MET . . . -149.21 -141.24 3.41 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 118.76 -1.686 . . . . 0.0 111.59 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.52 ' N ' HD12 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -52.25 -166.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.869 -0.783 . . . . 0.0 110.717 -178.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.788 HG13 ' CD ' ' A' ' 68' ' ' ARG . 22.4 t -112.14 165.44 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.349 -0.845 . . . . 0.0 109.951 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.557 HG21 ' HB3' ' A' ' 67' ' ' ALA . 98.1 t -124.55 156.66 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.337 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.492 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 14.4 pt-20 -115.59 110.19 18.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -0.943 . . . . 0.0 109.587 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.7 t0 . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.342 179.842 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.557 ' HG2' ' CG2' ' A' ' 12' ' ' VAL . 32.8 Cg_endo . . . . . 0 C--O 1.216 -0.578 0 CA-C-O 121.652 0.605 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 12' ' ' VAL . . . -54.17 -54.91 33.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.474 -0.766 . . . . 0.0 110.669 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -30.99 -36.84 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.695 -0.628 . . . . 0.0 111.079 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.557 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 1.2 t -81.33 -53.22 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.964 -1.085 . . . . 0.0 109.706 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.48 HD22 ' HD3' ' A' ' 47' ' ' LYS . 2.1 mp -46.42 -45.3 17.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.267 -0.896 . . . . 0.0 109.981 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.446 HD22 ' HB2' ' A' ' 67' ' ' ALA . 5.3 mt -67.24 -37.57 83.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.906 . . . . 0.0 110.015 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.99 -33.93 76.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.275 -0.89 . . . . 0.0 110.387 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -92.96 -8.28 43.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.965 -1.084 . . . . 0.0 109.676 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.421 ' HB1' ' CD ' ' A' ' 39' ' ' LYS . . . -76.27 -37.74 57.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 109.643 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.899 . . . . 0.0 109.675 -179.841 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 34' ' ' THR . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.253 0.549 . . . . 0.0 109.893 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.848 HG22 HG12 ' A' ' 73' ' ' VAL . 16.6 p -160.32 126.35 4.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.395 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.404 HG23 HG13 ' A' ' 72' ' ' ILE . 41.5 pt -86.35 175.18 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.962 . . . . 0.0 109.413 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.74 138.62 45.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.204 -0.935 . . . . 0.0 109.699 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.483 ' NH1' ' OD1' ' A' ' 76' ' ' ASP . 4.6 mtp180 -53.4 -35.7 60.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.34 -0.85 . . . . 0.0 109.457 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.32 -54.54 8.77 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.257 -0.902 . . . . 0.0 109.381 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 40' ' ' VAL . 2.5 mttt -56.9 -55.63 32.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.29 -0.881 . . . . 0.0 109.355 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.845 HG13 HG21 ' A' ' 63' ' ' ILE . 99.2 t -42.32 -29.61 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -0.848 . . . . 0.0 110.171 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -77.66 -44.96 26.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.109 -0.994 . . . . 0.0 110.13 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.404 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 2.7 tp10 -63.48 -61.58 2.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.102 -0.999 . . . . 0.0 109.998 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 19.3 mt -57.47 -31.37 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.321 -0.862 . . . . 0.0 110.242 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 40' ' ' VAL . . . -63.6 -31.65 72.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.112 -0.993 . . . . 0.0 110.024 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -92.68 -65.15 1.02 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.096 -1.003 . . . . 0.0 109.965 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 33.8 mt -53.35 -19.33 3.26 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.24 -0.912 . . . . 0.0 110.204 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.48 ' HD3' HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -116.14 -11.21 11.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.071 -1.018 . . . . 0.0 109.871 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.469 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 0.9 OUTLIER -39.23 99.14 0.19 Allowed Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.6 -0.687 . . . . 0.0 109.927 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 47' ' ' LYS . 36.4 Cg_endo -79.84 -82.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.55 2.167 . . . . 0.0 110.127 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -144.0 -72.96 0.27 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.361 -0.837 . . . . 0.0 109.342 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.824 HD22 ' SD ' ' A' ' 62' ' ' MET . 3.6 mt 54.34 18.19 1.79 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.191 -0.943 . . . . 0.0 109.505 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER 40.34 33.8 0.19 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.449 -0.782 . . . . 0.0 109.792 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.53 154.37 42.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 0.0 109.452 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.23 -26.55 42.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 109.589 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m -158.41 -58.41 0.07 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.165 -0.959 . . . . 0.0 108.88 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.42 HG23 ' N ' ' A' ' 57' ' ' GLU . 1.4 tt -172.51 -33.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.256 -0.903 . . . . 0.0 109.201 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.42 ' N ' HG23 ' A' ' 56' ' ' ILE . 1.3 tt0 -47.97 -60.18 2.8 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.268 -0.895 . . . . 0.0 109.33 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.97 -49.86 29.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.454 -0.779 . . . . 0.0 109.339 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 62' ' ' MET . . . -49.06 -42.09 37.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 109.177 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -37.75 88.47 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.228 -0.92 . . . . 0.0 109.329 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.99 -13.16 62.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 108.914 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.824 ' SD ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -82.63 -51.07 8.09 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.333 -0.855 . . . . 0.0 109.329 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.845 HG21 HG13 ' A' ' 40' ' ' VAL . 4.8 mt -56.35 -42.6 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.895 . . . . 0.0 109.619 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.528 ' CG ' HG21 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -61.55 -53.83 51.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.898 -1.126 . . . . 0.0 109.43 -179.737 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -56.4 -15.57 12.0 Favored Glycine 0 N--CA 1.48 1.618 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 90.5 m -81.71 -59.99 2.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.3 -1.118 . . . . 0.0 109.546 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.709 ' HB1' HD11 ' A' ' 72' ' ' ILE . . . -73.41 -2.78 23.74 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.238 -0.914 . . . . 0.0 109.528 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.526 ' NH1' ' HG3' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -86.56 -50.24 6.98 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.19 -0.944 . . . . 0.0 109.725 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.47 -8.75 34.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.106 -0.996 . . . . 0.0 109.894 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.48 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -71.06 -69.16 0.39 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.064 -1.022 . . . . 0.0 109.086 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -161.44 -79.9 0.03 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.709 HD11 ' HB1' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -57.88 -169.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.464 -1.021 . . . . 0.0 109.995 -179.631 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.848 HG12 HG22 ' A' ' 34' ' ' THR . 0.4 OUTLIER -138.64 169.97 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.4 -0.812 . . . . 0.0 108.884 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.528 HG21 ' CG ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -106.69 151.48 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.027 -1.046 . . . . 0.0 109.425 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -125.22 145.47 49.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.901 . . . . 0.0 109.494 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.483 ' OD1' ' NH1' ' A' ' 37' ' ' ARG . 14.2 t70 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.452 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.527 ' O ' HD12 ' A' ' 13' ' ' LEU . 35.3 Cg_endo . . . . . 0 C--O 1.214 -0.691 0 N-CA-C 110.528 -0.605 . . . . 0.0 110.528 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -79.38 -66.99 0.8 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.252 -0.905 . . . . 0.0 110.052 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -37.25 -46.24 0.72 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.51 -0.744 . . . . 0.0 110.187 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.7 t -67.67 -46.78 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.213 -0.929 . . . . 0.0 109.423 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 9' ' ' PRO . 3.3 mt -46.85 -48.93 20.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.433 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.499 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -68.71 -38.48 80.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.594 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.6 -66.02 0.46 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 109.669 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -59.11 -32.93 70.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.152 -0.968 . . . . 0.0 109.739 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 14' ' ' LEU . . . -50.05 -65.1 0.62 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.141 -0.975 . . . . 0.0 109.548 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 109.406 179.914 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.195 0.521 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.1 p -118.6 148.93 42.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.188 -0.945 . . . . 0.0 109.425 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.765 HG13 HG13 ' A' ' 74' ' ' VAL . 11.6 pt -105.74 -179.09 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.297 -0.877 . . . . 0.0 109.618 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -95.61 146.96 24.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.294 -0.879 . . . . 0.0 109.487 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.9 ppt_? -60.42 -15.44 26.43 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.235 -0.916 . . . . 0.0 109.517 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -47.92 -39.25 18.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.325 -0.859 . . . . 0.0 109.561 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.43 -45.99 90.57 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.314 -0.866 . . . . 0.0 109.52 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.559 HG13 ' HB ' ' A' ' 63' ' ' ILE . 30.4 t -61.79 -12.89 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 0.0 109.48 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.9 -55.15 5.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 109.912 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -72.44 -51.07 21.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.228 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 63.2 mt -57.44 -45.92 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 110.094 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' A' ' 40' ' ' VAL . . . -57.28 -39.18 75.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -0.959 . . . . 0.0 109.981 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.35 -36.78 77.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.125 -0.985 . . . . 0.0 109.831 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mt -87.49 14.89 7.32 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.171 -0.956 . . . . 0.0 109.596 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -134.48 24.38 3.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 0.0 109.264 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.597 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -69.8 -51.01 16.16 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.389 -0.819 . . . . 0.0 109.942 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 48' ' ' MET . 34.1 Cg_endo -77.34 89.1 1.35 Allowed 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.336 2.024 . . . . 0.0 110.647 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -176.69 -62.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.703 HD11 ' HB2' ' A' ' 53' ' ' ALA . 1.5 pp -103.02 -0.75 30.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.387 -0.82 . . . . 0.0 109.22 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 52' ' ' ASN . 1.5 t30 45.95 81.11 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.273 -0.892 . . . . 0.0 109.713 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.703 ' HB2' HD11 ' A' ' 51' ' ' LEU . . . -87.62 163.13 16.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.0 109.277 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -46.45 -56.09 6.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 109.132 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m -160.07 -69.4 0.07 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.276 -0.89 . . . . 0.0 108.678 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -147.0 8.26 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.355 -0.84 . . . . 0.0 109.584 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -92.95 -51.98 4.81 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.111 -0.993 . . . . 0.0 109.483 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.641 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -73.21 -27.81 61.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.361 -0.837 . . . . 0.0 109.543 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.73 -37.61 70.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 109.354 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.64 -50.73 23.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.694 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -61.18 -17.5 53.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.624 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.573 ' SD ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -75.64 -54.75 6.47 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.251 -0.906 . . . . 0.0 110.087 -179.653 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.559 ' HB ' HG13 ' A' ' 40' ' ' VAL . 12.3 mt -56.16 -38.87 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 110.482 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.4 ' C ' ' N ' ' A' ' 66' ' ' THR . 1.7 tt0 -63.11 -60.95 2.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.712 -1.242 . . . . 0.0 109.303 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.74 -16.6 7.71 Favored Glycine 0 N--CA 1.479 1.501 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 33.2 m -74.14 -55.1 6.49 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.234 -1.156 . . . . 0.0 109.272 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -67.76 -14.25 62.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.181 -0.949 . . . . 0.0 109.249 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.403 ' HG2' HG13 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -67.54 -52.29 40.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 0.0 109.803 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.17 -9.92 29.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.206 -0.934 . . . . 0.0 110.49 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.493 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -97.15 -49.85 4.82 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.097 -1.002 . . . . 0.0 110.109 -179.264 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -138.64 -127.02 2.46 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.654 -1.26 . . . . 0.0 110.167 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.525 ' O ' HD12 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -85.69 179.28 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.361 -1.082 . . . . 0.0 109.973 -179.446 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 74' ' ' VAL . 0.2 OUTLIER -94.41 -169.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.917 . . . . 0.0 109.545 179.818 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.765 HG13 HG13 ' A' ' 35' ' ' ILE . 8.8 t -135.6 167.56 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 0.0 109.525 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.475 ' N ' HG12 ' A' ' 74' ' ' VAL . 5.0 pt-20 -122.01 152.44 39.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.451 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.4 t70 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.455 -179.935 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo . . . . . 0 C--O 1.215 -0.671 0 N-CA-C 110.332 -0.68 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.478 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -72.49 -67.25 0.57 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.21 -0.931 . . . . 0.0 110.11 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -33.93 -53.8 0.46 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.761 -0.587 . . . . 0.0 110.663 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 99.4 t -57.31 -50.39 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.089 -1.007 . . . . 0.0 109.783 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 13' ' ' LEU . 39.5 mt -48.18 -68.52 0.18 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.117 -0.99 . . . . 0.0 109.767 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.521 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 6.0 mt -55.67 -20.72 15.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.198 -0.939 . . . . 0.0 109.6 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -61.34 -57.32 12.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.501 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 17' ' ' ALA . 47.0 mmtm -60.22 -25.55 65.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 0.0 109.319 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 14' ' ' LEU . . . -42.92 -35.91 1.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.39 -0.819 . . . . 0.0 109.408 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.269 -0.894 . . . . 0.0 109.565 179.937 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.449 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.283 0.563 . . . . 0.0 109.584 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.769 HG22 HG23 ' A' ' 73' ' ' VAL . 11.1 p -126.54 143.5 51.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 109.378 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.077 HD11 HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -112.53 -171.63 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.172 -0.955 . . . . 0.0 109.615 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -100.17 168.69 9.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.386 -0.821 . . . . 0.0 109.931 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.04 -11.22 57.07 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.379 -0.826 . . . . 0.0 110.046 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -51.09 -44.9 61.33 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.135 -0.978 . . . . 0.0 109.776 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.446 ' NZ ' HD23 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -59.77 -34.62 73.23 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.319 -0.863 . . . . 0.0 109.852 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.753 HG13 ' HB ' ' A' ' 63' ' ' ILE . 68.1 t -63.06 -30.59 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 110.017 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -80.73 -23.33 39.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.112 -0.992 . . . . 0.0 110.008 -179.673 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -80.67 -52.6 7.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.971 . . . . 0.0 109.62 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.4 mt -65.99 -36.47 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.663 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.7 -38.71 80.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.212 -0.93 . . . . 0.0 109.636 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -74.52 -27.22 60.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 0.0 109.698 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.03 -0.06 54.61 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.093 -1.005 . . . . 0.0 109.595 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -149.44 47.92 0.96 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.325 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.582 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -62.7 -50.37 78.25 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.273 -0.892 . . . . 0.0 110.033 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 48' ' ' MET . 36.4 Cg_endo -80.7 49.43 3.22 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.711 2.274 . . . . 0.0 110.815 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -123.2 -33.65 3.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.095 -1.003 . . . . 0.0 109.233 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.675 HD11 ' HB2' ' A' ' 53' ' ' ALA . 0.8 OUTLIER -123.86 34.87 4.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -0.885 . . . . 0.0 109.334 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' A' ' 52' ' ' ASN . 29.1 t-20 42.95 38.16 1.33 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.357 -0.84 . . . . 0.0 109.537 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.675 ' HB2' HD11 ' A' ' 51' ' ' LEU . . . -61.54 135.64 57.73 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.187 -0.946 . . . . 0.0 109.318 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.9 -73.41 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.891 . . . . 0.0 109.536 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.461 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -139.08 -51.21 0.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 109.635 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.478 HD13 ' HA ' ' A' ' 56' ' ' ILE . 10.4 mm -157.31 -32.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.385 -0.822 . . . . 0.0 109.371 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.42 -59.12 5.91 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.24 -0.912 . . . . 0.0 110.578 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.9 -50.25 66.79 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.379 -0.826 . . . . 0.0 110.831 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.481 ' HB2' ' CB ' ' A' ' 53' ' ' ALA . . . -66.23 -24.76 66.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.983 -1.073 . . . . 0.0 110.089 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -74.24 -38.06 63.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 109.771 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.08 -13.18 57.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.341 -0.849 . . . . 0.0 109.871 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.05 -53.96 7.56 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.19 -0.944 . . . . 0.0 109.398 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.753 ' HB ' HG13 ' A' ' 40' ' ' VAL . 12.2 mt -64.98 -41.12 91.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.91 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.433 ' HG2' ' CZ ' ' A' ' 68' ' ' ARG . 18.1 tt0 -61.66 -53.35 57.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.04 -1.038 . . . . 0.0 109.722 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.67 -10.66 32.0 Favored Glycine 0 N--CA 1.479 1.537 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 5.0 m -85.12 -44.25 13.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.272 -1.134 . . . . 0.0 109.667 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -72.38 -32.88 66.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -0.932 . . . . 0.0 109.584 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.885 ' HD2' HG12 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -65.35 -55.49 17.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.239 -0.913 . . . . 0.0 110.073 -179.629 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 70' ' ' MET . 0.1 OUTLIER -67.9 -46.45 71.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.965 . . . . 0.0 110.48 -179.275 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.477 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -44.9 -72.02 0.07 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.05 -1.031 . . . . 0.0 109.458 -179.854 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -162.18 -93.2 0.09 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.077 HD13 HD11 ' A' ' 35' ' ' ILE . 2.2 pp -48.19 178.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.52 -0.988 . . . . 0.0 109.935 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.885 HG12 ' HD2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -122.09 -175.8 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.221 -0.924 . . . . 0.0 109.817 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.8 t -146.53 145.57 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.617 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.68 178.58 5.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 109.376 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.3 t0 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.483 -179.924 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 34.5 Cg_endo . . . . . 0 C--O 1.215 -0.653 0 N-CA-C 110.222 -0.722 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.06 -65.76 0.49 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.337 -0.852 . . . . 0.0 110.837 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.782 ' HB2' ' HE1' ' A' ' 70' ' ' MET . . . -45.35 -65.66 0.51 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.26 -0.9 . . . . 0.0 111.415 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 80.4 t -55.99 -20.62 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.954 -1.091 . . . . 0.0 111.354 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.84 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -87.83 -24.8 23.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.766 -1.209 . . . . 0.0 110.002 -179.418 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 1.011 HD11 HG22 ' A' ' 66' ' ' THR . 10.3 mt -71.26 -50.73 29.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.011 -1.056 . . . . 0.0 109.237 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.511 ' CD ' ' N ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -66.6 -41.43 88.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.207 -0.933 . . . . 0.0 109.169 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.511 ' N ' ' CD ' ' A' ' 15' ' ' LYS . 9.4 tttp -49.93 -36.95 29.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -0.927 . . . . 0.0 109.114 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.428 ' HB1' ' HD3' ' A' ' 39' ' ' LYS . . . -99.81 -75.33 0.57 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.325 -0.859 . . . . 0.0 109.186 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.359 -0.838 . . . . 0.0 109.497 179.892 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.438 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.257 0.551 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.458 ' OG1' ' N ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -106.16 176.39 5.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 109.472 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.458 ' N ' ' OG1' ' A' ' 34' ' ' THR . 12.8 pt -125.94 165.78 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.295 -0.878 . . . . 0.0 109.434 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.8 mtpt -89.53 144.95 25.62 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.336 -0.852 . . . . 0.0 109.293 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -60.77 -13.47 15.33 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.269 -0.894 . . . . 0.0 109.619 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 37' ' ' ARG . 2.5 t0 -42.76 -41.07 3.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.295 -0.878 . . . . 0.0 109.549 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.428 ' HD3' ' HB1' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -71.48 -47.53 54.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -0.857 . . . . 0.0 109.501 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.683 HG22 HG22 ' A' ' 63' ' ' ILE . 75.0 t -53.03 -20.51 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.799 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -81.16 -62.07 1.77 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.94 . . . . 0.0 109.694 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.65 -55.69 23.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.352 -0.842 . . . . 0.0 110.032 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.584 HD13 HD11 ' A' ' 13' ' ' LEU . 74.3 mt -54.24 -58.41 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.916 . . . . 0.0 110.178 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 43' ' ' ILE . . . -42.19 -28.82 0.21 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.223 -0.923 . . . . 0.0 109.77 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -67.03 -51.29 56.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.186 -0.947 . . . . 0.0 109.49 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.5 mt -77.49 -2.24 34.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.875 . . . . 0.0 109.702 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HD3' HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -127.27 23.15 6.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.119 -0.988 . . . . 0.0 109.529 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.617 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 5.5 ttp -69.32 -43.12 23.04 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 110.755 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 48' ' ' MET . 36.2 Cg_endo -79.51 13.7 2.01 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 122.055 1.837 . . . . 0.0 111.194 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.53 -35.46 79.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.97 -1.081 . . . . 0.0 109.412 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.848 HD21 ' SD ' ' A' ' 62' ' ' MET . 0.3 OUTLIER -143.99 23.81 1.69 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -0.87 . . . . 0.0 109.595 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 51' ' ' LEU . 35.3 t-20 44.99 56.69 5.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -0.894 . . . . 0.0 109.626 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 1.021 ' HB1' ' HB3' ' A' ' 58' ' ' ALA . . . -52.56 170.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 109.396 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.27 -44.35 68.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.923 . . . . 0.0 109.367 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.55 -50.81 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.218 -0.926 . . . . 0.0 108.841 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.1 tt -172.53 -31.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 121.207 -0.933 . . . . 0.0 109.518 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -57.2 -45.53 83.69 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.208 -0.932 . . . . 0.0 109.806 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 1.021 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -60.04 -35.84 75.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.337 -0.852 . . . . 0.0 109.813 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.519 ' O ' ' HG3' ' A' ' 62' ' ' MET . . . -63.21 -25.56 68.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.975 . . . . 0.0 109.396 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.421 ' HG3' HG12 ' A' ' 40' ' ' VAL . 1.3 mtt -81.06 -23.54 38.45 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.113 -0.992 . . . . 0.0 108.395 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.05 -22.42 36.39 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.605 -0.685 . . . . 0.0 109.847 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.848 ' SD ' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -82.47 -50.34 8.96 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.894 -1.129 . . . . 0.0 109.425 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.683 HG22 HG22 ' A' ' 40' ' ' VAL . 8.0 mt -57.68 -37.92 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.418 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.39 -50.72 70.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.102 -0.999 . . . . 0.0 109.21 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.77 -12.99 23.11 Favored Glycine 0 N--CA 1.481 1.635 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . 1.011 HG22 HD11 ' A' ' 14' ' ' LEU . 54.0 m -82.54 -54.16 5.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -1.15 . . . . 0.0 109.089 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.473 ' HB1' HD11 ' A' ' 72' ' ' ILE . . . -79.21 3.27 18.33 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.374 -0.829 . . . . 0.0 109.261 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.44 -49.91 5.9 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.173 -0.955 . . . . 0.0 109.384 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -21.53 24.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.878 . . . . 0.0 109.877 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.782 ' HE1' ' HB2' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -60.18 -64.34 0.98 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.057 -1.027 . . . . 0.0 109.478 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -159.08 -98.54 0.14 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.765 ' C ' HD12 ' A' ' 72' ' ' ILE . 2.5 pp -53.14 -172.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -1.115 . . . . 0.0 109.692 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.54 176.85 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 109.276 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.435 ' CG2' ' HB3' ' A' ' 67' ' ' ALA . 2.9 t -123.98 151.36 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.337 -0.852 . . . . 0.0 109.476 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.505 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -113.93 65.41 0.66 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.934 . . . . 0.0 109.519 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.6 t0 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.456 179.993 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.53 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 34.7 Cg_endo . . . . . 0 C--O 1.216 -0.592 0 N-CA-C 110.535 -0.602 . . . . 0.0 110.535 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -64.46 -43.56 93.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.867 . . . . 0.0 109.956 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 14' ' ' LEU . . . -37.5 -51.66 1.15 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.507 -0.746 . . . . 0.0 110.269 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 9' ' ' PRO . 3.1 m -66.8 -41.04 87.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 121.018 -1.051 . . . . 0.0 109.105 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.518 ' HA ' HD23 ' A' ' 13' ' ' LEU . 9.4 mt -61.86 -15.62 43.85 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.019 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 4.9 mt -77.65 -51.4 10.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 108.778 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -50.43 -34.86 26.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.86 . . . . 0.0 108.968 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.417 ' NZ ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -64.32 -51.33 63.98 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.316 -0.865 . . . . 0.0 109.286 179.808 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 18' ' ' ALA . . . -61.7 -69.23 0.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 0.0 109.411 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 17' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.165 -0.959 . . . . 0.0 109.326 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.314 0.578 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.413 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 14.6 p -144.73 133.91 22.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.314 -0.866 . . . . 0.0 109.212 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.848 ' CG1' HG13 ' A' ' 74' ' ' VAL . 6.0 pt -90.88 -171.47 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.109 -0.994 . . . . 0.0 109.493 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.469 ' HE3' ' HA ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -97.56 148.21 23.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 109.373 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 38' ' ' ASP . 1.6 mtt180 -75.03 -16.46 60.6 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.278 -0.889 . . . . 0.0 109.458 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 37' ' ' ARG . 5.9 t0 -43.73 -54.33 5.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.453 -0.779 . . . . 0.0 109.468 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.437 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -53.7 -41.18 66.68 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.177 -0.952 . . . . 0.0 109.656 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.687 HG22 ' CG2' ' A' ' 63' ' ' ILE . 75.1 t -57.35 -36.45 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.313 -0.867 . . . . 0.0 109.927 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -29.56 65.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.157 -0.964 . . . . 0.0 110.052 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -80.92 -24.5 38.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.064 -1.022 . . . . 0.0 109.808 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 39' ' ' LYS . 29.6 mt -95.63 -14.59 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.811 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.29 -22.21 13.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.114 -0.991 . . . . 0.0 110.022 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -96.13 -41.12 8.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.096 -1.002 . . . . 0.0 109.759 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.444 ' C ' ' HG2' ' A' ' 47' ' ' LYS . 5.4 mt -84.09 2.8 37.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.15 -0.969 . . . . 0.0 109.662 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.444 ' HG2' ' C ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -139.09 41.43 2.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.151 -0.968 . . . . 0.0 109.458 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.578 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.2 OUTLIER -45.37 -51.57 25.7 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.215 -0.928 . . . . 0.0 109.806 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 48' ' ' MET . 35.4 Cg_endo -78.5 75.66 4.83 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.442 2.095 . . . . 0.0 110.447 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.71 -59.7 0.89 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -0.895 . . . . 0.0 109.678 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.575 HD12 ' HB3' ' A' ' 52' ' ' ASN . 2.3 pp -120.13 -32.88 4.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.143 -0.973 . . . . 0.0 109.991 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.699 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 8.8 t30 162.41 -90.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.471 -0.768 . . . . 0.0 109.121 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 52' ' ' ASN . . . 76.0 128.82 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.473 -0.767 . . . . 0.0 109.73 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -89.47 -41.45 12.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 109.228 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -158.16 -48.84 0.06 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.417 -0.802 . . . . 0.0 108.854 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.2 tt -177.14 -31.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.317 -0.865 . . . . 0.0 108.985 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.46 -59.87 3.55 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.332 -0.855 . . . . 0.0 110.049 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.94 -30.0 68.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.272 -0.893 . . . . 0.0 110.43 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.55 -33.32 66.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.152 -0.968 . . . . 0.0 109.97 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -50.04 13.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.175 -0.953 . . . . 0.0 110.138 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.7 -17.89 61.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.319 -0.863 . . . . 0.0 109.81 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.92 -55.62 4.67 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.165 -0.959 . . . . 0.0 110.072 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.687 ' CG2' HG22 ' A' ' 40' ' ' VAL . 3.1 mt -51.24 -43.08 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.05 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.479 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 12.3 pt-20 -64.81 -45.62 85.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.869 -1.144 . . . . 0.0 108.867 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.479 ' N ' ' HG3' ' A' ' 64' ' ' GLU . . . -60.26 -14.41 33.16 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 86.7 m -85.73 -60.36 2.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.388 -1.066 . . . . 0.0 109.265 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.463 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -61.86 -13.8 27.76 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.166 -0.959 . . . . 0.0 109.061 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 1.085 ' CG ' HG13 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -77.67 -62.3 1.71 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.329 -0.857 . . . . 0.0 109.269 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.01 -15.48 63.62 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.315 -0.866 . . . . 0.0 109.261 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.413 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.1 OUTLIER -88.4 -34.35 17.58 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.328 -0.858 . . . . 0.0 109.885 -179.754 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -159.64 -102.16 0.18 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.571 ' C ' HD12 ' A' ' 72' ' ' ILE . 1.1 pp -108.16 -169.63 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -1.197 . . . . 0.0 110.103 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 1.085 HG13 ' CG ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -103.92 -176.8 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.392 -0.818 . . . . 0.0 109.517 179.848 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.848 HG13 ' CG1' ' A' ' 35' ' ' ILE . 1.5 t -109.54 -170.15 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.363 -0.836 . . . . 0.0 109.216 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.674 ' H ' HG12 ' A' ' 74' ' ' VAL . 21.9 pt-20 -124.55 177.16 6.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 109.545 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.5 t70 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.461 179.935 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.9 ' O ' HD12 ' A' ' 13' ' ' LEU . 35.5 Cg_endo . . . . . 0 C--O 1.214 -0.703 0 N-CA-C 110.081 -0.776 . . . . 0.0 110.081 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -91.7 -65.66 0.99 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.13 -0.981 . . . . 0.0 109.793 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 15' ' ' LYS . . . -41.78 -30.01 0.22 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.014 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.542 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 70.1 t -84.54 -46.46 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.137 -0.977 . . . . 0.0 109.603 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.9 HD12 ' O ' ' A' ' 9' ' ' PRO . 6.3 mt -52.62 -54.72 29.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.586 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.38 -43.98 96.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.312 -0.867 . . . . 0.0 109.531 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 7.9 ttpt -54.18 -30.07 48.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 0.0 109.534 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -45.45 35.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.145 -0.972 . . . . 0.0 109.627 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -102.04 47.5 0.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 109.773 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 17' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.206 -0.934 . . . . 0.0 109.535 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.3 p -145.53 152.51 39.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.003 . . . . 0.0 109.689 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.8 pt -115.54 -175.38 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 109.223 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.76 127.6 45.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.0 109.621 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.408 ' NH1' ' HG3' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -56.1 -35.86 67.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.957 . . . . 0.0 109.121 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -49.07 -38.68 25.02 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.471 -0.768 . . . . 0.0 109.61 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -63.96 -45.77 87.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.119 -0.988 . . . . 0.0 109.665 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.723 HG12 ' HB ' ' A' ' 63' ' ' ILE . 1.8 t -68.55 -11.08 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.039 -1.038 . . . . 0.0 109.132 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.45 -47.49 10.59 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.275 -0.89 . . . . 0.0 108.895 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.516 ' O ' HD23 ' A' ' 46' ' ' LEU . 3.1 tt0 -55.44 -33.97 64.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.266 -0.896 . . . . 0.0 109.226 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 12.7 mt -83.36 -22.9 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.379 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.37 -24.54 61.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.913 . . . . 0.0 109.375 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.459 ' HA ' ' SD ' ' A' ' 48' ' ' MET . 31.2 mt-10 -93.47 -35.8 12.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 109.171 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.516 HD23 ' O ' ' A' ' 42' ' ' GLU . 0.5 OUTLIER -66.93 -8.58 30.47 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.332 -0.855 . . . . 0.0 109.795 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HD2' ' O ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -140.86 48.67 1.7 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.206 -0.934 . . . . 0.0 109.61 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.556 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 3.7 tpp -43.42 -52.97 12.35 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.297 -0.877 . . . . 0.0 109.42 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.556 ' HD3' ' CB ' ' A' ' 48' ' ' MET . 36.2 Cg_endo -79.46 86.3 1.7 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.498 2.132 . . . . 0.0 110.131 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -134.66 -60.23 0.79 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.135 -0.978 . . . . 0.0 109.815 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.694 ' C ' HD12 ' A' ' 51' ' ' LEU . 3.9 pp -127.16 -10.69 5.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 110.091 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.672 ' N ' HD12 ' A' ' 51' ' ' LEU . 10.5 t30 164.35 -89.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.318 -0.864 . . . . 0.0 109.024 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.563 ' CB ' ' HB2' ' A' ' 59' ' ' ALA . . . 63.37 72.4 0.48 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.515 -0.74 . . . . 0.0 109.592 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.81 -30.51 57.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.176 -0.953 . . . . 0.0 108.983 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.484 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -164.17 -61.43 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.364 -0.835 . . . . 0.0 109.247 179.855 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -165.8 -34.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -65.54 -62.82 1.3 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.273 -0.892 . . . . 0.0 110.519 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.95 -38.98 71.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.319 -0.863 . . . . 0.0 110.297 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.563 ' HB2' ' CB ' ' A' ' 53' ' ' ALA . . . -66.3 -70.13 0.26 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.161 -0.962 . . . . 0.0 110.033 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.581 ' HA ' HG12 ' A' ' 63' ' ' ILE . 0.7 OUTLIER -46.68 -28.37 1.47 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.181 -0.949 . . . . 0.0 110.405 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.468 ' HA ' ' OE2' ' A' ' 64' ' ' GLU . 2.3 mmm180 -74.63 -41.28 60.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.975 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.452 ' SD ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -69.49 -47.21 64.61 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.233 -0.917 . . . . 0.0 110.258 -179.3 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.723 ' HB ' HG12 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -52.08 -57.95 3.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.246 -0.909 . . . . 0.0 111.159 -179.421 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.631 ' N ' HD12 ' A' ' 63' ' ' ILE . 9.9 pt-20 -56.44 -55.14 37.34 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 120.946 -1.097 . . . . 0.0 109.519 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.57 -19.41 13.28 Favored Glycine 0 N--CA 1.483 1.778 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.544 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 63.8 m -77.95 -42.82 31.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.473 -1.016 . . . . 0.0 109.119 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -80.72 -1.38 42.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.24 -0.913 . . . . 0.0 108.946 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.98 -55.0 4.46 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.323 -0.861 . . . . 0.0 109.94 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.67 -11.05 43.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.13 -0.981 . . . . 0.0 110.597 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -65.71 -50.35 65.16 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.935 -1.103 . . . . 0.0 110.122 -179.65 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -156.79 -71.56 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.092 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.53 ' C ' HD12 ' A' ' 72' ' ' ILE . 1.0 OUTLIER -98.04 -174.27 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.148 -1.207 . . . . 0.0 109.848 -179.557 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.635 HG22 ' H ' ' A' ' 74' ' ' VAL . 2.3 p -107.98 -179.26 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.465 -0.772 . . . . 0.0 109.043 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.635 ' H ' HG22 ' A' ' 73' ' ' VAL . 0.1 OUTLIER -127.16 159.11 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.989 . . . . 0.0 109.308 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 1.9 pp20? -133.81 157.59 45.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.9 t0 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.5 -179.893 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.718 ' O ' HD12 ' A' ' 13' ' ' LEU . 35.9 Cg_endo . . . . . 0 C--O 1.214 -0.678 0 N-CA-C 110.308 -0.689 . . . . 0.0 110.308 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.691 ' HA ' HD13 ' A' ' 13' ' ' LEU . . . -51.88 -50.65 60.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.305 -0.872 . . . . 0.0 109.995 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -42.57 -50.87 5.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.22 -0.925 . . . . 0.0 109.87 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.457 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 42.8 t -56.28 -48.83 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 109.973 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.718 HD12 ' O ' ' A' ' 9' ' ' PRO . 4.9 mp -53.25 -58.08 8.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.145 -0.972 . . . . 0.0 109.835 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.59 ' CD2' ' HB2' ' A' ' 67' ' ' ALA . 0.3 OUTLIER -49.06 -33.5 11.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.907 . . . . 0.0 109.604 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -60.9 -62.89 1.53 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 0.0 110.112 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.86 -3.56 29.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.104 -0.997 . . . . 0.0 109.818 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.43 ' HB1' ' NZ ' ' A' ' 39' ' ' LYS . . . -84.57 -25.16 28.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.079 -1.013 . . . . 0.0 109.426 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.483 -179.931 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 34' ' ' THR . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -159.16 150.24 20.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -0.883 . . . . 0.0 109.682 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 35' ' ' ILE . 6.5 pt -145.3 170.3 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.213 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -82.2 142.88 31.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -0.963 . . . . 0.0 109.808 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' A' ' 38' ' ' ASP . 30.0 mtt180 -70.33 -10.41 58.91 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.442 -0.786 . . . . 0.0 109.77 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 37' ' ' ARG . 66.3 t0 -39.5 -50.24 2.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.69 -0.631 . . . . 0.0 109.955 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.43 ' NZ ' ' HB1' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -61.19 -48.24 82.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 0.0 109.726 -179.805 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.78 HG13 ' CG2' ' A' ' 63' ' ' ILE . 46.2 t -45.1 -25.94 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.096 -1.002 . . . . 0.0 109.856 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -84.54 -39.36 18.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.199 -0.938 . . . . 0.0 109.922 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 3.5 tt0 -66.56 -27.87 68.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 0.0 109.924 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.524 HG22 ' HD2' ' A' ' 47' ' ' LYS . 10.7 mt -90.81 -42.41 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.077 -1.015 . . . . 0.0 109.775 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.513 ' HA ' ' CD ' ' A' ' 47' ' ' LYS . . . -56.26 -21.57 24.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.073 -1.017 . . . . 0.0 109.114 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.34 -44.75 12.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.624 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mt -72.21 -10.94 60.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 109.753 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.524 ' HD2' HG22 ' A' ' 43' ' ' ILE . 14.9 ptmt -111.0 29.19 8.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -0.963 . . . . 0.0 110.085 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.58 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -64.88 -51.31 57.87 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.1 -1.0 . . . . 0.0 109.551 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 48' ' ' MET . 36.7 Cg_endo -80.96 57.5 6.56 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.734 2.29 . . . . 0.0 110.605 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.95 -76.67 0.23 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.995 -1.066 . . . . 0.0 109.719 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 51' ' ' LEU . 1.6 pp -89.27 17.99 5.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 109.934 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 51' ' ' LEU . 19.2 t-20 45.23 73.08 0.17 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.152 -0.968 . . . . 0.0 109.464 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.522 ' CB ' ' HB2' ' A' ' 59' ' ' ALA . . . -73.88 138.07 44.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.19 -0.944 . . . . 0.0 109.564 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.41 -68.14 0.2 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.951 . . . . 0.0 109.334 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.475 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -143.25 -52.5 0.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.348 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -165.13 -32.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.319 -0.863 . . . . 0.0 108.971 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -60.57 -70.29 0.18 Allowed 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.102 -0.998 . . . . 0.0 110.323 -179.45 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 57' ' ' GLU . . . -42.8 -58.65 2.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 110.007 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.522 ' HB2' ' CB ' ' A' ' 53' ' ' ALA . . . -49.36 -40.02 34.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.215 -0.928 . . . . 0.0 110.186 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.56 -35.67 81.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.168 -0.957 . . . . 0.0 110.207 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -14.81 58.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.12 -0.988 . . . . 0.0 109.677 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.447 ' SD ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -76.79 -57.46 3.84 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.177 -0.952 . . . . 0.0 109.644 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.78 ' CG2' HG13 ' A' ' 40' ' ' VAL . 9.1 mt -61.31 -36.82 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.063 -1.023 . . . . 0.0 109.585 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -63.95 -48.13 77.72 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.076 -1.015 . . . . 0.0 108.972 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.0 -9.39 34.19 Favored Glycine 0 N--CA 1.48 1.601 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 70' ' ' MET . 85.5 m -87.89 -48.2 7.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -1.13 . . . . 0.0 109.752 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.59 ' HB2' ' CD2' ' A' ' 14' ' ' LEU . . . -80.92 -12.13 59.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.127 -0.983 . . . . 0.0 109.622 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.569 ' NH2' ' CG1' ' A' ' 73' ' ' VAL . 0.1 OUTLIER -88.99 -46.0 9.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.176 -0.952 . . . . 0.0 109.435 179.814 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.59 -23.51 42.66 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.362 -0.837 . . . . 0.0 109.91 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.455 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -65.98 -66.01 0.6 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.195 -0.941 . . . . 0.0 109.354 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -161.62 -92.19 0.09 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.753 ' C ' HD12 ' A' ' 72' ' ' ILE . 2.8 pp -48.96 177.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.441 -1.035 . . . . 0.0 110.298 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.569 ' CG1' ' NH2' ' A' ' 68' ' ' ARG . 0.5 OUTLIER -112.26 -171.19 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.394 -0.816 . . . . 0.0 110.014 -179.525 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.552 ' H ' HG12 ' A' ' 73' ' ' VAL . 3.7 t -134.03 163.78 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.076 -1.015 . . . . 0.0 109.767 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -129.76 176.86 7.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.228 -0.92 . . . . 0.0 109.689 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 t70 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.443 179.97 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.548 ' O ' HD12 ' A' ' 13' ' ' LEU . 34.4 Cg_endo . . . . . 0 C--O 1.213 -0.758 0 N-CA-C 110.32 -0.684 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . -75.76 -64.55 1.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 110.213 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -41.36 -61.46 1.04 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.313 -0.867 . . . . 0.0 110.141 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.543 ' HB ' ' HG2' ' A' ' 9' ' ' PRO . 17.5 t -65.48 -30.01 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 109.852 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.548 HD12 ' O ' ' A' ' 9' ' ' PRO . 1.1 mt -50.31 -60.54 2.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.078 -1.013 . . . . 0.0 109.581 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.626 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -59.91 -35.43 74.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 109.726 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -50.32 -63.26 1.17 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.879 . . . . 0.0 109.792 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -21.38 60.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 0.0 109.808 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 14' ' ' LEU . . . -54.84 -45.15 74.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 109.798 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 0.0 109.453 -179.941 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.23 0.538 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.73 HG22 ' CG1' ' A' ' 73' ' ' VAL . 5.6 p -81.22 -171.66 3.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -0.914 . . . . 0.0 109.55 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.476 ' CG1' HG22 ' A' ' 74' ' ' VAL . 3.3 pt -140.1 -170.08 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.888 . . . . 0.0 109.588 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.4 ptpt -95.11 130.32 41.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.352 -0.843 . . . . 0.0 109.641 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.404 ' O ' ' C ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -67.35 -8.5 33.04 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.223 -0.923 . . . . 0.0 109.655 179.896 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 37' ' ' ARG . 31.9 t70 -42.5 -54.64 3.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.363 -0.836 . . . . 0.0 109.912 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -42.34 90.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 109.809 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.64 HG13 ' HB ' ' A' ' 63' ' ' ILE . 68.2 t -57.38 -21.59 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.193 -0.942 . . . . 0.0 109.717 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.7 ttp85 -84.87 -59.02 2.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.442 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -48.61 -58.18 5.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 109.509 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.479 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 92.2 mt -56.69 -56.21 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 109.571 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -45.59 -25.27 0.44 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.962 . . . . 0.0 109.564 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -75.44 -57.34 3.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.944 . . . . 0.0 109.663 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.578 HD12 ' C ' ' A' ' 46' ' ' LEU . 4.4 pp -70.46 -4.64 23.67 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.122 -0.986 . . . . 0.0 109.867 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.34 5.26 49.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.146 -0.971 . . . . 0.0 109.572 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.587 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -48.39 -50.06 59.63 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 110.199 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 48' ' ' MET . 34.8 Cg_endo -77.47 77.49 3.83 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.258 1.972 . . . . 0.0 110.575 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.704 ' HB3' HD23 ' A' ' 51' ' ' LEU . 7.7 t0 -172.34 -35.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.388 -0.82 . . . . 0.0 109.412 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.704 HD23 ' HB3' ' A' ' 50' ' ' ASP . 0.1 OUTLIER -143.74 16.56 1.79 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.441 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 52' ' ' ASN . 7.3 p-10 40.58 67.7 0.48 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.506 -0.746 . . . . 0.0 109.833 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.753 ' HB1' ' HB3' ' A' ' 58' ' ' ALA . . . -85.37 154.6 21.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 109.549 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -47.65 -51.44 21.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.17 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.12 -52.1 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.368 -0.833 . . . . 0.0 108.931 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.72 HG22 ' O ' ' A' ' 56' ' ' ILE . 20.8 mm -149.99 9.44 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.453 -0.779 . . . . 0.0 109.612 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -97.61 -52.7 3.68 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 120.899 -1.125 . . . . 0.0 109.717 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.753 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -69.51 -43.41 73.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.365 -0.834 . . . . 0.0 109.352 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.67 -24.33 64.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.355 -0.841 . . . . 0.0 109.438 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.43 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -70.66 -38.69 73.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.311 -0.868 . . . . 0.0 109.63 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.51 -14.85 58.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.276 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.37 -60.65 2.28 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.367 -0.833 . . . . 0.0 109.57 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.64 ' HB ' HG13 ' A' ' 40' ' ' VAL . 15.3 mt -59.34 -36.27 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 109.787 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -62.85 -60.02 4.06 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.083 -1.011 . . . . 0.0 109.498 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.414 ' HA2' ' HB2' ' A' ' 68' ' ' ARG . . . -56.52 -15.85 13.5 Favored Glycine 0 N--CA 1.479 1.547 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.746 HG23 ' SD ' ' A' ' 70' ' ' MET . 60.8 m -74.1 -55.86 5.6 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.243 -1.151 . . . . 0.0 109.153 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.473 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -62.2 -27.2 68.81 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.414 ' HB2' ' HA2' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -47.77 -61.81 1.76 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.525 -0.735 . . . . 0.0 109.17 179.302 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.55 -68.58 0.78 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.332 -0.855 . . . . 0.0 110.312 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.746 ' SD ' HG23 ' A' ' 66' ' ' THR . 1.1 mpt? -45.49 -21.02 0.08 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.177 -0.952 . . . . 0.0 111.615 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' A' ' 67' ' ' ALA . . . -150.1 -133.13 2.09 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 118.898 -1.62 . . . . 0.0 110.764 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.506 ' C ' HD12 ' A' ' 72' ' ' ILE . 1.0 OUTLIER -102.81 -170.26 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.529 -0.983 . . . . 0.0 110.215 -179.354 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.73 ' CG1' HG22 ' A' ' 34' ' ' THR . 9.1 p -84.08 165.06 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -0.869 . . . . 0.0 109.85 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.523 HG12 ' N ' ' A' ' 75' ' ' GLU . 54.5 t -124.7 161.95 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.218 -0.926 . . . . 0.0 109.578 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.523 ' N ' HG12 ' A' ' 74' ' ' VAL . 2.3 pp20? -114.51 135.14 54.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 109.38 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.4 179.929 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo . . . . . 0 C--O 1.214 -0.682 0 N-CA-C 110.441 -0.638 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.471 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -67.51 -66.16 0.6 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.244 -0.91 . . . . 0.0 109.883 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.764 ' HB2' ' SD ' ' A' ' 70' ' ' MET . . . -34.51 -67.73 0.13 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.677 -0.639 . . . . 0.0 110.705 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.1 t -49.55 -44.19 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.07 -1.019 . . . . 0.0 109.906 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 14.8 mt -54.13 -69.41 0.12 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.148 -0.97 . . . . 0.0 109.752 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.805 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -48.48 -26.91 2.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.77 -179.801 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -64.58 0.89 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 0.0 109.717 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.4 tptp -56.68 -32.59 65.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -0.942 . . . . 0.0 109.326 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.414 ' HB1' ' HD3' ' A' ' 39' ' ' LYS . . . -105.01 48.62 0.83 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.569 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.805 ' HB2' ' O ' ' A' ' 14' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.14 -0.975 . . . . 0.0 109.532 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.41 0.624 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.543 ' O ' HG23 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -161.05 179.62 8.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.409 -0.807 . . . . 0.0 109.678 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.608 HG13 HG13 ' A' ' 74' ' ' VAL . 0.8 OUTLIER -159.7 164.0 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.299 -0.876 . . . . 0.0 109.301 179.582 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.5 146.32 31.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 109.707 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.45 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 3.3 ppt_? -64.04 -17.12 63.06 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.353 -0.842 . . . . 0.0 109.791 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 37' ' ' ARG . 11.9 t70 -46.04 -47.87 16.9 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.112 -0.993 . . . . 0.0 109.258 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.433 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -62.71 -44.78 95.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 0.0 109.322 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.648 HG13 ' HB ' ' A' ' 63' ' ' ILE . 47.9 t -53.09 -20.43 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.299 -0.876 . . . . 0.0 109.585 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.24 -52.6 5.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.301 -0.874 . . . . 0.0 109.546 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -59.21 -21.38 59.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.244 -0.91 . . . . 0.0 109.664 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 39' ' ' LYS . 14.2 mt -101.36 -22.0 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.269 -0.895 . . . . 0.0 109.388 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.709 ' HB1' ' HB1' ' A' ' 59' ' ' ALA . . . -83.49 -4.66 58.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.436 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -97.77 -39.65 8.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.156 -0.965 . . . . 0.0 109.529 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.4 mt -91.91 -29.42 16.69 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.158 -0.964 . . . . 0.0 109.5 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.411 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -81.37 -2.44 49.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -0.867 . . . . 0.0 109.542 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.6 ttp -45.22 105.66 0.48 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.199 -0.938 . . . . 0.0 109.321 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HG2' HD21 ' A' ' 51' ' ' LEU . 35.2 Cg_endo -76.85 -69.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.397 2.065 . . . . 0.0 110.66 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.603 ' C ' HD23 ' A' ' 51' ' ' LEU . 2.6 t0 -169.11 34.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.638 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.694 ' N ' HD23 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -102.23 -16.44 16.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.171 -0.956 . . . . 0.0 109.773 -179.734 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 53' ' ' ALA . 10.7 t-20 48.31 69.38 0.55 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.095 -1.003 . . . . 0.0 109.047 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.545 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . . . -43.0 100.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.344 -0.847 . . . . 0.0 109.495 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 52' ' ' ASN . . . -50.35 -31.12 13.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.233 -0.917 . . . . 0.0 109.385 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.511 ' O ' HG12 ' A' ' 56' ' ' ILE . 16.4 m -145.87 -67.71 0.29 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.199 -0.938 . . . . 0.0 109.219 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.516 HD13 ' HA ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -168.28 -30.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.391 -0.818 . . . . 0.0 109.167 -179.814 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.63 -54.98 30.02 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 120.952 -1.093 . . . . 0.0 109.955 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.545 ' HB3' ' HA ' ' A' ' 53' ' ' ALA . . . -43.8 -72.7 0.05 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.612 -0.68 . . . . 0.0 110.972 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.709 ' HB1' ' HB1' ' A' ' 44' ' ' ALA . . . -52.94 -54.91 27.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.337 -0.852 . . . . 0.0 111.111 -178.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -50.63 -25.83 4.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.077 -1.014 . . . . 0.0 110.815 -178.946 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -81.56 -32.93 31.98 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.015 -1.053 . . . . 0.0 109.643 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.576 ' SD ' HD11 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -70.57 -54.93 10.15 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.218 -0.927 . . . . 0.0 109.534 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.648 ' HB ' HG13 ' A' ' 40' ' ' VAL . 7.5 mt -67.56 -42.36 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.211 -0.931 . . . . 0.0 109.974 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' A' ' 60' ' ' MET . 2.9 tm-20 -60.11 -54.29 47.73 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.083 -1.011 . . . . 0.0 109.61 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.21 -15.87 31.93 Favored Glycine 0 N--CA 1.479 1.548 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.48 ' O ' ' HB2' ' A' ' 70' ' ' MET . 29.9 m -75.0 -55.05 6.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.282 -1.128 . . . . 0.0 109.001 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.487 ' O ' ' C ' ' A' ' 71' ' ' GLY . . . -64.91 -23.84 67.35 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.003 -1.06 . . . . 0.0 108.493 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.44 -51.53 68.07 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.009 -1.057 . . . . 0.0 109.371 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.46 -53.18 3.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.19 -0.944 . . . . 0.0 110.169 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.764 ' SD ' ' HB2' ' A' ' 11' ' ' ALA . 2.5 mmt -62.64 -23.63 67.18 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.233 -0.917 . . . . 0.0 111.12 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.487 ' C ' ' O ' ' A' ' 67' ' ' ALA . . . -142.85 -123.53 1.82 Allowed Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.586 -1.293 . . . . 0.0 110.372 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.544 ' C ' HD12 ' A' ' 72' ' ' ILE . 1.2 pp -115.4 -174.55 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.188 -1.184 . . . . 0.0 109.894 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 34' ' ' THR . 3.8 t -79.53 157.47 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 109.751 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.608 HG13 HG13 ' A' ' 35' ' ' ILE . 4.9 t -127.61 170.45 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.936 . . . . 0.0 109.594 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.522 ' H ' HG12 ' A' ' 74' ' ' VAL . 2.0 pt-20 -130.21 149.28 51.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.398 -0.814 . . . . 0.0 109.419 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 t70 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.921 -1.038 . . . . 0.0 109.525 -179.939 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo . . . . . 0 C--O 1.215 -0.633 0 N-CA-C 110.152 -0.749 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -54.6 -45.16 73.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -0.872 . . . . 0.0 109.911 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -41.3 -44.52 2.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.008 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.1 t -75.55 -36.91 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.179 -0.951 . . . . 0.0 110.014 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 10' ' ' ALA . 90.6 mt -57.77 -33.09 68.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.92 . . . . 0.0 110.093 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.1 -36.27 40.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.052 -1.03 . . . . 0.0 109.802 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.68 -13.54 60.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.214 -0.929 . . . . 0.0 109.964 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -92.58 -29.35 16.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.079 -1.013 . . . . 0.0 109.594 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.13 -47.54 79.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.193 -0.942 . . . . 0.0 109.356 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 109.351 179.823 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.35 0.595 . . . . 0.0 109.978 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 73' ' ' VAL . 1.5 p -125.91 169.18 12.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.379 -0.826 . . . . 0.0 109.265 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.554 HG13 HG13 ' A' ' 74' ' ' VAL . 27.3 pt -107.75 169.91 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 109.41 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt -109.9 164.77 12.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.185 -0.947 . . . . 0.0 109.524 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.486 ' HD2' ' CE ' ' A' ' 60' ' ' MET . 0.3 OUTLIER -60.8 -15.52 30.77 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.285 -0.885 . . . . 0.0 109.694 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 37' ' ' ARG . 37.1 t0 -43.63 -55.29 4.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 0.0 109.655 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -61.05 -57.42 12.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.221 -0.925 . . . . 0.0 109.692 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.879 HG13 ' HB ' ' A' ' 63' ' ' ILE . 60.8 t -41.68 -28.68 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.89 . . . . 0.0 110.407 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -74.66 -49.91 19.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.078 -1.014 . . . . 0.0 110.216 -179.447 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -67.73 -21.08 65.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.078 -1.014 . . . . 0.0 110.109 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 19.7 mt -101.33 -13.62 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.457 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.57 ' HB2' ' O ' ' A' ' 40' ' ' VAL . . . -88.15 -14.25 39.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.317 -0.865 . . . . 0.0 109.252 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.67 -52.86 4.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.345 -0.847 . . . . 0.0 109.624 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.2 mt -88.11 32.03 0.77 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -0.944 . . . . 0.0 109.695 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -159.43 23.55 0.19 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.211 -0.931 . . . . 0.0 109.407 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -121.97 85.28 45.47 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.312 -0.867 . . . . 0.0 109.623 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.544 ' HD2' HD23 ' A' ' 51' ' ' LEU . 36.4 Cg_endo -80.42 43.61 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.865 2.376 . . . . 0.0 110.755 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 18.9 t0 53.99 25.63 5.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.062 -1.024 . . . . 0.0 109.23 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 52' ' ' ASN . 1.9 pp -44.44 -39.29 4.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.616 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.557 ' N ' HD12 ' A' ' 51' ' ' LEU . 7.1 t-20 161.47 95.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.636 -0.665 . . . . 0.0 109.21 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.836 ' CB ' ' HB3' ' A' ' 58' ' ' ALA . . . -171.31 139.31 1.3 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.946 . . . . 0.0 109.425 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 53' ' ' ALA . . . -45.09 -59.6 2.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.202 -0.936 . . . . 0.0 109.127 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.8 -65.43 0.1 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.342 -0.849 . . . . 0.0 108.959 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.539 ' O ' ' CG2' ' A' ' 56' ' ' ILE . 2.7 mm -137.82 1.84 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.385 -0.822 . . . . 0.0 108.99 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.32 -57.07 3.22 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.039 -1.038 . . . . 0.0 109.681 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.836 ' HB3' ' CB ' ' A' ' 53' ' ' ALA . . . -64.26 -52.23 59.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.387 -0.821 . . . . 0.0 109.532 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.593 ' H ' ' HB1' ' A' ' 53' ' ' ALA . . . -51.3 -40.96 60.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 109.4 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.486 ' CE ' ' HD2' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -62.56 -37.94 88.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.867 . . . . 0.0 109.671 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.524 ' HA ' ' CG ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -68.05 -16.75 64.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.581 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.404 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -78.56 -53.7 6.93 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.287 -0.883 . . . . 0.0 109.835 -179.724 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.879 ' HB ' HG13 ' A' ' 40' ' ' VAL . 7.8 mt -60.57 -42.3 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.179 -0.951 . . . . 0.0 109.714 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.524 ' CG ' ' HA ' ' A' ' 61' ' ' ARG . 2.0 pp20? -64.25 -44.62 91.23 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.961 -1.087 . . . . 0.0 109.602 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.49 -12.38 55.89 Favored Glycine 0 C--N 1.298 -1.568 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 14.7 m -84.8 -56.11 3.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.401 -1.058 . . . . 0.0 109.644 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -64.46 -31.07 72.13 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.93 -1.106 . . . . 0.0 108.75 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -60.13 4.15 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.331 -0.856 . . . . 0.0 109.433 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.51 -56.25 3.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.092 -1.005 . . . . 0.0 109.876 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.45 ' HB2' ' O ' ' A' ' 66' ' ' THR . 9.5 mtp -64.49 -10.01 22.66 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.321 -0.862 . . . . 0.0 111.009 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 67' ' ' ALA . . . -142.94 -130.73 2.48 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.272 -1.442 . . . . 0.0 110.839 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.511 ' C ' HD12 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -101.31 -169.83 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.491 -1.005 . . . . 0.0 110.301 -179.217 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.406 ' O ' ' HB ' ' A' ' 34' ' ' THR . 1.4 t -81.94 145.76 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -0.846 . . . . 0.0 109.69 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.554 HG13 HG13 ' A' ' 35' ' ' ILE . 20.6 t -120.36 147.28 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.407 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 35' ' ' ILE . 12.4 pt-20 -95.27 139.82 31.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.302 -0.874 . . . . 0.0 109.477 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.9 t0 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.438 179.917 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.224 0.535 . . . . 0.0 109.58 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.09 92.51 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 0.0 109.462 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.33 65.87 1.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 109.463 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.494 HG13 ' N ' ' A' ' 5' ' ' THR . 5.2 tp -162.23 153.53 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.906 . . . . 0.0 109.571 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.494 ' N ' HG13 ' A' ' 4' ' ' ILE . 1.5 t -47.62 172.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.276 -0.89 . . . . 0.0 109.388 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 7' ' ' THR . 0.1 OUTLIER -59.35 169.29 1.24 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.202 -0.936 . . . . 0.0 109.527 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.451 ' CB ' ' O ' ' A' ' 6' ' ' LYS . 0.2 OUTLIER 70.83 122.08 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.878 . . . . 0.0 109.46 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.31 170.44 18.54 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.394 2.063 . . . . 0.0 110.383 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.537 ' HG2' ' CG2' ' A' ' 12' ' ' VAL . 34.5 Cg_endo -77.12 162.63 31.46 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.53 2.154 . . . . 0.0 110.311 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -72.07 -61.18 1.88 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 109.828 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -39.64 -54.5 2.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.507 -0.746 . . . . 0.0 110.031 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.537 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 89.6 t -59.82 -41.59 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.106 -0.996 . . . . 0.0 109.668 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 9' ' ' PRO . 0.8 OUTLIER -55.35 -65.05 0.65 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.931 . . . . 0.0 109.62 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.725 HD11 HG23 ' A' ' 63' ' ' ILE . 2.1 mt -46.25 -27.12 0.93 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.163 -0.96 . . . . 0.0 109.209 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.465 ' HD3' ' CD1' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -68.5 -47.54 66.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.867 . . . . 0.0 109.39 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -67.74 -13.45 62.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.338 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.22 -42.04 80.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.381 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.81 -23.36 4.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.196 -0.94 . . . . 0.0 109.51 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.01 24.72 7.88 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.465 ' CD1' ' HD3' ' A' ' 15' ' ' LYS . 57.4 mt -48.26 -38.52 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.214 -1.168 . . . . 0.0 109.837 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -97.85 70.68 2.17 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.539 -0.726 . . . . 0.0 109.339 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.8 m -147.58 163.67 35.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -0.89 . . . . 0.0 109.434 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 25' ' ' GLY . . . -73.33 -65.27 2.29 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.7 m 49.28 -94.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.131 -1.217 . . . . 0.0 109.578 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . 131.07 -95.35 0.32 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -46.85 158.43 0.42 Allowed Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 121.318 -1.107 . . . . 0.0 109.872 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.37 114.05 3.46 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.625 2.217 . . . . 0.0 110.242 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.488 ' O ' ' HD2' ' A' ' 29' ' ' ARG . 3.7 m-20 -96.41 43.11 1.08 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.245 -0.909 . . . . 0.0 109.628 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.488 ' HD2' ' O ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -146.22 113.44 6.22 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 109.532 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -166.98 -66.11 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.327 -0.858 . . . . 0.0 109.501 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.9 -172.48 2.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.259 -0.901 . . . . 0.0 109.283 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.5 t -65.96 104.37 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.934 . . . . 0.0 109.606 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.96 176.5 6.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 0.0 109.344 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.98 148.08 25.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 109.403 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.426 HG13 HG13 ' A' ' 74' ' ' VAL . 38.9 pt -107.19 -174.28 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.213 -0.929 . . . . 0.0 109.536 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.49 ' HB3' ' OD1' ' A' ' 38' ' ' ASP . 20.3 tptt -96.44 167.01 11.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.253 -0.904 . . . . 0.0 109.757 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.64 -24.77 31.25 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.282 -0.887 . . . . 0.0 109.726 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.49 ' OD1' ' HB3' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -48.77 -38.11 20.93 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.135 -0.978 . . . . 0.0 109.417 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.403 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 6.9 mmtp -59.48 -45.58 91.27 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.317 -0.864 . . . . 0.0 109.441 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.721 HG13 ' HB ' ' A' ' 63' ' ' ILE . 39.4 t -58.3 -23.48 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.354 -0.841 . . . . 0.0 109.734 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 3.4 ttm180 -83.7 -42.07 17.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.179 -0.95 . . . . 0.0 109.507 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -62.75 -59.39 4.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.332 -0.855 . . . . 0.0 109.93 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 16.3 mt -56.54 -50.75 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.925 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.423 ' N ' HD11 ' A' ' 63' ' ' ILE . . . -59.17 -21.43 59.38 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 109.931 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -78.61 -37.67 41.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.145 -0.972 . . . . 0.0 109.68 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.5 mt -82.82 -17.29 44.54 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.19 -0.944 . . . . 0.0 109.623 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.419 ' C ' ' HD2' ' A' ' 49' ' ' PRO . 0.2 OUTLIER -121.4 8.9 10.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.437 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.575 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -44.41 -51.41 20.18 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 0.0 109.893 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 48' ' ' MET . 35.2 Cg_endo -78.48 97.7 1.15 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.338 2.026 . . . . 0.0 110.436 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -170.15 -46.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.29 -0.881 . . . . 0.0 109.594 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' A' ' 52' ' ' ASN . 0.9 OUTLIER -115.57 39.43 2.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -0.95 . . . . 0.0 109.584 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 51' ' ' LEU . 32.5 t30 41.98 57.85 3.07 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.396 -0.815 . . . . 0.0 109.747 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.94 173.6 3.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.228 -0.92 . . . . 0.0 109.446 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -86.66 -45.92 10.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.905 . . . . 0.0 109.263 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.46 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -174.57 -39.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.303 -0.873 . . . . 0.0 109.3 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -172.93 -32.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -63.55 -59.98 3.93 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.411 -0.806 . . . . 0.0 109.995 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.97 -44.35 74.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 109.657 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.85 -24.22 66.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.227 -0.921 . . . . 0.0 109.656 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.85 -29.76 56.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 109.855 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -77.74 -23.35 49.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.9 . . . . 0.0 109.721 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.11 -56.05 5.01 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.19 -0.944 . . . . 0.0 109.892 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.725 HG23 HD11 ' A' ' 14' ' ' LEU . 6.4 mt -56.0 -38.06 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.111 -0.993 . . . . 0.0 109.857 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 15.9 mt-10 -60.34 -55.03 38.56 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.106 -0.996 . . . . 0.0 109.474 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -52.94 -17.43 4.99 Favored Glycine 0 N--CA 1.482 1.754 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.556 HG21 HD12 ' A' ' 14' ' ' LEU . 61.1 m -84.57 -50.01 8.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.118 -1.225 . . . . 0.0 110.267 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.704 ' HB3' HG21 ' A' ' 74' ' ' VAL . . . -86.41 3.68 42.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.079 -1.013 . . . . 0.0 110.058 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 10.4 mtp180 -104.32 -36.3 7.66 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.058 -1.026 . . . . 0.0 109.415 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.96 -8.36 37.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 110.038 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.473 ' HG3' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -77.55 -62.94 1.5 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.074 -1.016 . . . . 0.0 109.544 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -159.19 -86.54 0.06 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.796 ' C ' HD12 ' A' ' 72' ' ' ILE . 2.5 pp -59.88 174.21 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -1.124 . . . . 0.0 109.665 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.481 ' N ' HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -114.5 157.76 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.37 -0.831 . . . . 0.0 109.211 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.704 HG21 ' HB3' ' A' ' 67' ' ' ALA . 2.3 t -115.8 142.79 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.443 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 13.0 pt-20 -105.1 97.38 7.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.268 -0.895 . . . . 0.0 109.491 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.425 ' HB2' ' OE2' ' A' ' 64' ' ' GLU . 51.2 t0 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.507 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttp . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.9 p -92.79 -173.28 3.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.336 -0.853 . . . . 0.0 109.624 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 56.76 28.1 13.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 109.363 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.511 ' HA ' HD13 ' A' ' 4' ' ' ILE . 6.5 mm -137.92 113.68 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.906 . . . . 0.0 109.087 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -42.61 113.59 0.48 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.869 . . . . 0.0 109.691 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.432 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -149.69 163.92 36.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 0.0 109.342 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.5 m -115.76 85.47 14.32 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.3 -0.875 . . . . 0.0 109.756 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.763 ' HG2' HG21 ' A' ' 12' ' ' VAL . 30.1 Cg_endo -75.16 168.33 24.96 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.208 1.939 . . . . 0.0 109.845 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.632 ' HA ' ' CD2' ' A' ' 13' ' ' LEU . 36.7 Cg_endo -80.96 -156.05 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 123.298 2.665 . . . . 0.0 112.698 -177.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.507 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . 32.0 -121.12 0.06 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.209 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.507 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -24.0 -61.78 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.831 -0.543 . . . . 0.0 112.273 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.763 HG21 ' HG2' ' A' ' 8' ' ' PRO . 19.6 t -62.85 -47.47 92.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.004 -1.06 . . . . 0.0 110.849 -178.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.632 ' CD2' ' HA ' ' A' ' 9' ' ' PRO . 1.3 mm? -60.97 -18.0 54.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.794 -1.191 . . . . 0.0 109.977 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 15' ' ' LYS . 17.7 mt -86.38 -53.74 4.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.088 -1.007 . . . . 0.0 109.717 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -45.5 -44.89 12.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -0.967 . . . . 0.0 109.181 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -40.47 86.47 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.335 -0.853 . . . . 0.0 109.416 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.409 ' HB1' ' HG2' ' A' ' 39' ' ' LYS . . . -51.09 -37.64 46.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.432 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.01 -66.55 0.74 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.895 . . . . 0.0 109.588 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 20' ' ' ILE . . . 115.32 41.2 0.82 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.423 ' C ' ' O ' ' A' ' 19' ' ' GLY . 46.8 mt -43.49 100.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.26 -1.141 . . . . 0.0 109.774 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 19' ' ' GLY . 5.7 mt-10 -106.81 -90.74 0.42 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.171 -0.956 . . . . 0.0 109.246 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.5 m -81.14 179.36 7.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.345 -0.847 . . . . 0.0 109.23 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 24' ' ' SER . . . 179.48 -115.9 0.5 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER 75.5 -176.12 0.13 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -1.116 . . . . 0.0 109.57 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 26' ' ' GLU . . . -67.41 -15.33 65.75 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 25' ' ' GLY . 18.1 tt0 -43.24 111.68 1.1 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.249 -1.147 . . . . 0.0 109.686 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.87 128.95 9.56 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.44 2.094 . . . . 0.0 110.369 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -141.88 41.14 1.68 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.176 -0.953 . . . . 0.0 109.716 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.04 9.75 7.85 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.151 -0.968 . . . . 0.0 109.855 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -95.9 -18.62 20.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.066 -1.021 . . . . 0.0 109.845 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.7 mtpt -96.88 -172.95 2.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.139 -0.976 . . . . 0.0 109.458 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 80.8 t -92.57 122.24 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.189 -0.945 . . . . 0.0 109.304 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.07 58.46 1.52 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.203 -0.936 . . . . 0.0 109.527 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.456 HG22 ' CG2' ' A' ' 73' ' ' VAL . 1.0 OUTLIER -132.16 179.34 6.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 109.321 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.622 HD11 ' HB1' ' A' ' 67' ' ' ALA . 8.9 pt -120.04 -175.19 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.913 . . . . 0.0 109.552 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -109.04 156.91 19.21 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.262 -0.899 . . . . 0.0 109.653 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.98 -16.31 64.27 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.3 -0.875 . . . . 0.0 109.628 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.441 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 11.7 t70 -48.25 -44.51 33.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 109.449 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.441 ' NZ ' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -55.0 -61.68 2.15 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.285 -0.884 . . . . 0.0 109.258 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.946 HG13 ' HB ' ' A' ' 63' ' ' ILE . 46.0 t -46.94 -23.42 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.277 -0.89 . . . . 0.0 109.893 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.441 ' HB3' ' O ' ' A' ' 38' ' ' ASP . 4.0 ttt85 -75.12 -61.29 1.94 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.073 -1.017 . . . . 0.0 109.851 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -58.17 -52.64 64.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.233 -0.917 . . . . 0.0 110.032 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 82.8 mt -61.13 -43.06 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.205 -0.935 . . . . 0.0 110.082 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 40' ' ' VAL . . . -52.96 -49.59 65.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.045 -1.034 . . . . 0.0 109.72 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -49.22 78.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.505 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.423 ' N ' ' CD2' ' A' ' 46' ' ' LEU . 0.3 OUTLIER -65.07 -15.02 61.9 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.256 -0.903 . . . . 0.0 110.094 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -102.89 21.46 15.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.139 -0.975 . . . . 0.0 109.919 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.571 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -57.21 -53.83 61.2 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.085 -1.009 . . . . 0.0 109.325 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.571 ' HD3' ' CB ' ' A' ' 48' ' ' MET . 36.5 Cg_endo -79.54 74.49 5.52 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.52 2.146 . . . . 0.0 110.296 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -150.26 -65.35 0.2 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.18 -0.95 . . . . 0.0 109.418 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 52' ' ' ASN . 1.5 pp -117.3 18.85 14.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.37 -0.831 . . . . 0.0 109.368 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 51' ' ' LEU . 1.2 p-10 39.73 68.16 0.4 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.483 -0.761 . . . . 0.0 109.915 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.487 ' CB ' ' HB2' ' A' ' 59' ' ' ALA . . . -63.5 168.35 4.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.171 -0.956 . . . . 0.0 109.501 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 53' ' ' ALA . . . -44.0 -36.54 2.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.893 . . . . 0.0 109.061 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m 174.3 -40.06 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.343 -0.848 . . . . 0.0 108.842 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.7 tt -171.34 -33.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 121.321 -0.862 . . . . 0.0 109.028 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.6 -67.42 0.46 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.297 -0.877 . . . . 0.0 110.331 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -44.67 -39.82 5.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.28 -0.887 . . . . 0.0 110.217 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.487 ' HB2' ' CB ' ' A' ' 53' ' ' ALA . . . -61.26 -44.38 97.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.065 -1.022 . . . . 0.0 110.041 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -40.14 94.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 110.347 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -70.38 -21.05 62.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -0.965 . . . . 0.0 110.151 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -56.45 5.09 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.097 -1.002 . . . . 0.0 109.605 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.946 ' HB ' HG13 ' A' ' 40' ' ' VAL . 15.3 mt -54.37 -35.74 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.256 -0.903 . . . . 0.0 109.423 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 1.2 tt0 -59.21 -56.83 17.09 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.225 -0.922 . . . . 0.0 109.378 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.88 -20.13 2.83 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.522 ' O ' ' CG ' ' A' ' 70' ' ' MET . 12.0 m -79.86 -57.5 3.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.397 -1.061 . . . . 0.0 109.921 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.622 ' HB1' HD11 ' A' ' 35' ' ' ILE . . . -78.15 10.62 2.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.961 . . . . 0.0 110.345 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -105.17 -55.48 2.32 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.993 -1.067 . . . . 0.0 110.476 -179.554 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.87 -25.7 12.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.078 -1.014 . . . . 0.0 111.899 -178.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.547 ' HG3' ' N ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -70.36 -30.81 67.83 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.543 -1.348 . . . . 0.0 110.901 -178.356 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.547 ' N ' ' HG3' ' A' ' 70' ' ' MET . . . -160.83 -123.09 0.66 Allowed Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.206 -1.473 . . . . 0.0 110.744 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.606 ' N ' HD12 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -48.99 -178.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.491 -1.005 . . . . 0.0 110.527 -179.025 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.475 ' O ' HG12 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -110.99 -168.61 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.539 -0.725 . . . . 0.0 109.421 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.429 ' CG2' ' C ' ' A' ' 73' ' ' VAL . 2.1 t -151.34 155.53 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 109.659 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -115.79 135.29 54.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 109.384 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.493 -179.934 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ttt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.4 m 60.81 52.58 4.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.932 . . . . 0.0 109.286 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.13 62.77 1.46 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 109.464 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.645 HG23 ' O ' ' A' ' 4' ' ' ILE . 1.2 tt -160.41 116.15 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.898 . . . . 0.0 109.518 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.478 ' O ' HG22 ' A' ' 5' ' ' THR . 45.5 m 43.71 80.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 109.524 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 7' ' ' THR . 0.3 OUTLIER -79.76 87.43 5.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.306 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER 44.83 90.72 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.321 -0.862 . . . . 0.0 109.618 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.704 ' HG2' HD11 ' A' ' 13' ' ' LEU . 35.5 Cg_endo -77.3 174.87 12.07 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.612 2.208 . . . . 0.0 110.091 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.499 ' O ' ' CG ' ' A' ' 13' ' ' LEU . 34.0 Cg_endo -77.04 142.56 22.03 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.46 2.107 . . . . 0.0 110.403 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . -73.3 -55.78 5.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 109.843 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -42.92 -65.25 0.5 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.882 . . . . 0.0 109.884 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.489 ' HB ' ' HG2' ' A' ' 9' ' ' PRO . 92.9 t -61.21 -38.08 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.791 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.704 HD11 ' HG2' ' A' ' 8' ' ' PRO . 5.3 mt -44.67 -42.48 7.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 109.698 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.595 HD22 ' HB2' ' A' ' 67' ' ' ALA . 0.8 OUTLIER -74.12 -40.35 62.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.087 -1.008 . . . . 0.0 109.553 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -50.06 -37.24 32.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.885 . . . . 0.0 109.296 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -79.6 -33.45 41.56 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.323 -0.861 . . . . 0.0 109.435 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.04 -25.33 58.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.564 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.99 -73.68 0.17 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 109.379 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.75 49.72 0.83 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.401 ' O ' ' C ' ' A' ' 21' ' ' GLU . 20.4 mt -68.63 -4.67 3.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.303 -1.116 . . . . 0.0 110.022 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 20' ' ' ILE . 20.0 tp10 -45.48 116.4 1.15 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.139 -0.976 . . . . 0.0 109.447 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 t -175.2 -76.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 109.413 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.61 -96.74 0.03 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.98 160.1 15.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.306 -1.114 . . . . 0.0 109.679 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 26' ' ' GLU . . . 96.06 95.46 1.79 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 0.4 OUTLIER -44.43 143.85 1.89 Allowed Pre-proline 0 C--N 1.306 -1.312 0 O-C-N 121.202 -1.175 . . . . 0.0 109.4 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 35.7 Cg_endo -77.53 119.83 5.01 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.598 2.199 . . . . 0.0 110.683 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -110.57 -79.61 0.58 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.91 . . . . 0.0 109.466 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.8 82.68 5.85 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.176 -0.952 . . . . 0.0 109.558 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.409 ' OD1' ' O ' ' A' ' 30' ' ' ASN . 38.7 p30 -96.94 145.9 25.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.178 -0.951 . . . . 0.0 109.402 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.81 -171.65 2.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.167 -0.958 . . . . 0.0 109.742 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.879 ' O ' HG22 ' A' ' 34' ' ' THR . 38.6 t -60.31 130.89 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.375 -0.828 . . . . 0.0 109.434 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.87 93.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.128 -0.983 . . . . 0.0 109.175 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.879 HG22 ' O ' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -157.66 176.16 12.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.199 -0.938 . . . . 0.0 109.691 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.9 HG13 HG13 ' A' ' 74' ' ' VAL . 27.3 pt -126.26 160.11 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.438 -0.789 . . . . 0.0 109.37 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.89 122.52 26.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.293 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -57.47 -15.69 7.6 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.231 -0.918 . . . . 0.0 110.083 -179.589 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 37' ' ' ARG . 31.2 t0 -43.9 -37.27 2.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.048 -1.032 . . . . 0.0 109.351 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.471 ' O ' HG13 ' A' ' 43' ' ' ILE . 13.4 mmtt -65.96 -56.31 12.32 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.155 -0.965 . . . . 0.0 109.11 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.85 HG22 ' CG2' ' A' ' 63' ' ' ILE . 37.9 t -42.06 -28.28 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 109.453 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -69.47 -54.74 12.79 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.305 -0.872 . . . . 0.0 109.375 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.21 -9.77 56.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.265 -0.897 . . . . 0.0 109.912 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 39' ' ' LYS . 11.9 mt -105.07 -8.73 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.098 -1.001 . . . . 0.0 109.855 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.461 ' HA ' ' HG2' ' A' ' 48' ' ' MET . . . -101.87 -19.12 15.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.971 . . . . 0.0 110.047 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -105.57 -32.34 8.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.384 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.6 mt -95.49 11.17 33.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.092 -1.005 . . . . 0.0 110.454 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.423 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -134.47 -53.2 0.83 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.049 -1.032 . . . . 0.0 109.496 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.475 ' HB3' HD21 ' A' ' 51' ' ' LEU . 19.4 mmt -58.86 111.49 3.74 Favored Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 121.31 -0.869 . . . . 0.0 109.733 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.56 ' HD2' ' CD2' ' A' ' 51' ' ' LEU . 34.9 Cg_endo -76.32 -30.7 5.14 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.366 2.044 . . . . 0.0 110.927 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.561 ' C ' ' HG ' ' A' ' 51' ' ' LEU . 12.4 t70 -173.14 -53.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.803 -1.186 . . . . 0.0 110.857 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.85 HD13 ' CE ' ' A' ' 62' ' ' MET . 0.0 OUTLIER 27.04 38.77 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.927 -0.483 . . . . 0.0 111.089 -179.068 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.555 ' N ' ' O ' ' A' ' 50' ' ' ASP . 26.6 t-20 37.63 59.8 1.21 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.498 -0.751 . . . . 0.0 109.928 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.568 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . . . -107.68 134.98 49.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.958 . . . . 0.0 109.798 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.19 -59.33 5.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.276 -0.89 . . . . 0.0 109.22 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.43 ' C ' HG13 ' A' ' 56' ' ' ILE . 3.1 p 178.51 -48.82 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.35 -0.844 . . . . 0.0 109.32 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.588 HG22 ' O ' ' A' ' 56' ' ' ILE . 3.3 mt -137.35 5.14 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 O-C-N 121.175 -0.953 . . . . 0.0 109.345 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 61' ' ' ARG . 0.8 OUTLIER -100.32 -54.24 2.91 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.162 -0.962 . . . . 0.0 110.031 -179.249 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.568 ' HB3' ' HA ' ' A' ' 53' ' ' ALA . . . -80.38 -61.86 1.85 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.325 -0.859 . . . . 0.0 109.959 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.439 ' H ' ' HB1' ' A' ' 53' ' ' ALA . . . -52.08 -37.78 55.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 109.791 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.529 ' CE ' HG23 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -75.91 -41.15 52.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.152 -0.967 . . . . 0.0 110.032 -179.638 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 57' ' ' GLU . 16.8 mtp180 -74.65 -7.36 52.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.105 -0.997 . . . . 0.0 109.534 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.85 ' CE ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -83.71 -54.85 4.62 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.275 -0.891 . . . . 0.0 109.38 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.85 ' CG2' HG22 ' A' ' 40' ' ' VAL . 10.8 mt -63.69 -36.35 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.625 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -64.49 -50.97 65.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.103 -0.998 . . . . 0.0 109.125 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.07 -12.44 30.13 Favored Glycine 0 N--CA 1.481 1.693 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 13.7 m -84.23 -51.55 6.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -1.147 . . . . 0.0 109.425 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.595 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -79.78 -5.03 54.53 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.254 -0.904 . . . . 0.0 109.638 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 1.5 ttp180 -87.77 -48.09 8.11 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.946 -1.096 . . . . 0.0 109.505 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.59 -49.21 16.89 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.353 -0.842 . . . . 0.0 110.459 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.488 ' HG3' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -100.92 -30.49 11.63 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.127 -0.983 . . . . 0.0 110.496 -178.553 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.488 ' N ' ' HG3' ' A' ' 70' ' ' MET . . . -89.31 -147.95 17.19 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.96 -1.114 . . . . 0.0 110.674 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.559 ' C ' HD12 ' A' ' 72' ' ' ILE . 1.1 pp -105.87 -170.26 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.517 -0.99 . . . . 0.0 109.995 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.3 t -84.77 111.15 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.145 -0.972 . . . . 0.0 109.676 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.9 HG13 HG13 ' A' ' 35' ' ' ILE . 3.0 t -80.19 153.46 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 0.0 109.378 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 35' ' ' ILE . 14.8 pt-20 -113.63 -176.17 2.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.899 . . . . 0.0 109.458 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.6 t70 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.464 179.983 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.1 t -115.14 165.96 12.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -0.931 . . . . 0.0 109.421 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.573 ' CG ' ' O ' ' A' ' 3' ' ' PHE . 1.0 OUTLIER -61.46 119.34 8.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.956 . . . . 0.0 109.787 -179.841 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.05 17.83 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.168 -0.957 . . . . 0.0 109.464 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.9 t -165.45 27.85 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 0.0 109.325 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.19 124.12 25.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.349 -0.845 . . . . 0.0 109.959 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.34 135.67 21.71 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.287 -0.883 . . . . 0.0 109.417 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 36.2 Cg_endo -79.76 156.48 24.23 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.412 2.075 . . . . 0.0 109.972 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.445 ' HD2' ' HB ' ' A' ' 12' ' ' VAL . 35.5 Cg_endo -77.4 -170.27 0.9 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.557 2.172 . . . . 0.0 110.543 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -70.66 -68.63 0.42 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.208 -0.932 . . . . 0.0 109.862 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -37.29 -45.03 0.63 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.507 -0.746 . . . . 0.0 110.683 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.445 ' HB ' ' HD2' ' A' ' 9' ' ' PRO . 49.0 t -65.96 -47.32 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.101 -1.0 . . . . 0.0 109.815 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.454 ' HA ' HD23 ' A' ' 13' ' ' LEU . 19.8 mt -57.9 -63.04 1.39 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.669 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.454 HD21 ' HE2' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -44.39 -30.68 0.88 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.263 -0.898 . . . . 0.0 109.744 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 12' ' ' VAL . 10.6 tttt -69.52 -46.45 66.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.73 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.1 9.89 9.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.634 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.06 -23.03 31.01 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.183 -0.948 . . . . 0.0 109.478 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.65 -50.82 10.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.942 . . . . 0.0 109.386 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.43 64.58 0.45 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.4 mt -62.29 94.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.21 -1.171 . . . . 0.0 109.522 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -80.36 131.53 35.64 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.262 -0.899 . . . . 0.0 109.379 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.34 133.39 35.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.194 -0.941 . . . . 0.0 109.621 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.03 67.89 0.01 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.478 ' OG ' ' N ' ' A' ' 25' ' ' GLY . 0.8 OUTLIER -87.21 176.34 7.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -1.142 . . . . 0.0 109.593 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.478 ' N ' ' OG ' ' A' ' 24' ' ' SER . . . 152.85 40.03 0.02 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 0.7 OUTLIER 175.6 104.49 0.09 OUTLIER Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 121.589 -0.948 . . . . 0.0 108.721 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -76.82 105.57 2.1 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.351 2.034 . . . . 0.0 110.64 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -101.12 -161.21 0.84 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.38 -0.825 . . . . 0.0 109.411 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.48 -93.13 0.45 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.219 -0.926 . . . . 0.0 109.425 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -77.06 108.42 10.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -0.869 . . . . 0.0 109.521 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.96 83.87 5.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.436 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.29 144.39 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.703 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -161.45 85.49 0.65 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.327 -0.858 . . . . 0.0 109.301 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.01 162.29 14.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 109.616 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.909 HD12 ' O ' ' A' ' 36' ' ' LYS . 1.2 pp -136.92 172.9 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -0.844 . . . . 0.0 109.517 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.909 ' O ' HD12 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -86.31 173.95 9.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.747 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -88.34 15.21 8.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.438 -0.789 . . . . 0.0 109.607 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.433 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 6.2 t70 -50.09 -39.95 44.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.599 -0.688 . . . . 0.0 110.194 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.483 ' HE3' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -71.9 -31.25 66.22 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.178 -0.951 . . . . 0.0 110.594 -179.177 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 1.012 HG22 HG22 ' A' ' 63' ' ' ILE . 47.4 t -65.04 -29.1 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.976 -1.077 . . . . 0.0 110.056 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.46 ' NH2' ' HB2' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -82.78 -30.89 28.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.114 -0.991 . . . . 0.0 109.973 -179.524 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 38' ' ' ASP . 6.7 mm-40 -76.26 -58.24 3.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.954 . . . . 0.0 109.819 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.3 mt -61.26 -55.11 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 110.273 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.603 ' HB2' HD12 ' A' ' 63' ' ' ILE . . . -47.25 -50.73 20.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.225 -0.922 . . . . 0.0 110.504 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -71.64 -24.63 61.89 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.044 -1.035 . . . . 0.0 110.368 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 mt -80.38 -11.68 59.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.004 -1.06 . . . . 0.0 109.627 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.48 39.99 1.89 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.265 -0.897 . . . . 0.0 109.274 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.569 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -50.5 -53.21 48.08 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.178 -0.951 . . . . 0.0 109.218 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.569 ' HD3' ' CB ' ' A' ' 48' ' ' MET . 36.8 Cg_endo -80.99 41.54 1.17 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.612 2.208 . . . . 0.0 110.404 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.44 ' HB3' HD23 ' A' ' 51' ' ' LEU . 33.8 t0 -111.13 -14.55 13.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.097 -1.002 . . . . 0.0 109.819 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -127.63 -99.24 0.37 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.13 -0.981 . . . . 0.0 109.591 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 57.0 t30 177.78 34.56 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.187 -0.946 . . . . 0.0 109.454 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.428 ' HB1' ' HB3' ' A' ' 58' ' ' ALA . . . -55.74 164.45 1.11 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.23 -22.38 66.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.267 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.465 ' O ' ' SD ' ' A' ' 48' ' ' MET . 0.1 OUTLIER -172.34 -50.19 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.286 -0.884 . . . . 0.0 108.937 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.439 HG23 ' N ' ' A' ' 57' ' ' GLU . 1.8 tt -174.9 -34.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.439 ' N ' HG23 ' A' ' 56' ' ' ILE . 15.9 tt0 -57.85 -66.1 0.53 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.533 -0.73 . . . . 0.0 109.805 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 57' ' ' GLU . . . -42.63 -36.65 1.46 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.354 -0.841 . . . . 0.0 109.751 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.13 -47.95 75.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.135 -0.978 . . . . 0.0 109.772 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.7 -38.02 83.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.989 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.439 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 35.7 mtp180 -74.0 -18.26 60.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 0.0 109.769 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.75 -39.77 30.29 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.125 -0.984 . . . . 0.0 109.672 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.012 HG22 HG22 ' A' ' 40' ' ' VAL . 7.4 mt -65.46 -42.39 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.143 -0.973 . . . . 0.0 109.874 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.495 ' CD ' ' N ' ' A' ' 65' ' ' GLY . 3.0 pp20? -63.35 -47.09 83.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.996 -1.065 . . . . 0.0 109.384 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.495 ' N ' ' CD ' ' A' ' 64' ' ' GLU . . . -65.4 -11.09 51.61 Favored Glycine 0 N--CA 1.478 1.485 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 70' ' ' MET . 86.2 m -81.57 -44.62 17.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.388 -1.066 . . . . 0.0 109.517 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.547 ' HB3' HG21 ' A' ' 74' ' ' VAL . . . -82.35 -16.09 50.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 108.777 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -40.78 65.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.459 -0.775 . . . . 0.0 109.38 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.81 -31.3 14.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.13 -0.981 . . . . 0.0 109.87 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -53.99 -72.95 0.05 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.211 -0.931 . . . . 0.0 109.19 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 72' ' ' ILE . . . -162.48 -87.74 0.07 OUTLIER Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.495 HD13 ' C ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -39.56 152.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.642 -0.916 . . . . 0.0 110.389 -179.526 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.64 135.52 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.547 HG21 ' HB3' ' A' ' 67' ' ' ALA . 2.1 t -108.63 155.39 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.982 -1.074 . . . . 0.0 110.176 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -110.35 -171.37 1.82 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.396 -0.815 . . . . 0.0 109.123 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.9 t70 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.637 -179.928 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.454 ' HG3' ' N ' ' A' ' 2' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.504 ' C ' ' CG ' ' A' ' 3' ' ' PHE . 60.2 p -95.49 85.81 4.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.438 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.529 ' O ' ' CB ' ' A' ' 4' ' ' ILE . 0.8 OUTLIER 64.71 113.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.924 . . . . 0.0 109.132 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.529 ' CB ' ' O ' ' A' ' 3' ' ' PHE . 0.5 OUTLIER 80.46 133.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.455 -0.778 . . . . 0.0 109.176 -179.821 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.0 m -86.17 -20.5 28.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.906 . . . . 0.0 109.536 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.415 ' O ' ' CB ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -68.18 169.28 10.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.181 -0.949 . . . . 0.0 109.351 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.472 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 0.2 OUTLIER 70.5 63.69 0.47 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.209 -0.932 . . . . 0.0 109.713 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 7' ' ' THR . 35.2 Cg_endo -77.7 148.12 25.4 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.568 2.179 . . . . 0.0 110.48 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.553 ' HG2' ' CG2' ' A' ' 12' ' ' VAL . 35.8 Cg_endo -77.52 147.76 25.59 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.73 2.286 . . . . 0.0 110.37 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.517 ' HA ' HD12 ' A' ' 13' ' ' LEU . . . -52.52 -61.31 2.36 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.294 -0.879 . . . . 0.0 110.129 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -36.4 -40.73 0.25 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.619 -0.676 . . . . 0.0 110.49 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.553 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 72.8 t -74.94 -43.01 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.09 -1.006 . . . . 0.0 109.465 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 10' ' ' ALA . 63.0 mt -56.04 -66.74 0.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.994 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.596 HD13 ' HB2' ' A' ' 67' ' ' ALA . 1.8 pp -57.74 -28.18 63.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.176 -0.953 . . . . 0.0 109.658 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.488 ' N ' ' HG ' ' A' ' 14' ' ' LEU . 57.1 tttt -56.29 -50.81 70.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.546 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -25.54 65.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.686 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.423 ' HB1' ' HE3' ' A' ' 39' ' ' LYS . . . -74.44 -8.84 57.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.201 -0.937 . . . . 0.0 109.58 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.547 ' HB1' HG21 ' A' ' 72' ' ' ILE . . . -93.54 -36.54 12.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.61 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.65 51.61 19.61 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 20' ' ' ILE . 35.0 mt -60.97 -22.74 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.29 -1.123 . . . . 0.0 109.823 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -82.05 121.87 27.1 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.318 -0.864 . . . . 0.0 109.413 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 77.6 p -125.75 179.1 5.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.131 -0.98 . . . . 0.0 109.61 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.38 -105.7 0.78 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 t -112.58 142.68 44.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -1.148 . . . . 0.0 109.378 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 26' ' ' GLU . . . 101.77 170.39 27.64 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 25' ' ' GLY . 61.6 tt0 45.2 85.79 0.16 Allowed Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.225 -1.162 . . . . 0.0 109.073 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.62 163.2 32.09 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.562 2.174 . . . . 0.0 110.423 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -59.85 106.14 0.46 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.309 -0.869 . . . . 0.0 109.465 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -73.23 -166.51 0.33 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.241 -0.912 . . . . 0.0 109.766 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.1 -48.51 17.56 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.272 -0.892 . . . . 0.0 109.709 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.42 129.93 45.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 109.522 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.569 ' CG1' ' CG2' ' A' ' 73' ' ' VAL . 6.3 p -48.74 161.47 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.232 -0.918 . . . . 0.0 109.503 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . -66.58 124.09 21.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.477 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.866 HG22 ' O ' ' A' ' 73' ' ' VAL . 0.9 OUTLIER -101.83 140.04 36.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.419 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 pt -91.69 171.79 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.233 -0.917 . . . . 0.0 109.441 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 mtmt -89.75 151.49 21.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 109.357 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.16 -16.58 64.1 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.206 -0.933 . . . . 0.0 109.303 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -45.69 -41.64 10.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.365 -0.835 . . . . 0.0 109.608 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.471 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.7 OUTLIER -59.76 -64.19 1.04 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 109.367 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.893 HG22 ' CG2' ' A' ' 63' ' ' ILE . 56.1 t -45.74 -23.64 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 0.0 109.973 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -42.79 32.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.118 -0.989 . . . . 0.0 110.162 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -84.6 -6.57 59.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.11 -0.994 . . . . 0.0 110.026 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 39' ' ' LYS . 7.6 mt -93.51 -39.68 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.061 -1.024 . . . . 0.0 109.898 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 48' ' ' MET . . . -77.97 -39.68 41.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.148 -0.97 . . . . 0.0 109.525 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -53.87 -20.59 6.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.272 -0.892 . . . . 0.0 109.77 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 46' ' ' LEU . 9.3 mt -96.01 -30.89 13.33 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.141 -0.975 . . . . 0.0 109.653 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 50' ' ' ASP . 33.3 mmtt -131.39 43.51 3.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.913 . . . . 0.0 109.264 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.565 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -64.03 -52.54 55.32 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.387 -0.821 . . . . 0.0 110.01 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 48' ' ' MET . 35.5 Cg_endo -78.21 -3.03 13.06 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.41 2.074 . . . . 0.0 110.575 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.492 ' C ' HD23 ' A' ' 51' ' ' LEU . 18.3 t70 -62.26 -13.32 26.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.348 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.772 ' N ' HD23 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -139.84 27.81 2.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.397 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 51' ' ' LEU . 20.6 t30 42.33 74.58 0.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.344 -0.848 . . . . 0.0 109.622 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.852 ' CB ' ' HB2' ' A' ' 59' ' ' ALA . . . -77.29 155.33 32.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 0.0 109.504 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -45.49 -35.31 3.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.467 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 m 174.87 -44.67 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.253 -0.904 . . . . 0.0 109.107 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.404 HG23 ' N ' ' A' ' 57' ' ' GLU . 1.5 tt -173.5 -33.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.278 -0.889 . . . . 0.0 109.011 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 58' ' ' ALA . 1.2 tt0 -75.23 -66.41 0.77 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.409 -0.807 . . . . 0.0 110.195 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 57' ' ' GLU . . . -42.49 -40.53 2.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.254 -0.904 . . . . 0.0 110.205 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.852 ' HB2' ' CB ' ' A' ' 53' ' ' ALA . . . -60.41 -47.87 84.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.958 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.6 mtm -59.2 -46.7 87.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 110.186 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.6 mtp-105 -66.58 -19.18 65.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 110.006 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -68.36 -50.84 50.34 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.083 -1.011 . . . . 0.0 109.341 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.893 ' CG2' HG22 ' A' ' 40' ' ' VAL . 6.0 mt -59.73 -35.47 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.219 -0.926 . . . . 0.0 109.607 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.91 -52.3 64.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.086 -1.009 . . . . 0.0 109.061 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -55.59 -16.82 11.88 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 75.7 m -82.29 -52.29 7.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.359 -1.083 . . . . 0.0 109.351 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.596 ' HB2' HD13 ' A' ' 14' ' ' LEU . . . -75.71 -3.73 36.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.308 -0.87 . . . . 0.0 109.322 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -86.87 -48.68 7.98 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.211 -0.931 . . . . 0.0 109.299 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.8 p -81.43 -33.2 32.27 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.265 -0.897 . . . . 0.0 109.65 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -70.5 0.09 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.184 -0.948 . . . . 0.0 109.657 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -160.12 -74.29 0.02 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.547 HG21 ' HB1' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -66.74 -174.98 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -1.16 . . . . 0.0 109.939 -179.632 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.866 ' O ' HG22 ' A' ' 34' ' ' THR . 0.1 OUTLIER -132.17 132.4 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.34 -0.85 . . . . 0.0 109.22 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.528 ' CG2' ' HB3' ' A' ' 67' ' ' ALA . 27.7 t -81.64 157.48 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.632 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.411 ' N ' HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -115.08 95.06 5.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 109.449 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.518 -179.973 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.294 0.569 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.09 32.25 6.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 109.572 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -111.58 95.57 5.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 109.637 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.695 HG23 ' O ' ' A' ' 4' ' ' ILE . 0.6 OUTLIER -97.12 115.49 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.917 . . . . 0.0 109.332 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.443 HG22 ' H ' ' A' ' 5' ' ' THR . 0.6 OUTLIER -69.71 88.03 0.52 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.517 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.22 74.03 1.16 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.253 -0.904 . . . . 0.0 109.421 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.559 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 53.83 56.39 13.08 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.038 -1.039 . . . . 0.0 109.459 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.637 ' N ' ' CD ' ' A' ' 9' ' ' PRO . 26.0 Cg_endo -69.27 -33.78 17.68 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.1 1.866 . . . . 0.0 111.981 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 8' ' ' PRO . 32.9 Cg_endo -74.29 -41.3 0.93 Allowed 'Trans proline' 0 C--O 1.207 -1.07 0 C-N-CA 121.363 1.375 . . . . 0.0 109.95 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.557 ' C ' ' O ' ' A' ' 9' ' ' PRO . . . -17.63 -66.55 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.191 0.519 . . . . 0.0 111.502 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.66 -51.06 70.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.069 -1.019 . . . . 0.0 109.551 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 9' ' ' PRO . 42.4 t -45.81 -53.36 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.335 -0.853 . . . . 0.0 109.783 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.572 HD23 HG23 ' A' ' 43' ' ' ILE . 8.9 mp -47.17 -70.56 0.09 Allowed 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.331 -0.855 . . . . 0.0 110.15 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.484 ' HA ' HD23 ' A' ' 14' ' ' LEU . 5.4 mt -55.94 -17.23 6.1 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.289 -0.882 . . . . 0.0 110.18 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.83 -38.07 67.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.096 -1.002 . . . . 0.0 109.237 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -79.09 -22.29 45.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.266 -0.896 . . . . 0.0 109.229 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.8 -66.59 0.38 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.219 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.5 -87.53 0.08 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.272 -0.892 . . . . 0.0 109.209 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.08 43.58 0.04 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.0 mm -50.51 -72.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.214 -1.168 . . . . 0.0 109.348 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.461 ' O ' ' OE1' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -80.74 123.66 28.39 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.63 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.3 m -107.89 -174.18 2.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.212 -0.93 . . . . 0.0 109.787 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' ' 24' ' ' SER . . . -67.93 -8.76 54.69 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 2.6 m 73.28 172.51 0.3 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -1.139 . . . . 0.0 109.507 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.511 ' O ' ' HD3' ' A' ' 27' ' ' PRO . . . 90.06 -90.19 1.59 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -112.14 91.83 16.96 Favored Pre-proline 0 C--N 1.306 -1.297 0 O-C-N 121.257 -1.143 . . . . 0.0 109.774 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 25' ' ' GLY . 36.6 Cg_endo -78.4 122.73 5.71 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.583 2.189 . . . . 0.0 110.413 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.572 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 30.4 t-20 -56.5 120.05 7.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.187 -0.946 . . . . 0.0 109.363 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.4 ' O ' ' HB3' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -56.15 99.74 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.282 -0.886 . . . . 0.0 109.704 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.572 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 1.6 p30 -178.66 145.31 0.3 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.866 . . . . 0.0 109.408 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.51 -171.93 2.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.153 -0.967 . . . . 0.0 109.647 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 m -65.26 174.21 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.34 -0.85 . . . . 0.0 110.145 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -156.82 171.28 20.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.453 -0.779 . . . . 0.0 109.394 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.79 133.22 34.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 109.575 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.484 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 4.1 pt -107.93 170.88 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 0.0 109.386 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -79.83 147.27 31.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.768 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.18 -6.37 33.92 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.288 -0.882 . . . . 0.0 109.699 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -41.98 -39.88 2.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.33 -0.857 . . . . 0.0 109.945 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -58.25 7.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.148 -0.97 . . . . 0.0 109.693 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.99 HG13 ' HB ' ' A' ' 63' ' ' ILE . 86.1 t -46.73 -27.77 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.303 -0.873 . . . . 0.0 110.024 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -70.92 -46.59 62.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.105 -0.997 . . . . 0.0 109.791 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 43' ' ' ILE . 2.0 tt0 -78.26 -65.4 0.98 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.155 -0.966 . . . . 0.0 109.791 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.572 HG23 HD23 ' A' ' 13' ' ' LEU . 10.8 mt -43.12 -44.8 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.927 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.733 ' HB1' ' HB1' ' A' ' 59' ' ' ALA . . . -64.86 -43.77 91.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.164 -0.96 . . . . 0.0 109.717 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -58.08 -16.49 13.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 109.5 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.42 23.88 2.42 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.29 -0.881 . . . . 0.0 109.499 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.512 ' HD3' ' CB ' ' A' ' 50' ' ' ASP . 0.1 OUTLIER -144.0 18.02 1.77 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.0 109.413 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.553 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -43.73 -54.14 11.18 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.278 -0.889 . . . . 0.0 109.648 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.553 ' HD3' ' CB ' ' A' ' 48' ' ' MET . 36.5 Cg_endo -78.61 73.17 6.03 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.411 2.074 . . . . 0.0 110.438 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.512 ' CB ' ' HD3' ' A' ' 47' ' ' LYS . 36.8 t0 -162.4 -67.89 0.05 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.113 -0.992 . . . . 0.0 109.897 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -114.18 38.7 2.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.139 -0.976 . . . . 0.0 109.868 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 51' ' ' LEU . 4.2 p-10 40.21 28.15 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.479 -0.763 . . . . 0.0 109.916 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.678 ' HB1' ' HB2' ' A' ' 59' ' ' ALA . . . -51.81 124.6 12.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.19 -0.944 . . . . 0.0 109.531 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.458 ' O ' ' CB ' ' A' ' 55' ' ' SER . . . -45.11 -57.92 3.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.939 . . . . 0.0 109.205 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 0.5 OUTLIER 166.32 -45.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.406 -0.809 . . . . 0.0 108.859 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.671 HG22 ' O ' ' A' ' 56' ' ' ILE . 82.5 mt -140.05 7.8 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -104.92 -67.11 0.93 Allowed 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.259 -0.9 . . . . 0.0 109.45 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.09 -37.06 58.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.501 -0.749 . . . . 0.0 109.879 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.733 ' HB1' ' HB1' ' A' ' 44' ' ' ALA . . . -71.08 -31.66 68.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.128 -0.982 . . . . 0.0 109.383 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.498 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -78.64 -39.79 36.05 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.233 -0.917 . . . . 0.0 109.516 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -20.32 62.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.374 -0.829 . . . . 0.0 109.767 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.2 -60.82 2.18 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.179 -0.951 . . . . 0.0 110.075 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.99 ' HB ' HG13 ' A' ' 40' ' ' VAL . 14.9 mt -63.75 -42.75 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.191 -0.943 . . . . 0.0 109.967 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.684 ' HG2' HG21 ' A' ' 74' ' ' VAL . 24.2 tt0 -64.06 -48.52 75.91 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.092 -1.005 . . . . 0.0 109.302 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -67.25 -7.22 43.99 Favored Glycine 0 N--CA 1.478 1.447 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 8.5 m -87.26 -49.53 7.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -1.13 . . . . 0.0 109.46 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -71.49 -36.73 71.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.165 -0.96 . . . . 0.0 109.373 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -64.61 -59.2 4.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.403 -0.811 . . . . 0.0 109.907 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.71 -51.84 68.07 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.244 -0.91 . . . . 0.0 110.045 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.0 -68.88 0.15 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.217 -0.927 . . . . 0.0 109.384 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 72' ' ' ILE . . . -161.96 -88.02 0.07 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.556 HD13 ' C ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -36.39 152.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.884 -0.774 . . . . 0.0 110.279 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.471 ' O ' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -112.88 164.76 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.391 -0.818 . . . . 0.0 108.881 179.527 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.684 HG21 ' HG2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -111.82 -174.55 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.13 -0.981 . . . . 0.0 109.695 -179.583 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 35' ' ' ILE . 0.4 OUTLIER -143.1 151.0 40.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.907 . . . . 0.0 109.267 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.7 t70 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.443 -179.951 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mtt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.9 t -100.41 -22.46 15.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.875 . . . . 0.0 109.573 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.553 ' CG ' ' O ' ' A' ' 3' ' ' PHE . 8.0 p90 -45.47 118.73 1.85 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 0.0 109.631 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.8 tp -54.05 135.05 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.926 . . . . 0.0 109.359 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -64.81 95.74 0.16 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.26 -0.9 . . . . 0.0 109.492 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.467 ' O ' ' O ' ' A' ' 5' ' ' THR . 0.1 OUTLIER 60.78 132.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.296 -0.878 . . . . 0.0 109.493 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.505 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -49.56 173.72 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.31 -0.869 . . . . 0.0 109.669 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' A' ' 7' ' ' THR . 35.7 Cg_endo -78.48 173.72 13.35 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.669 2.246 . . . . 0.0 110.562 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.469 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 35.9 Cg_endo -78.12 115.44 3.75 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.728 2.286 . . . . 0.0 110.398 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.609 ' HA ' HD12 ' A' ' 13' ' ' LEU . . . -47.52 -48.73 27.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.787 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -41.51 -50.58 3.97 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.387 -0.821 . . . . 0.0 109.652 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.408 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 91.5 t -68.34 -36.53 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.69 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.609 HD12 ' HA ' ' A' ' 10' ' ' ALA . 38.4 mt -53.88 -65.85 0.5 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.939 . . . . 0.0 109.57 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 15' ' ' LYS . 1.1 mt -43.18 -48.28 6.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -0.841 . . . . 0.0 109.76 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 14' ' ' LEU . 7.7 ttpt -42.85 -55.18 3.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 109.666 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.33 -43.72 98.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.206 -0.934 . . . . 0.0 109.564 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.592 ' HB1' ' HD3' ' A' ' 39' ' ' LYS . . . -46.63 -35.66 6.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.226 -0.921 . . . . 0.0 109.583 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.63 -66.5 0.86 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.184 -0.947 . . . . 0.0 109.422 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 20' ' ' ILE . . . 114.02 31.55 2.24 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.441 ' C ' ' O ' ' A' ' 19' ' ' GLY . 20.1 mt -42.5 100.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.252 -1.146 . . . . 0.0 109.558 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -91.65 -0.44 57.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.333 -0.854 . . . . 0.0 109.608 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 m -148.66 134.08 18.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.393 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -116.43 -15.36 7.06 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.73 177.24 4.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -1.12 . . . . 0.0 109.545 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 26' ' ' GLU . . . 141.47 -155.94 25.49 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.464 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 25.4 tp10 179.47 65.16 0.13 Allowed Pre-proline 0 N--CA 1.485 1.314 0 O-C-N 121.235 -1.156 . . . . 0.0 109.634 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.464 ' HD3' ' N ' ' A' ' 26' ' ' GLU . 35.2 Cg_endo -78.28 144.67 20.83 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.679 2.252 . . . . 0.0 110.332 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -58.79 -23.55 60.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.153 -0.967 . . . . 0.0 109.515 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' LYS . 6.5 ptp180 -90.43 27.07 1.78 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.214 -0.929 . . . . 0.0 109.881 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.46 ' O ' ' HG2' ' A' ' 27' ' ' PRO . 17.3 t-20 42.2 -93.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.277 -0.889 . . . . 0.0 110.046 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -141.6 105.87 4.81 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.133 -0.979 . . . . 0.0 109.402 -179.662 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.2 t -140.92 109.35 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.162 -0.961 . . . . 0.0 109.524 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -171.29 128.23 0.69 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 0.0 109.296 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.524 HG22 ' CG1' ' A' ' 73' ' ' VAL . 1.8 p -112.96 142.39 45.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 109.738 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.45 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 2.8 pt -98.31 -170.13 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.333 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.466 ' HE2' ' OE2' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -95.1 167.4 11.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.898 . . . . 0.0 109.712 -179.791 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 1.051 ' O ' HG12 ' A' ' 40' ' ' VAL . 5.5 mtm180 -97.29 -19.25 18.67 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.236 -0.915 . . . . 0.0 109.681 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.466 ' C ' ' O ' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -37.81 -34.9 0.12 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.67 -0.644 . . . . 0.0 109.929 -179.753 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.592 ' HD3' ' HB1' ' A' ' 17' ' ' ALA . 8.5 mttm -72.93 -48.87 33.23 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.344 -0.848 . . . . 0.0 109.623 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 1.051 HG12 ' O ' ' A' ' 37' ' ' ARG . 9.8 p -51.29 -20.07 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 110.174 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -85.94 -62.39 1.53 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.085 -1.01 . . . . 0.0 109.778 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 16.6 pt-20 -50.19 -27.29 5.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.248 -0.908 . . . . 0.0 110.024 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.677 HG22 ' HB2' ' A' ' 47' ' ' LYS . 20.9 mt -96.75 -34.54 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.061 -1.025 . . . . 0.0 109.635 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.829 ' HB2' ' O ' ' A' ' 40' ' ' VAL . . . -47.43 -33.58 6.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.324 -0.86 . . . . 0.0 109.415 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.467 ' HA ' ' SD ' ' A' ' 48' ' ' MET . 2.6 mt-10 -88.46 -35.85 16.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.848 . . . . 0.0 109.268 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.4 mt -91.78 25.11 2.85 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.346 -0.846 . . . . 0.0 109.412 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.677 ' HB2' HG22 ' A' ' 43' ' ' ILE . 14.2 tppt? -143.35 21.47 1.88 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.135 -0.978 . . . . 0.0 109.841 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.467 ' SD ' ' HA ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -114.32 78.49 4.67 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.024 -1.047 . . . . 0.0 109.733 179.775 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 47' ' ' LYS . 36.1 Cg_endo -78.53 -44.55 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.594 2.196 . . . . 0.0 110.126 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -120.36 1.62 10.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.41 -0.807 . . . . 0.0 109.343 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.544 ' CG ' ' O ' ' A' ' 51' ' ' LEU . 0.7 OUTLIER -116.39 64.99 0.71 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.253 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 53' ' ' ALA . 42.3 t-20 -41.16 -28.69 0.1 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.867 . . . . 0.0 109.673 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.658 ' HB1' ' HB3' ' A' ' 58' ' ' ALA . . . 60.66 142.15 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.457 -0.777 . . . . 0.0 109.556 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -46.51 -61.86 1.62 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.282 -0.886 . . . . 0.0 109.315 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.455 ' O ' HG12 ' A' ' 56' ' ' ILE . 41.1 p -152.19 -49.96 0.11 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.245 -0.91 . . . . 0.0 109.625 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.483 HD13 ' HA ' ' A' ' 56' ' ' ILE . 8.5 mm -154.48 -33.08 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.253 -0.904 . . . . 0.0 109.202 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.74 -59.39 5.29 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.186 -0.946 . . . . 0.0 110.233 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.658 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -50.16 -58.39 5.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.337 -0.852 . . . . 0.0 110.126 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.97 -21.0 63.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.195 -0.941 . . . . 0.0 109.994 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.449 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -77.4 -33.06 55.14 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.171 -0.956 . . . . 0.0 109.83 -179.673 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.14 -13.32 55.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.63 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -80.81 -57.24 3.64 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.249 -0.907 . . . . 0.0 109.956 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.824 ' CG2' HG23 ' A' ' 40' ' ' VAL . 6.5 mt -63.34 -42.17 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.343 -0.848 . . . . 0.0 109.753 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -63.88 -48.39 76.89 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.975 -1.078 . . . . 0.0 108.93 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.39 -12.88 34.28 Favored Glycine 0 N--CA 1.48 1.621 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.491 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 54.2 m -83.78 -51.68 7.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -1.131 . . . . 0.0 109.017 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -68.56 -17.92 64.24 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.328 -0.858 . . . . 0.0 109.193 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.02 -46.59 34.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.339 -0.851 . . . . 0.0 109.682 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.26 -6.14 53.71 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.166 -0.959 . . . . 0.0 109.802 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -99.23 -49.71 4.38 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.078 -1.014 . . . . 0.0 110.361 -179.45 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.1 -134.58 2.21 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.356 -1.402 . . . . 0.0 111.073 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.526 ' C ' HD12 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -52.81 -171.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.589 -0.948 . . . . 0.0 111.114 -178.785 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.729 HG22 ' H ' ' A' ' 74' ' ' VAL . 3.5 p -110.56 -175.89 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.729 ' H ' HG22 ' A' ' 73' ' ' VAL . 2.0 t -130.68 156.85 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.991 -1.068 . . . . 0.0 109.559 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.466 ' OE2' ' HE2' ' A' ' 36' ' ' LYS . 16.0 pt-20 -131.05 145.33 51.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 0.0 109.505 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 43.9 t0 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.393 -179.996 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.4 m 64.67 39.79 6.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.448 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -162.12 141.45 9.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 109.568 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.738 HD13 ' C ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -117.57 -14.55 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 109.28 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.52 32.82 3.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.282 -0.886 . . . . 0.0 109.313 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.425 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -96.62 151.01 20.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.308 -0.87 . . . . 0.0 109.639 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.482 ' C ' ' HD2' ' A' ' 9' ' ' PRO . 6.7 m -132.44 67.24 78.41 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.886 . . . . 0.0 109.379 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.627 ' N ' ' CD ' ' A' ' 9' ' ' PRO . 30.2 Cg_endo -72.74 -30.36 11.72 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.832 2.355 . . . . 0.0 113.929 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 8' ' ' PRO . 34.4 Cg_endo -75.02 122.8 7.43 Favored 'Trans proline' 0 C--N 1.321 -0.869 0 C-N-CA 121.143 1.229 . . . . 0.0 110.501 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.482 ' HA ' HD12 ' A' ' 13' ' ' LEU . . . -62.96 -41.75 99.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.232 -0.917 . . . . 0.0 109.826 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -36.85 -50.04 0.83 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.55 -0.719 . . . . 0.0 110.427 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.455 ' H ' HG22 ' A' ' 12' ' ' VAL . 2.4 m -72.02 -38.89 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.037 -1.039 . . . . 0.0 109.444 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 10' ' ' ALA . 65.1 mt -54.39 -66.81 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.403 -0.81 . . . . 0.0 109.934 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 18' ' ' ALA . 3.5 pp -52.76 -30.19 31.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 110.294 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.455 ' N ' HD12 ' A' ' 14' ' ' LEU . 19.4 tttt -53.11 -62.38 1.69 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.035 -1.041 . . . . 0.0 110.022 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -69.1 -28.76 66.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.055 -1.028 . . . . 0.0 109.666 -179.732 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.616 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -89.97 5.86 44.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.954 . . . . 0.0 109.701 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.681 ' O ' HD13 ' A' ' 35' ' ' ILE . . . 169.9 62.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.099 -1.0 . . . . 0.0 109.643 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.85 -82.66 0.05 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.1 mm -51.08 -89.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.318 -1.107 . . . . 0.0 109.542 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -71.58 132.24 44.38 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.148 -0.97 . . . . 0.0 109.45 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.9 m -59.48 -49.04 79.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.19 -0.944 . . . . 0.0 109.68 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.15 -77.84 0.35 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 m -44.65 -85.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.209 -1.171 . . . . 0.0 109.331 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 26' ' ' GLU . . . -165.63 99.94 0.17 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 25' ' ' GLY . 23.3 tt0 -43.53 110.53 0.95 Allowed Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.208 -1.172 . . . . 0.0 109.411 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -75.47 168.53 24.31 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.24 1.96 . . . . 0.0 110.113 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -104.34 44.67 1.01 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 109.879 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 30' ' ' ASN . 0.3 OUTLIER -124.36 -160.92 0.96 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.324 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 29' ' ' ARG . 5.7 p30 -44.33 129.44 6.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.16 -0.962 . . . . 0.0 109.455 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.93 160.86 3.26 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.228 -0.92 . . . . 0.0 109.39 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 63.7 t -129.51 131.46 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.579 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.845 ' O ' HG12 ' A' ' 73' ' ' VAL . . . -115.8 51.88 0.92 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.192 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.643 HG22 ' CG1' ' A' ' 73' ' ' VAL . 11.9 p -142.72 164.37 30.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.561 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.681 HD13 ' O ' ' A' ' 18' ' ' ALA . 3.4 pt -150.88 167.03 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 109.522 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -79.71 131.52 35.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.139 -0.976 . . . . 0.0 109.355 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -74.17 -8.01 54.66 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.133 -0.98 . . . . 0.0 109.554 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 37' ' ' ARG . 48.6 t0 -42.78 -33.08 0.69 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.302 -0.874 . . . . 0.0 109.716 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.434 ' HD2' HD11 ' A' ' 43' ' ' ILE . 1.4 mmtt -71.87 -52.82 15.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 109.338 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.937 HG13 ' HB ' ' A' ' 63' ' ' ILE . 57.8 t -48.37 -23.43 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.393 -0.817 . . . . 0.0 109.681 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.81 -44.13 17.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 0.0 109.661 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.42 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 7.4 mm-40 -72.71 -13.55 61.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.222 -0.924 . . . . 0.0 109.849 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.434 HD11 ' HD2' ' A' ' 39' ' ' LYS . 8.0 mt -105.2 -18.5 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.104 -0.997 . . . . 0.0 109.47 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 48' ' ' MET . . . -82.31 -34.98 28.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 109.544 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.27 -22.08 35.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.445 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.421 ' HA ' HD23 ' A' ' 46' ' ' LEU . 4.8 mt -73.4 -44.8 57.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.9 . . . . 0.0 109.445 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -119.58 32.32 6.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.307 -0.87 . . . . 0.0 109.177 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.57 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -48.08 -51.29 49.73 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.384 -0.822 . . . . 0.0 110.007 -179.73 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 48' ' ' MET . 36.4 Cg_endo -80.68 57.62 6.61 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.657 2.238 . . . . 0.0 110.76 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -136.68 4.45 2.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.171 -0.956 . . . . 0.0 109.672 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.616 HD12 ' H ' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -141.71 -91.58 0.14 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.071 -1.018 . . . . 0.0 109.464 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.616 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.4 t30 -176.63 87.09 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.301 -0.875 . . . . 0.0 109.757 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.457 ' CB ' ' HB3' ' A' ' 58' ' ' ALA . . . -120.37 178.69 4.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -0.909 . . . . 0.0 109.303 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -128.99 -38.35 1.65 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.295 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.425 ' O ' HG12 ' A' ' 56' ' ' ILE . 13.6 m -127.61 -63.82 1.01 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.257 -0.902 . . . . 0.0 109.108 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -175.96 -31.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.385 -0.822 . . . . 0.0 108.8 179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.543 ' HA ' ' CG ' ' A' ' 60' ' ' MET . 1.1 tt0 -56.89 -47.94 79.34 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.321 -0.862 . . . . 0.0 109.883 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.457 ' HB3' ' CB ' ' A' ' 53' ' ' ALA . . . -51.63 -43.23 62.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.389 -0.819 . . . . 0.0 110.148 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.01 -61.49 1.76 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.069 -1.019 . . . . 0.0 110.08 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.543 ' CG ' ' HA ' ' A' ' 57' ' ' GLU . 1.7 ppp? -52.86 -19.55 2.61 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.197 -0.94 . . . . 0.0 109.961 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -83.72 -34.88 24.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.175 -0.953 . . . . 0.0 109.599 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -47.41 72.88 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.283 -0.885 . . . . 0.0 109.713 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.937 ' HB ' HG13 ' A' ' 40' ' ' VAL . 8.9 mt -62.99 -40.4 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.938 . . . . 0.0 109.881 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.05 -49.65 73.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.88 -1.137 . . . . 0.0 109.383 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.12 -13.64 28.64 Favored Glycine 0 N--CA 1.479 1.562 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.497 ' O ' ' HB2' ' A' ' 70' ' ' MET . 50.4 m -86.14 -47.42 9.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.389 -1.065 . . . . 0.0 109.918 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -70.21 -19.04 63.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 109.775 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.462 ' CG ' HG23 ' A' ' 73' ' ' VAL . 1.9 ttp180 -79.35 -58.8 3.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.237 -0.914 . . . . 0.0 109.814 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.03 -25.0 63.37 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.23 -0.919 . . . . 0.0 110.329 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.497 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -96.24 -21.86 17.6 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.997 -1.065 . . . . 0.0 110.741 -179.114 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -154.8 -141.97 3.35 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.27 -1.443 . . . . 0.0 110.751 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.587 ' N ' HD12 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -70.81 -174.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.568 -0.96 . . . . 0.0 110.308 -179.315 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.845 HG12 ' O ' ' A' ' 33' ' ' ALA . 1.4 p -90.45 -172.46 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.474 -0.766 . . . . 0.0 108.984 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.667 ' H ' HG22 ' A' ' 73' ' ' VAL . 84.3 t -132.76 135.17 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.079 -1.013 . . . . 0.0 109.729 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 35' ' ' ILE . 22.4 pt-20 -98.65 160.6 14.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 109.26 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 43.6 t0 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.986 -1.006 . . . . 0.0 109.495 -179.957 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.81 38.76 1.66 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 109.4 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -124.66 78.08 1.65 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.298 -0.876 . . . . 0.0 109.396 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.503 ' O ' ' N ' ' A' ' 6' ' ' LYS . 2.9 tp -51.49 -24.15 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.574 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.96 93.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.266 -0.896 . . . . 0.0 109.43 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -135.46 -173.53 3.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 109.471 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.9 m -99.75 115.5 65.54 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.908 . . . . 0.0 109.365 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.71 170.31 19.33 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.34 2.027 . . . . 0.0 110.357 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.441 ' HD2' ' HB ' ' A' ' 12' ' ' VAL . 36.0 Cg_endo -77.77 -162.62 0.18 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.582 2.188 . . . . 0.0 110.559 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -84.02 -68.09 0.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.194 -0.942 . . . . 0.0 109.656 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -40.18 -53.8 2.42 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.422 -0.799 . . . . 0.0 109.973 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.441 ' HB ' ' HD2' ' A' ' 9' ' ' PRO . 48.8 t -60.14 -43.04 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 109.616 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 13' ' ' LEU . 7.9 mt -51.46 -48.13 62.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.214 -0.929 . . . . 0.0 109.789 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.445 ' CD1' HG22 ' A' ' 66' ' ' THR . 8.5 mt -67.4 -27.28 66.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.622 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -69.8 -30.84 68.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.481 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -76.56 -48.3 19.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 0.0 109.489 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.71 37.5 0.96 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.906 . . . . 0.0 109.465 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.768 ' HB1' HG21 ' A' ' 72' ' ' ILE . . . -90.8 -53.24 4.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.427 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 21' ' ' GLU . . . 140.84 -18.49 2.76 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.3 mt -46.86 96.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.318 -1.107 . . . . 0.0 109.532 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.497 ' HG2' ' N ' ' A' ' 22' ' ' SER . 22.9 tt0 -141.97 149.5 40.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.393 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.497 ' N ' ' HG2' ' A' ' 21' ' ' GLU . 39.8 m -54.24 156.59 3.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 109.592 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.24 47.49 0.1 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.35 -159.99 0.63 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -1.139 . . . . 0.0 109.306 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 26' ' ' GLU . . . -179.01 153.63 12.75 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 25' ' ' GLY . 3.6 tt0 45.47 94.23 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.407 -1.055 . . . . 0.0 109.865 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.09 143.52 20.36 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.61 2.207 . . . . 0.0 110.302 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.53 -76.05 0.52 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.205 -0.934 . . . . 0.0 109.62 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.11 -168.09 1.42 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.485 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.2 p-10 -52.88 137.19 32.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.393 -0.817 . . . . 0.0 109.418 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.89 97.46 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.231 -0.918 . . . . 0.0 109.589 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.1 t -58.71 102.73 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.214 -0.929 . . . . 0.0 109.242 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -151.75 125.57 9.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.178 -0.951 . . . . 0.0 109.455 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.2 p -125.81 176.76 6.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.312 -0.867 . . . . 0.0 109.373 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.766 HD12 ' HE2' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -141.1 168.76 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.166 179.77 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.484 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 15.8 ttmt -85.64 171.06 11.96 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.222 -0.924 . . . . 0.0 109.702 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.458 ' HD3' ' OE1' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -72.51 -14.37 61.64 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.34 -0.85 . . . . 0.0 109.474 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 37' ' ' ARG . 4.6 t0 -41.71 -33.64 0.52 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.492 -0.755 . . . . 0.0 109.674 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.766 ' HE2' HD12 ' A' ' 35' ' ' ILE . 1.8 ttpt -69.24 -61.86 1.61 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.191 -0.943 . . . . 0.0 109.442 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.896 HG13 ' HB ' ' A' ' 63' ' ' ILE . 84.8 t -49.69 -20.58 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.885 . . . . 0.0 110.053 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -72.96 -51.34 18.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.023 -1.048 . . . . 0.0 110.369 -179.438 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.478 ' HG3' ' N ' ' A' ' 43' ' ' ILE . 16.8 pt-20 -73.78 -39.2 64.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.02 -1.05 . . . . 0.0 110.476 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.518 ' HB ' HD13 ' A' ' 63' ' ' ILE . 9.6 mt -73.05 -14.44 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.101 -0.999 . . . . 0.0 109.917 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 40' ' ' VAL . . . -92.88 -26.52 17.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.096 -1.002 . . . . 0.0 109.748 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 2.4 pt-20 -96.39 -2.64 45.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.12 -0.987 . . . . 0.0 109.664 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 43' ' ' ILE . 0.3 OUTLIER -73.34 -24.82 60.41 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.235 -0.915 . . . . 0.0 109.744 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.429 ' N ' ' HG ' ' A' ' 46' ' ' LEU . 5.2 ttmt -159.07 58.4 0.42 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.144 -0.972 . . . . 0.0 109.394 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.559 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 1.3 mtp -43.87 -52.87 14.01 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.416 -0.803 . . . . 0.0 110.349 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 48' ' ' MET . 34.0 Cg_endo -77.04 96.26 1.1 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.417 2.078 . . . . 0.0 110.591 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 24.4 t0 178.7 -40.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.366 -0.834 . . . . 0.0 109.38 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.443 ' O ' ' C ' ' A' ' 52' ' ' ASN . 0.5 OUTLIER -107.34 35.84 2.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 109.594 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER 40.56 76.45 0.07 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.459 -0.776 . . . . 0.0 109.755 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.75 139.98 33.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.23 -0.919 . . . . 0.0 109.353 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.94 -47.85 64.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 109.497 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.52 -52.56 0.09 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.245 -0.91 . . . . 0.0 108.851 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.7 tt -175.41 -31.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.303 -0.873 . . . . 0.0 109.242 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -60.2 -53.65 55.22 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.279 -0.888 . . . . 0.0 109.448 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.04 -53.22 44.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.427 -0.795 . . . . 0.0 109.842 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.62 -42.32 61.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.795 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.46 -38.22 90.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.19 -0.943 . . . . 0.0 110.121 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -76.1 -15.99 59.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 109.656 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.61 -59.95 2.57 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.229 -0.92 . . . . 0.0 109.586 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.896 ' HB ' HG13 ' A' ' 40' ' ' VAL . 24.1 mt -57.38 -35.26 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.248 -0.908 . . . . 0.0 109.987 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.458 ' OE1' ' HD3' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -62.29 -51.53 67.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.091 -1.006 . . . . 0.0 109.326 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.81 -9.67 27.99 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 70' ' ' MET . 87.6 m -87.29 -51.17 6.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -1.114 . . . . 0.0 110.026 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -76.69 -14.97 59.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 109.736 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.66 -57.11 3.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.67 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.0 -21.84 62.24 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.284 -0.885 . . . . 0.0 110.172 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -65.08 -65.89 0.61 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.079 -1.013 . . . . 0.0 109.609 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -161.13 -65.96 0.02 OUTLIER Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.267 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.877 HD12 ' N ' ' A' ' 73' ' ' VAL . 1.7 pp -72.62 -179.37 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -1.117 . . . . 0.0 110.513 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.877 ' N ' HD12 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -126.33 151.59 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.583 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.31 168.53 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.146 -0.972 . . . . 0.0 109.588 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.484 ' HG3' ' HA ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -123.75 125.66 45.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.308 -0.87 . . . . 0.0 109.582 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.1 t0 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.52 179.931 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.311 0.577 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.9 m -137.31 -49.39 0.61 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.281 -0.887 . . . . 0.0 109.313 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.64 134.83 54.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 109.353 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.2 mp -137.23 130.97 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.207 -0.933 . . . . 0.0 109.498 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.33 130.95 35.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 109.405 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.73 149.31 41.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.634 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.6 m 63.71 79.02 0.26 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 109.548 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 34.9 Cg_endo -78.27 151.44 26.46 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.571 2.18 . . . . 0.0 110.331 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.473 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 35.4 Cg_endo -77.34 174.1 13.27 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.643 2.229 . . . . 0.0 110.431 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -73.74 -65.04 0.88 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.963 . . . . 0.0 109.822 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.506 ' HA ' ' CE ' ' A' ' 70' ' ' MET . . . -36.69 -39.27 0.2 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.565 -0.709 . . . . 0.0 110.703 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.433 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 38.8 t -75.35 -51.43 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.022 -1.049 . . . . 0.0 109.865 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 13' ' ' LEU . 21.5 mt -51.37 -60.96 2.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.054 -1.028 . . . . 0.0 109.366 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.512 HD13 HG22 ' A' ' 66' ' ' THR . 0.2 OUTLIER -50.06 -40.39 45.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.599 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' LYS . 14.4 mttt -52.89 -65.89 0.48 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 109.196 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.452 ' HA ' HD11 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -44.46 -26.37 0.34 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 108.944 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.726 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -105.22 51.89 0.75 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.454 -0.779 . . . . 0.0 109.34 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' A' ' 17' ' ' ALA . . . 88.75 102.33 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 20' ' ' ILE . . . 168.77 -47.67 0.22 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.476 ' O ' ' O ' ' A' ' 19' ' ' GLY . 1.8 mt -58.7 -120.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.391 -1.064 . . . . 0.0 109.726 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -89.34 88.64 7.57 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 120.7 -1.25 . . . . 0.0 109.442 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.1 m -98.53 8.79 44.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.148 -0.97 . . . . 0.0 109.642 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.1 129.14 1.16 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.0 p 50.94 -168.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.234 -1.156 . . . . 0.0 109.229 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 26' ' ' GLU . . . -158.19 -66.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 25' ' ' GLY . 1.6 pt-20 -43.66 130.48 3.94 Favored Pre-proline 0 C--N 1.305 -1.338 0 O-C-N 121.279 -1.13 . . . . 0.0 109.458 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.75 133.46 11.45 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.491 2.128 . . . . 0.0 110.719 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.67 153.39 35.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.329 -0.857 . . . . 0.0 109.399 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -71.21 -13.13 61.82 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.239 -0.913 . . . . 0.0 109.893 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -110.4 -15.7 13.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.158 -0.963 . . . . 0.0 109.603 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.72 -174.89 5.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.438 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.6 p -46.47 144.03 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 109.576 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.56 -169.43 2.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 0.0 109.656 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.445 ' OG1' ' HA ' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -95.95 171.08 8.85 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.294 -0.879 . . . . 0.0 109.733 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.6 HG21 ' CB ' ' A' ' 18' ' ' ALA . 6.9 pt -85.01 -173.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.374 -0.829 . . . . 0.0 109.91 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -99.3 147.81 24.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 0.0 109.572 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -73.99 -10.13 59.33 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.277 -0.889 . . . . 0.0 109.604 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 37' ' ' ARG . 0.4 OUTLIER -42.6 -51.73 5.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.334 -0.854 . . . . 0.0 109.837 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.465 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -57.32 -45.03 84.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.701 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.942 HG13 ' CG2' ' A' ' 63' ' ' ILE . 75.4 t -56.0 -28.06 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -0.846 . . . . 0.0 110.474 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -75.59 -51.62 12.46 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.986 -1.071 . . . . 0.0 110.072 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -60.97 -29.87 69.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 0.0 110.044 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 39' ' ' LYS . 45.3 mt -83.02 -34.37 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.006 -1.059 . . . . 0.0 109.981 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.03 -9.4 58.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.088 -1.008 . . . . 0.0 109.793 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -99.35 -33.67 10.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.148 -0.97 . . . . 0.0 109.525 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.815 ' O ' HD12 ' A' ' 46' ' ' LEU . 0.7 OUTLIER -77.47 -11.43 59.85 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.225 -0.922 . . . . 0.0 109.998 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -132.08 34.88 3.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 109.673 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.58 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 4.3 ttp -50.57 -48.41 82.18 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.163 -0.961 . . . . 0.0 109.808 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 48' ' ' MET . 35.9 Cg_endo -78.84 82.01 2.62 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.059 1.839 . . . . 0.0 110.168 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -144.57 -46.63 0.25 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -0.945 . . . . 0.0 109.794 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.416 HD13 ' SD ' ' A' ' 62' ' ' MET . 0.5 OUTLIER -117.41 22.29 12.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.212 -0.93 . . . . 0.0 109.681 -179.813 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 51' ' ' LEU . 3.5 t-20 44.14 72.62 0.18 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.157 -0.964 . . . . 0.0 109.556 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.414 ' HB1' ' HB3' ' A' ' 58' ' ' ALA . . . -100.87 174.05 6.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -0.942 . . . . 0.0 109.325 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.85 -57.69 9.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 0.0 109.521 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.1 m -162.9 -56.6 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.627 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.515 HD13 ' HA ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -157.23 -32.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.251 -0.906 . . . . 0.0 109.064 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -49.55 -65.0 0.64 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.164 -0.96 . . . . 0.0 110.085 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.414 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -53.6 -43.22 68.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.393 -0.817 . . . . 0.0 110.383 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.58 -28.94 68.87 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.024 -1.047 . . . . 0.0 110.15 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -31.3 49.52 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.127 -0.983 . . . . 0.0 109.311 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.429 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -77.32 -16.25 59.02 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.434 -0.791 . . . . 0.0 109.01 179.581 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.416 ' SD ' HD13 ' A' ' 51' ' ' LEU . 3.2 mtp -77.41 -52.06 9.76 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.4 -0.813 . . . . 0.0 109.461 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.942 ' CG2' HG13 ' A' ' 40' ' ' VAL . 2.3 mt -66.07 -45.88 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.762 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.543 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 7.8 pt-20 -64.01 -47.36 80.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.914 -1.116 . . . . 0.0 109.432 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.543 ' N ' ' HG3' ' A' ' 64' ' ' GLU . . . -61.43 -14.78 43.25 Favored Glycine 0 N--CA 1.479 1.53 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.52 ' O ' ' HG2' ' A' ' 70' ' ' MET . 61.0 m -98.02 -20.98 17.06 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.41 -1.053 . . . . 0.0 109.393 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.557 ' HB3' HG21 ' A' ' 74' ' ' VAL . . . -92.07 -9.39 42.87 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.218 -0.926 . . . . 0.0 109.048 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.788 ' CD ' HG13 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -105.36 -49.08 3.53 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.49 -0.757 . . . . 0.0 110.6 -179.362 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 p -75.54 -39.0 58.89 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.215 -0.928 . . . . 0.0 111.729 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.52 ' HG2' ' O ' ' A' ' 66' ' ' THR . 0.2 OUTLIER -81.62 -27.49 34.15 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 120.636 -1.29 . . . . 0.0 111.628 -177.88 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.504 ' N ' ' HG3' ' A' ' 70' ' ' MET . . . -149.21 -141.24 3.41 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 118.76 -1.686 . . . . 0.0 111.59 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.52 ' N ' HD12 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -52.25 -166.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.869 -0.783 . . . . 0.0 110.717 -178.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.788 HG13 ' CD ' ' A' ' 68' ' ' ARG . 22.4 t -112.14 165.44 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.349 -0.845 . . . . 0.0 109.951 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.557 HG21 ' HB3' ' A' ' 67' ' ' ALA . 98.1 t -124.55 156.66 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.337 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.492 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 14.4 pt-20 -115.59 110.19 18.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -0.943 . . . . 0.0 109.587 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.7 t0 . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.342 179.842 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.652 HG22 ' N ' ' A' ' 3' ' ' PHE . 18.9 m -118.58 -93.42 0.52 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 109.573 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.831 ' C ' HD12 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -107.34 124.24 49.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.18 -0.95 . . . . 0.0 109.68 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.831 HD12 ' C ' ' A' ' 3' ' ' PHE . 3.7 mp -136.69 158.3 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.292 -0.88 . . . . 0.0 109.271 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.76 HG23 ' O ' ' A' ' 5' ' ' THR . 14.2 t -102.66 107.41 18.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.698 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.491 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -80.95 -161.41 0.39 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.211 -0.931 . . . . 0.0 108.856 179.601 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.732 HG22 ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -129.66 52.09 8.68 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 120.989 -1.07 . . . . 0.0 110.15 179.731 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.623 ' N ' ' CD ' ' A' ' 9' ' ' PRO . 28.2 Cg_endo -71.15 -32.07 13.64 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.284 1.99 . . . . 0.0 113.643 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 8' ' ' PRO . 32.8 Cg_endo -75.89 136.13 18.29 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 C-N-CA 121.321 1.347 . . . . 0.0 110.596 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 12' ' ' VAL . . . -54.17 -54.91 33.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.474 -0.766 . . . . 0.0 110.669 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -30.99 -36.84 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.695 -0.628 . . . . 0.0 111.079 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.732 ' CG1' HG22 ' A' ' 7' ' ' THR . 1.2 t -81.33 -53.22 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.964 -1.085 . . . . 0.0 109.706 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.481 HD11 ' O ' ' A' ' 7' ' ' THR . 2.1 mp -46.42 -45.3 17.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.267 -0.896 . . . . 0.0 109.981 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.446 HD22 ' HB2' ' A' ' 67' ' ' ALA . 5.3 mt -67.24 -37.57 83.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.906 . . . . 0.0 110.015 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.99 -33.93 76.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.275 -0.89 . . . . 0.0 110.387 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -92.96 -8.28 43.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.965 -1.084 . . . . 0.0 109.676 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.421 ' HB1' ' CD ' ' A' ' 39' ' ' LYS . . . -76.27 -37.74 57.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 109.643 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.72 -36.53 25.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.899 . . . . 0.0 109.675 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.52 44.11 1.27 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.8 mm -63.73 -10.39 7.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 121.312 -1.111 . . . . 0.0 110.15 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -104.99 -33.07 8.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.033 -1.042 . . . . 0.0 109.807 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.05 -83.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.393 -0.817 . . . . 0.0 109.493 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.56 138.9 8.22 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.19 166.45 10.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -1.154 . . . . 0.0 109.365 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.54 -173.92 0.48 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -46.31 129.79 7.75 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.151 -1.205 . . . . 0.0 109.335 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.89 117.3 4.17 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.443 2.095 . . . . 0.0 110.341 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -151.39 46.28 0.81 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.145 -0.972 . . . . 0.0 109.922 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.44 ' O ' ' C ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -169.45 55.46 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.013 -1.054 . . . . 0.0 110.441 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 29' ' ' ARG . 1.9 p-10 39.69 50.96 2.31 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.36 -0.837 . . . . 0.0 110.3 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.54 104.34 4.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.129 -0.982 . . . . 0.0 109.309 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -171.56 143.21 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.148 -0.97 . . . . 0.0 110.032 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 34' ' ' THR . . . 48.17 74.95 0.15 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.378 -0.826 . . . . 0.0 109.893 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.848 HG22 HG12 ' A' ' 73' ' ' VAL . 16.6 p -160.32 126.35 4.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.395 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.404 HG23 HG13 ' A' ' 72' ' ' ILE . 41.5 pt -86.35 175.18 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.962 . . . . 0.0 109.413 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.74 138.62 45.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.204 -0.935 . . . . 0.0 109.699 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.483 ' NH1' ' OD1' ' A' ' 76' ' ' ASP . 4.6 mtp180 -53.4 -35.7 60.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.34 -0.85 . . . . 0.0 109.457 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.32 -54.54 8.77 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.257 -0.902 . . . . 0.0 109.381 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 40' ' ' VAL . 2.5 mttt -56.9 -55.63 32.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.29 -0.881 . . . . 0.0 109.355 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.845 HG13 HG21 ' A' ' 63' ' ' ILE . 99.2 t -42.32 -29.61 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -0.848 . . . . 0.0 110.171 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -77.66 -44.96 26.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.109 -0.994 . . . . 0.0 110.13 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.404 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 2.7 tp10 -63.48 -61.58 2.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.102 -0.999 . . . . 0.0 109.998 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 19.3 mt -57.47 -31.37 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.321 -0.862 . . . . 0.0 110.242 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 40' ' ' VAL . . . -63.6 -31.65 72.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.112 -0.993 . . . . 0.0 110.024 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -92.68 -65.15 1.02 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.096 -1.003 . . . . 0.0 109.965 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 33.8 mt -53.35 -19.33 3.26 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.24 -0.912 . . . . 0.0 110.204 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.48 ' HD3' HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -116.14 -11.21 11.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.071 -1.018 . . . . 0.0 109.871 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.469 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 0.9 OUTLIER -39.23 99.14 0.19 Allowed Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.6 -0.687 . . . . 0.0 109.927 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 47' ' ' LYS . 36.4 Cg_endo -79.84 -82.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.55 2.167 . . . . 0.0 110.127 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -144.0 -72.96 0.27 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.361 -0.837 . . . . 0.0 109.342 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.824 HD22 ' SD ' ' A' ' 62' ' ' MET . 3.6 mt 54.34 18.19 1.79 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.191 -0.943 . . . . 0.0 109.505 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER 40.34 33.8 0.19 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.449 -0.782 . . . . 0.0 109.792 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.53 154.37 42.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 0.0 109.452 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.23 -26.55 42.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 109.589 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m -158.41 -58.41 0.07 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.165 -0.959 . . . . 0.0 108.88 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.42 HG23 ' N ' ' A' ' 57' ' ' GLU . 1.4 tt -172.51 -33.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.256 -0.903 . . . . 0.0 109.201 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.42 ' N ' HG23 ' A' ' 56' ' ' ILE . 1.3 tt0 -47.97 -60.18 2.8 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.268 -0.895 . . . . 0.0 109.33 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.97 -49.86 29.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.454 -0.779 . . . . 0.0 109.339 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 62' ' ' MET . . . -49.06 -42.09 37.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 109.177 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -37.75 88.47 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.228 -0.92 . . . . 0.0 109.329 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.99 -13.16 62.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 108.914 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.824 ' SD ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -82.63 -51.07 8.09 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.333 -0.855 . . . . 0.0 109.329 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.845 HG21 HG13 ' A' ' 40' ' ' VAL . 4.8 mt -56.35 -42.6 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.895 . . . . 0.0 109.619 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.528 ' CG ' HG21 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -61.55 -53.83 51.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.898 -1.126 . . . . 0.0 109.43 -179.737 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -56.4 -15.57 12.0 Favored Glycine 0 N--CA 1.48 1.618 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 90.5 m -81.71 -59.99 2.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.3 -1.118 . . . . 0.0 109.546 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.709 ' HB1' HD11 ' A' ' 72' ' ' ILE . . . -73.41 -2.78 23.74 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.238 -0.914 . . . . 0.0 109.528 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.526 ' NH1' ' HG3' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -86.56 -50.24 6.98 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.19 -0.944 . . . . 0.0 109.725 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.47 -8.75 34.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.106 -0.996 . . . . 0.0 109.894 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.48 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -71.06 -69.16 0.39 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.064 -1.022 . . . . 0.0 109.086 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -161.44 -79.9 0.03 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.709 HD11 ' HB1' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -57.88 -169.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.464 -1.021 . . . . 0.0 109.995 -179.631 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.848 HG12 HG22 ' A' ' 34' ' ' THR . 0.4 OUTLIER -138.64 169.97 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.4 -0.812 . . . . 0.0 108.884 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.528 HG21 ' CG ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -106.69 151.48 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.027 -1.046 . . . . 0.0 109.425 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -125.22 145.47 49.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.901 . . . . 0.0 109.494 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.483 ' OD1' ' NH1' ' A' ' 37' ' ' ARG . 14.2 t70 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.452 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 71.1 p -69.9 -142.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.27 -0.893 . . . . 0.0 109.246 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -127.76 72.59 1.41 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.959 -1.088 . . . . 0.0 109.641 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.9 tp -98.0 148.88 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.226 -0.921 . . . . 0.0 109.417 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.87 41.74 3.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 109.624 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.95 -171.35 3.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.191 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 44.08 81.21 0.26 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 109.406 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.75 159.66 31.4 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.643 2.229 . . . . 0.0 110.314 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.527 ' O ' HD12 ' A' ' 13' ' ' LEU . 35.3 Cg_endo -77.68 -159.98 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.591 2.194 . . . . 0.0 110.528 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -79.38 -66.99 0.8 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.252 -0.905 . . . . 0.0 110.052 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -37.25 -46.24 0.72 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.51 -0.744 . . . . 0.0 110.187 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.7 t -67.67 -46.78 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.213 -0.929 . . . . 0.0 109.423 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 9' ' ' PRO . 3.3 mt -46.85 -48.93 20.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.433 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.499 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -68.71 -38.48 80.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.594 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.6 -66.02 0.46 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 109.669 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -59.11 -32.93 70.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.152 -0.968 . . . . 0.0 109.739 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 14' ' ' LEU . . . -50.05 -65.1 0.62 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.141 -0.975 . . . . 0.0 109.548 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.48 -29.49 36.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 109.406 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 21' ' ' GLU . . . 81.2 31.82 33.45 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.4 mm -53.55 94.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.196 -1.179 . . . . 0.0 109.769 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 19' ' ' GLY . 40.4 tt0 -121.52 109.23 14.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 109.266 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.3 m -137.12 57.14 1.77 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.328 -0.857 . . . . 0.0 109.536 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.27 -61.13 3.53 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 59.0 m -128.75 -2.08 5.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -1.149 . . . . 0.0 109.583 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.12 67.67 1.21 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -44.7 107.89 0.68 Allowed Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.31 -1.112 . . . . 0.0 109.736 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.96 124.56 7.45 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.439 2.093 . . . . 0.0 110.271 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -129.82 4.26 4.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.322 -0.861 . . . . 0.0 109.56 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.54 113.04 6.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.267 -0.895 . . . . 0.0 109.495 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -153.91 39.56 0.48 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.253 -0.905 . . . . 0.0 109.68 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -55.07 138.94 43.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.177 -0.952 . . . . 0.0 109.153 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.3 t 57.23 99.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.206 -0.933 . . . . 0.0 109.186 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.32 94.37 4.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 0.0 109.616 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.1 p -118.6 148.93 42.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.188 -0.945 . . . . 0.0 109.425 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.765 HG13 HG13 ' A' ' 74' ' ' VAL . 11.6 pt -105.74 -179.09 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.297 -0.877 . . . . 0.0 109.618 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -95.61 146.96 24.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.294 -0.879 . . . . 0.0 109.487 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.9 ppt_? -60.42 -15.44 26.43 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.235 -0.916 . . . . 0.0 109.517 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -47.92 -39.25 18.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.325 -0.859 . . . . 0.0 109.561 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.43 -45.99 90.57 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.314 -0.866 . . . . 0.0 109.52 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.559 HG13 ' HB ' ' A' ' 63' ' ' ILE . 30.4 t -61.79 -12.89 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 0.0 109.48 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.9 -55.15 5.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 109.912 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -72.44 -51.07 21.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.228 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 63.2 mt -57.44 -45.92 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 110.094 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' A' ' 40' ' ' VAL . . . -57.28 -39.18 75.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -0.959 . . . . 0.0 109.981 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.35 -36.78 77.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.125 -0.985 . . . . 0.0 109.831 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mt -87.49 14.89 7.32 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.171 -0.956 . . . . 0.0 109.596 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -134.48 24.38 3.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 0.0 109.264 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.597 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -69.8 -51.01 16.16 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.389 -0.819 . . . . 0.0 109.942 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 48' ' ' MET . 34.1 Cg_endo -77.34 89.1 1.35 Allowed 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.336 2.024 . . . . 0.0 110.647 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -176.69 -62.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.703 HD11 ' HB2' ' A' ' 53' ' ' ALA . 1.5 pp -103.02 -0.75 30.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.387 -0.82 . . . . 0.0 109.22 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 52' ' ' ASN . 1.5 t30 45.95 81.11 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.273 -0.892 . . . . 0.0 109.713 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.703 ' HB2' HD11 ' A' ' 51' ' ' LEU . . . -87.62 163.13 16.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.0 109.277 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -46.45 -56.09 6.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 109.132 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m -160.07 -69.4 0.07 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.276 -0.89 . . . . 0.0 108.678 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -147.0 8.26 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.355 -0.84 . . . . 0.0 109.584 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -92.95 -51.98 4.81 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.111 -0.993 . . . . 0.0 109.483 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.641 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -73.21 -27.81 61.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.361 -0.837 . . . . 0.0 109.543 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.73 -37.61 70.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 109.354 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.64 -50.73 23.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.694 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -61.18 -17.5 53.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.624 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.573 ' SD ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -75.64 -54.75 6.47 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.251 -0.906 . . . . 0.0 110.087 -179.653 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.559 ' HB ' HG13 ' A' ' 40' ' ' VAL . 12.3 mt -56.16 -38.87 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 110.482 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.4 ' C ' ' N ' ' A' ' 66' ' ' THR . 1.7 tt0 -63.11 -60.95 2.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.712 -1.242 . . . . 0.0 109.303 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.74 -16.6 7.71 Favored Glycine 0 N--CA 1.479 1.501 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 33.2 m -74.14 -55.1 6.49 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.234 -1.156 . . . . 0.0 109.272 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -67.76 -14.25 62.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.181 -0.949 . . . . 0.0 109.249 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.403 ' HG2' HG13 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -67.54 -52.29 40.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 0.0 109.803 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.17 -9.92 29.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.206 -0.934 . . . . 0.0 110.49 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.493 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -97.15 -49.85 4.82 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.097 -1.002 . . . . 0.0 110.109 -179.264 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -138.64 -127.02 2.46 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.654 -1.26 . . . . 0.0 110.167 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.525 ' O ' HD12 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -85.69 179.28 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.361 -1.082 . . . . 0.0 109.973 -179.446 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 74' ' ' VAL . 0.2 OUTLIER -94.41 -169.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.917 . . . . 0.0 109.545 179.818 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.765 HG13 HG13 ' A' ' 35' ' ' ILE . 8.8 t -135.6 167.56 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 0.0 109.525 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.475 ' N ' HG12 ' A' ' 74' ' ' VAL . 5.0 pt-20 -122.01 152.44 39.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.451 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.4 t70 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.455 -179.935 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.74 -35.27 20.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.656 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.499 ' O ' HG13 ' A' ' 4' ' ' ILE . 1.2 t80 59.46 104.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.153 -0.967 . . . . 0.0 109.346 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 3' ' ' PHE . 18.2 mt -146.45 -75.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.281 -0.887 . . . . 0.0 109.412 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.472 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 2.8 t -90.18 178.29 6.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.401 -0.812 . . . . 0.0 109.695 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 5' ' ' THR . 13.2 ttmt 62.77 124.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.407 -0.808 . . . . 0.0 109.513 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.408 ' OG1' ' HG2' ' A' ' 6' ' ' LYS . 1.7 m 66.34 81.71 0.21 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.325 -0.859 . . . . 0.0 109.42 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.404 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 35.1 Cg_endo -77.27 159.85 32.94 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.562 2.175 . . . . 0.0 110.189 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -76.9 -162.11 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.538 2.159 . . . . 0.0 110.332 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.478 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -72.49 -67.25 0.57 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.21 -0.931 . . . . 0.0 110.11 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -33.93 -53.8 0.46 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.761 -0.587 . . . . 0.0 110.663 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 99.4 t -57.31 -50.39 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.089 -1.007 . . . . 0.0 109.783 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 13' ' ' LEU . 39.5 mt -48.18 -68.52 0.18 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.117 -0.99 . . . . 0.0 109.767 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.521 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 6.0 mt -55.67 -20.72 15.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.198 -0.939 . . . . 0.0 109.6 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -61.34 -57.32 12.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.501 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 17' ' ' ALA . 47.0 mmtm -60.22 -25.55 65.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 0.0 109.319 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 14' ' ' LEU . . . -42.92 -35.91 1.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.39 -0.819 . . . . 0.0 109.408 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -102.83 -24.34 13.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.269 -0.894 . . . . 0.0 109.565 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.75 34.95 7.04 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.0 mm -54.43 100.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.249 -1.148 . . . . 0.0 109.746 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -51.23 163.42 0.24 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.872 . . . . 0.0 109.519 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.82 125.33 17.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 109.68 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 163.2 -175.53 39.49 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.1 t -62.09 170.64 2.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -1.118 . . . . 0.0 109.484 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.75 76.89 1.07 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -46.1 127.0 7.29 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.29 -1.124 . . . . 0.0 109.7 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.38 131.46 10.62 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.532 2.155 . . . . 0.0 110.286 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -118.96 -29.16 5.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.117 -0.989 . . . . 0.0 109.539 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.83 138.96 55.15 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.22 -0.925 . . . . 0.0 109.627 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -119.63 21.01 12.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.134 -0.979 . . . . 0.0 109.374 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.95 173.55 3.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.295 -0.878 . . . . 0.0 109.757 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.5 t -126.15 159.61 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.397 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.449 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . -133.22 157.3 45.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.212 -0.93 . . . . 0.0 109.584 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.769 HG22 HG23 ' A' ' 73' ' ' VAL . 11.1 p -126.54 143.5 51.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 109.378 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.077 HD11 HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -112.53 -171.63 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.172 -0.955 . . . . 0.0 109.615 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -100.17 168.69 9.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.386 -0.821 . . . . 0.0 109.931 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.04 -11.22 57.07 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.379 -0.826 . . . . 0.0 110.046 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -51.09 -44.9 61.33 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.135 -0.978 . . . . 0.0 109.776 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.446 ' NZ ' HD23 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -59.77 -34.62 73.23 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.319 -0.863 . . . . 0.0 109.852 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.753 HG13 ' HB ' ' A' ' 63' ' ' ILE . 68.1 t -63.06 -30.59 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 110.017 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -80.73 -23.33 39.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.112 -0.992 . . . . 0.0 110.008 -179.673 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -80.67 -52.6 7.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.971 . . . . 0.0 109.62 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.4 mt -65.99 -36.47 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.663 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.7 -38.71 80.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.212 -0.93 . . . . 0.0 109.636 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -74.52 -27.22 60.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 0.0 109.698 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.03 -0.06 54.61 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.093 -1.005 . . . . 0.0 109.595 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -149.44 47.92 0.96 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.325 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.582 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -62.7 -50.37 78.25 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.273 -0.892 . . . . 0.0 110.033 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 48' ' ' MET . 36.4 Cg_endo -80.7 49.43 3.22 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.711 2.274 . . . . 0.0 110.815 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -123.2 -33.65 3.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.095 -1.003 . . . . 0.0 109.233 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.675 HD11 ' HB2' ' A' ' 53' ' ' ALA . 0.8 OUTLIER -123.86 34.87 4.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -0.885 . . . . 0.0 109.334 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' A' ' 52' ' ' ASN . 29.1 t-20 42.95 38.16 1.33 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.357 -0.84 . . . . 0.0 109.537 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.675 ' HB2' HD11 ' A' ' 51' ' ' LEU . . . -61.54 135.64 57.73 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.187 -0.946 . . . . 0.0 109.318 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.9 -73.41 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.891 . . . . 0.0 109.536 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.461 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -139.08 -51.21 0.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 109.635 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.478 HD13 ' HA ' ' A' ' 56' ' ' ILE . 10.4 mm -157.31 -32.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.385 -0.822 . . . . 0.0 109.371 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.42 -59.12 5.91 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.24 -0.912 . . . . 0.0 110.578 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.9 -50.25 66.79 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.379 -0.826 . . . . 0.0 110.831 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.481 ' HB2' ' CB ' ' A' ' 53' ' ' ALA . . . -66.23 -24.76 66.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.983 -1.073 . . . . 0.0 110.089 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -74.24 -38.06 63.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 109.771 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.08 -13.18 57.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.341 -0.849 . . . . 0.0 109.871 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.05 -53.96 7.56 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.19 -0.944 . . . . 0.0 109.398 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.753 ' HB ' HG13 ' A' ' 40' ' ' VAL . 12.2 mt -64.98 -41.12 91.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.91 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.433 ' HG2' ' CZ ' ' A' ' 68' ' ' ARG . 18.1 tt0 -61.66 -53.35 57.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.04 -1.038 . . . . 0.0 109.722 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.67 -10.66 32.0 Favored Glycine 0 N--CA 1.479 1.537 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 5.0 m -85.12 -44.25 13.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.272 -1.134 . . . . 0.0 109.667 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -72.38 -32.88 66.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -0.932 . . . . 0.0 109.584 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.885 ' HD2' HG12 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -65.35 -55.49 17.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.239 -0.913 . . . . 0.0 110.073 -179.629 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 70' ' ' MET . 0.1 OUTLIER -67.9 -46.45 71.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.965 . . . . 0.0 110.48 -179.275 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.477 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -44.9 -72.02 0.07 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.05 -1.031 . . . . 0.0 109.458 -179.854 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -162.18 -93.2 0.09 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.077 HD13 HD11 ' A' ' 35' ' ' ILE . 2.2 pp -48.19 178.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.52 -0.988 . . . . 0.0 109.935 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.885 HG12 ' HD2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -122.09 -175.8 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.221 -0.924 . . . . 0.0 109.817 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.8 t -146.53 145.57 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.617 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.68 178.58 5.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 109.376 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.3 t0 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.483 -179.924 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.268 0.556 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.7 t -156.7 24.3 0.33 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.246 -0.909 . . . . 0.0 109.356 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 57.09 92.86 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.332 -0.855 . . . . 0.0 109.685 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.619 HG23 ' O ' ' A' ' 4' ' ' ILE . 1.5 tp -113.02 57.24 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.256 -0.902 . . . . 0.0 109.299 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 4' ' ' ILE . 10.9 t -44.05 161.18 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 109.571 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.8 -152.86 0.46 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.373 -0.829 . . . . 0.0 109.509 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 7' ' ' THR . 3.1 t -63.64 119.33 53.09 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.201 -0.937 . . . . 0.0 109.648 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.504 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 35.1 Cg_endo -78.09 175.18 11.45 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.448 2.099 . . . . 0.0 110.266 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.504 ' HD2' ' HB2' ' A' ' 8' ' ' PRO . 34.5 Cg_endo -76.42 154.58 36.06 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.455 2.103 . . . . 0.0 110.222 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.06 -65.76 0.49 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.337 -0.852 . . . . 0.0 110.837 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.782 ' HB2' ' HE1' ' A' ' 70' ' ' MET . . . -45.35 -65.66 0.51 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.26 -0.9 . . . . 0.0 111.415 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 80.4 t -55.99 -20.62 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.954 -1.091 . . . . 0.0 111.354 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.84 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -87.83 -24.8 23.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.766 -1.209 . . . . 0.0 110.002 -179.418 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 1.011 HD11 HG22 ' A' ' 66' ' ' THR . 10.3 mt -71.26 -50.73 29.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.011 -1.056 . . . . 0.0 109.237 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.511 ' CD ' ' N ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -66.6 -41.43 88.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.207 -0.933 . . . . 0.0 109.169 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.511 ' N ' ' CD ' ' A' ' 15' ' ' LYS . 9.4 tttp -49.93 -36.95 29.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -0.927 . . . . 0.0 109.114 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.428 ' HB1' ' HD3' ' A' ' 39' ' ' LYS . . . -99.81 -75.33 0.57 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.325 -0.859 . . . . 0.0 109.186 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -158.8 85.53 0.83 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.359 -0.838 . . . . 0.0 109.497 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -147.15 -105.84 0.43 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.489 ' HB ' ' HB3' ' A' ' 15' ' ' LYS . 11.7 mt -53.51 -19.18 2.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.29 -1.124 . . . . 0.0 109.479 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 20' ' ' ILE . 3.2 tt0 60.81 111.02 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.296 -0.877 . . . . 0.0 109.32 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.68 135.97 40.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.923 . . . . 0.0 109.433 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 24' ' ' SER . . . 133.12 41.96 0.17 Allowed Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' GLY . 9.5 m -43.89 136.62 3.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.286 -1.126 . . . . 0.0 109.459 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 26' ' ' GLU . . . -162.79 43.9 0.34 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 25' ' ' GLY . 15.0 tt0 49.1 97.21 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.349 -1.089 . . . . 0.0 109.465 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.26 165.68 27.42 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.54 2.16 . . . . 0.0 110.379 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -147.95 -161.79 1.41 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 109.571 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.41 41.52 1.13 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.365 -0.834 . . . . 0.0 108.898 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 31' ' ' LYS . 16.5 p30 -94.82 -145.64 0.26 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.435 -0.791 . . . . 0.0 109.586 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.487 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -71.08 141.65 50.84 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.147 -0.971 . . . . 0.0 110.01 -179.633 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 t -114.59 141.66 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.0 109.309 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.438 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . -97.4 143.26 28.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -0.929 . . . . 0.0 109.608 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.458 ' OG1' ' N ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -106.16 176.39 5.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 109.472 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.458 ' N ' ' OG1' ' A' ' 34' ' ' THR . 12.8 pt -125.94 165.78 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.295 -0.878 . . . . 0.0 109.434 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.8 mtpt -89.53 144.95 25.62 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.336 -0.852 . . . . 0.0 109.293 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -60.77 -13.47 15.33 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.269 -0.894 . . . . 0.0 109.619 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 37' ' ' ARG . 2.5 t0 -42.76 -41.07 3.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.295 -0.878 . . . . 0.0 109.549 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.428 ' HD3' ' HB1' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -71.48 -47.53 54.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -0.857 . . . . 0.0 109.501 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.683 HG22 HG22 ' A' ' 63' ' ' ILE . 75.0 t -53.03 -20.51 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.799 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -81.16 -62.07 1.77 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.94 . . . . 0.0 109.694 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.65 -55.69 23.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.352 -0.842 . . . . 0.0 110.032 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.584 HD13 HD11 ' A' ' 13' ' ' LEU . 74.3 mt -54.24 -58.41 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.916 . . . . 0.0 110.178 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 43' ' ' ILE . . . -42.19 -28.82 0.21 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.223 -0.923 . . . . 0.0 109.77 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -67.03 -51.29 56.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.186 -0.947 . . . . 0.0 109.49 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.5 mt -77.49 -2.24 34.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.875 . . . . 0.0 109.702 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HD3' HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -127.27 23.15 6.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.119 -0.988 . . . . 0.0 109.529 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.617 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 5.5 ttp -69.32 -43.12 23.04 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 110.755 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 48' ' ' MET . 36.2 Cg_endo -79.51 13.7 2.01 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 122.055 1.837 . . . . 0.0 111.194 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.53 -35.46 79.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.97 -1.081 . . . . 0.0 109.412 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.848 HD21 ' SD ' ' A' ' 62' ' ' MET . 0.3 OUTLIER -143.99 23.81 1.69 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -0.87 . . . . 0.0 109.595 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 51' ' ' LEU . 35.3 t-20 44.99 56.69 5.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -0.894 . . . . 0.0 109.626 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 1.021 ' HB1' ' HB3' ' A' ' 58' ' ' ALA . . . -52.56 170.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 109.396 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.27 -44.35 68.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.923 . . . . 0.0 109.367 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.55 -50.81 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.218 -0.926 . . . . 0.0 108.841 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.1 tt -172.53 -31.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 121.207 -0.933 . . . . 0.0 109.518 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -57.2 -45.53 83.69 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.208 -0.932 . . . . 0.0 109.806 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 1.021 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -60.04 -35.84 75.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.337 -0.852 . . . . 0.0 109.813 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.519 ' O ' ' HG3' ' A' ' 62' ' ' MET . . . -63.21 -25.56 68.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.975 . . . . 0.0 109.396 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.421 ' HG3' HG12 ' A' ' 40' ' ' VAL . 1.3 mtt -81.06 -23.54 38.45 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.113 -0.992 . . . . 0.0 108.395 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.05 -22.42 36.39 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.605 -0.685 . . . . 0.0 109.847 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.848 ' SD ' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -82.47 -50.34 8.96 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.894 -1.129 . . . . 0.0 109.425 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.683 HG22 HG22 ' A' ' 40' ' ' VAL . 8.0 mt -57.68 -37.92 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.418 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.39 -50.72 70.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.102 -0.999 . . . . 0.0 109.21 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.77 -12.99 23.11 Favored Glycine 0 N--CA 1.481 1.635 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . 1.011 HG22 HD11 ' A' ' 14' ' ' LEU . 54.0 m -82.54 -54.16 5.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -1.15 . . . . 0.0 109.089 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.473 ' HB1' HD11 ' A' ' 72' ' ' ILE . . . -79.21 3.27 18.33 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.374 -0.829 . . . . 0.0 109.261 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.44 -49.91 5.9 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.173 -0.955 . . . . 0.0 109.384 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -21.53 24.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.878 . . . . 0.0 109.877 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.782 ' HE1' ' HB2' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -60.18 -64.34 0.98 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.057 -1.027 . . . . 0.0 109.478 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -159.08 -98.54 0.14 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.765 ' C ' HD12 ' A' ' 72' ' ' ILE . 2.5 pp -53.14 -172.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -1.115 . . . . 0.0 109.692 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.54 176.85 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 109.276 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.435 ' CG2' ' HB3' ' A' ' 67' ' ' ALA . 2.9 t -123.98 151.36 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.337 -0.852 . . . . 0.0 109.476 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.505 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -113.93 65.41 0.66 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.934 . . . . 0.0 109.519 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.6 t0 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.456 179.993 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.404 ' O ' ' HB ' ' A' ' 2' ' ' THR . 9.7 ptt? . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.281 0.562 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.558 HG22 ' H ' ' A' ' 3' ' ' PHE . 8.5 m 66.02 171.53 0.23 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 109.6 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.558 ' H ' HG22 ' A' ' 2' ' ' THR . 0.5 OUTLIER -130.44 97.04 4.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -0.935 . . . . 0.0 109.696 -179.879 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.585 ' N ' HD12 ' A' ' 4' ' ' ILE . 2.0 mp 60.58 168.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 109.047 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.576 ' N ' HG22 ' A' ' 4' ' ' ILE . 3.5 m 63.21 125.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 0.0 109.415 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.524 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -104.32 -160.45 0.77 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.428 -179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.469 ' C ' ' HD2' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -112.05 86.02 7.21 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.247 -0.908 . . . . 0.0 109.523 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.628 ' N ' ' CD ' ' A' ' 9' ' ' PRO . 30.1 Cg_endo -72.18 -30.97 12.56 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.593 2.195 . . . . 0.0 113.647 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 8' ' ' PRO . 34.7 Cg_endo -75.64 127.47 10.28 Favored 'Trans proline' 0 C--N 1.323 -0.816 0 C-N-CA 121.243 1.295 . . . . 0.0 110.535 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -64.46 -43.56 93.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.867 . . . . 0.0 109.956 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 14' ' ' LEU . . . -37.5 -51.66 1.15 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.507 -0.746 . . . . 0.0 110.269 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 9' ' ' PRO . 3.1 m -66.8 -41.04 87.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 121.018 -1.051 . . . . 0.0 109.105 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.518 ' HA ' HD23 ' A' ' 13' ' ' LEU . 9.4 mt -61.86 -15.62 43.85 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.019 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 4.9 mt -77.65 -51.4 10.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 108.778 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -50.43 -34.86 26.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.86 . . . . 0.0 108.968 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.417 ' NZ ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -64.32 -51.33 63.98 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.316 -0.865 . . . . 0.0 109.286 179.808 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 18' ' ' ALA . . . -61.7 -69.23 0.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 0.0 109.411 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 17' ' ' ALA . . . -45.29 -68.95 0.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.165 -0.959 . . . . 0.0 109.326 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 21' ' ' GLU . . . 61.71 56.91 20.21 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.6 mt -50.01 91.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.24 -1.153 . . . . 0.0 109.594 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.8 tt0 -167.55 69.45 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.905 . . . . 0.0 109.487 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.12 47.68 2.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.167 -0.958 . . . . 0.0 109.297 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.01 -84.34 0.26 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 t -93.44 -165.11 1.27 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -1.162 . . . . 0.0 109.762 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 26' ' ' GLU . . . -134.73 95.58 0.27 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.496 ' HG3' ' HD2' ' A' ' 27' ' ' PRO . 0.5 OUTLIER -43.69 159.19 0.23 Allowed Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.338 -1.095 . . . . 0.0 109.782 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.496 ' HD2' ' HG3' ' A' ' 26' ' ' GLU . 34.8 Cg_endo -78.21 -163.86 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.686 2.258 . . . . 0.0 110.377 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.49 -22.98 15.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.413 -0.805 . . . . 0.0 109.803 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.517 ' CD ' ' OD1' ' A' ' 30' ' ' ASN . 7.1 ptp180 -66.99 -148.74 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.243 -0.911 . . . . 0.0 109.975 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.517 ' OD1' ' CD ' ' A' ' 29' ' ' ARG . 25.3 p-10 -46.64 157.95 0.13 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.27 -0.894 . . . . 0.0 109.786 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.32 106.16 16.18 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.272 -0.893 . . . . 0.0 109.475 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.551 HG22 ' N ' ' A' ' 33' ' ' ALA . 11.6 p -120.43 166.92 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.911 . . . . 0.0 109.418 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.551 ' N ' HG22 ' A' ' 32' ' ' VAL . . . -127.84 103.56 7.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.641 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.413 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 14.6 p -144.73 133.91 22.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.314 -0.866 . . . . 0.0 109.212 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.848 ' CG1' HG13 ' A' ' 74' ' ' VAL . 6.0 pt -90.88 -171.47 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.109 -0.994 . . . . 0.0 109.493 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.469 ' HE3' ' HA ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -97.56 148.21 23.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 109.373 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 38' ' ' ASP . 1.6 mtt180 -75.03 -16.46 60.6 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.278 -0.889 . . . . 0.0 109.458 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 37' ' ' ARG . 5.9 t0 -43.73 -54.33 5.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.453 -0.779 . . . . 0.0 109.468 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.437 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -53.7 -41.18 66.68 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.177 -0.952 . . . . 0.0 109.656 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.687 HG22 ' CG2' ' A' ' 63' ' ' ILE . 75.1 t -57.35 -36.45 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.313 -0.867 . . . . 0.0 109.927 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -29.56 65.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.157 -0.964 . . . . 0.0 110.052 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -80.92 -24.5 38.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.064 -1.022 . . . . 0.0 109.808 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 39' ' ' LYS . 29.6 mt -95.63 -14.59 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.811 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.29 -22.21 13.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.114 -0.991 . . . . 0.0 110.022 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -96.13 -41.12 8.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.096 -1.002 . . . . 0.0 109.759 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.444 ' C ' ' HG2' ' A' ' 47' ' ' LYS . 5.4 mt -84.09 2.8 37.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.15 -0.969 . . . . 0.0 109.662 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.444 ' HG2' ' C ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -139.09 41.43 2.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.151 -0.968 . . . . 0.0 109.458 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.578 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.2 OUTLIER -45.37 -51.57 25.7 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.215 -0.928 . . . . 0.0 109.806 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 48' ' ' MET . 35.4 Cg_endo -78.5 75.66 4.83 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.442 2.095 . . . . 0.0 110.447 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.71 -59.7 0.89 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -0.895 . . . . 0.0 109.678 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.575 HD12 ' HB3' ' A' ' 52' ' ' ASN . 2.3 pp -120.13 -32.88 4.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.143 -0.973 . . . . 0.0 109.991 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.699 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 8.8 t30 162.41 -90.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.471 -0.768 . . . . 0.0 109.121 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 52' ' ' ASN . . . 76.0 128.82 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.473 -0.767 . . . . 0.0 109.73 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -89.47 -41.45 12.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 109.228 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -158.16 -48.84 0.06 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.417 -0.802 . . . . 0.0 108.854 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.2 tt -177.14 -31.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.317 -0.865 . . . . 0.0 108.985 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.46 -59.87 3.55 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.332 -0.855 . . . . 0.0 110.049 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.94 -30.0 68.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.272 -0.893 . . . . 0.0 110.43 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.55 -33.32 66.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.152 -0.968 . . . . 0.0 109.97 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -50.04 13.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.175 -0.953 . . . . 0.0 110.138 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.7 -17.89 61.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.319 -0.863 . . . . 0.0 109.81 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.92 -55.62 4.67 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.165 -0.959 . . . . 0.0 110.072 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.687 ' CG2' HG22 ' A' ' 40' ' ' VAL . 3.1 mt -51.24 -43.08 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.05 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.479 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 12.3 pt-20 -64.81 -45.62 85.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.869 -1.144 . . . . 0.0 108.867 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.479 ' N ' ' HG3' ' A' ' 64' ' ' GLU . . . -60.26 -14.41 33.16 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 86.7 m -85.73 -60.36 2.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.388 -1.066 . . . . 0.0 109.265 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.463 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -61.86 -13.8 27.76 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.166 -0.959 . . . . 0.0 109.061 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 1.085 ' CG ' HG13 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -77.67 -62.3 1.71 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.329 -0.857 . . . . 0.0 109.269 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.01 -15.48 63.62 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.315 -0.866 . . . . 0.0 109.261 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.413 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.1 OUTLIER -88.4 -34.35 17.58 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.328 -0.858 . . . . 0.0 109.885 -179.754 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -159.64 -102.16 0.18 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.571 ' C ' HD12 ' A' ' 72' ' ' ILE . 1.1 pp -108.16 -169.63 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -1.197 . . . . 0.0 110.103 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 1.085 HG13 ' CG ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -103.92 -176.8 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.392 -0.818 . . . . 0.0 109.517 179.848 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.848 HG13 ' CG1' ' A' ' 35' ' ' ILE . 1.5 t -109.54 -170.15 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.363 -0.836 . . . . 0.0 109.216 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.674 ' H ' HG12 ' A' ' 74' ' ' VAL . 21.9 pt-20 -124.55 177.16 6.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 109.545 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.5 t70 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.461 179.935 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.59 -33.68 2.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.933 . . . . 0.0 109.401 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -158.12 99.85 1.67 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 0.0 109.482 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.442 HG12 ' N ' ' A' ' 5' ' ' THR . 19.2 tt -62.31 164.6 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.198 -0.939 . . . . 0.0 109.534 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.442 ' N ' HG12 ' A' ' 4' ' ' ILE . 6.3 t -85.48 137.24 33.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 109.335 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -137.67 104.05 5.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.236 -0.915 . . . . 0.0 109.379 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.4 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 35.0 p -99.64 136.8 20.21 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.125 -0.985 . . . . 0.0 109.195 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 36.0 Cg_endo -78.75 152.14 25.28 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.416 2.077 . . . . 0.0 110.515 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.9 ' O ' HD12 ' A' ' 13' ' ' LEU . 35.5 Cg_endo -77.97 -165.26 0.32 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.623 2.215 . . . . 0.0 110.081 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -91.7 -65.66 0.99 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.13 -0.981 . . . . 0.0 109.793 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 15' ' ' LYS . . . -41.78 -30.01 0.22 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.014 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.542 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 70.1 t -84.54 -46.46 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.137 -0.977 . . . . 0.0 109.603 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.9 HD12 ' O ' ' A' ' 9' ' ' PRO . 6.3 mt -52.62 -54.72 29.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.586 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.38 -43.98 96.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.312 -0.867 . . . . 0.0 109.531 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 7.9 ttpt -54.18 -30.07 48.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 0.0 109.534 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -45.45 35.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.145 -0.972 . . . . 0.0 109.627 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -102.04 47.5 0.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 109.773 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 17' ' ' ALA . . . 172.17 -42.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.206 -0.934 . . . . 0.0 109.535 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 21' ' ' GLU . . . -48.42 -79.19 0.07 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.535 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.1 mp -42.75 94.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.28 -1.129 . . . . 0.0 109.867 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.1 pt-20 -88.38 -22.28 23.86 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.239 -0.913 . . . . 0.0 109.439 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.7 163.27 13.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -0.81 . . . . 0.0 109.316 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -151.11 -45.91 0.02 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 p -159.49 -176.95 6.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -1.156 . . . . 0.0 109.671 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.97 116.36 0.01 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -47.21 160.23 0.36 Allowed Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 121.23 -1.159 . . . . 0.0 109.489 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.47 167.53 22.69 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.579 2.186 . . . . 0.0 110.449 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -157.03 -61.27 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.378 -0.826 . . . . 0.0 109.209 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -146.97 38.85 1.0 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.297 -0.877 . . . . 0.0 109.567 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -50.12 112.39 0.67 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -0.912 . . . . 0.0 109.13 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -118.88 115.24 23.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.757 -179.629 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 31' ' ' LYS . 52.7 t 58.94 117.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -0.891 . . . . 0.0 109.727 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.44 ' HB2' ' OE1' ' A' ' 21' ' ' GLU . . . -101.81 156.49 17.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 109.237 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.3 p -145.53 152.51 39.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.003 . . . . 0.0 109.689 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.8 pt -115.54 -175.38 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 109.223 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.76 127.6 45.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.0 109.621 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.408 ' NH1' ' HG3' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -56.1 -35.86 67.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.957 . . . . 0.0 109.121 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -49.07 -38.68 25.02 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.471 -0.768 . . . . 0.0 109.61 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -63.96 -45.77 87.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.119 -0.988 . . . . 0.0 109.665 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.723 HG12 ' HB ' ' A' ' 63' ' ' ILE . 1.8 t -68.55 -11.08 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.039 -1.038 . . . . 0.0 109.132 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.45 -47.49 10.59 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.275 -0.89 . . . . 0.0 108.895 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.516 ' O ' HD23 ' A' ' 46' ' ' LEU . 3.1 tt0 -55.44 -33.97 64.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.266 -0.896 . . . . 0.0 109.226 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 12.7 mt -83.36 -22.9 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.379 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.37 -24.54 61.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.913 . . . . 0.0 109.375 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.459 ' HA ' ' SD ' ' A' ' 48' ' ' MET . 31.2 mt-10 -93.47 -35.8 12.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 109.171 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.516 HD23 ' O ' ' A' ' 42' ' ' GLU . 0.5 OUTLIER -66.93 -8.58 30.47 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.332 -0.855 . . . . 0.0 109.795 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HD2' ' O ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -140.86 48.67 1.7 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.206 -0.934 . . . . 0.0 109.61 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.556 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 3.7 tpp -43.42 -52.97 12.35 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.297 -0.877 . . . . 0.0 109.42 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.556 ' HD3' ' CB ' ' A' ' 48' ' ' MET . 36.2 Cg_endo -79.46 86.3 1.7 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.498 2.132 . . . . 0.0 110.131 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -134.66 -60.23 0.79 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.135 -0.978 . . . . 0.0 109.815 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.694 ' C ' HD12 ' A' ' 51' ' ' LEU . 3.9 pp -127.16 -10.69 5.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 110.091 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.672 ' N ' HD12 ' A' ' 51' ' ' LEU . 10.5 t30 164.35 -89.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.318 -0.864 . . . . 0.0 109.024 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.563 ' CB ' ' HB2' ' A' ' 59' ' ' ALA . . . 63.37 72.4 0.48 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.515 -0.74 . . . . 0.0 109.592 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.81 -30.51 57.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.176 -0.953 . . . . 0.0 108.983 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.484 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -164.17 -61.43 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.364 -0.835 . . . . 0.0 109.247 179.855 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -165.8 -34.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -65.54 -62.82 1.3 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.273 -0.892 . . . . 0.0 110.519 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.95 -38.98 71.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.319 -0.863 . . . . 0.0 110.297 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.563 ' HB2' ' CB ' ' A' ' 53' ' ' ALA . . . -66.3 -70.13 0.26 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.161 -0.962 . . . . 0.0 110.033 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.581 ' HA ' HG12 ' A' ' 63' ' ' ILE . 0.7 OUTLIER -46.68 -28.37 1.47 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.181 -0.949 . . . . 0.0 110.405 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.468 ' HA ' ' OE2' ' A' ' 64' ' ' GLU . 2.3 mmm180 -74.63 -41.28 60.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.975 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.452 ' SD ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -69.49 -47.21 64.61 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.233 -0.917 . . . . 0.0 110.258 -179.3 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.723 ' HB ' HG12 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -52.08 -57.95 3.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.246 -0.909 . . . . 0.0 111.159 -179.421 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.631 ' N ' HD12 ' A' ' 63' ' ' ILE . 9.9 pt-20 -56.44 -55.14 37.34 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 120.946 -1.097 . . . . 0.0 109.519 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.57 -19.41 13.28 Favored Glycine 0 N--CA 1.483 1.778 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.544 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 63.8 m -77.95 -42.82 31.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.473 -1.016 . . . . 0.0 109.119 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -80.72 -1.38 42.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.24 -0.913 . . . . 0.0 108.946 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.98 -55.0 4.46 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.323 -0.861 . . . . 0.0 109.94 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.67 -11.05 43.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.13 -0.981 . . . . 0.0 110.597 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -65.71 -50.35 65.16 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.935 -1.103 . . . . 0.0 110.122 -179.65 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -156.79 -71.56 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.092 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.53 ' C ' HD12 ' A' ' 72' ' ' ILE . 1.0 OUTLIER -98.04 -174.27 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.148 -1.207 . . . . 0.0 109.848 -179.557 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.635 HG22 ' H ' ' A' ' 74' ' ' VAL . 2.3 p -107.98 -179.26 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.465 -0.772 . . . . 0.0 109.043 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.635 ' H ' HG22 ' A' ' 73' ' ' VAL . 0.1 OUTLIER -127.16 159.11 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.989 . . . . 0.0 109.308 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 1.9 pp20? -133.81 157.59 45.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.9 t0 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.5 -179.893 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.28 155.72 50.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 109.52 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.747 ' O ' HG22 ' A' ' 4' ' ' ILE . 62.9 m-85 -81.82 113.89 20.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.193 -0.942 . . . . 0.0 109.39 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 3' ' ' PHE . 1.5 tp 81.03 149.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.547 -0.721 . . . . 0.0 109.411 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 t -156.3 161.9 40.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.227 -0.92 . . . . 0.0 109.708 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.72 178.39 7.96 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.313 -0.867 . . . . 0.0 109.389 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 47.5 88.35 0.11 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 109.518 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.482 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 35.9 Cg_endo -78.65 174.43 12.31 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.665 2.243 . . . . 0.0 110.412 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.718 ' O ' HD12 ' A' ' 13' ' ' LEU . 35.9 Cg_endo -77.36 117.65 4.41 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.555 2.17 . . . . 0.0 110.308 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.691 ' HA ' HD13 ' A' ' 13' ' ' LEU . . . -51.88 -50.65 60.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.305 -0.872 . . . . 0.0 109.995 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -42.57 -50.87 5.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.22 -0.925 . . . . 0.0 109.87 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.457 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 42.8 t -56.28 -48.83 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 109.973 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.718 HD12 ' O ' ' A' ' 9' ' ' PRO . 4.9 mp -53.25 -58.08 8.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.145 -0.972 . . . . 0.0 109.835 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.59 ' CD2' ' HB2' ' A' ' 67' ' ' ALA . 0.3 OUTLIER -49.06 -33.5 11.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.907 . . . . 0.0 109.604 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -60.9 -62.89 1.53 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 0.0 110.112 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.86 -3.56 29.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.104 -0.997 . . . . 0.0 109.818 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.43 ' HB1' ' NZ ' ' A' ' 39' ' ' LYS . . . -84.57 -25.16 28.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.079 -1.013 . . . . 0.0 109.426 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.82 -73.55 0.1 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.483 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.88 47.89 0.26 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 mt -51.91 -20.77 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.193 -1.18 . . . . 0.0 109.727 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -100.26 136.93 39.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.225 -0.922 . . . . 0.0 109.519 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 p -135.12 -166.88 1.9 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.927 . . . . 0.0 109.72 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.15 -149.39 0.13 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -122.35 -12.55 8.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.335 -1.097 . . . . 0.0 109.517 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 26' ' ' GLU . . . -154.45 55.76 0.42 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.482 ' CG ' ' HD2' ' A' ' 27' ' ' PRO . 27.9 tt0 -44.1 138.97 3.27 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.248 -1.149 . . . . 0.0 109.532 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.482 ' HD2' ' CG ' ' A' ' 26' ' ' GLU . 36.3 Cg_endo -78.41 135.41 13.29 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.596 2.197 . . . . 0.0 110.369 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.418 ' O ' ' O ' ' A' ' 27' ' ' PRO . 27.1 t30 43.69 89.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.22 -0.925 . . . . 0.0 109.336 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.7 ptt-85 -62.11 146.74 49.61 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.281 -0.887 . . . . 0.0 109.713 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -149.19 -174.45 4.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.366 -0.833 . . . . 0.0 109.245 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.88 118.61 2.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.217 -0.927 . . . . 0.0 109.257 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.632 ' O ' HG13 ' A' ' 32' ' ' VAL . 6.2 p -107.16 38.4 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 109.393 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 34' ' ' THR . . . -132.11 58.69 1.73 Allowed 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.632 -0.668 . . . . 0.0 109.351 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -159.16 150.24 20.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -0.883 . . . . 0.0 109.682 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 35' ' ' ILE . 6.5 pt -145.3 170.3 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.213 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -82.2 142.88 31.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -0.963 . . . . 0.0 109.808 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' A' ' 38' ' ' ASP . 30.0 mtt180 -70.33 -10.41 58.91 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.442 -0.786 . . . . 0.0 109.77 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 37' ' ' ARG . 66.3 t0 -39.5 -50.24 2.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.69 -0.631 . . . . 0.0 109.955 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.43 ' NZ ' ' HB1' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -61.19 -48.24 82.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 0.0 109.726 -179.805 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.78 HG13 ' CG2' ' A' ' 63' ' ' ILE . 46.2 t -45.1 -25.94 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.096 -1.002 . . . . 0.0 109.856 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -84.54 -39.36 18.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.199 -0.938 . . . . 0.0 109.922 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 3.5 tt0 -66.56 -27.87 68.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 0.0 109.924 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.524 HG22 ' HD2' ' A' ' 47' ' ' LYS . 10.7 mt -90.81 -42.41 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.077 -1.015 . . . . 0.0 109.775 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.513 ' HA ' ' CD ' ' A' ' 47' ' ' LYS . . . -56.26 -21.57 24.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.073 -1.017 . . . . 0.0 109.114 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.34 -44.75 12.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.624 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mt -72.21 -10.94 60.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 109.753 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.524 ' HD2' HG22 ' A' ' 43' ' ' ILE . 14.9 ptmt -111.0 29.19 8.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -0.963 . . . . 0.0 110.085 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.58 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -64.88 -51.31 57.87 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.1 -1.0 . . . . 0.0 109.551 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 48' ' ' MET . 36.7 Cg_endo -80.96 57.5 6.56 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.734 2.29 . . . . 0.0 110.605 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.95 -76.67 0.23 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.995 -1.066 . . . . 0.0 109.719 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 51' ' ' LEU . 1.6 pp -89.27 17.99 5.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 109.934 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 51' ' ' LEU . 19.2 t-20 45.23 73.08 0.17 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.152 -0.968 . . . . 0.0 109.464 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.522 ' CB ' ' HB2' ' A' ' 59' ' ' ALA . . . -73.88 138.07 44.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.19 -0.944 . . . . 0.0 109.564 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.41 -68.14 0.2 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.951 . . . . 0.0 109.334 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.475 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -143.25 -52.5 0.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.348 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -165.13 -32.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.319 -0.863 . . . . 0.0 108.971 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -60.57 -70.29 0.18 Allowed 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.102 -0.998 . . . . 0.0 110.323 -179.45 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 57' ' ' GLU . . . -42.8 -58.65 2.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 110.007 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.522 ' HB2' ' CB ' ' A' ' 53' ' ' ALA . . . -49.36 -40.02 34.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.215 -0.928 . . . . 0.0 110.186 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.56 -35.67 81.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.168 -0.957 . . . . 0.0 110.207 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -14.81 58.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.12 -0.988 . . . . 0.0 109.677 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.447 ' SD ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -76.79 -57.46 3.84 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.177 -0.952 . . . . 0.0 109.644 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.78 ' CG2' HG13 ' A' ' 40' ' ' VAL . 9.1 mt -61.31 -36.82 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.063 -1.023 . . . . 0.0 109.585 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -63.95 -48.13 77.72 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.076 -1.015 . . . . 0.0 108.972 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.0 -9.39 34.19 Favored Glycine 0 N--CA 1.48 1.601 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 70' ' ' MET . 85.5 m -87.89 -48.2 7.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -1.13 . . . . 0.0 109.752 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.59 ' HB2' ' CD2' ' A' ' 14' ' ' LEU . . . -80.92 -12.13 59.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.127 -0.983 . . . . 0.0 109.622 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.569 ' NH2' ' CG1' ' A' ' 73' ' ' VAL . 0.1 OUTLIER -88.99 -46.0 9.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.176 -0.952 . . . . 0.0 109.435 179.814 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.59 -23.51 42.66 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.362 -0.837 . . . . 0.0 109.91 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.455 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -65.98 -66.01 0.6 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.195 -0.941 . . . . 0.0 109.354 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -161.62 -92.19 0.09 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.753 ' C ' HD12 ' A' ' 72' ' ' ILE . 2.8 pp -48.96 177.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.441 -1.035 . . . . 0.0 110.298 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.569 ' CG1' ' NH2' ' A' ' 68' ' ' ARG . 0.5 OUTLIER -112.26 -171.19 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.394 -0.816 . . . . 0.0 110.014 -179.525 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.552 ' H ' HG12 ' A' ' 73' ' ' VAL . 3.7 t -134.03 163.78 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.076 -1.015 . . . . 0.0 109.767 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -129.76 176.86 7.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.228 -0.92 . . . . 0.0 109.689 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 t70 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.443 179.97 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.452 ' O ' ' CB ' ' A' ' 2' ' ' THR . 24.6 mtt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.26 0.552 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.452 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.2 OUTLIER 72.16 99.22 0.07 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 109.367 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -74.79 84.82 2.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.642 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.3 tt -163.39 152.39 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.352 -0.842 . . . . 0.0 109.306 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.41 99.41 0.41 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.919 . . . . 0.0 109.768 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -137.99 -156.57 0.7 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.882 . . . . 0.0 109.391 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 19.6 p -98.45 139.66 21.31 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.226 -0.921 . . . . 0.0 109.515 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.621 ' HG2' HD11 ' A' ' 13' ' ' LEU . 35.8 Cg_endo -79.12 173.72 13.04 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.607 2.205 . . . . 0.0 110.454 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.548 ' O ' HD12 ' A' ' 13' ' ' LEU . 34.4 Cg_endo -76.64 151.07 32.0 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.726 2.284 . . . . 0.0 110.32 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . -75.76 -64.55 1.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 110.213 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -41.36 -61.46 1.04 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.313 -0.867 . . . . 0.0 110.141 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.543 ' HB ' ' HG2' ' A' ' 9' ' ' PRO . 17.5 t -65.48 -30.01 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 109.852 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.621 HD11 ' HG2' ' A' ' 8' ' ' PRO . 1.1 mt -50.31 -60.54 2.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.078 -1.013 . . . . 0.0 109.581 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.626 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -59.91 -35.43 74.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 109.726 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -50.32 -63.26 1.17 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.879 . . . . 0.0 109.792 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -21.38 60.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 0.0 109.808 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 14' ' ' LEU . . . -54.84 -45.15 74.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 109.798 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.07 -51.05 5.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 0.0 109.453 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.22 46.55 0.86 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.8 mt -56.11 97.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 O-C-N 121.27 -1.135 . . . . 0.0 109.738 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -150.07 -62.1 0.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.287 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 65.22 59.2 0.83 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.547 -0.721 . . . . 0.0 109.677 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.31 -23.89 7.42 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.14 161.59 37.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -1.134 . . . . 0.0 109.426 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.449 ' O ' ' C ' ' A' ' 26' ' ' GLU . . . 67.84 -113.22 5.29 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -39.76 100.59 0.22 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.552 -0.969 . . . . 0.0 109.95 -179.767 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 28' ' ' ASN . 36.2 Cg_endo -79.04 155.8 26.22 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.479 2.119 . . . . 0.0 110.076 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.446 ' O ' ' O ' ' A' ' 27' ' ' PRO . 3.5 t-20 60.54 150.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.275 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.94 137.19 32.55 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.292 -0.88 . . . . 0.0 109.602 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -169.2 29.44 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.927 . . . . 0.0 109.588 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.18 110.06 0.87 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.178 -0.951 . . . . 0.0 109.265 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.57 ' O ' HG13 ' A' ' 32' ' ' VAL . 8.6 p -162.34 39.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 0.0 109.518 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -124.22 177.28 5.92 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.668 -0.645 . . . . 0.0 109.589 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.73 HG22 ' CG1' ' A' ' 73' ' ' VAL . 5.6 p -81.22 -171.66 3.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -0.914 . . . . 0.0 109.55 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.476 ' CG1' HG22 ' A' ' 74' ' ' VAL . 3.3 pt -140.1 -170.08 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.888 . . . . 0.0 109.588 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.4 ptpt -95.11 130.32 41.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.352 -0.843 . . . . 0.0 109.641 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.404 ' O ' ' C ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -67.35 -8.5 33.04 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.223 -0.923 . . . . 0.0 109.655 179.896 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 37' ' ' ARG . 31.9 t70 -42.5 -54.64 3.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.363 -0.836 . . . . 0.0 109.912 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -42.34 90.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 109.809 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.64 HG13 ' HB ' ' A' ' 63' ' ' ILE . 68.2 t -57.38 -21.59 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.193 -0.942 . . . . 0.0 109.717 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.7 ttp85 -84.87 -59.02 2.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.442 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -48.61 -58.18 5.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 109.509 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.479 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 92.2 mt -56.69 -56.21 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 109.571 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -45.59 -25.27 0.44 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.962 . . . . 0.0 109.564 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -75.44 -57.34 3.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.944 . . . . 0.0 109.663 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.578 HD12 ' C ' ' A' ' 46' ' ' LEU . 4.4 pp -70.46 -4.64 23.67 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.122 -0.986 . . . . 0.0 109.867 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.34 5.26 49.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.146 -0.971 . . . . 0.0 109.572 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.587 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -48.39 -50.06 59.63 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 110.199 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 48' ' ' MET . 34.8 Cg_endo -77.47 77.49 3.83 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.258 1.972 . . . . 0.0 110.575 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.704 ' HB3' HD23 ' A' ' 51' ' ' LEU . 7.7 t0 -172.34 -35.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.388 -0.82 . . . . 0.0 109.412 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.704 HD23 ' HB3' ' A' ' 50' ' ' ASP . 0.1 OUTLIER -143.74 16.56 1.79 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.441 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 52' ' ' ASN . 7.3 p-10 40.58 67.7 0.48 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.506 -0.746 . . . . 0.0 109.833 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.753 ' HB1' ' HB3' ' A' ' 58' ' ' ALA . . . -85.37 154.6 21.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 109.549 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -47.65 -51.44 21.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.17 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.12 -52.1 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.368 -0.833 . . . . 0.0 108.931 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.72 HG22 ' O ' ' A' ' 56' ' ' ILE . 20.8 mm -149.99 9.44 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.453 -0.779 . . . . 0.0 109.612 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -97.61 -52.7 3.68 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 120.899 -1.125 . . . . 0.0 109.717 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.753 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -69.51 -43.41 73.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.365 -0.834 . . . . 0.0 109.352 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.67 -24.33 64.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.355 -0.841 . . . . 0.0 109.438 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.43 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -70.66 -38.69 73.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.311 -0.868 . . . . 0.0 109.63 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.51 -14.85 58.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.276 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.37 -60.65 2.28 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.367 -0.833 . . . . 0.0 109.57 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.64 ' HB ' HG13 ' A' ' 40' ' ' VAL . 15.3 mt -59.34 -36.27 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 109.787 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -62.85 -60.02 4.06 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.083 -1.011 . . . . 0.0 109.498 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.414 ' HA2' ' HB2' ' A' ' 68' ' ' ARG . . . -56.52 -15.85 13.5 Favored Glycine 0 N--CA 1.479 1.547 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.746 HG23 ' SD ' ' A' ' 70' ' ' MET . 60.8 m -74.1 -55.86 5.6 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.243 -1.151 . . . . 0.0 109.153 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.473 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -62.2 -27.2 68.81 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.414 ' HB2' ' HA2' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -47.77 -61.81 1.76 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.525 -0.735 . . . . 0.0 109.17 179.302 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.55 -68.58 0.78 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.332 -0.855 . . . . 0.0 110.312 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.746 ' SD ' HG23 ' A' ' 66' ' ' THR . 1.1 mpt? -45.49 -21.02 0.08 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.177 -0.952 . . . . 0.0 111.615 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' A' ' 67' ' ' ALA . . . -150.1 -133.13 2.09 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 118.898 -1.62 . . . . 0.0 110.764 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.506 ' C ' HD12 ' A' ' 72' ' ' ILE . 1.0 OUTLIER -102.81 -170.26 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.529 -0.983 . . . . 0.0 110.215 -179.354 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.73 ' CG1' HG22 ' A' ' 34' ' ' THR . 9.1 p -84.08 165.06 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -0.869 . . . . 0.0 109.85 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.523 HG12 ' N ' ' A' ' 75' ' ' GLU . 54.5 t -124.7 161.95 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.218 -0.926 . . . . 0.0 109.578 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.523 ' N ' HG12 ' A' ' 74' ' ' VAL . 2.3 pp20? -114.51 135.14 54.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 109.38 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.4 179.929 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.6 mtm . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.445 HG23 ' N ' ' A' ' 3' ' ' PHE . 2.2 t -157.13 -42.24 0.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.89 . . . . 0.0 109.63 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.445 ' N ' HG23 ' A' ' 2' ' ' THR . 13.6 t80 -173.88 46.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -0.92 . . . . 0.0 109.342 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.559 HG23 ' O ' ' A' ' 4' ' ' ILE . 2.6 tp -119.69 71.25 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 109.494 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.08 146.76 47.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.221 -0.925 . . . . 0.0 109.564 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.401 ' O ' ' HB ' ' A' ' 7' ' ' THR . 3.9 tptp -60.35 -178.71 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.501 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.454 ' OG1' ' HD2' ' A' ' 8' ' ' PRO . 8.4 t -179.87 146.98 0.45 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.858 . . . . 0.0 109.448 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.454 ' HD2' ' OG1' ' A' ' 7' ' ' THR . 34.8 Cg_endo -77.28 171.47 17.69 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.61 2.207 . . . . 0.0 110.327 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.56 174.47 12.62 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.622 2.215 . . . . 0.0 110.441 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.471 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -67.51 -66.16 0.6 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.244 -0.91 . . . . 0.0 109.883 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.764 ' HB2' ' SD ' ' A' ' 70' ' ' MET . . . -34.51 -67.73 0.13 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.677 -0.639 . . . . 0.0 110.705 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.1 t -49.55 -44.19 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.07 -1.019 . . . . 0.0 109.906 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 14.8 mt -54.13 -69.41 0.12 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.148 -0.97 . . . . 0.0 109.752 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.805 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -48.48 -26.91 2.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.77 -179.801 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -64.58 0.89 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 0.0 109.717 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.4 tptp -56.68 -32.59 65.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -0.942 . . . . 0.0 109.326 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.414 ' HB1' ' HD3' ' A' ' 39' ' ' LYS . . . -105.01 48.62 0.83 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.569 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.805 ' HB2' ' O ' ' A' ' 14' ' ' LEU . . . -133.13 -36.7 1.0 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.14 -0.975 . . . . 0.0 109.532 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.01 63.19 1.91 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 19.8 mm -70.23 -15.28 19.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 O-C-N 121.24 -1.153 . . . . 0.0 109.748 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -97.83 75.38 2.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -0.908 . . . . 0.0 109.817 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 51.09 -157.22 0.11 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.763 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' A' ' 24' ' ' SER . . . -89.18 -82.04 1.31 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 3.6 t 73.78 141.0 0.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.249 -1.148 . . . . 0.0 109.455 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 26' ' ' GLU . . . 101.99 -150.01 18.15 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.438 ' HG3' ' HD2' ' A' ' 27' ' ' PRO . 19.3 tt0 -44.42 136.49 4.19 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.206 -1.173 . . . . 0.0 109.215 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.438 ' HD2' ' HG3' ' A' ' 26' ' ' GLU . 36.3 Cg_endo -78.49 135.12 12.95 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.522 2.148 . . . . 0.0 110.776 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.89 -173.75 2.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.357 -0.839 . . . . 0.0 109.277 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.15 -36.18 14.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.737 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -156.76 81.14 0.95 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.483 -0.76 . . . . 0.0 109.224 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.47 101.07 8.09 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 109.814 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.8 p -152.23 133.36 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.305 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 51.29 43.51 29.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.856 . . . . 0.0 109.625 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.543 ' O ' HG23 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -161.05 179.62 8.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.409 -0.807 . . . . 0.0 109.678 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.608 HG13 HG13 ' A' ' 74' ' ' VAL . 0.8 OUTLIER -159.7 164.0 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.299 -0.876 . . . . 0.0 109.301 179.582 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.5 146.32 31.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 109.707 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.45 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 3.3 ppt_? -64.04 -17.12 63.06 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.353 -0.842 . . . . 0.0 109.791 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 37' ' ' ARG . 11.9 t70 -46.04 -47.87 16.9 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.112 -0.993 . . . . 0.0 109.258 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.433 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -62.71 -44.78 95.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 0.0 109.322 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.648 HG13 ' HB ' ' A' ' 63' ' ' ILE . 47.9 t -53.09 -20.43 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.299 -0.876 . . . . 0.0 109.585 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.24 -52.6 5.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.301 -0.874 . . . . 0.0 109.546 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -59.21 -21.38 59.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.244 -0.91 . . . . 0.0 109.664 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 39' ' ' LYS . 14.2 mt -101.36 -22.0 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.269 -0.895 . . . . 0.0 109.388 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.709 ' HB1' ' HB1' ' A' ' 59' ' ' ALA . . . -83.49 -4.66 58.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.436 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -97.77 -39.65 8.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.156 -0.965 . . . . 0.0 109.529 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.4 mt -91.91 -29.42 16.69 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.158 -0.964 . . . . 0.0 109.5 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.411 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -81.37 -2.44 49.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -0.867 . . . . 0.0 109.542 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.6 ttp -45.22 105.66 0.48 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.199 -0.938 . . . . 0.0 109.321 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HG2' HD21 ' A' ' 51' ' ' LEU . 35.2 Cg_endo -76.85 -69.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.397 2.065 . . . . 0.0 110.66 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.603 ' C ' HD23 ' A' ' 51' ' ' LEU . 2.6 t0 -169.11 34.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.638 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.694 ' N ' HD23 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -102.23 -16.44 16.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.171 -0.956 . . . . 0.0 109.773 -179.734 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 53' ' ' ALA . 10.7 t-20 48.31 69.38 0.55 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.095 -1.003 . . . . 0.0 109.047 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.545 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . . . -43.0 100.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.344 -0.847 . . . . 0.0 109.495 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 52' ' ' ASN . . . -50.35 -31.12 13.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.233 -0.917 . . . . 0.0 109.385 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.511 ' O ' HG12 ' A' ' 56' ' ' ILE . 16.4 m -145.87 -67.71 0.29 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.199 -0.938 . . . . 0.0 109.219 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.516 HD13 ' HA ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -168.28 -30.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.391 -0.818 . . . . 0.0 109.167 -179.814 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.63 -54.98 30.02 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 120.952 -1.093 . . . . 0.0 109.955 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.545 ' HB3' ' HA ' ' A' ' 53' ' ' ALA . . . -43.8 -72.7 0.05 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.612 -0.68 . . . . 0.0 110.972 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.709 ' HB1' ' HB1' ' A' ' 44' ' ' ALA . . . -52.94 -54.91 27.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.337 -0.852 . . . . 0.0 111.111 -178.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -50.63 -25.83 4.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.077 -1.014 . . . . 0.0 110.815 -178.946 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -81.56 -32.93 31.98 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.015 -1.053 . . . . 0.0 109.643 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.576 ' SD ' HD11 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -70.57 -54.93 10.15 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.218 -0.927 . . . . 0.0 109.534 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.648 ' HB ' HG13 ' A' ' 40' ' ' VAL . 7.5 mt -67.56 -42.36 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.211 -0.931 . . . . 0.0 109.974 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' A' ' 60' ' ' MET . 2.9 tm-20 -60.11 -54.29 47.73 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.083 -1.011 . . . . 0.0 109.61 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.21 -15.87 31.93 Favored Glycine 0 N--CA 1.479 1.548 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.48 ' O ' ' HB2' ' A' ' 70' ' ' MET . 29.9 m -75.0 -55.05 6.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.282 -1.128 . . . . 0.0 109.001 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.487 ' O ' ' C ' ' A' ' 71' ' ' GLY . . . -64.91 -23.84 67.35 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.003 -1.06 . . . . 0.0 108.493 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.44 -51.53 68.07 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.009 -1.057 . . . . 0.0 109.371 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.46 -53.18 3.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.19 -0.944 . . . . 0.0 110.169 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.764 ' SD ' ' HB2' ' A' ' 11' ' ' ALA . 2.5 mmt -62.64 -23.63 67.18 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.233 -0.917 . . . . 0.0 111.12 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.487 ' C ' ' O ' ' A' ' 67' ' ' ALA . . . -142.85 -123.53 1.82 Allowed Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.586 -1.293 . . . . 0.0 110.372 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.544 ' C ' HD12 ' A' ' 72' ' ' ILE . 1.2 pp -115.4 -174.55 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.188 -1.184 . . . . 0.0 109.894 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 34' ' ' THR . 3.8 t -79.53 157.47 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 109.751 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.608 HG13 HG13 ' A' ' 35' ' ' ILE . 4.9 t -127.61 170.45 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.936 . . . . 0.0 109.594 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.522 ' H ' HG12 ' A' ' 74' ' ' VAL . 2.0 pt-20 -130.21 149.28 51.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.398 -0.814 . . . . 0.0 109.419 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 t70 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.921 -1.038 . . . . 0.0 109.525 -179.939 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttp . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 2' ' ' THR . 2.5 t -169.56 121.83 0.73 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.19 -0.944 . . . . 0.0 109.398 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.422 ' O ' HG13 ' A' ' 4' ' ' ILE . 0.3 OUTLIER 68.91 62.36 0.32 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.356 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 3' ' ' PHE . 26.9 mt -155.61 -66.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.392 -0.818 . . . . 0.0 109.122 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 m -119.62 44.25 2.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.342 -0.849 . . . . 0.0 109.046 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.467 ' O ' ' HB ' ' A' ' 7' ' ' THR . 4.6 mmtt -100.42 163.24 12.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.333 -0.854 . . . . 0.0 109.656 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 6' ' ' LYS . 8.4 m 70.24 123.12 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.336 -0.853 . . . . 0.0 109.62 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.53 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 34.8 Cg_endo -79.38 176.16 9.96 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.621 2.214 . . . . 0.0 110.187 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.53 ' HD2' ' HB2' ' A' ' 8' ' ' PRO . 34.1 Cg_endo -76.48 118.12 4.79 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.419 2.08 . . . . 0.0 110.152 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -54.6 -45.16 73.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -0.872 . . . . 0.0 109.911 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -41.3 -44.52 2.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.008 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.1 t -75.55 -36.91 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.179 -0.951 . . . . 0.0 110.014 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.484 HD11 ' HG2' ' A' ' 8' ' ' PRO . 90.6 mt -57.77 -33.09 68.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.92 . . . . 0.0 110.093 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.1 -36.27 40.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.052 -1.03 . . . . 0.0 109.802 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.68 -13.54 60.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.214 -0.929 . . . . 0.0 109.964 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -92.58 -29.35 16.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.079 -1.013 . . . . 0.0 109.594 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.13 -47.54 79.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.193 -0.942 . . . . 0.0 109.356 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.23 -49.74 8.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 109.351 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.89 81.81 1.24 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 95.5 mt -56.61 -20.13 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.197 -1.178 . . . . 0.0 109.714 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -96.81 36.94 1.34 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 109.629 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 47.15 -149.11 0.14 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.94 . . . . 0.0 109.428 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.3 -149.88 1.83 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.48 15.54 15.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.244 -1.151 . . . . 0.0 109.497 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.456 ' O ' ' HD3' ' A' ' 27' ' ' PRO . . . 163.49 -92.98 0.11 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -40.89 100.89 0.23 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.474 -1.015 . . . . 0.0 109.543 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 25' ' ' GLY . 36.1 Cg_endo -77.95 128.64 9.31 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.483 2.122 . . . . 0.0 110.787 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -94.58 110.93 22.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.326 -0.859 . . . . 0.0 109.163 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.07 120.94 31.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.158 -0.964 . . . . 0.0 110.037 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -166.52 -159.69 0.38 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.339 -0.851 . . . . 0.0 109.252 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -66.08 156.13 34.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.191 -0.943 . . . . 0.0 109.346 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.2 t -52.12 123.18 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.116 -0.99 . . . . 0.0 109.022 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.62 145.69 32.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 109.978 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 73' ' ' VAL . 1.5 p -125.91 169.18 12.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.379 -0.826 . . . . 0.0 109.265 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.554 HG13 HG13 ' A' ' 74' ' ' VAL . 27.3 pt -107.75 169.91 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 109.41 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt -109.9 164.77 12.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.185 -0.947 . . . . 0.0 109.524 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.486 ' HD2' ' CE ' ' A' ' 60' ' ' MET . 0.3 OUTLIER -60.8 -15.52 30.77 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.285 -0.885 . . . . 0.0 109.694 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 37' ' ' ARG . 37.1 t0 -43.63 -55.29 4.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 0.0 109.655 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -61.05 -57.42 12.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.221 -0.925 . . . . 0.0 109.692 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.879 HG13 ' HB ' ' A' ' 63' ' ' ILE . 60.8 t -41.68 -28.68 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.89 . . . . 0.0 110.407 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -74.66 -49.91 19.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.078 -1.014 . . . . 0.0 110.216 -179.447 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -67.73 -21.08 65.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.078 -1.014 . . . . 0.0 110.109 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 19.7 mt -101.33 -13.62 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.457 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.57 ' HB2' ' O ' ' A' ' 40' ' ' VAL . . . -88.15 -14.25 39.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.317 -0.865 . . . . 0.0 109.252 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.67 -52.86 4.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.345 -0.847 . . . . 0.0 109.624 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.2 mt -88.11 32.03 0.77 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -0.944 . . . . 0.0 109.695 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -159.43 23.55 0.19 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.211 -0.931 . . . . 0.0 109.407 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -121.97 85.28 45.47 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.312 -0.867 . . . . 0.0 109.623 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.544 ' HD2' HD23 ' A' ' 51' ' ' LEU . 36.4 Cg_endo -80.42 43.61 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.865 2.376 . . . . 0.0 110.755 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 18.9 t0 53.99 25.63 5.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.062 -1.024 . . . . 0.0 109.23 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 52' ' ' ASN . 1.9 pp -44.44 -39.29 4.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.616 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.557 ' N ' HD12 ' A' ' 51' ' ' LEU . 7.1 t-20 161.47 95.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.636 -0.665 . . . . 0.0 109.21 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.836 ' CB ' ' HB3' ' A' ' 58' ' ' ALA . . . -171.31 139.31 1.3 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.946 . . . . 0.0 109.425 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 53' ' ' ALA . . . -45.09 -59.6 2.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.202 -0.936 . . . . 0.0 109.127 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.8 -65.43 0.1 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.342 -0.849 . . . . 0.0 108.959 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.539 ' O ' ' CG2' ' A' ' 56' ' ' ILE . 2.7 mm -137.82 1.84 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.385 -0.822 . . . . 0.0 108.99 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.32 -57.07 3.22 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.039 -1.038 . . . . 0.0 109.681 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.836 ' HB3' ' CB ' ' A' ' 53' ' ' ALA . . . -64.26 -52.23 59.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.387 -0.821 . . . . 0.0 109.532 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.593 ' H ' ' HB1' ' A' ' 53' ' ' ALA . . . -51.3 -40.96 60.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 109.4 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.486 ' CE ' ' HD2' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -62.56 -37.94 88.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.867 . . . . 0.0 109.671 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.524 ' HA ' ' CG ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -68.05 -16.75 64.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.581 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.404 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -78.56 -53.7 6.93 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.287 -0.883 . . . . 0.0 109.835 -179.724 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.879 ' HB ' HG13 ' A' ' 40' ' ' VAL . 7.8 mt -60.57 -42.3 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.179 -0.951 . . . . 0.0 109.714 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.524 ' CG ' ' HA ' ' A' ' 61' ' ' ARG . 2.0 pp20? -64.25 -44.62 91.23 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.961 -1.087 . . . . 0.0 109.602 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.49 -12.38 55.89 Favored Glycine 0 C--N 1.298 -1.568 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 14.7 m -84.8 -56.11 3.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.401 -1.058 . . . . 0.0 109.644 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -64.46 -31.07 72.13 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.93 -1.106 . . . . 0.0 108.75 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -60.13 4.15 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.331 -0.856 . . . . 0.0 109.433 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.51 -56.25 3.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.092 -1.005 . . . . 0.0 109.876 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.45 ' HB2' ' O ' ' A' ' 66' ' ' THR . 9.5 mtp -64.49 -10.01 22.66 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.321 -0.862 . . . . 0.0 111.009 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 67' ' ' ALA . . . -142.94 -130.73 2.48 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.272 -1.442 . . . . 0.0 110.839 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.511 ' C ' HD12 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -101.31 -169.83 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.491 -1.005 . . . . 0.0 110.301 -179.217 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.406 ' O ' ' HB ' ' A' ' 34' ' ' THR . 1.4 t -81.94 145.76 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -0.846 . . . . 0.0 109.69 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.554 HG13 HG13 ' A' ' 35' ' ' ILE . 20.6 t -120.36 147.28 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.407 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 35' ' ' ILE . 12.4 pt-20 -95.27 139.82 31.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.302 -0.874 . . . . 0.0 109.477 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.9 t0 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.438 179.917 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.537 ' HG2' ' CG2' ' A' ' 12' ' ' VAL . 34.5 Cg_endo . . . . . 0 C--O 1.215 -0.658 0 N-CA-C 110.311 -0.688 . . . . 0.0 110.311 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -72.07 -61.18 1.88 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 109.828 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -39.64 -54.5 2.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.507 -0.746 . . . . 0.0 110.031 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.537 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 89.6 t -59.82 -41.59 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.106 -0.996 . . . . 0.0 109.668 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 9' ' ' PRO . 0.8 OUTLIER -55.35 -65.05 0.65 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.931 . . . . 0.0 109.62 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.725 HD11 HG23 ' A' ' 63' ' ' ILE . 2.1 mt -46.25 -27.12 0.93 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.163 -0.96 . . . . 0.0 109.209 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.5 -47.54 66.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.867 . . . . 0.0 109.39 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -67.74 -13.45 62.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.338 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.22 -42.04 80.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.381 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.196 -0.94 . . . . 0.0 109.51 179.966 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.98 148.08 25.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 109.403 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.426 HG13 HG13 ' A' ' 74' ' ' VAL . 38.9 pt -107.19 -174.28 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.213 -0.929 . . . . 0.0 109.536 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.49 ' HB3' ' OD1' ' A' ' 38' ' ' ASP . 20.3 tptt -96.44 167.01 11.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.253 -0.904 . . . . 0.0 109.757 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.64 -24.77 31.25 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.282 -0.887 . . . . 0.0 109.726 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.49 ' OD1' ' HB3' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -48.77 -38.11 20.93 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.135 -0.978 . . . . 0.0 109.417 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.403 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 6.9 mmtp -59.48 -45.58 91.27 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.317 -0.864 . . . . 0.0 109.441 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.721 HG13 ' HB ' ' A' ' 63' ' ' ILE . 39.4 t -58.3 -23.48 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.354 -0.841 . . . . 0.0 109.734 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 3.4 ttm180 -83.7 -42.07 17.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.179 -0.95 . . . . 0.0 109.507 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -62.75 -59.39 4.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.332 -0.855 . . . . 0.0 109.93 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 16.3 mt -56.54 -50.75 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.925 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.423 ' N ' HD11 ' A' ' 63' ' ' ILE . . . -59.17 -21.43 59.38 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 109.931 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -78.61 -37.67 41.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.145 -0.972 . . . . 0.0 109.68 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.5 mt -82.82 -17.29 44.54 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.19 -0.944 . . . . 0.0 109.623 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.419 ' C ' ' HD2' ' A' ' 49' ' ' PRO . 0.2 OUTLIER -121.4 8.9 10.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.437 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.575 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -44.41 -51.41 20.18 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 0.0 109.893 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 48' ' ' MET . 35.2 Cg_endo -78.48 97.7 1.15 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.338 2.026 . . . . 0.0 110.436 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -170.15 -46.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.29 -0.881 . . . . 0.0 109.594 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' A' ' 52' ' ' ASN . 0.9 OUTLIER -115.57 39.43 2.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -0.95 . . . . 0.0 109.584 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 51' ' ' LEU . 32.5 t30 41.98 57.85 3.07 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.396 -0.815 . . . . 0.0 109.747 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.94 173.6 3.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.228 -0.92 . . . . 0.0 109.446 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -86.66 -45.92 10.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.905 . . . . 0.0 109.263 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.46 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -174.57 -39.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.303 -0.873 . . . . 0.0 109.3 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -172.93 -32.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -63.55 -59.98 3.93 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.411 -0.806 . . . . 0.0 109.995 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.97 -44.35 74.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 109.657 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.85 -24.22 66.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.227 -0.921 . . . . 0.0 109.656 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.85 -29.76 56.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 109.855 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -77.74 -23.35 49.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.9 . . . . 0.0 109.721 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.11 -56.05 5.01 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.19 -0.944 . . . . 0.0 109.892 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.725 HG23 HD11 ' A' ' 14' ' ' LEU . 6.4 mt -56.0 -38.06 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.111 -0.993 . . . . 0.0 109.857 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 15.9 mt-10 -60.34 -55.03 38.56 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.106 -0.996 . . . . 0.0 109.474 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -52.94 -17.43 4.99 Favored Glycine 0 N--CA 1.482 1.754 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.556 HG21 HD12 ' A' ' 14' ' ' LEU . 61.1 m -84.57 -50.01 8.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.118 -1.225 . . . . 0.0 110.267 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.704 ' HB3' HG21 ' A' ' 74' ' ' VAL . . . -86.41 3.68 42.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.079 -1.013 . . . . 0.0 110.058 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 10.4 mtp180 -104.32 -36.3 7.66 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.058 -1.026 . . . . 0.0 109.415 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.96 -8.36 37.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 110.038 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.473 ' HG3' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -77.55 -62.94 1.5 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.074 -1.016 . . . . 0.0 109.544 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -159.19 -86.54 0.06 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.796 ' C ' HD12 ' A' ' 72' ' ' ILE . 2.5 pp -59.88 174.21 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -1.124 . . . . 0.0 109.665 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.481 ' N ' HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -114.5 157.76 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.37 -0.831 . . . . 0.0 109.211 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.704 HG21 ' HB3' ' A' ' 67' ' ' ALA . 2.3 t -115.8 142.79 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.443 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 13.0 pt-20 -105.1 97.38 7.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.268 -0.895 . . . . 0.0 109.491 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.425 ' HB2' ' OE2' ' A' ' 64' ' ' GLU . 51.2 t0 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.507 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.632 ' HA ' ' CD2' ' A' ' 13' ' ' LEU . 36.7 Cg_endo . . . . . 0 CA--C 1.54 0.785 0 CA-C-O 121.899 0.708 . . . . 0.0 112.698 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.507 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . 32.0 -121.12 0.06 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.209 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.507 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -24.0 -61.78 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.831 -0.543 . . . . 0.0 112.273 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.6 t -62.85 -47.47 92.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.004 -1.06 . . . . 0.0 110.849 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.632 ' CD2' ' HA ' ' A' ' 9' ' ' PRO . 1.3 mm? -60.97 -18.0 54.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.794 -1.191 . . . . 0.0 109.977 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 15' ' ' LYS . 17.7 mt -86.38 -53.74 4.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.088 -1.007 . . . . 0.0 109.717 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -45.5 -44.89 12.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -0.967 . . . . 0.0 109.181 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -40.47 86.47 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.335 -0.853 . . . . 0.0 109.416 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.409 ' HB1' ' HG2' ' A' ' 39' ' ' LYS . . . -51.09 -37.64 46.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.432 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.895 . . . . 0.0 109.588 -179.889 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.456 HG22 ' CG2' ' A' ' 73' ' ' VAL . 1.0 OUTLIER -132.16 179.34 6.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 109.321 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.622 HD11 ' HB1' ' A' ' 67' ' ' ALA . 8.9 pt -120.04 -175.19 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.913 . . . . 0.0 109.552 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -109.04 156.91 19.21 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.262 -0.899 . . . . 0.0 109.653 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.98 -16.31 64.27 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.3 -0.875 . . . . 0.0 109.628 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.441 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 11.7 t70 -48.25 -44.51 33.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 109.449 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.441 ' NZ ' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -55.0 -61.68 2.15 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.285 -0.884 . . . . 0.0 109.258 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.946 HG13 ' HB ' ' A' ' 63' ' ' ILE . 46.0 t -46.94 -23.42 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.277 -0.89 . . . . 0.0 109.893 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.441 ' HB3' ' O ' ' A' ' 38' ' ' ASP . 4.0 ttt85 -75.12 -61.29 1.94 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.073 -1.017 . . . . 0.0 109.851 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -58.17 -52.64 64.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.233 -0.917 . . . . 0.0 110.032 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 82.8 mt -61.13 -43.06 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.205 -0.935 . . . . 0.0 110.082 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 40' ' ' VAL . . . -52.96 -49.59 65.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.045 -1.034 . . . . 0.0 109.72 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -49.22 78.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.505 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.423 ' N ' ' CD2' ' A' ' 46' ' ' LEU . 0.3 OUTLIER -65.07 -15.02 61.9 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.256 -0.903 . . . . 0.0 110.094 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -102.89 21.46 15.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.139 -0.975 . . . . 0.0 109.919 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.571 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -57.21 -53.83 61.2 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.085 -1.009 . . . . 0.0 109.325 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.571 ' HD3' ' CB ' ' A' ' 48' ' ' MET . 36.5 Cg_endo -79.54 74.49 5.52 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.52 2.146 . . . . 0.0 110.296 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -150.26 -65.35 0.2 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.18 -0.95 . . . . 0.0 109.418 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 52' ' ' ASN . 1.5 pp -117.3 18.85 14.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.37 -0.831 . . . . 0.0 109.368 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 51' ' ' LEU . 1.2 p-10 39.73 68.16 0.4 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.483 -0.761 . . . . 0.0 109.915 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.487 ' CB ' ' HB2' ' A' ' 59' ' ' ALA . . . -63.5 168.35 4.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.171 -0.956 . . . . 0.0 109.501 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 53' ' ' ALA . . . -44.0 -36.54 2.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.893 . . . . 0.0 109.061 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m 174.3 -40.06 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.343 -0.848 . . . . 0.0 108.842 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.7 tt -171.34 -33.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 121.321 -0.862 . . . . 0.0 109.028 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.6 -67.42 0.46 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.297 -0.877 . . . . 0.0 110.331 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -44.67 -39.82 5.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.28 -0.887 . . . . 0.0 110.217 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.487 ' HB2' ' CB ' ' A' ' 53' ' ' ALA . . . -61.26 -44.38 97.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.065 -1.022 . . . . 0.0 110.041 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -40.14 94.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 110.347 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -70.38 -21.05 62.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -0.965 . . . . 0.0 110.151 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -56.45 5.09 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.097 -1.002 . . . . 0.0 109.605 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.946 ' HB ' HG13 ' A' ' 40' ' ' VAL . 15.3 mt -54.37 -35.74 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.256 -0.903 . . . . 0.0 109.423 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 1.2 tt0 -59.21 -56.83 17.09 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.225 -0.922 . . . . 0.0 109.378 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.88 -20.13 2.83 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.522 ' O ' ' CG ' ' A' ' 70' ' ' MET . 12.0 m -79.86 -57.5 3.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.397 -1.061 . . . . 0.0 109.921 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.622 ' HB1' HD11 ' A' ' 35' ' ' ILE . . . -78.15 10.62 2.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.961 . . . . 0.0 110.345 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -105.17 -55.48 2.32 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.993 -1.067 . . . . 0.0 110.476 -179.554 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.87 -25.7 12.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.078 -1.014 . . . . 0.0 111.899 -178.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.547 ' HG3' ' N ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -70.36 -30.81 67.83 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.543 -1.348 . . . . 0.0 110.901 -178.356 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.547 ' N ' ' HG3' ' A' ' 70' ' ' MET . . . -160.83 -123.09 0.66 Allowed Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.206 -1.473 . . . . 0.0 110.744 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.606 ' N ' HD12 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -48.99 -178.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.491 -1.005 . . . . 0.0 110.527 -179.025 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.475 ' O ' HG12 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -110.99 -168.61 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.539 -0.725 . . . . 0.0 109.421 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.429 ' CG2' ' C ' ' A' ' 73' ' ' VAL . 2.1 t -151.34 155.53 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 109.659 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -115.79 135.29 54.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 109.384 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.493 -179.934 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.499 ' O ' ' CG ' ' A' ' 13' ' ' LEU . 34.0 Cg_endo . . . . . 0 C--O 1.215 -0.63 0 N-CA-C 110.403 -0.653 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . -73.3 -55.78 5.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 109.843 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -42.92 -65.25 0.5 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.882 . . . . 0.0 109.884 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.489 ' HB ' ' HG2' ' A' ' 9' ' ' PRO . 92.9 t -61.21 -38.08 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.791 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.499 ' CG ' ' O ' ' A' ' 9' ' ' PRO . 5.3 mt -44.67 -42.48 7.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 109.698 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.595 HD22 ' HB2' ' A' ' 67' ' ' ALA . 0.8 OUTLIER -74.12 -40.35 62.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.087 -1.008 . . . . 0.0 109.553 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -50.06 -37.24 32.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.885 . . . . 0.0 109.296 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -79.6 -33.45 41.56 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.323 -0.861 . . . . 0.0 109.435 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.04 -25.33 58.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.564 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 109.379 179.836 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.453 ' OG1' ' N ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -157.66 176.16 12.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.199 -0.938 . . . . 0.0 109.691 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.9 HG13 HG13 ' A' ' 74' ' ' VAL . 27.3 pt -126.26 160.11 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.438 -0.789 . . . . 0.0 109.37 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.89 122.52 26.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.293 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -57.47 -15.69 7.6 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.231 -0.918 . . . . 0.0 110.083 -179.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 37' ' ' ARG . 31.2 t0 -43.9 -37.27 2.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.048 -1.032 . . . . 0.0 109.351 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.471 ' O ' HG13 ' A' ' 43' ' ' ILE . 13.4 mmtt -65.96 -56.31 12.32 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.155 -0.965 . . . . 0.0 109.11 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.85 HG22 ' CG2' ' A' ' 63' ' ' ILE . 37.9 t -42.06 -28.28 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 109.453 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -69.47 -54.74 12.79 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.305 -0.872 . . . . 0.0 109.375 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.21 -9.77 56.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.265 -0.897 . . . . 0.0 109.912 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 39' ' ' LYS . 11.9 mt -105.07 -8.73 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.098 -1.001 . . . . 0.0 109.855 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.461 ' HA ' ' HG2' ' A' ' 48' ' ' MET . . . -101.87 -19.12 15.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.971 . . . . 0.0 110.047 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -105.57 -32.34 8.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.384 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.6 mt -95.49 11.17 33.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.092 -1.005 . . . . 0.0 110.454 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.423 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -134.47 -53.2 0.83 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.049 -1.032 . . . . 0.0 109.496 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.475 ' HB3' HD21 ' A' ' 51' ' ' LEU . 19.4 mmt -58.86 111.49 3.74 Favored Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 121.31 -0.869 . . . . 0.0 109.733 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.56 ' HD2' ' CD2' ' A' ' 51' ' ' LEU . 34.9 Cg_endo -76.32 -30.7 5.14 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.366 2.044 . . . . 0.0 110.927 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.561 ' C ' ' HG ' ' A' ' 51' ' ' LEU . 12.4 t70 -173.14 -53.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.803 -1.186 . . . . 0.0 110.857 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.85 HD13 ' CE ' ' A' ' 62' ' ' MET . 0.0 OUTLIER 27.04 38.77 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.927 -0.483 . . . . 0.0 111.089 -179.068 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.555 ' N ' ' O ' ' A' ' 50' ' ' ASP . 26.6 t-20 37.63 59.8 1.21 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.498 -0.751 . . . . 0.0 109.928 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.568 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . . . -107.68 134.98 49.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.958 . . . . 0.0 109.798 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.19 -59.33 5.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.276 -0.89 . . . . 0.0 109.22 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.43 ' C ' HG13 ' A' ' 56' ' ' ILE . 3.1 p 178.51 -48.82 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.35 -0.844 . . . . 0.0 109.32 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.588 HG22 ' O ' ' A' ' 56' ' ' ILE . 3.3 mt -137.35 5.14 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 O-C-N 121.175 -0.953 . . . . 0.0 109.345 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 61' ' ' ARG . 0.8 OUTLIER -100.32 -54.24 2.91 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.162 -0.962 . . . . 0.0 110.031 -179.249 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.568 ' HB3' ' HA ' ' A' ' 53' ' ' ALA . . . -80.38 -61.86 1.85 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.325 -0.859 . . . . 0.0 109.959 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.439 ' H ' ' HB1' ' A' ' 53' ' ' ALA . . . -52.08 -37.78 55.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 109.791 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.529 ' CE ' HG23 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -75.91 -41.15 52.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.152 -0.967 . . . . 0.0 110.032 -179.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 57' ' ' GLU . 16.8 mtp180 -74.65 -7.36 52.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.105 -0.997 . . . . 0.0 109.534 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.85 ' CE ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -83.71 -54.85 4.62 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.275 -0.891 . . . . 0.0 109.38 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.85 ' CG2' HG22 ' A' ' 40' ' ' VAL . 10.8 mt -63.69 -36.35 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.625 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -64.49 -50.97 65.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.103 -0.998 . . . . 0.0 109.125 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.07 -12.44 30.13 Favored Glycine 0 N--CA 1.481 1.693 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 13.7 m -84.23 -51.55 6.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -1.147 . . . . 0.0 109.425 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.595 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -79.78 -5.03 54.53 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.254 -0.904 . . . . 0.0 109.638 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 1.5 ttp180 -87.77 -48.09 8.11 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.946 -1.096 . . . . 0.0 109.505 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.59 -49.21 16.89 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.353 -0.842 . . . . 0.0 110.459 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.488 ' HG3' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -100.92 -30.49 11.63 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.127 -0.983 . . . . 0.0 110.496 -178.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.488 ' N ' ' HG3' ' A' ' 70' ' ' MET . . . -89.31 -147.95 17.19 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.96 -1.114 . . . . 0.0 110.674 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.559 ' C ' HD12 ' A' ' 72' ' ' ILE . 1.1 pp -105.87 -170.26 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.517 -0.99 . . . . 0.0 109.995 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.3 t -84.77 111.15 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.145 -0.972 . . . . 0.0 109.676 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.9 HG13 HG13 ' A' ' 35' ' ' ILE . 3.0 t -80.19 153.46 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 0.0 109.378 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 35' ' ' ILE . 14.8 pt-20 -113.63 -176.17 2.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.899 . . . . 0.0 109.458 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.6 t70 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.464 179.983 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.445 ' HD2' ' HB ' ' A' ' 12' ' ' VAL . 35.5 Cg_endo . . . . . 0 C--O 1.215 -0.654 0 N-CA-C 110.543 -0.599 . . . . 0.0 110.543 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -70.66 -68.63 0.42 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.208 -0.932 . . . . 0.0 109.862 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -37.29 -45.03 0.63 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.507 -0.746 . . . . 0.0 110.683 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.445 ' HB ' ' HD2' ' A' ' 9' ' ' PRO . 49.0 t -65.96 -47.32 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.101 -1.0 . . . . 0.0 109.815 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.454 ' HA ' HD23 ' A' ' 13' ' ' LEU . 19.8 mt -57.9 -63.04 1.39 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.669 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.454 HD21 ' HE2' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -44.39 -30.68 0.88 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.263 -0.898 . . . . 0.0 109.744 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 12' ' ' VAL . 10.6 tttt -69.52 -46.45 66.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.73 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.1 9.89 9.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.634 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.06 -23.03 31.01 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.183 -0.948 . . . . 0.0 109.478 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.942 . . . . 0.0 109.386 179.844 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.01 162.29 14.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 109.616 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.909 HD12 ' O ' ' A' ' 36' ' ' LYS . 1.2 pp -136.92 172.9 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -0.844 . . . . 0.0 109.517 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.909 ' O ' HD12 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -86.31 173.95 9.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.747 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -88.34 15.21 8.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.438 -0.789 . . . . 0.0 109.607 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.433 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 6.2 t70 -50.09 -39.95 44.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.599 -0.688 . . . . 0.0 110.194 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.483 ' HE3' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -71.9 -31.25 66.22 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.178 -0.951 . . . . 0.0 110.594 -179.177 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 1.012 HG22 HG22 ' A' ' 63' ' ' ILE . 47.4 t -65.04 -29.1 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.976 -1.077 . . . . 0.0 110.056 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.46 ' NH2' ' HB2' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -82.78 -30.89 28.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.114 -0.991 . . . . 0.0 109.973 -179.524 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 38' ' ' ASP . 6.7 mm-40 -76.26 -58.24 3.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.954 . . . . 0.0 109.819 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.3 mt -61.26 -55.11 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 110.273 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.603 ' HB2' HD12 ' A' ' 63' ' ' ILE . . . -47.25 -50.73 20.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.225 -0.922 . . . . 0.0 110.504 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -71.64 -24.63 61.89 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.044 -1.035 . . . . 0.0 110.368 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 mt -80.38 -11.68 59.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.004 -1.06 . . . . 0.0 109.627 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.48 39.99 1.89 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.265 -0.897 . . . . 0.0 109.274 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.569 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -50.5 -53.21 48.08 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.178 -0.951 . . . . 0.0 109.218 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.569 ' HD3' ' CB ' ' A' ' 48' ' ' MET . 36.8 Cg_endo -80.99 41.54 1.17 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.612 2.208 . . . . 0.0 110.404 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.44 ' HB3' HD23 ' A' ' 51' ' ' LEU . 33.8 t0 -111.13 -14.55 13.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.097 -1.002 . . . . 0.0 109.819 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -127.63 -99.24 0.37 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.13 -0.981 . . . . 0.0 109.591 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 57.0 t30 177.78 34.56 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.187 -0.946 . . . . 0.0 109.454 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.428 ' HB1' ' HB3' ' A' ' 58' ' ' ALA . . . -55.74 164.45 1.11 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.23 -22.38 66.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.267 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.465 ' O ' ' SD ' ' A' ' 48' ' ' MET . 0.1 OUTLIER -172.34 -50.19 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.286 -0.884 . . . . 0.0 108.937 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.439 HG23 ' N ' ' A' ' 57' ' ' GLU . 1.8 tt -174.9 -34.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.439 ' N ' HG23 ' A' ' 56' ' ' ILE . 15.9 tt0 -57.85 -66.1 0.53 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.533 -0.73 . . . . 0.0 109.805 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 57' ' ' GLU . . . -42.63 -36.65 1.46 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.354 -0.841 . . . . 0.0 109.751 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.13 -47.95 75.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.135 -0.978 . . . . 0.0 109.772 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.7 -38.02 83.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.989 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.439 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 35.7 mtp180 -74.0 -18.26 60.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 0.0 109.769 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.75 -39.77 30.29 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.125 -0.984 . . . . 0.0 109.672 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.012 HG22 HG22 ' A' ' 40' ' ' VAL . 7.4 mt -65.46 -42.39 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.143 -0.973 . . . . 0.0 109.874 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.495 ' CD ' ' N ' ' A' ' 65' ' ' GLY . 3.0 pp20? -63.35 -47.09 83.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.996 -1.065 . . . . 0.0 109.384 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.495 ' N ' ' CD ' ' A' ' 64' ' ' GLU . . . -65.4 -11.09 51.61 Favored Glycine 0 N--CA 1.478 1.485 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 70' ' ' MET . 86.2 m -81.57 -44.62 17.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.388 -1.066 . . . . 0.0 109.517 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.547 ' HB3' HG21 ' A' ' 74' ' ' VAL . . . -82.35 -16.09 50.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 108.777 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -40.78 65.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.459 -0.775 . . . . 0.0 109.38 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.81 -31.3 14.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.13 -0.981 . . . . 0.0 109.87 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -53.99 -72.95 0.05 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.211 -0.931 . . . . 0.0 109.19 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 72' ' ' ILE . . . -162.48 -87.74 0.07 OUTLIER Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.495 HD13 ' C ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -39.56 152.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.642 -0.916 . . . . 0.0 110.389 -179.526 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.64 135.52 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.547 HG21 ' HB3' ' A' ' 67' ' ' ALA . 2.1 t -108.63 155.39 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.982 -1.074 . . . . 0.0 110.176 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -110.35 -171.37 1.82 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.396 -0.815 . . . . 0.0 109.123 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.9 t70 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.637 -179.928 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.553 ' HG2' ' CG2' ' A' ' 12' ' ' VAL . 35.8 Cg_endo . . . . . 0 C--O 1.214 -0.682 0 N-CA-C 110.37 -0.666 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.517 ' HA ' HD12 ' A' ' 13' ' ' LEU . . . -52.52 -61.31 2.36 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.294 -0.879 . . . . 0.0 110.129 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -36.4 -40.73 0.25 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.619 -0.676 . . . . 0.0 110.49 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.553 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 72.8 t -74.94 -43.01 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.09 -1.006 . . . . 0.0 109.465 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 10' ' ' ALA . 63.0 mt -56.04 -66.74 0.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.994 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.596 HD13 ' HB2' ' A' ' 67' ' ' ALA . 1.8 pp -57.74 -28.18 63.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.176 -0.953 . . . . 0.0 109.658 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.488 ' N ' ' HG ' ' A' ' 14' ' ' LEU . 57.1 tttt -56.29 -50.81 70.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.546 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -25.54 65.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.686 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.423 ' HB1' ' HE3' ' A' ' 39' ' ' LYS . . . -74.44 -8.84 57.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.201 -0.937 . . . . 0.0 109.58 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.547 ' HB1' HG21 ' A' ' 72' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.61 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.866 HG22 ' O ' ' A' ' 73' ' ' VAL . 0.9 OUTLIER -101.83 140.04 36.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.419 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 pt -91.69 171.79 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.233 -0.917 . . . . 0.0 109.441 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 mtmt -89.75 151.49 21.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 109.357 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.16 -16.58 64.1 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.206 -0.933 . . . . 0.0 109.303 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -45.69 -41.64 10.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.365 -0.835 . . . . 0.0 109.608 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.471 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.7 OUTLIER -59.76 -64.19 1.04 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 109.367 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.893 HG22 ' CG2' ' A' ' 63' ' ' ILE . 56.1 t -45.74 -23.64 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 0.0 109.973 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -42.79 32.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.118 -0.989 . . . . 0.0 110.162 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -84.6 -6.57 59.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.11 -0.994 . . . . 0.0 110.026 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 39' ' ' LYS . 7.6 mt -93.51 -39.68 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.061 -1.024 . . . . 0.0 109.898 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 48' ' ' MET . . . -77.97 -39.68 41.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.148 -0.97 . . . . 0.0 109.525 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -53.87 -20.59 6.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.272 -0.892 . . . . 0.0 109.77 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 46' ' ' LEU . 9.3 mt -96.01 -30.89 13.33 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.141 -0.975 . . . . 0.0 109.653 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 50' ' ' ASP . 33.3 mmtt -131.39 43.51 3.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.913 . . . . 0.0 109.264 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.565 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -64.03 -52.54 55.32 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.387 -0.821 . . . . 0.0 110.01 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 48' ' ' MET . 35.5 Cg_endo -78.21 -3.03 13.06 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.41 2.074 . . . . 0.0 110.575 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.492 ' C ' HD23 ' A' ' 51' ' ' LEU . 18.3 t70 -62.26 -13.32 26.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.348 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.772 ' N ' HD23 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -139.84 27.81 2.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.397 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 51' ' ' LEU . 20.6 t30 42.33 74.58 0.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.344 -0.848 . . . . 0.0 109.622 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.852 ' CB ' ' HB2' ' A' ' 59' ' ' ALA . . . -77.29 155.33 32.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 0.0 109.504 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -45.49 -35.31 3.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.467 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 m 174.87 -44.67 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.253 -0.904 . . . . 0.0 109.107 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.404 HG23 ' N ' ' A' ' 57' ' ' GLU . 1.5 tt -173.5 -33.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.278 -0.889 . . . . 0.0 109.011 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 58' ' ' ALA . 1.2 tt0 -75.23 -66.41 0.77 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.409 -0.807 . . . . 0.0 110.195 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 57' ' ' GLU . . . -42.49 -40.53 2.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.254 -0.904 . . . . 0.0 110.205 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.852 ' HB2' ' CB ' ' A' ' 53' ' ' ALA . . . -60.41 -47.87 84.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.958 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.6 mtm -59.2 -46.7 87.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 110.186 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.6 mtp-105 -66.58 -19.18 65.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 110.006 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -68.36 -50.84 50.34 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.083 -1.011 . . . . 0.0 109.341 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.893 ' CG2' HG22 ' A' ' 40' ' ' VAL . 6.0 mt -59.73 -35.47 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.219 -0.926 . . . . 0.0 109.607 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.91 -52.3 64.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.086 -1.009 . . . . 0.0 109.061 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -55.59 -16.82 11.88 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 75.7 m -82.29 -52.29 7.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.359 -1.083 . . . . 0.0 109.351 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.596 ' HB2' HD13 ' A' ' 14' ' ' LEU . . . -75.71 -3.73 36.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.308 -0.87 . . . . 0.0 109.322 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -86.87 -48.68 7.98 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.211 -0.931 . . . . 0.0 109.299 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.8 p -81.43 -33.2 32.27 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.265 -0.897 . . . . 0.0 109.65 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -70.5 0.09 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.184 -0.948 . . . . 0.0 109.657 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -160.12 -74.29 0.02 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.547 HG21 ' HB1' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -66.74 -174.98 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -1.16 . . . . 0.0 109.939 -179.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.866 ' O ' HG22 ' A' ' 34' ' ' THR . 0.1 OUTLIER -132.17 132.4 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.34 -0.85 . . . . 0.0 109.22 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.528 ' CG2' ' HB3' ' A' ' 67' ' ' ALA . 27.7 t -81.64 157.48 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.632 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.411 ' N ' HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -115.08 95.06 5.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 109.449 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.518 -179.973 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.57 ' HB2' ' CD1' ' A' ' 13' ' ' LEU . 32.9 Cg_endo . . . . . 0 C--O 1.207 -1.07 0 N-CA-C 109.95 -0.827 . . . . 0.0 109.95 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.557 ' C ' ' O ' ' A' ' 9' ' ' PRO . . . -17.63 -66.55 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.191 0.519 . . . . 0.0 111.502 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.66 -51.06 70.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.069 -1.019 . . . . 0.0 109.551 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 9' ' ' PRO . 42.4 t -45.81 -53.36 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.335 -0.853 . . . . 0.0 109.783 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.572 HD23 HG23 ' A' ' 43' ' ' ILE . 8.9 mp -47.17 -70.56 0.09 Allowed 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.331 -0.855 . . . . 0.0 110.15 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.484 ' HA ' HD23 ' A' ' 14' ' ' LEU . 5.4 mt -55.94 -17.23 6.1 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.289 -0.882 . . . . 0.0 110.18 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.83 -38.07 67.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.096 -1.002 . . . . 0.0 109.237 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -79.09 -22.29 45.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.266 -0.896 . . . . 0.0 109.229 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.8 -66.59 0.38 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.219 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.272 -0.892 . . . . 0.0 109.209 179.742 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.79 133.22 34.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 109.575 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.484 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 4.1 pt -107.93 170.88 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 0.0 109.386 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -79.83 147.27 31.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.768 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.18 -6.37 33.92 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.288 -0.882 . . . . 0.0 109.699 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -41.98 -39.88 2.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.33 -0.857 . . . . 0.0 109.945 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -58.25 7.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.148 -0.97 . . . . 0.0 109.693 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.99 HG13 ' HB ' ' A' ' 63' ' ' ILE . 86.1 t -46.73 -27.77 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.303 -0.873 . . . . 0.0 110.024 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -70.92 -46.59 62.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.105 -0.997 . . . . 0.0 109.791 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 43' ' ' ILE . 2.0 tt0 -78.26 -65.4 0.98 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.155 -0.966 . . . . 0.0 109.791 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.572 HG23 HD23 ' A' ' 13' ' ' LEU . 10.8 mt -43.12 -44.8 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.927 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.733 ' HB1' ' HB1' ' A' ' 59' ' ' ALA . . . -64.86 -43.77 91.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.164 -0.96 . . . . 0.0 109.717 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -58.08 -16.49 13.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 109.5 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.42 23.88 2.42 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.29 -0.881 . . . . 0.0 109.499 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.512 ' HD3' ' CB ' ' A' ' 50' ' ' ASP . 0.1 OUTLIER -144.0 18.02 1.77 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.0 109.413 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.553 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -43.73 -54.14 11.18 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.278 -0.889 . . . . 0.0 109.648 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.553 ' HD3' ' CB ' ' A' ' 48' ' ' MET . 36.5 Cg_endo -78.61 73.17 6.03 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.411 2.074 . . . . 0.0 110.438 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.512 ' CB ' ' HD3' ' A' ' 47' ' ' LYS . 36.8 t0 -162.4 -67.89 0.05 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.113 -0.992 . . . . 0.0 109.897 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -114.18 38.7 2.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.139 -0.976 . . . . 0.0 109.868 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 51' ' ' LEU . 4.2 p-10 40.21 28.15 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.479 -0.763 . . . . 0.0 109.916 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.678 ' HB1' ' HB2' ' A' ' 59' ' ' ALA . . . -51.81 124.6 12.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.19 -0.944 . . . . 0.0 109.531 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.458 ' O ' ' CB ' ' A' ' 55' ' ' SER . . . -45.11 -57.92 3.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.939 . . . . 0.0 109.205 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 0.5 OUTLIER 166.32 -45.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.406 -0.809 . . . . 0.0 108.859 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.671 HG22 ' O ' ' A' ' 56' ' ' ILE . 82.5 mt -140.05 7.8 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -104.92 -67.11 0.93 Allowed 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.259 -0.9 . . . . 0.0 109.45 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.09 -37.06 58.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.501 -0.749 . . . . 0.0 109.879 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.733 ' HB1' ' HB1' ' A' ' 44' ' ' ALA . . . -71.08 -31.66 68.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.128 -0.982 . . . . 0.0 109.383 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.498 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -78.64 -39.79 36.05 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.233 -0.917 . . . . 0.0 109.516 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -20.32 62.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.374 -0.829 . . . . 0.0 109.767 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.2 -60.82 2.18 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.179 -0.951 . . . . 0.0 110.075 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.99 ' HB ' HG13 ' A' ' 40' ' ' VAL . 14.9 mt -63.75 -42.75 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.191 -0.943 . . . . 0.0 109.967 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.684 ' HG2' HG21 ' A' ' 74' ' ' VAL . 24.2 tt0 -64.06 -48.52 75.91 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.092 -1.005 . . . . 0.0 109.302 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -67.25 -7.22 43.99 Favored Glycine 0 N--CA 1.478 1.447 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 8.5 m -87.26 -49.53 7.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -1.13 . . . . 0.0 109.46 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -71.49 -36.73 71.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.165 -0.96 . . . . 0.0 109.373 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -64.61 -59.2 4.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.403 -0.811 . . . . 0.0 109.907 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.71 -51.84 68.07 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.244 -0.91 . . . . 0.0 110.045 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.0 -68.88 0.15 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.217 -0.927 . . . . 0.0 109.384 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 72' ' ' ILE . . . -161.96 -88.02 0.07 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.556 HD13 ' C ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -36.39 152.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.884 -0.774 . . . . 0.0 110.279 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.471 ' O ' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -112.88 164.76 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.391 -0.818 . . . . 0.0 108.881 179.527 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.684 HG21 ' HG2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -111.82 -174.55 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.13 -0.981 . . . . 0.0 109.695 -179.583 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 35' ' ' ILE . 0.4 OUTLIER -143.1 151.0 40.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.907 . . . . 0.0 109.267 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.7 t70 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.443 -179.951 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.469 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 35.9 Cg_endo . . . . . 0 C--O 1.215 -0.654 0 N-CA-C 110.398 -0.655 . . . . 0.0 110.398 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.609 ' HA ' HD12 ' A' ' 13' ' ' LEU . . . -47.52 -48.73 27.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.787 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -41.51 -50.58 3.97 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.387 -0.821 . . . . 0.0 109.652 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.408 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 91.5 t -68.34 -36.53 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.69 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.609 HD12 ' HA ' ' A' ' 10' ' ' ALA . 38.4 mt -53.88 -65.85 0.5 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.939 . . . . 0.0 109.57 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 15' ' ' LYS . 1.1 mt -43.18 -48.28 6.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -0.841 . . . . 0.0 109.76 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 14' ' ' LEU . 7.7 ttpt -42.85 -55.18 3.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 109.666 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.33 -43.72 98.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.206 -0.934 . . . . 0.0 109.564 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.592 ' HB1' ' HD3' ' A' ' 39' ' ' LYS . . . -46.63 -35.66 6.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.226 -0.921 . . . . 0.0 109.583 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.184 -0.947 . . . . 0.0 109.422 179.95 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.524 HG22 ' CG1' ' A' ' 73' ' ' VAL . 1.8 p -112.96 142.39 45.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 109.738 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.45 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 2.8 pt -98.31 -170.13 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.333 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.466 ' HE2' ' OE2' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -95.1 167.4 11.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.898 . . . . 0.0 109.712 -179.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 1.051 ' O ' HG12 ' A' ' 40' ' ' VAL . 5.5 mtm180 -97.29 -19.25 18.67 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.236 -0.915 . . . . 0.0 109.681 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.466 ' C ' ' O ' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -37.81 -34.9 0.12 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.67 -0.644 . . . . 0.0 109.929 -179.753 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.592 ' HD3' ' HB1' ' A' ' 17' ' ' ALA . 8.5 mttm -72.93 -48.87 33.23 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.344 -0.848 . . . . 0.0 109.623 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 1.051 HG12 ' O ' ' A' ' 37' ' ' ARG . 9.8 p -51.29 -20.07 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 110.174 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -85.94 -62.39 1.53 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.085 -1.01 . . . . 0.0 109.778 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 16.6 pt-20 -50.19 -27.29 5.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.248 -0.908 . . . . 0.0 110.024 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.677 HG22 ' HB2' ' A' ' 47' ' ' LYS . 20.9 mt -96.75 -34.54 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.061 -1.025 . . . . 0.0 109.635 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.829 ' HB2' ' O ' ' A' ' 40' ' ' VAL . . . -47.43 -33.58 6.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.324 -0.86 . . . . 0.0 109.415 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.467 ' HA ' ' SD ' ' A' ' 48' ' ' MET . 2.6 mt-10 -88.46 -35.85 16.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.848 . . . . 0.0 109.268 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.4 mt -91.78 25.11 2.85 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.346 -0.846 . . . . 0.0 109.412 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.677 ' HB2' HG22 ' A' ' 43' ' ' ILE . 14.2 tppt? -143.35 21.47 1.88 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.135 -0.978 . . . . 0.0 109.841 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.467 ' SD ' ' HA ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -114.32 78.49 4.67 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.024 -1.047 . . . . 0.0 109.733 179.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 47' ' ' LYS . 36.1 Cg_endo -78.53 -44.55 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.594 2.196 . . . . 0.0 110.126 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -120.36 1.62 10.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.41 -0.807 . . . . 0.0 109.343 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.544 ' CG ' ' O ' ' A' ' 51' ' ' LEU . 0.7 OUTLIER -116.39 64.99 0.71 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.253 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 53' ' ' ALA . 42.3 t-20 -41.16 -28.69 0.1 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.867 . . . . 0.0 109.673 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.658 ' HB1' ' HB3' ' A' ' 58' ' ' ALA . . . 60.66 142.15 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.457 -0.777 . . . . 0.0 109.556 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -46.51 -61.86 1.62 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.282 -0.886 . . . . 0.0 109.315 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.455 ' O ' HG12 ' A' ' 56' ' ' ILE . 41.1 p -152.19 -49.96 0.11 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.245 -0.91 . . . . 0.0 109.625 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.483 HD13 ' HA ' ' A' ' 56' ' ' ILE . 8.5 mm -154.48 -33.08 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.253 -0.904 . . . . 0.0 109.202 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.74 -59.39 5.29 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.186 -0.946 . . . . 0.0 110.233 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.658 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -50.16 -58.39 5.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.337 -0.852 . . . . 0.0 110.126 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.97 -21.0 63.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.195 -0.941 . . . . 0.0 109.994 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.449 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -77.4 -33.06 55.14 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.171 -0.956 . . . . 0.0 109.83 -179.673 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.14 -13.32 55.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.63 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -80.81 -57.24 3.64 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.249 -0.907 . . . . 0.0 109.956 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.824 ' CG2' HG23 ' A' ' 40' ' ' VAL . 6.5 mt -63.34 -42.17 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.343 -0.848 . . . . 0.0 109.753 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -63.88 -48.39 76.89 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.975 -1.078 . . . . 0.0 108.93 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.39 -12.88 34.28 Favored Glycine 0 N--CA 1.48 1.621 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.491 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 54.2 m -83.78 -51.68 7.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -1.131 . . . . 0.0 109.017 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -68.56 -17.92 64.24 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.328 -0.858 . . . . 0.0 109.193 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.02 -46.59 34.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.339 -0.851 . . . . 0.0 109.682 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.26 -6.14 53.71 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.166 -0.959 . . . . 0.0 109.802 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -99.23 -49.71 4.38 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.078 -1.014 . . . . 0.0 110.361 -179.45 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.1 -134.58 2.21 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.356 -1.402 . . . . 0.0 111.073 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.526 ' C ' HD12 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -52.81 -171.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.589 -0.948 . . . . 0.0 111.114 -178.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.729 HG22 ' H ' ' A' ' 74' ' ' VAL . 3.5 p -110.56 -175.89 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.729 ' H ' HG22 ' A' ' 73' ' ' VAL . 2.0 t -130.68 156.85 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.991 -1.068 . . . . 0.0 109.559 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.466 ' OE2' ' HE2' ' A' ' 36' ' ' LYS . 16.0 pt-20 -131.05 145.33 51.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 0.0 109.505 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 43.9 t0 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.393 -179.996 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.451 ' HG2' ' CG2' ' A' ' 12' ' ' VAL . 34.4 Cg_endo . . . . . 0 C--O 1.215 -0.658 0 N-CA-C 110.501 -0.615 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.482 ' HA ' HD12 ' A' ' 13' ' ' LEU . . . -62.96 -41.75 99.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.232 -0.917 . . . . 0.0 109.826 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -36.85 -50.04 0.83 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.55 -0.719 . . . . 0.0 110.427 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.455 ' H ' HG22 ' A' ' 12' ' ' VAL . 2.4 m -72.02 -38.89 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.037 -1.039 . . . . 0.0 109.444 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 10' ' ' ALA . 65.1 mt -54.39 -66.81 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.403 -0.81 . . . . 0.0 109.934 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 18' ' ' ALA . 3.5 pp -52.76 -30.19 31.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 110.294 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.455 ' N ' HD12 ' A' ' 14' ' ' LEU . 19.4 tttt -53.11 -62.38 1.69 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.035 -1.041 . . . . 0.0 110.022 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -69.1 -28.76 66.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.055 -1.028 . . . . 0.0 109.666 -179.732 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.616 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -89.97 5.86 44.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.954 . . . . 0.0 109.701 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.681 ' O ' HD13 ' A' ' 35' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.099 -1.0 . . . . 0.0 109.643 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.845 ' O ' HG12 ' A' ' 73' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.643 HG22 ' CG1' ' A' ' 73' ' ' VAL . 11.9 p -142.72 164.37 30.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.561 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.681 HD13 ' O ' ' A' ' 18' ' ' ALA . 3.4 pt -150.88 167.03 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 109.522 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -79.71 131.52 35.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.139 -0.976 . . . . 0.0 109.355 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -74.17 -8.01 54.66 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.133 -0.98 . . . . 0.0 109.554 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 37' ' ' ARG . 48.6 t0 -42.78 -33.08 0.69 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.302 -0.874 . . . . 0.0 109.716 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.434 ' HD2' HD11 ' A' ' 43' ' ' ILE . 1.4 mmtt -71.87 -52.82 15.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 109.338 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.937 HG13 ' HB ' ' A' ' 63' ' ' ILE . 57.8 t -48.37 -23.43 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.393 -0.817 . . . . 0.0 109.681 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.81 -44.13 17.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 0.0 109.661 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.42 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 7.4 mm-40 -72.71 -13.55 61.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.222 -0.924 . . . . 0.0 109.849 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.434 HD11 ' HD2' ' A' ' 39' ' ' LYS . 8.0 mt -105.2 -18.5 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.104 -0.997 . . . . 0.0 109.47 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 48' ' ' MET . . . -82.31 -34.98 28.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 109.544 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.27 -22.08 35.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.445 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.421 ' HA ' HD23 ' A' ' 46' ' ' LEU . 4.8 mt -73.4 -44.8 57.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.9 . . . . 0.0 109.445 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -119.58 32.32 6.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.307 -0.87 . . . . 0.0 109.177 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.57 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -48.08 -51.29 49.73 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.384 -0.822 . . . . 0.0 110.007 -179.73 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 48' ' ' MET . 36.4 Cg_endo -80.68 57.62 6.61 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.657 2.238 . . . . 0.0 110.76 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -136.68 4.45 2.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.171 -0.956 . . . . 0.0 109.672 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.616 HD12 ' H ' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -141.71 -91.58 0.14 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.071 -1.018 . . . . 0.0 109.464 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.616 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.4 t30 -176.63 87.09 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.301 -0.875 . . . . 0.0 109.757 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.457 ' CB ' ' HB3' ' A' ' 58' ' ' ALA . . . -120.37 178.69 4.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -0.909 . . . . 0.0 109.303 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -128.99 -38.35 1.65 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.295 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.425 ' O ' HG12 ' A' ' 56' ' ' ILE . 13.6 m -127.61 -63.82 1.01 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.257 -0.902 . . . . 0.0 109.108 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -175.96 -31.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.385 -0.822 . . . . 0.0 108.8 179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.543 ' HA ' ' CG ' ' A' ' 60' ' ' MET . 1.1 tt0 -56.89 -47.94 79.34 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.321 -0.862 . . . . 0.0 109.883 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.457 ' HB3' ' CB ' ' A' ' 53' ' ' ALA . . . -51.63 -43.23 62.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.389 -0.819 . . . . 0.0 110.148 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.01 -61.49 1.76 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.069 -1.019 . . . . 0.0 110.08 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.543 ' CG ' ' HA ' ' A' ' 57' ' ' GLU . 1.7 ppp? -52.86 -19.55 2.61 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.197 -0.94 . . . . 0.0 109.961 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -83.72 -34.88 24.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.175 -0.953 . . . . 0.0 109.599 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -47.41 72.88 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.283 -0.885 . . . . 0.0 109.713 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.937 ' HB ' HG13 ' A' ' 40' ' ' VAL . 8.9 mt -62.99 -40.4 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.938 . . . . 0.0 109.881 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.05 -49.65 73.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.88 -1.137 . . . . 0.0 109.383 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.12 -13.64 28.64 Favored Glycine 0 N--CA 1.479 1.562 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.497 ' O ' ' HB2' ' A' ' 70' ' ' MET . 50.4 m -86.14 -47.42 9.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.389 -1.065 . . . . 0.0 109.918 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -70.21 -19.04 63.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 109.775 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.462 ' CG ' HG23 ' A' ' 73' ' ' VAL . 1.9 ttp180 -79.35 -58.8 3.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.237 -0.914 . . . . 0.0 109.814 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.03 -25.0 63.37 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.23 -0.919 . . . . 0.0 110.329 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.497 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -96.24 -21.86 17.6 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.997 -1.065 . . . . 0.0 110.741 -179.114 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -154.8 -141.97 3.35 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.27 -1.443 . . . . 0.0 110.751 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.587 ' N ' HD12 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -70.81 -174.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.568 -0.96 . . . . 0.0 110.308 -179.315 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.845 HG12 ' O ' ' A' ' 33' ' ' ALA . 1.4 p -90.45 -172.46 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.474 -0.766 . . . . 0.0 108.984 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.667 ' H ' HG22 ' A' ' 73' ' ' VAL . 84.3 t -132.76 135.17 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.079 -1.013 . . . . 0.0 109.729 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 35' ' ' ILE . 22.4 pt-20 -98.65 160.6 14.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 109.26 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 43.6 t0 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.986 -1.006 . . . . 0.0 109.495 -179.957 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.441 ' HD2' ' HB ' ' A' ' 12' ' ' VAL . 36.0 Cg_endo . . . . . 0 C--O 1.215 -0.626 0 N-CA-C 110.559 -0.593 . . . . 0.0 110.559 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -84.02 -68.09 0.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.194 -0.942 . . . . 0.0 109.656 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -40.18 -53.8 2.42 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.422 -0.799 . . . . 0.0 109.973 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.441 ' HB ' ' HD2' ' A' ' 9' ' ' PRO . 48.8 t -60.14 -43.04 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 109.616 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 13' ' ' LEU . 7.9 mt -51.46 -48.13 62.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.214 -0.929 . . . . 0.0 109.789 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.445 ' CD1' HG22 ' A' ' 66' ' ' THR . 8.5 mt -67.4 -27.28 66.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.622 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -69.8 -30.84 68.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.481 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -76.56 -48.3 19.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 0.0 109.489 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.71 37.5 0.96 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.906 . . . . 0.0 109.465 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.768 ' HB1' HG21 ' A' ' 72' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.427 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.2 p -125.81 176.76 6.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.312 -0.867 . . . . 0.0 109.373 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.766 HD12 ' HE2' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -141.1 168.76 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.166 179.77 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.484 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 15.8 ttmt -85.64 171.06 11.96 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.222 -0.924 . . . . 0.0 109.702 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.458 ' HD3' ' OE1' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -72.51 -14.37 61.64 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.34 -0.85 . . . . 0.0 109.474 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 37' ' ' ARG . 4.6 t0 -41.71 -33.64 0.52 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.492 -0.755 . . . . 0.0 109.674 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.766 ' HE2' HD12 ' A' ' 35' ' ' ILE . 1.8 ttpt -69.24 -61.86 1.61 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.191 -0.943 . . . . 0.0 109.442 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.896 HG13 ' HB ' ' A' ' 63' ' ' ILE . 84.8 t -49.69 -20.58 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.885 . . . . 0.0 110.053 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -72.96 -51.34 18.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.023 -1.048 . . . . 0.0 110.369 -179.438 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.478 ' HG3' ' N ' ' A' ' 43' ' ' ILE . 16.8 pt-20 -73.78 -39.2 64.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.02 -1.05 . . . . 0.0 110.476 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.518 ' HB ' HD13 ' A' ' 63' ' ' ILE . 9.6 mt -73.05 -14.44 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.101 -0.999 . . . . 0.0 109.917 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 40' ' ' VAL . . . -92.88 -26.52 17.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.096 -1.002 . . . . 0.0 109.748 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 2.4 pt-20 -96.39 -2.64 45.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.12 -0.987 . . . . 0.0 109.664 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 43' ' ' ILE . 0.3 OUTLIER -73.34 -24.82 60.41 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.235 -0.915 . . . . 0.0 109.744 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.429 ' N ' ' HG ' ' A' ' 46' ' ' LEU . 5.2 ttmt -159.07 58.4 0.42 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.144 -0.972 . . . . 0.0 109.394 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.559 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 1.3 mtp -43.87 -52.87 14.01 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.416 -0.803 . . . . 0.0 110.349 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 48' ' ' MET . 34.0 Cg_endo -77.04 96.26 1.1 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.417 2.078 . . . . 0.0 110.591 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 24.4 t0 178.7 -40.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.366 -0.834 . . . . 0.0 109.38 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.443 ' O ' ' C ' ' A' ' 52' ' ' ASN . 0.5 OUTLIER -107.34 35.84 2.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 109.594 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER 40.56 76.45 0.07 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.459 -0.776 . . . . 0.0 109.755 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.75 139.98 33.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.23 -0.919 . . . . 0.0 109.353 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.94 -47.85 64.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 109.497 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.52 -52.56 0.09 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.245 -0.91 . . . . 0.0 108.851 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.7 tt -175.41 -31.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.303 -0.873 . . . . 0.0 109.242 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -60.2 -53.65 55.22 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.279 -0.888 . . . . 0.0 109.448 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.04 -53.22 44.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.427 -0.795 . . . . 0.0 109.842 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.62 -42.32 61.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.795 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.46 -38.22 90.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.19 -0.943 . . . . 0.0 110.121 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -76.1 -15.99 59.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 109.656 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.61 -59.95 2.57 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.229 -0.92 . . . . 0.0 109.586 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.896 ' HB ' HG13 ' A' ' 40' ' ' VAL . 24.1 mt -57.38 -35.26 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.248 -0.908 . . . . 0.0 109.987 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.458 ' OE1' ' HD3' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -62.29 -51.53 67.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.091 -1.006 . . . . 0.0 109.326 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.81 -9.67 27.99 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 70' ' ' MET . 87.6 m -87.29 -51.17 6.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -1.114 . . . . 0.0 110.026 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -76.69 -14.97 59.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 109.736 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.66 -57.11 3.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.67 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.0 -21.84 62.24 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.284 -0.885 . . . . 0.0 110.172 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -65.08 -65.89 0.61 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.079 -1.013 . . . . 0.0 109.609 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -161.13 -65.96 0.02 OUTLIER Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.267 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.877 HD12 ' N ' ' A' ' 73' ' ' VAL . 1.7 pp -72.62 -179.37 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -1.117 . . . . 0.0 110.513 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.877 ' N ' HD12 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -126.33 151.59 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.583 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.31 168.53 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.146 -0.972 . . . . 0.0 109.588 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.484 ' HG3' ' HA ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -123.75 125.66 45.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.308 -0.87 . . . . 0.0 109.582 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.1 t0 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.52 179.931 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.473 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 35.4 Cg_endo . . . . . 0 C--O 1.214 -0.695 0 N-CA-C 110.431 -0.642 . . . . 0.0 110.431 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -73.74 -65.04 0.88 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.963 . . . . 0.0 109.822 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.506 ' HA ' ' CE ' ' A' ' 70' ' ' MET . . . -36.69 -39.27 0.2 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.565 -0.709 . . . . 0.0 110.703 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.433 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 38.8 t -75.35 -51.43 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.022 -1.049 . . . . 0.0 109.865 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 13' ' ' LEU . 21.5 mt -51.37 -60.96 2.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.054 -1.028 . . . . 0.0 109.366 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.512 HD13 HG22 ' A' ' 66' ' ' THR . 0.2 OUTLIER -50.06 -40.39 45.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.599 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' LYS . 14.4 mttt -52.89 -65.89 0.48 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 109.196 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -44.46 -26.37 0.34 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 108.944 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.726 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -105.22 51.89 0.75 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.454 -0.779 . . . . 0.0 109.34 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' A' ' 17' ' ' ALA . . . . . . . . 0 N--CA 1.497 1.901 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.312 0.577 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.445 ' OG1' ' HA ' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -95.95 171.08 8.85 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.294 -0.879 . . . . 0.0 109.733 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.6 HG21 ' CB ' ' A' ' 18' ' ' ALA . 6.9 pt -85.01 -173.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.374 -0.829 . . . . 0.0 109.91 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -99.3 147.81 24.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 0.0 109.572 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -73.99 -10.13 59.33 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.277 -0.889 . . . . 0.0 109.604 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 37' ' ' ARG . 0.4 OUTLIER -42.6 -51.73 5.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.334 -0.854 . . . . 0.0 109.837 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.465 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -57.32 -45.03 84.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.701 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.942 HG13 ' CG2' ' A' ' 63' ' ' ILE . 75.4 t -56.0 -28.06 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -0.846 . . . . 0.0 110.474 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -75.59 -51.62 12.46 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.986 -1.071 . . . . 0.0 110.072 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -60.97 -29.87 69.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 0.0 110.044 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 39' ' ' LYS . 45.3 mt -83.02 -34.37 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.006 -1.059 . . . . 0.0 109.981 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.03 -9.4 58.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.088 -1.008 . . . . 0.0 109.793 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -99.35 -33.67 10.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.148 -0.97 . . . . 0.0 109.525 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.815 ' O ' HD12 ' A' ' 46' ' ' LEU . 0.7 OUTLIER -77.47 -11.43 59.85 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.225 -0.922 . . . . 0.0 109.998 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -132.08 34.88 3.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 109.673 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.58 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 4.3 ttp -50.57 -48.41 82.18 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.163 -0.961 . . . . 0.0 109.808 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 48' ' ' MET . 35.9 Cg_endo -78.84 82.01 2.62 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.059 1.839 . . . . 0.0 110.168 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -144.57 -46.63 0.25 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -0.945 . . . . 0.0 109.794 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.416 HD13 ' SD ' ' A' ' 62' ' ' MET . 0.5 OUTLIER -117.41 22.29 12.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.212 -0.93 . . . . 0.0 109.681 -179.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 51' ' ' LEU . 3.5 t-20 44.14 72.62 0.18 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.157 -0.964 . . . . 0.0 109.556 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.414 ' HB1' ' HB3' ' A' ' 58' ' ' ALA . . . -100.87 174.05 6.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -0.942 . . . . 0.0 109.325 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.85 -57.69 9.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 0.0 109.521 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.1 m -162.9 -56.6 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.627 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.515 HD13 ' HA ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -157.23 -32.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.251 -0.906 . . . . 0.0 109.064 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -49.55 -65.0 0.64 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.164 -0.96 . . . . 0.0 110.085 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.414 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -53.6 -43.22 68.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.393 -0.817 . . . . 0.0 110.383 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.58 -28.94 68.87 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.024 -1.047 . . . . 0.0 110.15 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -31.3 49.52 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.127 -0.983 . . . . 0.0 109.311 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.429 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -77.32 -16.25 59.02 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.434 -0.791 . . . . 0.0 109.01 179.581 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.416 ' SD ' HD13 ' A' ' 51' ' ' LEU . 3.2 mtp -77.41 -52.06 9.76 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.4 -0.813 . . . . 0.0 109.461 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.942 ' CG2' HG13 ' A' ' 40' ' ' VAL . 2.3 mt -66.07 -45.88 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.762 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.543 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 7.8 pt-20 -64.01 -47.36 80.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.914 -1.116 . . . . 0.0 109.432 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.543 ' N ' ' HG3' ' A' ' 64' ' ' GLU . . . -61.43 -14.78 43.25 Favored Glycine 0 N--CA 1.479 1.53 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.52 ' O ' ' HG2' ' A' ' 70' ' ' MET . 61.0 m -98.02 -20.98 17.06 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.41 -1.053 . . . . 0.0 109.393 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.557 ' HB3' HG21 ' A' ' 74' ' ' VAL . . . -92.07 -9.39 42.87 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.218 -0.926 . . . . 0.0 109.048 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.788 ' CD ' HG13 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -105.36 -49.08 3.53 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.49 -0.757 . . . . 0.0 110.6 -179.362 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 p -75.54 -39.0 58.89 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.215 -0.928 . . . . 0.0 111.729 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.52 ' HG2' ' O ' ' A' ' 66' ' ' THR . 0.2 OUTLIER -81.62 -27.49 34.15 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 120.636 -1.29 . . . . 0.0 111.628 -177.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.504 ' N ' ' HG3' ' A' ' 70' ' ' MET . . . -149.21 -141.24 3.41 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 118.76 -1.686 . . . . 0.0 111.59 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.52 ' N ' HD12 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -52.25 -166.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.869 -0.783 . . . . 0.0 110.717 -178.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.788 HG13 ' CD ' ' A' ' 68' ' ' ARG . 22.4 t -112.14 165.44 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.349 -0.845 . . . . 0.0 109.951 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.557 HG21 ' HB3' ' A' ' 67' ' ' ALA . 98.1 t -124.55 156.66 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.337 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.492 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 14.4 pt-20 -115.59 110.19 18.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -0.943 . . . . 0.0 109.587 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.7 t0 . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.342 179.842 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.557 ' HG2' ' CG2' ' A' ' 12' ' ' VAL . 32.8 Cg_endo . . . . . 0 C--O 1.216 -0.578 0 CA-C-O 121.652 0.605 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 12' ' ' VAL . . . -54.17 -54.91 33.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.474 -0.766 . . . . 0.0 110.669 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -30.99 -36.84 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.695 -0.628 . . . . 0.0 111.079 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.557 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 1.2 t -81.33 -53.22 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.964 -1.085 . . . . 0.0 109.706 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.48 HD22 ' HD3' ' A' ' 47' ' ' LYS . 2.1 mp -46.42 -45.3 17.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.267 -0.896 . . . . 0.0 109.981 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.446 HD22 ' HB2' ' A' ' 67' ' ' ALA . 5.3 mt -67.24 -37.57 83.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.906 . . . . 0.0 110.015 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.99 -33.93 76.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.275 -0.89 . . . . 0.0 110.387 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -92.96 -8.28 43.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.965 -1.084 . . . . 0.0 109.676 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.421 ' HB1' ' CD ' ' A' ' 39' ' ' LYS . . . -76.27 -37.74 57.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 109.643 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.899 . . . . 0.0 109.675 -179.841 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 34' ' ' THR . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.253 0.549 . . . . 0.0 109.893 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.848 HG22 HG12 ' A' ' 73' ' ' VAL . 16.6 p -160.32 126.35 4.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.395 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.404 HG23 HG13 ' A' ' 72' ' ' ILE . 41.5 pt -86.35 175.18 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.962 . . . . 0.0 109.413 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.74 138.62 45.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.204 -0.935 . . . . 0.0 109.699 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.483 ' NH1' ' OD1' ' A' ' 76' ' ' ASP . 4.6 mtp180 -53.4 -35.7 60.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.34 -0.85 . . . . 0.0 109.457 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.32 -54.54 8.77 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.257 -0.902 . . . . 0.0 109.381 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 40' ' ' VAL . 2.5 mttt -56.9 -55.63 32.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.29 -0.881 . . . . 0.0 109.355 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.845 HG13 HG21 ' A' ' 63' ' ' ILE . 99.2 t -42.32 -29.61 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -0.848 . . . . 0.0 110.171 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -77.66 -44.96 26.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.109 -0.994 . . . . 0.0 110.13 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.404 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 2.7 tp10 -63.48 -61.58 2.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.102 -0.999 . . . . 0.0 109.998 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 19.3 mt -57.47 -31.37 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.321 -0.862 . . . . 0.0 110.242 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 40' ' ' VAL . . . -63.6 -31.65 72.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.112 -0.993 . . . . 0.0 110.024 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -92.68 -65.15 1.02 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.096 -1.003 . . . . 0.0 109.965 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 33.8 mt -53.35 -19.33 3.26 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.24 -0.912 . . . . 0.0 110.204 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.48 ' HD3' HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -116.14 -11.21 11.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.071 -1.018 . . . . 0.0 109.871 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.469 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 0.9 OUTLIER -39.23 99.14 0.19 Allowed Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.6 -0.687 . . . . 0.0 109.927 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 47' ' ' LYS . 36.4 Cg_endo -79.84 -82.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.55 2.167 . . . . 0.0 110.127 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -144.0 -72.96 0.27 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.361 -0.837 . . . . 0.0 109.342 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.824 HD22 ' SD ' ' A' ' 62' ' ' MET . 3.6 mt 54.34 18.19 1.79 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.191 -0.943 . . . . 0.0 109.505 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER 40.34 33.8 0.19 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.449 -0.782 . . . . 0.0 109.792 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.53 154.37 42.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 0.0 109.452 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.23 -26.55 42.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 109.589 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m -158.41 -58.41 0.07 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.165 -0.959 . . . . 0.0 108.88 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.42 HG23 ' N ' ' A' ' 57' ' ' GLU . 1.4 tt -172.51 -33.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.256 -0.903 . . . . 0.0 109.201 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.42 ' N ' HG23 ' A' ' 56' ' ' ILE . 1.3 tt0 -47.97 -60.18 2.8 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.268 -0.895 . . . . 0.0 109.33 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.97 -49.86 29.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.454 -0.779 . . . . 0.0 109.339 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 62' ' ' MET . . . -49.06 -42.09 37.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 109.177 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -37.75 88.47 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.228 -0.92 . . . . 0.0 109.329 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.99 -13.16 62.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 108.914 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.824 ' SD ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -82.63 -51.07 8.09 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.333 -0.855 . . . . 0.0 109.329 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.845 HG21 HG13 ' A' ' 40' ' ' VAL . 4.8 mt -56.35 -42.6 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.895 . . . . 0.0 109.619 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.528 ' CG ' HG21 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -61.55 -53.83 51.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.898 -1.126 . . . . 0.0 109.43 -179.737 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -56.4 -15.57 12.0 Favored Glycine 0 N--CA 1.48 1.618 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 90.5 m -81.71 -59.99 2.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.3 -1.118 . . . . 0.0 109.546 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.709 ' HB1' HD11 ' A' ' 72' ' ' ILE . . . -73.41 -2.78 23.74 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.238 -0.914 . . . . 0.0 109.528 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.526 ' NH1' ' HG3' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -86.56 -50.24 6.98 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.19 -0.944 . . . . 0.0 109.725 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.47 -8.75 34.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.106 -0.996 . . . . 0.0 109.894 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.48 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -71.06 -69.16 0.39 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.064 -1.022 . . . . 0.0 109.086 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -161.44 -79.9 0.03 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.709 HD11 ' HB1' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -57.88 -169.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.464 -1.021 . . . . 0.0 109.995 -179.631 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.848 HG12 HG22 ' A' ' 34' ' ' THR . 0.4 OUTLIER -138.64 169.97 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.4 -0.812 . . . . 0.0 108.884 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.528 HG21 ' CG ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -106.69 151.48 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.027 -1.046 . . . . 0.0 109.425 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -125.22 145.47 49.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.901 . . . . 0.0 109.494 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.483 ' OD1' ' NH1' ' A' ' 37' ' ' ARG . 14.2 t70 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.452 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.527 ' O ' HD12 ' A' ' 13' ' ' LEU . 35.3 Cg_endo . . . . . 0 C--O 1.214 -0.691 0 N-CA-C 110.528 -0.605 . . . . 0.0 110.528 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -79.38 -66.99 0.8 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.252 -0.905 . . . . 0.0 110.052 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -37.25 -46.24 0.72 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.51 -0.744 . . . . 0.0 110.187 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.7 t -67.67 -46.78 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.213 -0.929 . . . . 0.0 109.423 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 9' ' ' PRO . 3.3 mt -46.85 -48.93 20.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.433 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.499 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -68.71 -38.48 80.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.594 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.6 -66.02 0.46 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 109.669 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -59.11 -32.93 70.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.152 -0.968 . . . . 0.0 109.739 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 14' ' ' LEU . . . -50.05 -65.1 0.62 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.141 -0.975 . . . . 0.0 109.548 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 109.406 179.914 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.195 0.521 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.1 p -118.6 148.93 42.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.188 -0.945 . . . . 0.0 109.425 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.765 HG13 HG13 ' A' ' 74' ' ' VAL . 11.6 pt -105.74 -179.09 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.297 -0.877 . . . . 0.0 109.618 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -95.61 146.96 24.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.294 -0.879 . . . . 0.0 109.487 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.9 ppt_? -60.42 -15.44 26.43 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.235 -0.916 . . . . 0.0 109.517 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -47.92 -39.25 18.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.325 -0.859 . . . . 0.0 109.561 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.43 -45.99 90.57 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.314 -0.866 . . . . 0.0 109.52 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.559 HG13 ' HB ' ' A' ' 63' ' ' ILE . 30.4 t -61.79 -12.89 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 0.0 109.48 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.9 -55.15 5.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 109.912 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -72.44 -51.07 21.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.228 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 63.2 mt -57.44 -45.92 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 110.094 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' A' ' 40' ' ' VAL . . . -57.28 -39.18 75.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -0.959 . . . . 0.0 109.981 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.35 -36.78 77.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.125 -0.985 . . . . 0.0 109.831 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mt -87.49 14.89 7.32 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.171 -0.956 . . . . 0.0 109.596 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -134.48 24.38 3.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 0.0 109.264 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.597 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -69.8 -51.01 16.16 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.389 -0.819 . . . . 0.0 109.942 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 48' ' ' MET . 34.1 Cg_endo -77.34 89.1 1.35 Allowed 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.336 2.024 . . . . 0.0 110.647 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -176.69 -62.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.703 HD11 ' HB2' ' A' ' 53' ' ' ALA . 1.5 pp -103.02 -0.75 30.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.387 -0.82 . . . . 0.0 109.22 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 45.95 81.11 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.273 -0.892 . . . . 0.0 109.713 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.703 ' HB2' HD11 ' A' ' 51' ' ' LEU . . . -87.62 163.13 16.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.0 109.277 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -46.45 -56.09 6.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 109.132 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m -160.07 -69.4 0.07 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.276 -0.89 . . . . 0.0 108.678 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -147.0 8.26 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.355 -0.84 . . . . 0.0 109.584 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -92.95 -51.98 4.81 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.111 -0.993 . . . . 0.0 109.483 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.641 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -73.21 -27.81 61.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.361 -0.837 . . . . 0.0 109.543 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.73 -37.61 70.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 109.354 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.64 -50.73 23.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.694 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -61.18 -17.5 53.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.624 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.573 ' SD ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -75.64 -54.75 6.47 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.251 -0.906 . . . . 0.0 110.087 -179.653 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.559 ' HB ' HG13 ' A' ' 40' ' ' VAL . 12.3 mt -56.16 -38.87 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 110.482 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.4 ' C ' ' N ' ' A' ' 66' ' ' THR . 1.7 tt0 -63.11 -60.95 2.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.712 -1.242 . . . . 0.0 109.303 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.74 -16.6 7.71 Favored Glycine 0 N--CA 1.479 1.501 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 33.2 m -74.14 -55.1 6.49 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.234 -1.156 . . . . 0.0 109.272 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -67.76 -14.25 62.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.181 -0.949 . . . . 0.0 109.249 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.403 ' HG2' HG13 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -67.54 -52.29 40.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 0.0 109.803 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.17 -9.92 29.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.206 -0.934 . . . . 0.0 110.49 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.493 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -97.15 -49.85 4.82 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.097 -1.002 . . . . 0.0 110.109 -179.264 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -138.64 -127.02 2.46 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.654 -1.26 . . . . 0.0 110.167 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.525 ' O ' HD12 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -85.69 179.28 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.361 -1.082 . . . . 0.0 109.973 -179.446 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 74' ' ' VAL . 0.2 OUTLIER -94.41 -169.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.917 . . . . 0.0 109.545 179.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.765 HG13 HG13 ' A' ' 35' ' ' ILE . 8.8 t -135.6 167.56 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 0.0 109.525 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.475 ' N ' HG12 ' A' ' 74' ' ' VAL . 5.0 pt-20 -122.01 152.44 39.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.451 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.4 t70 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.455 -179.935 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo . . . . . 0 C--O 1.215 -0.671 0 N-CA-C 110.332 -0.68 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.478 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -72.49 -67.25 0.57 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.21 -0.931 . . . . 0.0 110.11 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -33.93 -53.8 0.46 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.761 -0.587 . . . . 0.0 110.663 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 99.4 t -57.31 -50.39 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.089 -1.007 . . . . 0.0 109.783 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 13' ' ' LEU . 39.5 mt -48.18 -68.52 0.18 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.117 -0.99 . . . . 0.0 109.767 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.521 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 6.0 mt -55.67 -20.72 15.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.198 -0.939 . . . . 0.0 109.6 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -61.34 -57.32 12.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.501 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 17' ' ' ALA . 47.0 mmtm -60.22 -25.55 65.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 0.0 109.319 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 14' ' ' LEU . . . -42.92 -35.91 1.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.39 -0.819 . . . . 0.0 109.408 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.269 -0.894 . . . . 0.0 109.565 179.937 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.449 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.283 0.563 . . . . 0.0 109.584 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.769 HG22 HG23 ' A' ' 73' ' ' VAL . 11.1 p -126.54 143.5 51.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 109.378 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.077 HD11 HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -112.53 -171.63 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.172 -0.955 . . . . 0.0 109.615 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -100.17 168.69 9.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.386 -0.821 . . . . 0.0 109.931 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.04 -11.22 57.07 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.379 -0.826 . . . . 0.0 110.046 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -51.09 -44.9 61.33 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.135 -0.978 . . . . 0.0 109.776 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.446 ' NZ ' HD23 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -59.77 -34.62 73.23 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.319 -0.863 . . . . 0.0 109.852 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.753 HG13 ' HB ' ' A' ' 63' ' ' ILE . 68.1 t -63.06 -30.59 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 110.017 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -80.73 -23.33 39.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.112 -0.992 . . . . 0.0 110.008 -179.673 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -80.67 -52.6 7.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.971 . . . . 0.0 109.62 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.4 mt -65.99 -36.47 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.663 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.7 -38.71 80.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.212 -0.93 . . . . 0.0 109.636 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -74.52 -27.22 60.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 0.0 109.698 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.03 -0.06 54.61 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.093 -1.005 . . . . 0.0 109.595 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -149.44 47.92 0.96 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.325 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.582 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -62.7 -50.37 78.25 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.273 -0.892 . . . . 0.0 110.033 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 48' ' ' MET . 36.4 Cg_endo -80.7 49.43 3.22 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.711 2.274 . . . . 0.0 110.815 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -123.2 -33.65 3.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.095 -1.003 . . . . 0.0 109.233 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.675 HD11 ' HB2' ' A' ' 53' ' ' ALA . 0.8 OUTLIER -123.86 34.87 4.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -0.885 . . . . 0.0 109.334 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' A' ' 52' ' ' ASN . 29.1 t-20 42.95 38.16 1.33 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.357 -0.84 . . . . 0.0 109.537 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.675 ' HB2' HD11 ' A' ' 51' ' ' LEU . . . -61.54 135.64 57.73 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.187 -0.946 . . . . 0.0 109.318 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.9 -73.41 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.891 . . . . 0.0 109.536 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.461 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -139.08 -51.21 0.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 109.635 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.478 HD13 ' HA ' ' A' ' 56' ' ' ILE . 10.4 mm -157.31 -32.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.385 -0.822 . . . . 0.0 109.371 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.42 -59.12 5.91 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.24 -0.912 . . . . 0.0 110.578 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.9 -50.25 66.79 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.379 -0.826 . . . . 0.0 110.831 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.481 ' HB2' ' CB ' ' A' ' 53' ' ' ALA . . . -66.23 -24.76 66.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.983 -1.073 . . . . 0.0 110.089 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -74.24 -38.06 63.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 109.771 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.08 -13.18 57.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.341 -0.849 . . . . 0.0 109.871 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.05 -53.96 7.56 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.19 -0.944 . . . . 0.0 109.398 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.753 ' HB ' HG13 ' A' ' 40' ' ' VAL . 12.2 mt -64.98 -41.12 91.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.91 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.433 ' HG2' ' CZ ' ' A' ' 68' ' ' ARG . 18.1 tt0 -61.66 -53.35 57.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.04 -1.038 . . . . 0.0 109.722 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.67 -10.66 32.0 Favored Glycine 0 N--CA 1.479 1.537 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 5.0 m -85.12 -44.25 13.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.272 -1.134 . . . . 0.0 109.667 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -72.38 -32.88 66.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -0.932 . . . . 0.0 109.584 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.885 ' HD2' HG12 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -65.35 -55.49 17.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.239 -0.913 . . . . 0.0 110.073 -179.629 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 70' ' ' MET . 0.1 OUTLIER -67.9 -46.45 71.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.965 . . . . 0.0 110.48 -179.275 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.477 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -44.9 -72.02 0.07 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.05 -1.031 . . . . 0.0 109.458 -179.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -162.18 -93.2 0.09 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.077 HD13 HD11 ' A' ' 35' ' ' ILE . 2.2 pp -48.19 178.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.52 -0.988 . . . . 0.0 109.935 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.885 HG12 ' HD2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -122.09 -175.8 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.221 -0.924 . . . . 0.0 109.817 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.8 t -146.53 145.57 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.617 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.68 178.58 5.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 109.376 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.3 t0 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.483 -179.924 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 34.5 Cg_endo . . . . . 0 C--O 1.215 -0.653 0 N-CA-C 110.222 -0.722 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.06 -65.76 0.49 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.337 -0.852 . . . . 0.0 110.837 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.782 ' HB2' ' HE1' ' A' ' 70' ' ' MET . . . -45.35 -65.66 0.51 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.26 -0.9 . . . . 0.0 111.415 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 80.4 t -55.99 -20.62 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.954 -1.091 . . . . 0.0 111.354 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.84 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -87.83 -24.8 23.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.766 -1.209 . . . . 0.0 110.002 -179.418 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 1.011 HD11 HG22 ' A' ' 66' ' ' THR . 10.3 mt -71.26 -50.73 29.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.011 -1.056 . . . . 0.0 109.237 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.511 ' CD ' ' N ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -66.6 -41.43 88.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.207 -0.933 . . . . 0.0 109.169 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.511 ' N ' ' CD ' ' A' ' 15' ' ' LYS . 9.4 tttp -49.93 -36.95 29.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -0.927 . . . . 0.0 109.114 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.428 ' HB1' ' HD3' ' A' ' 39' ' ' LYS . . . -99.81 -75.33 0.57 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.325 -0.859 . . . . 0.0 109.186 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.359 -0.838 . . . . 0.0 109.497 179.892 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.438 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.257 0.551 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.458 ' OG1' ' N ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -106.16 176.39 5.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 109.472 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.458 ' N ' ' OG1' ' A' ' 34' ' ' THR . 12.8 pt -125.94 165.78 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.295 -0.878 . . . . 0.0 109.434 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.8 mtpt -89.53 144.95 25.62 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.336 -0.852 . . . . 0.0 109.293 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -60.77 -13.47 15.33 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.269 -0.894 . . . . 0.0 109.619 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 37' ' ' ARG . 2.5 t0 -42.76 -41.07 3.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.295 -0.878 . . . . 0.0 109.549 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.428 ' HD3' ' HB1' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -71.48 -47.53 54.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -0.857 . . . . 0.0 109.501 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.683 HG22 HG22 ' A' ' 63' ' ' ILE . 75.0 t -53.03 -20.51 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.799 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -81.16 -62.07 1.77 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.94 . . . . 0.0 109.694 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.65 -55.69 23.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.352 -0.842 . . . . 0.0 110.032 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.584 HD13 HD11 ' A' ' 13' ' ' LEU . 74.3 mt -54.24 -58.41 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.916 . . . . 0.0 110.178 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 43' ' ' ILE . . . -42.19 -28.82 0.21 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.223 -0.923 . . . . 0.0 109.77 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -67.03 -51.29 56.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.186 -0.947 . . . . 0.0 109.49 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.5 mt -77.49 -2.24 34.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.875 . . . . 0.0 109.702 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HD3' HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -127.27 23.15 6.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.119 -0.988 . . . . 0.0 109.529 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.617 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 5.5 ttp -69.32 -43.12 23.04 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 110.755 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 48' ' ' MET . 36.2 Cg_endo -79.51 13.7 2.01 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 122.055 1.837 . . . . 0.0 111.194 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.53 -35.46 79.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.97 -1.081 . . . . 0.0 109.412 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.848 HD21 ' SD ' ' A' ' 62' ' ' MET . 0.3 OUTLIER -143.99 23.81 1.69 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -0.87 . . . . 0.0 109.595 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 51' ' ' LEU . 35.3 t-20 44.99 56.69 5.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -0.894 . . . . 0.0 109.626 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 1.021 ' HB1' ' HB3' ' A' ' 58' ' ' ALA . . . -52.56 170.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 109.396 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.27 -44.35 68.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.923 . . . . 0.0 109.367 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.55 -50.81 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.218 -0.926 . . . . 0.0 108.841 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.1 tt -172.53 -31.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 121.207 -0.933 . . . . 0.0 109.518 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -57.2 -45.53 83.69 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.208 -0.932 . . . . 0.0 109.806 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 1.021 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -60.04 -35.84 75.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.337 -0.852 . . . . 0.0 109.813 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.519 ' O ' ' HG3' ' A' ' 62' ' ' MET . . . -63.21 -25.56 68.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.975 . . . . 0.0 109.396 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.421 ' HG3' HG12 ' A' ' 40' ' ' VAL . 1.3 mtt -81.06 -23.54 38.45 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.113 -0.992 . . . . 0.0 108.395 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.05 -22.42 36.39 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.605 -0.685 . . . . 0.0 109.847 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.848 ' SD ' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -82.47 -50.34 8.96 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.894 -1.129 . . . . 0.0 109.425 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.683 HG22 HG22 ' A' ' 40' ' ' VAL . 8.0 mt -57.68 -37.92 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.418 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.39 -50.72 70.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.102 -0.999 . . . . 0.0 109.21 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.77 -12.99 23.11 Favored Glycine 0 N--CA 1.481 1.635 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 1.011 HG22 HD11 ' A' ' 14' ' ' LEU . 54.0 m -82.54 -54.16 5.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -1.15 . . . . 0.0 109.089 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.473 ' HB1' HD11 ' A' ' 72' ' ' ILE . . . -79.21 3.27 18.33 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.374 -0.829 . . . . 0.0 109.261 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.44 -49.91 5.9 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.173 -0.955 . . . . 0.0 109.384 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -21.53 24.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.878 . . . . 0.0 109.877 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.782 ' HE1' ' HB2' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -60.18 -64.34 0.98 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.057 -1.027 . . . . 0.0 109.478 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -159.08 -98.54 0.14 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.765 ' C ' HD12 ' A' ' 72' ' ' ILE . 2.5 pp -53.14 -172.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -1.115 . . . . 0.0 109.692 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.54 176.85 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 109.276 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.435 ' CG2' ' HB3' ' A' ' 67' ' ' ALA . 2.9 t -123.98 151.36 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.337 -0.852 . . . . 0.0 109.476 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.505 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -113.93 65.41 0.66 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.934 . . . . 0.0 109.519 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.6 t0 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.456 179.993 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.53 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 34.7 Cg_endo . . . . . 0 C--O 1.216 -0.592 0 N-CA-C 110.535 -0.602 . . . . 0.0 110.535 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -64.46 -43.56 93.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.867 . . . . 0.0 109.956 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 14' ' ' LEU . . . -37.5 -51.66 1.15 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.507 -0.746 . . . . 0.0 110.269 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 9' ' ' PRO . 3.1 m -66.8 -41.04 87.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 121.018 -1.051 . . . . 0.0 109.105 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.518 ' HA ' HD23 ' A' ' 13' ' ' LEU . 9.4 mt -61.86 -15.62 43.85 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.019 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 4.9 mt -77.65 -51.4 10.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 108.778 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -50.43 -34.86 26.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.86 . . . . 0.0 108.968 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.417 ' NZ ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -64.32 -51.33 63.98 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.316 -0.865 . . . . 0.0 109.286 179.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 18' ' ' ALA . . . -61.7 -69.23 0.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 0.0 109.411 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 17' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.165 -0.959 . . . . 0.0 109.326 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.314 0.578 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.413 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 14.6 p -144.73 133.91 22.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.314 -0.866 . . . . 0.0 109.212 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.848 ' CG1' HG13 ' A' ' 74' ' ' VAL . 6.0 pt -90.88 -171.47 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.109 -0.994 . . . . 0.0 109.493 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.469 ' HE3' ' HA ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -97.56 148.21 23.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 109.373 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 38' ' ' ASP . 1.6 mtt180 -75.03 -16.46 60.6 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.278 -0.889 . . . . 0.0 109.458 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 37' ' ' ARG . 5.9 t0 -43.73 -54.33 5.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.453 -0.779 . . . . 0.0 109.468 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.437 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -53.7 -41.18 66.68 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.177 -0.952 . . . . 0.0 109.656 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.687 HG22 ' CG2' ' A' ' 63' ' ' ILE . 75.1 t -57.35 -36.45 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.313 -0.867 . . . . 0.0 109.927 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -29.56 65.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.157 -0.964 . . . . 0.0 110.052 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -80.92 -24.5 38.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.064 -1.022 . . . . 0.0 109.808 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 39' ' ' LYS . 29.6 mt -95.63 -14.59 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.811 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.29 -22.21 13.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.114 -0.991 . . . . 0.0 110.022 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -96.13 -41.12 8.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.096 -1.002 . . . . 0.0 109.759 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.444 ' C ' ' HG2' ' A' ' 47' ' ' LYS . 5.4 mt -84.09 2.8 37.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.15 -0.969 . . . . 0.0 109.662 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.444 ' HG2' ' C ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -139.09 41.43 2.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.151 -0.968 . . . . 0.0 109.458 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.578 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.2 OUTLIER -45.37 -51.57 25.7 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.215 -0.928 . . . . 0.0 109.806 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 48' ' ' MET . 35.4 Cg_endo -78.5 75.66 4.83 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.442 2.095 . . . . 0.0 110.447 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.71 -59.7 0.89 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -0.895 . . . . 0.0 109.678 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.575 HD12 ' HB3' ' A' ' 52' ' ' ASN . 2.3 pp -120.13 -32.88 4.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.143 -0.973 . . . . 0.0 109.991 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.699 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 1.1 t-20 162.41 -90.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.471 -0.768 . . . . 0.0 109.121 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 52' ' ' ASN . . . 76.0 128.82 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.473 -0.767 . . . . 0.0 109.73 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -89.47 -41.45 12.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 109.228 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -158.16 -48.84 0.06 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.417 -0.802 . . . . 0.0 108.854 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.2 tt -177.14 -31.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.317 -0.865 . . . . 0.0 108.985 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.46 -59.87 3.55 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.332 -0.855 . . . . 0.0 110.049 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.94 -30.0 68.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.272 -0.893 . . . . 0.0 110.43 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.55 -33.32 66.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.152 -0.968 . . . . 0.0 109.97 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -50.04 13.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.175 -0.953 . . . . 0.0 110.138 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.7 -17.89 61.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.319 -0.863 . . . . 0.0 109.81 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.92 -55.62 4.67 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.165 -0.959 . . . . 0.0 110.072 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.687 ' CG2' HG22 ' A' ' 40' ' ' VAL . 3.1 mt -51.24 -43.08 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.05 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.479 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 12.3 pt-20 -64.81 -45.62 85.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.869 -1.144 . . . . 0.0 108.867 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.479 ' N ' ' HG3' ' A' ' 64' ' ' GLU . . . -60.26 -14.41 33.16 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 86.7 m -85.73 -60.36 2.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.388 -1.066 . . . . 0.0 109.265 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.463 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -61.86 -13.8 27.76 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.166 -0.959 . . . . 0.0 109.061 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 1.085 ' CG ' HG13 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -77.67 -62.3 1.71 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.329 -0.857 . . . . 0.0 109.269 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.01 -15.48 63.62 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.315 -0.866 . . . . 0.0 109.261 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.413 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.1 OUTLIER -88.4 -34.35 17.58 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.328 -0.858 . . . . 0.0 109.885 -179.754 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -159.64 -102.16 0.18 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.571 ' C ' HD12 ' A' ' 72' ' ' ILE . 1.1 pp -108.16 -169.63 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -1.197 . . . . 0.0 110.103 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 1.085 HG13 ' CG ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -103.92 -176.8 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.392 -0.818 . . . . 0.0 109.517 179.848 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.848 HG13 ' CG1' ' A' ' 35' ' ' ILE . 1.5 t -109.54 -170.15 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.363 -0.836 . . . . 0.0 109.216 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.674 ' H ' HG12 ' A' ' 74' ' ' VAL . 21.9 pt-20 -124.55 177.16 6.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 109.545 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.5 t70 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.461 179.935 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.9 ' O ' HD12 ' A' ' 13' ' ' LEU . 35.5 Cg_endo . . . . . 0 C--O 1.214 -0.703 0 N-CA-C 110.081 -0.776 . . . . 0.0 110.081 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -91.7 -65.66 0.99 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.13 -0.981 . . . . 0.0 109.793 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 15' ' ' LYS . . . -41.78 -30.01 0.22 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.014 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.542 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 70.1 t -84.54 -46.46 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.137 -0.977 . . . . 0.0 109.603 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.9 HD12 ' O ' ' A' ' 9' ' ' PRO . 6.3 mt -52.62 -54.72 29.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.586 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.38 -43.98 96.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.312 -0.867 . . . . 0.0 109.531 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 7.9 ttpt -54.18 -30.07 48.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 0.0 109.534 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -45.45 35.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.145 -0.972 . . . . 0.0 109.627 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -102.04 47.5 0.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 109.773 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 17' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.206 -0.934 . . . . 0.0 109.535 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.3 p -145.53 152.51 39.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.003 . . . . 0.0 109.689 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.8 pt -115.54 -175.38 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 109.223 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.76 127.6 45.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.0 109.621 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.408 ' NH1' ' HG3' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -56.1 -35.86 67.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.957 . . . . 0.0 109.121 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -49.07 -38.68 25.02 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.471 -0.768 . . . . 0.0 109.61 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -63.96 -45.77 87.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.119 -0.988 . . . . 0.0 109.665 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.723 HG12 ' HB ' ' A' ' 63' ' ' ILE . 1.8 t -68.55 -11.08 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.039 -1.038 . . . . 0.0 109.132 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.45 -47.49 10.59 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.275 -0.89 . . . . 0.0 108.895 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.516 ' O ' HD23 ' A' ' 46' ' ' LEU . 3.1 tt0 -55.44 -33.97 64.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.266 -0.896 . . . . 0.0 109.226 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 12.7 mt -83.36 -22.9 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.379 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.37 -24.54 61.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.913 . . . . 0.0 109.375 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.459 ' HA ' ' SD ' ' A' ' 48' ' ' MET . 31.2 mt-10 -93.47 -35.8 12.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 109.171 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.516 HD23 ' O ' ' A' ' 42' ' ' GLU . 0.5 OUTLIER -66.93 -8.58 30.47 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.332 -0.855 . . . . 0.0 109.795 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HD2' ' O ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -140.86 48.67 1.7 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.206 -0.934 . . . . 0.0 109.61 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.556 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 3.7 tpp -43.42 -52.97 12.35 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.297 -0.877 . . . . 0.0 109.42 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.556 ' HD3' ' CB ' ' A' ' 48' ' ' MET . 36.2 Cg_endo -79.46 86.3 1.7 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.498 2.132 . . . . 0.0 110.131 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -134.66 -60.23 0.79 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.135 -0.978 . . . . 0.0 109.815 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.694 ' C ' HD12 ' A' ' 51' ' ' LEU . 3.9 pp -127.16 -10.69 5.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 110.091 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.672 ' N ' HD12 ' A' ' 51' ' ' LEU . 10.5 t30 164.35 -89.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.318 -0.864 . . . . 0.0 109.024 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.563 ' CB ' ' HB2' ' A' ' 59' ' ' ALA . . . 63.37 72.4 0.48 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.515 -0.74 . . . . 0.0 109.592 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.81 -30.51 57.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.176 -0.953 . . . . 0.0 108.983 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.484 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -164.17 -61.43 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.364 -0.835 . . . . 0.0 109.247 179.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -165.8 -34.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -65.54 -62.82 1.3 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.273 -0.892 . . . . 0.0 110.519 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.95 -38.98 71.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.319 -0.863 . . . . 0.0 110.297 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.563 ' HB2' ' CB ' ' A' ' 53' ' ' ALA . . . -66.3 -70.13 0.26 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.161 -0.962 . . . . 0.0 110.033 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.581 ' HA ' HG12 ' A' ' 63' ' ' ILE . 0.7 OUTLIER -46.68 -28.37 1.47 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.181 -0.949 . . . . 0.0 110.405 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.468 ' HA ' ' OE2' ' A' ' 64' ' ' GLU . 2.3 mmm180 -74.63 -41.28 60.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.975 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.452 ' SD ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -69.49 -47.21 64.61 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.233 -0.917 . . . . 0.0 110.258 -179.3 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.723 ' HB ' HG12 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -52.08 -57.95 3.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.246 -0.909 . . . . 0.0 111.159 -179.421 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.631 ' N ' HD12 ' A' ' 63' ' ' ILE . 9.9 pt-20 -56.44 -55.14 37.34 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 120.946 -1.097 . . . . 0.0 109.519 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.57 -19.41 13.28 Favored Glycine 0 N--CA 1.483 1.778 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.544 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 63.8 m -77.95 -42.82 31.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.473 -1.016 . . . . 0.0 109.119 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -80.72 -1.38 42.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.24 -0.913 . . . . 0.0 108.946 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.98 -55.0 4.46 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.323 -0.861 . . . . 0.0 109.94 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.67 -11.05 43.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.13 -0.981 . . . . 0.0 110.597 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -65.71 -50.35 65.16 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.935 -1.103 . . . . 0.0 110.122 -179.65 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -156.79 -71.56 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.092 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.53 ' C ' HD12 ' A' ' 72' ' ' ILE . 1.0 OUTLIER -98.04 -174.27 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.148 -1.207 . . . . 0.0 109.848 -179.557 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.635 HG22 ' H ' ' A' ' 74' ' ' VAL . 2.3 p -107.98 -179.26 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.465 -0.772 . . . . 0.0 109.043 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.635 ' H ' HG22 ' A' ' 73' ' ' VAL . 0.1 OUTLIER -127.16 159.11 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.989 . . . . 0.0 109.308 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 1.9 pp20? -133.81 157.59 45.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.9 t0 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.5 -179.893 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.718 ' O ' HD12 ' A' ' 13' ' ' LEU . 35.9 Cg_endo . . . . . 0 C--O 1.214 -0.678 0 N-CA-C 110.308 -0.689 . . . . 0.0 110.308 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.691 ' HA ' HD13 ' A' ' 13' ' ' LEU . . . -51.88 -50.65 60.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.305 -0.872 . . . . 0.0 109.995 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -42.57 -50.87 5.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.22 -0.925 . . . . 0.0 109.87 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.457 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 42.8 t -56.28 -48.83 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 109.973 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.718 HD12 ' O ' ' A' ' 9' ' ' PRO . 4.9 mp -53.25 -58.08 8.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.145 -0.972 . . . . 0.0 109.835 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.59 ' CD2' ' HB2' ' A' ' 67' ' ' ALA . 0.3 OUTLIER -49.06 -33.5 11.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.907 . . . . 0.0 109.604 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -60.9 -62.89 1.53 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 0.0 110.112 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.86 -3.56 29.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.104 -0.997 . . . . 0.0 109.818 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.43 ' HB1' ' NZ ' ' A' ' 39' ' ' LYS . . . -84.57 -25.16 28.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.079 -1.013 . . . . 0.0 109.426 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.483 -179.931 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 34' ' ' THR . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -159.16 150.24 20.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -0.883 . . . . 0.0 109.682 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 35' ' ' ILE . 6.5 pt -145.3 170.3 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.213 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -82.2 142.88 31.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -0.963 . . . . 0.0 109.808 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' A' ' 38' ' ' ASP . 30.0 mtt180 -70.33 -10.41 58.91 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.442 -0.786 . . . . 0.0 109.77 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 37' ' ' ARG . 66.3 t0 -39.5 -50.24 2.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.69 -0.631 . . . . 0.0 109.955 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.43 ' NZ ' ' HB1' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -61.19 -48.24 82.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 0.0 109.726 -179.805 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.78 HG13 ' CG2' ' A' ' 63' ' ' ILE . 46.2 t -45.1 -25.94 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.096 -1.002 . . . . 0.0 109.856 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -84.54 -39.36 18.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.199 -0.938 . . . . 0.0 109.922 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 3.5 tt0 -66.56 -27.87 68.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 0.0 109.924 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.524 HG22 ' HD2' ' A' ' 47' ' ' LYS . 10.7 mt -90.81 -42.41 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.077 -1.015 . . . . 0.0 109.775 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.513 ' HA ' ' CD ' ' A' ' 47' ' ' LYS . . . -56.26 -21.57 24.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.073 -1.017 . . . . 0.0 109.114 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.34 -44.75 12.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.624 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mt -72.21 -10.94 60.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 109.753 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.524 ' HD2' HG22 ' A' ' 43' ' ' ILE . 14.9 ptmt -111.0 29.19 8.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -0.963 . . . . 0.0 110.085 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.58 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -64.88 -51.31 57.87 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.1 -1.0 . . . . 0.0 109.551 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 48' ' ' MET . 36.7 Cg_endo -80.96 57.5 6.56 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.734 2.29 . . . . 0.0 110.605 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.95 -76.67 0.23 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.995 -1.066 . . . . 0.0 109.719 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 51' ' ' LEU . 1.6 pp -89.27 17.99 5.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 109.934 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 52' ' ' ASN . 8.5 t30 45.23 73.08 0.17 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.152 -0.968 . . . . 0.0 109.464 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.522 ' CB ' ' HB2' ' A' ' 59' ' ' ALA . . . -73.88 138.07 44.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.19 -0.944 . . . . 0.0 109.564 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.41 -68.14 0.2 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.951 . . . . 0.0 109.334 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.475 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -143.25 -52.5 0.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.348 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -165.13 -32.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.319 -0.863 . . . . 0.0 108.971 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -60.57 -70.29 0.18 Allowed 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.102 -0.998 . . . . 0.0 110.323 -179.45 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 57' ' ' GLU . . . -42.8 -58.65 2.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 110.007 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.522 ' HB2' ' CB ' ' A' ' 53' ' ' ALA . . . -49.36 -40.02 34.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.215 -0.928 . . . . 0.0 110.186 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.56 -35.67 81.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.168 -0.957 . . . . 0.0 110.207 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -14.81 58.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.12 -0.988 . . . . 0.0 109.677 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.447 ' SD ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -76.79 -57.46 3.84 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.177 -0.952 . . . . 0.0 109.644 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.78 ' CG2' HG13 ' A' ' 40' ' ' VAL . 9.1 mt -61.31 -36.82 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.063 -1.023 . . . . 0.0 109.585 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -63.95 -48.13 77.72 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.076 -1.015 . . . . 0.0 108.972 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.0 -9.39 34.19 Favored Glycine 0 N--CA 1.48 1.601 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 70' ' ' MET . 85.5 m -87.89 -48.2 7.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -1.13 . . . . 0.0 109.752 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.59 ' HB2' ' CD2' ' A' ' 14' ' ' LEU . . . -80.92 -12.13 59.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.127 -0.983 . . . . 0.0 109.622 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.569 ' NH2' ' CG1' ' A' ' 73' ' ' VAL . 0.1 OUTLIER -88.99 -46.0 9.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.176 -0.952 . . . . 0.0 109.435 179.814 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.59 -23.51 42.66 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.362 -0.837 . . . . 0.0 109.91 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.455 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -65.98 -66.01 0.6 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.195 -0.941 . . . . 0.0 109.354 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -161.62 -92.19 0.09 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.753 ' C ' HD12 ' A' ' 72' ' ' ILE . 2.8 pp -48.96 177.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.441 -1.035 . . . . 0.0 110.298 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.569 ' CG1' ' NH2' ' A' ' 68' ' ' ARG . 0.5 OUTLIER -112.26 -171.19 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.394 -0.816 . . . . 0.0 110.014 -179.525 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.552 ' H ' HG12 ' A' ' 73' ' ' VAL . 3.7 t -134.03 163.78 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.076 -1.015 . . . . 0.0 109.767 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -129.76 176.86 7.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.228 -0.92 . . . . 0.0 109.689 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 t70 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.443 179.97 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.548 ' O ' HD12 ' A' ' 13' ' ' LEU . 34.4 Cg_endo . . . . . 0 C--O 1.213 -0.758 0 N-CA-C 110.32 -0.684 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . -75.76 -64.55 1.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 110.213 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -41.36 -61.46 1.04 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.313 -0.867 . . . . 0.0 110.141 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.543 ' HB ' ' HG2' ' A' ' 9' ' ' PRO . 17.5 t -65.48 -30.01 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 109.852 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.548 HD12 ' O ' ' A' ' 9' ' ' PRO . 1.1 mt -50.31 -60.54 2.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.078 -1.013 . . . . 0.0 109.581 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.626 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -59.91 -35.43 74.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 109.726 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -50.32 -63.26 1.17 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.879 . . . . 0.0 109.792 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -21.38 60.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 0.0 109.808 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 14' ' ' LEU . . . -54.84 -45.15 74.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 109.798 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 0.0 109.453 -179.941 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.23 0.538 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.73 HG22 ' CG1' ' A' ' 73' ' ' VAL . 5.6 p -81.22 -171.66 3.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -0.914 . . . . 0.0 109.55 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.476 ' CG1' HG22 ' A' ' 74' ' ' VAL . 3.3 pt -140.1 -170.08 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.888 . . . . 0.0 109.588 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.4 ptpt -95.11 130.32 41.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.352 -0.843 . . . . 0.0 109.641 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.404 ' O ' ' C ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -67.35 -8.5 33.04 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.223 -0.923 . . . . 0.0 109.655 179.896 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 37' ' ' ARG . 31.9 t70 -42.5 -54.64 3.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.363 -0.836 . . . . 0.0 109.912 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -42.34 90.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 109.809 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.64 HG13 ' HB ' ' A' ' 63' ' ' ILE . 68.2 t -57.38 -21.59 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.193 -0.942 . . . . 0.0 109.717 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.7 ttp85 -84.87 -59.02 2.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.442 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -48.61 -58.18 5.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 109.509 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.479 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 92.2 mt -56.69 -56.21 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 109.571 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -45.59 -25.27 0.44 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.962 . . . . 0.0 109.564 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -75.44 -57.34 3.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.944 . . . . 0.0 109.663 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.578 HD12 ' C ' ' A' ' 46' ' ' LEU . 4.4 pp -70.46 -4.64 23.67 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.122 -0.986 . . . . 0.0 109.867 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.34 5.26 49.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.146 -0.971 . . . . 0.0 109.572 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.587 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -48.39 -50.06 59.63 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 110.199 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 48' ' ' MET . 34.8 Cg_endo -77.47 77.49 3.83 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.258 1.972 . . . . 0.0 110.575 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.704 ' HB3' HD23 ' A' ' 51' ' ' LEU . 7.7 t0 -172.34 -35.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.388 -0.82 . . . . 0.0 109.412 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.704 HD23 ' HB3' ' A' ' 50' ' ' ASP . 0.1 OUTLIER -143.74 16.56 1.79 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.441 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 52' ' ' ASN . 7.3 p-10 40.58 67.7 0.48 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.506 -0.746 . . . . 0.0 109.833 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.753 ' HB1' ' HB3' ' A' ' 58' ' ' ALA . . . -85.37 154.6 21.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 109.549 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -47.65 -51.44 21.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.17 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.12 -52.1 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.368 -0.833 . . . . 0.0 108.931 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.72 HG22 ' O ' ' A' ' 56' ' ' ILE . 20.8 mm -149.99 9.44 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.453 -0.779 . . . . 0.0 109.612 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -97.61 -52.7 3.68 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 120.899 -1.125 . . . . 0.0 109.717 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.753 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -69.51 -43.41 73.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.365 -0.834 . . . . 0.0 109.352 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.67 -24.33 64.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.355 -0.841 . . . . 0.0 109.438 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.43 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -70.66 -38.69 73.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.311 -0.868 . . . . 0.0 109.63 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.51 -14.85 58.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.276 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.37 -60.65 2.28 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.367 -0.833 . . . . 0.0 109.57 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.64 ' HB ' HG13 ' A' ' 40' ' ' VAL . 15.3 mt -59.34 -36.27 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 109.787 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -62.85 -60.02 4.06 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.083 -1.011 . . . . 0.0 109.498 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.414 ' HA2' ' HB2' ' A' ' 68' ' ' ARG . . . -56.52 -15.85 13.5 Favored Glycine 0 N--CA 1.479 1.547 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.746 HG23 ' SD ' ' A' ' 70' ' ' MET . 60.8 m -74.1 -55.86 5.6 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.243 -1.151 . . . . 0.0 109.153 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.473 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -62.2 -27.2 68.81 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.414 ' HB2' ' HA2' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -47.77 -61.81 1.76 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.525 -0.735 . . . . 0.0 109.17 179.302 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.55 -68.58 0.78 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.332 -0.855 . . . . 0.0 110.312 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.746 ' SD ' HG23 ' A' ' 66' ' ' THR . 1.1 mpt? -45.49 -21.02 0.08 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.177 -0.952 . . . . 0.0 111.615 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' A' ' 67' ' ' ALA . . . -150.1 -133.13 2.09 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 118.898 -1.62 . . . . 0.0 110.764 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.506 ' C ' HD12 ' A' ' 72' ' ' ILE . 1.0 OUTLIER -102.81 -170.26 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.529 -0.983 . . . . 0.0 110.215 -179.354 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.73 ' CG1' HG22 ' A' ' 34' ' ' THR . 9.1 p -84.08 165.06 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -0.869 . . . . 0.0 109.85 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.523 HG12 ' N ' ' A' ' 75' ' ' GLU . 54.5 t -124.7 161.95 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.218 -0.926 . . . . 0.0 109.578 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.523 ' N ' HG12 ' A' ' 74' ' ' VAL . 2.3 pp20? -114.51 135.14 54.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 109.38 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.4 179.929 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo . . . . . 0 C--O 1.214 -0.682 0 N-CA-C 110.441 -0.638 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.471 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -67.51 -66.16 0.6 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.244 -0.91 . . . . 0.0 109.883 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.764 ' HB2' ' SD ' ' A' ' 70' ' ' MET . . . -34.51 -67.73 0.13 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.677 -0.639 . . . . 0.0 110.705 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.1 t -49.55 -44.19 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.07 -1.019 . . . . 0.0 109.906 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 14.8 mt -54.13 -69.41 0.12 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.148 -0.97 . . . . 0.0 109.752 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.805 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -48.48 -26.91 2.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.77 -179.801 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -64.58 0.89 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 0.0 109.717 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.4 tptp -56.68 -32.59 65.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -0.942 . . . . 0.0 109.326 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.414 ' HB1' ' HD3' ' A' ' 39' ' ' LYS . . . -105.01 48.62 0.83 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.569 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.805 ' HB2' ' O ' ' A' ' 14' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.14 -0.975 . . . . 0.0 109.532 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.41 0.624 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.543 ' O ' HG23 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -161.05 179.62 8.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.409 -0.807 . . . . 0.0 109.678 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.608 HG13 HG13 ' A' ' 74' ' ' VAL . 0.8 OUTLIER -159.7 164.0 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.299 -0.876 . . . . 0.0 109.301 179.582 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.5 146.32 31.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 109.707 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.45 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 3.3 ppt_? -64.04 -17.12 63.06 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.353 -0.842 . . . . 0.0 109.791 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 37' ' ' ARG . 11.9 t70 -46.04 -47.87 16.9 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.112 -0.993 . . . . 0.0 109.258 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.433 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -62.71 -44.78 95.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 0.0 109.322 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.648 HG13 ' HB ' ' A' ' 63' ' ' ILE . 47.9 t -53.09 -20.43 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.299 -0.876 . . . . 0.0 109.585 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.24 -52.6 5.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.301 -0.874 . . . . 0.0 109.546 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -59.21 -21.38 59.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.244 -0.91 . . . . 0.0 109.664 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 39' ' ' LYS . 14.2 mt -101.36 -22.0 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.269 -0.895 . . . . 0.0 109.388 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.709 ' HB1' ' HB1' ' A' ' 59' ' ' ALA . . . -83.49 -4.66 58.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.436 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -97.77 -39.65 8.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.156 -0.965 . . . . 0.0 109.529 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.4 mt -91.91 -29.42 16.69 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.158 -0.964 . . . . 0.0 109.5 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.411 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -81.37 -2.44 49.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -0.867 . . . . 0.0 109.542 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.6 ttp -45.22 105.66 0.48 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.199 -0.938 . . . . 0.0 109.321 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HG2' HD21 ' A' ' 51' ' ' LEU . 35.2 Cg_endo -76.85 -69.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.397 2.065 . . . . 0.0 110.66 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.603 ' C ' HD23 ' A' ' 51' ' ' LEU . 2.6 t0 -169.11 34.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.638 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.694 ' N ' HD23 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -102.23 -16.44 16.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.171 -0.956 . . . . 0.0 109.773 -179.734 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 53' ' ' ALA . 10.7 t-20 48.31 69.38 0.55 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.095 -1.003 . . . . 0.0 109.047 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.545 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . . . -43.0 100.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.344 -0.847 . . . . 0.0 109.495 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 52' ' ' ASN . . . -50.35 -31.12 13.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.233 -0.917 . . . . 0.0 109.385 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.511 ' O ' HG12 ' A' ' 56' ' ' ILE . 16.4 m -145.87 -67.71 0.29 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.199 -0.938 . . . . 0.0 109.219 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.516 HD13 ' HA ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -168.28 -30.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.391 -0.818 . . . . 0.0 109.167 -179.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.63 -54.98 30.02 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 120.952 -1.093 . . . . 0.0 109.955 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.545 ' HB3' ' HA ' ' A' ' 53' ' ' ALA . . . -43.8 -72.7 0.05 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.612 -0.68 . . . . 0.0 110.972 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.709 ' HB1' ' HB1' ' A' ' 44' ' ' ALA . . . -52.94 -54.91 27.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.337 -0.852 . . . . 0.0 111.111 -178.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -50.63 -25.83 4.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.077 -1.014 . . . . 0.0 110.815 -178.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -81.56 -32.93 31.98 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.015 -1.053 . . . . 0.0 109.643 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.576 ' SD ' HD11 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -70.57 -54.93 10.15 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.218 -0.927 . . . . 0.0 109.534 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.648 ' HB ' HG13 ' A' ' 40' ' ' VAL . 7.5 mt -67.56 -42.36 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.211 -0.931 . . . . 0.0 109.974 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' A' ' 60' ' ' MET . 2.9 tm-20 -60.11 -54.29 47.73 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.083 -1.011 . . . . 0.0 109.61 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.21 -15.87 31.93 Favored Glycine 0 N--CA 1.479 1.548 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.48 ' O ' ' HB2' ' A' ' 70' ' ' MET . 29.9 m -75.0 -55.05 6.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.282 -1.128 . . . . 0.0 109.001 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.487 ' O ' ' C ' ' A' ' 71' ' ' GLY . . . -64.91 -23.84 67.35 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.003 -1.06 . . . . 0.0 108.493 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.44 -51.53 68.07 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.009 -1.057 . . . . 0.0 109.371 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.46 -53.18 3.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.19 -0.944 . . . . 0.0 110.169 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.764 ' SD ' ' HB2' ' A' ' 11' ' ' ALA . 2.5 mmt -62.64 -23.63 67.18 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.233 -0.917 . . . . 0.0 111.12 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.487 ' C ' ' O ' ' A' ' 67' ' ' ALA . . . -142.85 -123.53 1.82 Allowed Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.586 -1.293 . . . . 0.0 110.372 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.544 ' C ' HD12 ' A' ' 72' ' ' ILE . 1.2 pp -115.4 -174.55 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.188 -1.184 . . . . 0.0 109.894 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 34' ' ' THR . 3.8 t -79.53 157.47 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 109.751 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.608 HG13 HG13 ' A' ' 35' ' ' ILE . 4.9 t -127.61 170.45 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.936 . . . . 0.0 109.594 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.522 ' H ' HG12 ' A' ' 74' ' ' VAL . 2.0 pt-20 -130.21 149.28 51.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.398 -0.814 . . . . 0.0 109.419 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 t70 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.921 -1.038 . . . . 0.0 109.525 -179.939 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo . . . . . 0 C--O 1.215 -0.633 0 N-CA-C 110.152 -0.749 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -54.6 -45.16 73.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -0.872 . . . . 0.0 109.911 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -41.3 -44.52 2.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.008 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.1 t -75.55 -36.91 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.179 -0.951 . . . . 0.0 110.014 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 10' ' ' ALA . 90.6 mt -57.77 -33.09 68.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.92 . . . . 0.0 110.093 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.1 -36.27 40.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.052 -1.03 . . . . 0.0 109.802 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.68 -13.54 60.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.214 -0.929 . . . . 0.0 109.964 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -92.58 -29.35 16.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.079 -1.013 . . . . 0.0 109.594 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.13 -47.54 79.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.193 -0.942 . . . . 0.0 109.356 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 109.351 179.823 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.35 0.595 . . . . 0.0 109.978 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 73' ' ' VAL . 1.5 p -125.91 169.18 12.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.379 -0.826 . . . . 0.0 109.265 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.554 HG13 HG13 ' A' ' 74' ' ' VAL . 27.3 pt -107.75 169.91 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 109.41 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt -109.9 164.77 12.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.185 -0.947 . . . . 0.0 109.524 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.486 ' HD2' ' CE ' ' A' ' 60' ' ' MET . 0.3 OUTLIER -60.8 -15.52 30.77 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.285 -0.885 . . . . 0.0 109.694 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 37' ' ' ARG . 37.1 t0 -43.63 -55.29 4.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 0.0 109.655 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -61.05 -57.42 12.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.221 -0.925 . . . . 0.0 109.692 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.879 HG13 ' HB ' ' A' ' 63' ' ' ILE . 60.8 t -41.68 -28.68 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.89 . . . . 0.0 110.407 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -74.66 -49.91 19.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.078 -1.014 . . . . 0.0 110.216 -179.447 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -67.73 -21.08 65.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.078 -1.014 . . . . 0.0 110.109 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 19.7 mt -101.33 -13.62 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.457 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.57 ' HB2' ' O ' ' A' ' 40' ' ' VAL . . . -88.15 -14.25 39.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.317 -0.865 . . . . 0.0 109.252 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.67 -52.86 4.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.345 -0.847 . . . . 0.0 109.624 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.2 mt -88.11 32.03 0.77 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -0.944 . . . . 0.0 109.695 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -159.43 23.55 0.19 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.211 -0.931 . . . . 0.0 109.407 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -121.97 85.28 45.47 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.312 -0.867 . . . . 0.0 109.623 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.544 ' HD2' HD23 ' A' ' 51' ' ' LEU . 36.4 Cg_endo -80.42 43.61 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.865 2.376 . . . . 0.0 110.755 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 18.9 t0 53.99 25.63 5.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.062 -1.024 . . . . 0.0 109.23 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 52' ' ' ASN . 1.9 pp -44.44 -39.29 4.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.616 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.557 ' N ' HD12 ' A' ' 51' ' ' LEU . 7.1 t-20 161.47 95.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.636 -0.665 . . . . 0.0 109.21 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.836 ' CB ' ' HB3' ' A' ' 58' ' ' ALA . . . -171.31 139.31 1.3 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.946 . . . . 0.0 109.425 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 53' ' ' ALA . . . -45.09 -59.6 2.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.202 -0.936 . . . . 0.0 109.127 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.8 -65.43 0.1 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.342 -0.849 . . . . 0.0 108.959 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.539 ' O ' ' CG2' ' A' ' 56' ' ' ILE . 2.7 mm -137.82 1.84 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.385 -0.822 . . . . 0.0 108.99 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.32 -57.07 3.22 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.039 -1.038 . . . . 0.0 109.681 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.836 ' HB3' ' CB ' ' A' ' 53' ' ' ALA . . . -64.26 -52.23 59.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.387 -0.821 . . . . 0.0 109.532 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.593 ' H ' ' HB1' ' A' ' 53' ' ' ALA . . . -51.3 -40.96 60.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 109.4 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.486 ' CE ' ' HD2' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -62.56 -37.94 88.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.867 . . . . 0.0 109.671 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.524 ' HA ' ' CG ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -68.05 -16.75 64.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.581 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.404 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -78.56 -53.7 6.93 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.287 -0.883 . . . . 0.0 109.835 -179.724 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.879 ' HB ' HG13 ' A' ' 40' ' ' VAL . 7.8 mt -60.57 -42.3 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.179 -0.951 . . . . 0.0 109.714 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.524 ' CG ' ' HA ' ' A' ' 61' ' ' ARG . 2.0 pp20? -64.25 -44.62 91.23 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.961 -1.087 . . . . 0.0 109.602 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.49 -12.38 55.89 Favored Glycine 0 C--N 1.298 -1.568 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 14.7 m -84.8 -56.11 3.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.401 -1.058 . . . . 0.0 109.644 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -64.46 -31.07 72.13 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.93 -1.106 . . . . 0.0 108.75 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -60.13 4.15 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.331 -0.856 . . . . 0.0 109.433 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.51 -56.25 3.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.092 -1.005 . . . . 0.0 109.876 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.45 ' HB2' ' O ' ' A' ' 66' ' ' THR . 9.5 mtp -64.49 -10.01 22.66 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.321 -0.862 . . . . 0.0 111.009 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 67' ' ' ALA . . . -142.94 -130.73 2.48 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.272 -1.442 . . . . 0.0 110.839 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.511 ' C ' HD12 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -101.31 -169.83 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.491 -1.005 . . . . 0.0 110.301 -179.217 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.406 ' O ' ' HB ' ' A' ' 34' ' ' THR . 1.4 t -81.94 145.76 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -0.846 . . . . 0.0 109.69 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.554 HG13 HG13 ' A' ' 35' ' ' ILE . 20.6 t -120.36 147.28 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.407 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 35' ' ' ILE . 12.4 pt-20 -95.27 139.82 31.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.302 -0.874 . . . . 0.0 109.477 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.9 t0 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.438 179.917 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.224 0.535 . . . . 0.0 109.58 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.09 92.51 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 0.0 109.462 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.33 65.87 1.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 109.463 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.494 HG13 ' N ' ' A' ' 5' ' ' THR . 5.2 tp -162.23 153.53 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.906 . . . . 0.0 109.571 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.494 ' N ' HG13 ' A' ' 4' ' ' ILE . 1.5 t -47.62 172.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.276 -0.89 . . . . 0.0 109.388 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 7' ' ' THR . 0.1 OUTLIER -59.35 169.29 1.24 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.202 -0.936 . . . . 0.0 109.527 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.451 ' CB ' ' O ' ' A' ' 6' ' ' LYS . 0.2 OUTLIER 70.83 122.08 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.878 . . . . 0.0 109.46 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.31 170.44 18.54 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.394 2.063 . . . . 0.0 110.383 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.537 ' HG2' ' CG2' ' A' ' 12' ' ' VAL . 34.5 Cg_endo -77.12 162.63 31.46 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.53 2.154 . . . . 0.0 110.311 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -72.07 -61.18 1.88 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 109.828 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -39.64 -54.5 2.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.507 -0.746 . . . . 0.0 110.031 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.537 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 89.6 t -59.82 -41.59 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.106 -0.996 . . . . 0.0 109.668 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 9' ' ' PRO . 0.8 OUTLIER -55.35 -65.05 0.65 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.931 . . . . 0.0 109.62 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.725 HD11 HG23 ' A' ' 63' ' ' ILE . 2.1 mt -46.25 -27.12 0.93 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.163 -0.96 . . . . 0.0 109.209 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.465 ' HD3' ' CD1' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -68.5 -47.54 66.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.867 . . . . 0.0 109.39 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -67.74 -13.45 62.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.338 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.22 -42.04 80.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.381 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.81 -23.36 4.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.196 -0.94 . . . . 0.0 109.51 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.01 24.72 7.88 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.465 ' CD1' ' HD3' ' A' ' 15' ' ' LYS . 57.4 mt -48.26 -38.52 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.214 -1.168 . . . . 0.0 109.837 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -97.85 70.68 2.17 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.539 -0.726 . . . . 0.0 109.339 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.8 m -147.58 163.67 35.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -0.89 . . . . 0.0 109.434 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 25' ' ' GLY . . . -73.33 -65.27 2.29 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.7 m 49.28 -94.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.131 -1.217 . . . . 0.0 109.578 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . 131.07 -95.35 0.32 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -46.85 158.43 0.42 Allowed Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 121.318 -1.107 . . . . 0.0 109.872 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.37 114.05 3.46 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.625 2.217 . . . . 0.0 110.242 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.488 ' O ' ' HD2' ' A' ' 29' ' ' ARG . 3.7 m-20 -96.41 43.11 1.08 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.245 -0.909 . . . . 0.0 109.628 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.488 ' HD2' ' O ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -146.22 113.44 6.22 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 109.532 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -166.98 -66.11 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.327 -0.858 . . . . 0.0 109.501 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.9 -172.48 2.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.259 -0.901 . . . . 0.0 109.283 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.5 t -65.96 104.37 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.934 . . . . 0.0 109.606 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.96 176.5 6.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 0.0 109.344 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.98 148.08 25.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 109.403 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.426 HG13 HG13 ' A' ' 74' ' ' VAL . 38.9 pt -107.19 -174.28 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.213 -0.929 . . . . 0.0 109.536 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.49 ' HB3' ' OD1' ' A' ' 38' ' ' ASP . 20.3 tptt -96.44 167.01 11.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.253 -0.904 . . . . 0.0 109.757 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.64 -24.77 31.25 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.282 -0.887 . . . . 0.0 109.726 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.49 ' OD1' ' HB3' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -48.77 -38.11 20.93 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.135 -0.978 . . . . 0.0 109.417 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.403 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 6.9 mmtp -59.48 -45.58 91.27 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.317 -0.864 . . . . 0.0 109.441 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.721 HG13 ' HB ' ' A' ' 63' ' ' ILE . 39.4 t -58.3 -23.48 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.354 -0.841 . . . . 0.0 109.734 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 3.4 ttm180 -83.7 -42.07 17.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.179 -0.95 . . . . 0.0 109.507 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -62.75 -59.39 4.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.332 -0.855 . . . . 0.0 109.93 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 16.3 mt -56.54 -50.75 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.925 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.423 ' N ' HD11 ' A' ' 63' ' ' ILE . . . -59.17 -21.43 59.38 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 109.931 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -78.61 -37.67 41.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.145 -0.972 . . . . 0.0 109.68 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.5 mt -82.82 -17.29 44.54 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.19 -0.944 . . . . 0.0 109.623 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.419 ' C ' ' HD2' ' A' ' 49' ' ' PRO . 0.2 OUTLIER -121.4 8.9 10.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.437 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.575 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -44.41 -51.41 20.18 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 0.0 109.893 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 48' ' ' MET . 35.2 Cg_endo -78.48 97.7 1.15 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.338 2.026 . . . . 0.0 110.436 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -170.15 -46.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.29 -0.881 . . . . 0.0 109.594 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' A' ' 52' ' ' ASN . 0.9 OUTLIER -115.57 39.43 2.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -0.95 . . . . 0.0 109.584 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 51' ' ' LEU . 32.5 t30 41.98 57.85 3.07 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.396 -0.815 . . . . 0.0 109.747 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.94 173.6 3.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.228 -0.92 . . . . 0.0 109.446 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -86.66 -45.92 10.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.905 . . . . 0.0 109.263 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.46 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -174.57 -39.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.303 -0.873 . . . . 0.0 109.3 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -172.93 -32.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -63.55 -59.98 3.93 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.411 -0.806 . . . . 0.0 109.995 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.97 -44.35 74.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 109.657 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.85 -24.22 66.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.227 -0.921 . . . . 0.0 109.656 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.85 -29.76 56.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 109.855 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -77.74 -23.35 49.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.9 . . . . 0.0 109.721 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.11 -56.05 5.01 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.19 -0.944 . . . . 0.0 109.892 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.725 HG23 HD11 ' A' ' 14' ' ' LEU . 6.4 mt -56.0 -38.06 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.111 -0.993 . . . . 0.0 109.857 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 15.9 mt-10 -60.34 -55.03 38.56 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.106 -0.996 . . . . 0.0 109.474 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -52.94 -17.43 4.99 Favored Glycine 0 N--CA 1.482 1.754 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.556 HG21 HD12 ' A' ' 14' ' ' LEU . 61.1 m -84.57 -50.01 8.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.118 -1.225 . . . . 0.0 110.267 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.704 ' HB3' HG21 ' A' ' 74' ' ' VAL . . . -86.41 3.68 42.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.079 -1.013 . . . . 0.0 110.058 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 10.4 mtp180 -104.32 -36.3 7.66 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.058 -1.026 . . . . 0.0 109.415 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.96 -8.36 37.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 110.038 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.473 ' HG3' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -77.55 -62.94 1.5 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.074 -1.016 . . . . 0.0 109.544 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -159.19 -86.54 0.06 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.796 ' C ' HD12 ' A' ' 72' ' ' ILE . 2.5 pp -59.88 174.21 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -1.124 . . . . 0.0 109.665 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.481 ' N ' HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -114.5 157.76 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.37 -0.831 . . . . 0.0 109.211 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.704 HG21 ' HB3' ' A' ' 67' ' ' ALA . 2.3 t -115.8 142.79 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.443 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 13.0 pt-20 -105.1 97.38 7.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.268 -0.895 . . . . 0.0 109.491 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.425 ' HB2' ' OE2' ' A' ' 64' ' ' GLU . 51.2 t0 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.507 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttp . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.9 p -92.79 -173.28 3.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.336 -0.853 . . . . 0.0 109.624 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 56.76 28.1 13.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 109.363 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.511 ' HA ' HD13 ' A' ' 4' ' ' ILE . 6.5 mm -137.92 113.68 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.906 . . . . 0.0 109.087 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -42.61 113.59 0.48 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.869 . . . . 0.0 109.691 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.432 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -149.69 163.92 36.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 0.0 109.342 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.5 m -115.76 85.47 14.32 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.3 -0.875 . . . . 0.0 109.756 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.763 ' HG2' HG21 ' A' ' 12' ' ' VAL . 30.1 Cg_endo -75.16 168.33 24.96 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.208 1.939 . . . . 0.0 109.845 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.632 ' HA ' ' CD2' ' A' ' 13' ' ' LEU . 36.7 Cg_endo -80.96 -156.05 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 123.298 2.665 . . . . 0.0 112.698 -177.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.507 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . 32.0 -121.12 0.06 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.209 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.507 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -24.0 -61.78 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.831 -0.543 . . . . 0.0 112.273 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.763 HG21 ' HG2' ' A' ' 8' ' ' PRO . 19.6 t -62.85 -47.47 92.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.004 -1.06 . . . . 0.0 110.849 -178.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.632 ' CD2' ' HA ' ' A' ' 9' ' ' PRO . 1.3 mm? -60.97 -18.0 54.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.794 -1.191 . . . . 0.0 109.977 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 15' ' ' LYS . 17.7 mt -86.38 -53.74 4.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.088 -1.007 . . . . 0.0 109.717 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -45.5 -44.89 12.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -0.967 . . . . 0.0 109.181 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -40.47 86.47 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.335 -0.853 . . . . 0.0 109.416 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.409 ' HB1' ' HG2' ' A' ' 39' ' ' LYS . . . -51.09 -37.64 46.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.432 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.01 -66.55 0.74 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.895 . . . . 0.0 109.588 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 20' ' ' ILE . . . 115.32 41.2 0.82 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.423 ' C ' ' O ' ' A' ' 19' ' ' GLY . 46.8 mt -43.49 100.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.26 -1.141 . . . . 0.0 109.774 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 19' ' ' GLY . 5.7 mt-10 -106.81 -90.74 0.42 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.171 -0.956 . . . . 0.0 109.246 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.5 m -81.14 179.36 7.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.345 -0.847 . . . . 0.0 109.23 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 24' ' ' SER . . . 179.48 -115.9 0.5 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER 75.5 -176.12 0.13 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -1.116 . . . . 0.0 109.57 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 26' ' ' GLU . . . -67.41 -15.33 65.75 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 25' ' ' GLY . 18.1 tt0 -43.24 111.68 1.1 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.249 -1.147 . . . . 0.0 109.686 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.87 128.95 9.56 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.44 2.094 . . . . 0.0 110.369 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -141.88 41.14 1.68 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.176 -0.953 . . . . 0.0 109.716 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.04 9.75 7.85 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.151 -0.968 . . . . 0.0 109.855 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -95.9 -18.62 20.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.066 -1.021 . . . . 0.0 109.845 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.7 mtpt -96.88 -172.95 2.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.139 -0.976 . . . . 0.0 109.458 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 80.8 t -92.57 122.24 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.189 -0.945 . . . . 0.0 109.304 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.07 58.46 1.52 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.203 -0.936 . . . . 0.0 109.527 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.456 HG22 ' CG2' ' A' ' 73' ' ' VAL . 1.0 OUTLIER -132.16 179.34 6.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 109.321 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.622 HD11 ' HB1' ' A' ' 67' ' ' ALA . 8.9 pt -120.04 -175.19 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.913 . . . . 0.0 109.552 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -109.04 156.91 19.21 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.262 -0.899 . . . . 0.0 109.653 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.98 -16.31 64.27 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.3 -0.875 . . . . 0.0 109.628 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.441 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 11.7 t70 -48.25 -44.51 33.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 109.449 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.441 ' NZ ' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -55.0 -61.68 2.15 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.285 -0.884 . . . . 0.0 109.258 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.946 HG13 ' HB ' ' A' ' 63' ' ' ILE . 46.0 t -46.94 -23.42 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.277 -0.89 . . . . 0.0 109.893 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.441 ' HB3' ' O ' ' A' ' 38' ' ' ASP . 4.0 ttt85 -75.12 -61.29 1.94 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.073 -1.017 . . . . 0.0 109.851 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -58.17 -52.64 64.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.233 -0.917 . . . . 0.0 110.032 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 82.8 mt -61.13 -43.06 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.205 -0.935 . . . . 0.0 110.082 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 40' ' ' VAL . . . -52.96 -49.59 65.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.045 -1.034 . . . . 0.0 109.72 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -49.22 78.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.505 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.423 ' N ' ' CD2' ' A' ' 46' ' ' LEU . 0.3 OUTLIER -65.07 -15.02 61.9 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.256 -0.903 . . . . 0.0 110.094 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -102.89 21.46 15.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.139 -0.975 . . . . 0.0 109.919 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.571 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -57.21 -53.83 61.2 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.085 -1.009 . . . . 0.0 109.325 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.571 ' HD3' ' CB ' ' A' ' 48' ' ' MET . 36.5 Cg_endo -79.54 74.49 5.52 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.52 2.146 . . . . 0.0 110.296 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -150.26 -65.35 0.2 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.18 -0.95 . . . . 0.0 109.418 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 52' ' ' ASN . 1.5 pp -117.3 18.85 14.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.37 -0.831 . . . . 0.0 109.368 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 51' ' ' LEU . 1.2 p-10 39.73 68.16 0.4 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.483 -0.761 . . . . 0.0 109.915 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.487 ' CB ' ' HB2' ' A' ' 59' ' ' ALA . . . -63.5 168.35 4.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.171 -0.956 . . . . 0.0 109.501 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 53' ' ' ALA . . . -44.0 -36.54 2.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.893 . . . . 0.0 109.061 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m 174.3 -40.06 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.343 -0.848 . . . . 0.0 108.842 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.7 tt -171.34 -33.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 121.321 -0.862 . . . . 0.0 109.028 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.6 -67.42 0.46 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.297 -0.877 . . . . 0.0 110.331 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -44.67 -39.82 5.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.28 -0.887 . . . . 0.0 110.217 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.487 ' HB2' ' CB ' ' A' ' 53' ' ' ALA . . . -61.26 -44.38 97.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.065 -1.022 . . . . 0.0 110.041 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -40.14 94.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 110.347 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -70.38 -21.05 62.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -0.965 . . . . 0.0 110.151 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -56.45 5.09 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.097 -1.002 . . . . 0.0 109.605 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.946 ' HB ' HG13 ' A' ' 40' ' ' VAL . 15.3 mt -54.37 -35.74 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.256 -0.903 . . . . 0.0 109.423 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 1.2 tt0 -59.21 -56.83 17.09 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.225 -0.922 . . . . 0.0 109.378 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.88 -20.13 2.83 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.522 ' O ' ' CG ' ' A' ' 70' ' ' MET . 12.0 m -79.86 -57.5 3.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.397 -1.061 . . . . 0.0 109.921 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.622 ' HB1' HD11 ' A' ' 35' ' ' ILE . . . -78.15 10.62 2.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.961 . . . . 0.0 110.345 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -105.17 -55.48 2.32 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.993 -1.067 . . . . 0.0 110.476 -179.554 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.87 -25.7 12.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.078 -1.014 . . . . 0.0 111.899 -178.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.547 ' HG3' ' N ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -70.36 -30.81 67.83 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.543 -1.348 . . . . 0.0 110.901 -178.356 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.547 ' N ' ' HG3' ' A' ' 70' ' ' MET . . . -160.83 -123.09 0.66 Allowed Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.206 -1.473 . . . . 0.0 110.744 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.606 ' N ' HD12 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -48.99 -178.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.491 -1.005 . . . . 0.0 110.527 -179.025 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.475 ' O ' HG12 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -110.99 -168.61 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.539 -0.725 . . . . 0.0 109.421 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.429 ' CG2' ' C ' ' A' ' 73' ' ' VAL . 2.1 t -151.34 155.53 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 109.659 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -115.79 135.29 54.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 109.384 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.493 -179.934 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ttt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.4 m 60.81 52.58 4.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.932 . . . . 0.0 109.286 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.13 62.77 1.46 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 109.464 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.645 HG23 ' O ' ' A' ' 4' ' ' ILE . 1.2 tt -160.41 116.15 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.898 . . . . 0.0 109.518 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.478 ' O ' HG22 ' A' ' 5' ' ' THR . 45.5 m 43.71 80.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 109.524 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 7' ' ' THR . 0.3 OUTLIER -79.76 87.43 5.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.306 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER 44.83 90.72 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.321 -0.862 . . . . 0.0 109.618 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.704 ' HG2' HD11 ' A' ' 13' ' ' LEU . 35.5 Cg_endo -77.3 174.87 12.07 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.612 2.208 . . . . 0.0 110.091 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.499 ' O ' ' CG ' ' A' ' 13' ' ' LEU . 34.0 Cg_endo -77.04 142.56 22.03 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.46 2.107 . . . . 0.0 110.403 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . -73.3 -55.78 5.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 109.843 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -42.92 -65.25 0.5 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.882 . . . . 0.0 109.884 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.489 ' HB ' ' HG2' ' A' ' 9' ' ' PRO . 92.9 t -61.21 -38.08 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.791 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.704 HD11 ' HG2' ' A' ' 8' ' ' PRO . 5.3 mt -44.67 -42.48 7.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 109.698 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.595 HD22 ' HB2' ' A' ' 67' ' ' ALA . 0.8 OUTLIER -74.12 -40.35 62.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.087 -1.008 . . . . 0.0 109.553 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -50.06 -37.24 32.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.885 . . . . 0.0 109.296 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -79.6 -33.45 41.56 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.323 -0.861 . . . . 0.0 109.435 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.04 -25.33 58.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.564 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.99 -73.68 0.17 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 109.379 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.75 49.72 0.83 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.401 ' O ' ' C ' ' A' ' 21' ' ' GLU . 20.4 mt -68.63 -4.67 3.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.303 -1.116 . . . . 0.0 110.022 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 20' ' ' ILE . 20.0 tp10 -45.48 116.4 1.15 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.139 -0.976 . . . . 0.0 109.447 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 t -175.2 -76.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 109.413 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.61 -96.74 0.03 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.98 160.1 15.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.306 -1.114 . . . . 0.0 109.679 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 26' ' ' GLU . . . 96.06 95.46 1.79 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 0.4 OUTLIER -44.43 143.85 1.89 Allowed Pre-proline 0 C--N 1.306 -1.312 0 O-C-N 121.202 -1.175 . . . . 0.0 109.4 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 35.7 Cg_endo -77.53 119.83 5.01 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.598 2.199 . . . . 0.0 110.683 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -110.57 -79.61 0.58 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.91 . . . . 0.0 109.466 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.8 82.68 5.85 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.176 -0.952 . . . . 0.0 109.558 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.409 ' OD1' ' O ' ' A' ' 30' ' ' ASN . 38.7 p30 -96.94 145.9 25.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.178 -0.951 . . . . 0.0 109.402 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.81 -171.65 2.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.167 -0.958 . . . . 0.0 109.742 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.879 ' O ' HG22 ' A' ' 34' ' ' THR . 38.6 t -60.31 130.89 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.375 -0.828 . . . . 0.0 109.434 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.87 93.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.128 -0.983 . . . . 0.0 109.175 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.879 HG22 ' O ' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -157.66 176.16 12.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.199 -0.938 . . . . 0.0 109.691 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.9 HG13 HG13 ' A' ' 74' ' ' VAL . 27.3 pt -126.26 160.11 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.438 -0.789 . . . . 0.0 109.37 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.89 122.52 26.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.293 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -57.47 -15.69 7.6 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.231 -0.918 . . . . 0.0 110.083 -179.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 37' ' ' ARG . 31.2 t0 -43.9 -37.27 2.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.048 -1.032 . . . . 0.0 109.351 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.471 ' O ' HG13 ' A' ' 43' ' ' ILE . 13.4 mmtt -65.96 -56.31 12.32 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.155 -0.965 . . . . 0.0 109.11 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.85 HG22 ' CG2' ' A' ' 63' ' ' ILE . 37.9 t -42.06 -28.28 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 109.453 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -69.47 -54.74 12.79 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.305 -0.872 . . . . 0.0 109.375 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.21 -9.77 56.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.265 -0.897 . . . . 0.0 109.912 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 39' ' ' LYS . 11.9 mt -105.07 -8.73 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.098 -1.001 . . . . 0.0 109.855 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.461 ' HA ' ' HG2' ' A' ' 48' ' ' MET . . . -101.87 -19.12 15.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.971 . . . . 0.0 110.047 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -105.57 -32.34 8.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.384 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.6 mt -95.49 11.17 33.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.092 -1.005 . . . . 0.0 110.454 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.423 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -134.47 -53.2 0.83 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.049 -1.032 . . . . 0.0 109.496 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.475 ' HB3' HD21 ' A' ' 51' ' ' LEU . 19.4 mmt -58.86 111.49 3.74 Favored Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 121.31 -0.869 . . . . 0.0 109.733 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.56 ' HD2' ' CD2' ' A' ' 51' ' ' LEU . 34.9 Cg_endo -76.32 -30.7 5.14 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.366 2.044 . . . . 0.0 110.927 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.561 ' C ' ' HG ' ' A' ' 51' ' ' LEU . 12.4 t70 -173.14 -53.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.803 -1.186 . . . . 0.0 110.857 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.85 HD13 ' CE ' ' A' ' 62' ' ' MET . 0.0 OUTLIER 27.04 38.77 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.927 -0.483 . . . . 0.0 111.089 -179.068 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.555 ' N ' ' O ' ' A' ' 50' ' ' ASP . 26.6 t-20 37.63 59.8 1.21 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.498 -0.751 . . . . 0.0 109.928 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.568 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . . . -107.68 134.98 49.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.958 . . . . 0.0 109.798 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.19 -59.33 5.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.276 -0.89 . . . . 0.0 109.22 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.43 ' C ' HG13 ' A' ' 56' ' ' ILE . 3.1 p 178.51 -48.82 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.35 -0.844 . . . . 0.0 109.32 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.588 HG22 ' O ' ' A' ' 56' ' ' ILE . 3.3 mt -137.35 5.14 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 O-C-N 121.175 -0.953 . . . . 0.0 109.345 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 61' ' ' ARG . 0.8 OUTLIER -100.32 -54.24 2.91 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.162 -0.962 . . . . 0.0 110.031 -179.249 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.568 ' HB3' ' HA ' ' A' ' 53' ' ' ALA . . . -80.38 -61.86 1.85 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.325 -0.859 . . . . 0.0 109.959 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.439 ' H ' ' HB1' ' A' ' 53' ' ' ALA . . . -52.08 -37.78 55.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 109.791 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.529 ' CE ' HG23 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -75.91 -41.15 52.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.152 -0.967 . . . . 0.0 110.032 -179.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 57' ' ' GLU . 16.8 mtp180 -74.65 -7.36 52.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.105 -0.997 . . . . 0.0 109.534 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.85 ' CE ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -83.71 -54.85 4.62 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.275 -0.891 . . . . 0.0 109.38 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.85 ' CG2' HG22 ' A' ' 40' ' ' VAL . 10.8 mt -63.69 -36.35 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.625 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -64.49 -50.97 65.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.103 -0.998 . . . . 0.0 109.125 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.07 -12.44 30.13 Favored Glycine 0 N--CA 1.481 1.693 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 13.7 m -84.23 -51.55 6.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -1.147 . . . . 0.0 109.425 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.595 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -79.78 -5.03 54.53 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.254 -0.904 . . . . 0.0 109.638 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 1.5 ttp180 -87.77 -48.09 8.11 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.946 -1.096 . . . . 0.0 109.505 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.59 -49.21 16.89 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.353 -0.842 . . . . 0.0 110.459 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.488 ' HG3' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -100.92 -30.49 11.63 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.127 -0.983 . . . . 0.0 110.496 -178.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.488 ' N ' ' HG3' ' A' ' 70' ' ' MET . . . -89.31 -147.95 17.19 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.96 -1.114 . . . . 0.0 110.674 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.559 ' C ' HD12 ' A' ' 72' ' ' ILE . 1.1 pp -105.87 -170.26 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.517 -0.99 . . . . 0.0 109.995 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.3 t -84.77 111.15 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.145 -0.972 . . . . 0.0 109.676 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.9 HG13 HG13 ' A' ' 35' ' ' ILE . 3.0 t -80.19 153.46 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 0.0 109.378 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 35' ' ' ILE . 14.8 pt-20 -113.63 -176.17 2.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.899 . . . . 0.0 109.458 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.6 t70 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.464 179.983 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.1 t -115.14 165.96 12.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -0.931 . . . . 0.0 109.421 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.573 ' CG ' ' O ' ' A' ' 3' ' ' PHE . 1.0 OUTLIER -61.46 119.34 8.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.956 . . . . 0.0 109.787 -179.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.05 17.83 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.168 -0.957 . . . . 0.0 109.464 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.9 t -165.45 27.85 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 0.0 109.325 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.19 124.12 25.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.349 -0.845 . . . . 0.0 109.959 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.34 135.67 21.71 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.287 -0.883 . . . . 0.0 109.417 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 36.2 Cg_endo -79.76 156.48 24.23 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.412 2.075 . . . . 0.0 109.972 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.445 ' HD2' ' HB ' ' A' ' 12' ' ' VAL . 35.5 Cg_endo -77.4 -170.27 0.9 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.557 2.172 . . . . 0.0 110.543 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -70.66 -68.63 0.42 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.208 -0.932 . . . . 0.0 109.862 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -37.29 -45.03 0.63 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.507 -0.746 . . . . 0.0 110.683 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.445 ' HB ' ' HD2' ' A' ' 9' ' ' PRO . 49.0 t -65.96 -47.32 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.101 -1.0 . . . . 0.0 109.815 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.454 ' HA ' HD23 ' A' ' 13' ' ' LEU . 19.8 mt -57.9 -63.04 1.39 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.669 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.454 HD21 ' HE2' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -44.39 -30.68 0.88 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.263 -0.898 . . . . 0.0 109.744 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 12' ' ' VAL . 10.6 tttt -69.52 -46.45 66.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.73 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.1 9.89 9.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.634 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.06 -23.03 31.01 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.183 -0.948 . . . . 0.0 109.478 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.65 -50.82 10.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.942 . . . . 0.0 109.386 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.43 64.58 0.45 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.4 mt -62.29 94.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.21 -1.171 . . . . 0.0 109.522 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -80.36 131.53 35.64 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.262 -0.899 . . . . 0.0 109.379 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.34 133.39 35.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.194 -0.941 . . . . 0.0 109.621 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.03 67.89 0.01 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.478 ' OG ' ' N ' ' A' ' 25' ' ' GLY . 0.8 OUTLIER -87.21 176.34 7.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -1.142 . . . . 0.0 109.593 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.478 ' N ' ' OG ' ' A' ' 24' ' ' SER . . . 152.85 40.03 0.02 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 0.7 OUTLIER 175.6 104.49 0.09 OUTLIER Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 121.589 -0.948 . . . . 0.0 108.721 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -76.82 105.57 2.1 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.351 2.034 . . . . 0.0 110.64 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -101.12 -161.21 0.84 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.38 -0.825 . . . . 0.0 109.411 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.48 -93.13 0.45 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.219 -0.926 . . . . 0.0 109.425 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -77.06 108.42 10.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -0.869 . . . . 0.0 109.521 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.96 83.87 5.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.436 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.29 144.39 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.703 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -161.45 85.49 0.65 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.327 -0.858 . . . . 0.0 109.301 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.01 162.29 14.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 109.616 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.909 HD12 ' O ' ' A' ' 36' ' ' LYS . 1.2 pp -136.92 172.9 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -0.844 . . . . 0.0 109.517 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.909 ' O ' HD12 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -86.31 173.95 9.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.747 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -88.34 15.21 8.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.438 -0.789 . . . . 0.0 109.607 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.433 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 6.2 t70 -50.09 -39.95 44.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.599 -0.688 . . . . 0.0 110.194 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.483 ' HE3' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -71.9 -31.25 66.22 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.178 -0.951 . . . . 0.0 110.594 -179.177 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 1.012 HG22 HG22 ' A' ' 63' ' ' ILE . 47.4 t -65.04 -29.1 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.976 -1.077 . . . . 0.0 110.056 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.46 ' NH2' ' HB2' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -82.78 -30.89 28.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.114 -0.991 . . . . 0.0 109.973 -179.524 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 38' ' ' ASP . 6.7 mm-40 -76.26 -58.24 3.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.954 . . . . 0.0 109.819 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.3 mt -61.26 -55.11 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 110.273 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.603 ' HB2' HD12 ' A' ' 63' ' ' ILE . . . -47.25 -50.73 20.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.225 -0.922 . . . . 0.0 110.504 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -71.64 -24.63 61.89 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.044 -1.035 . . . . 0.0 110.368 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 mt -80.38 -11.68 59.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.004 -1.06 . . . . 0.0 109.627 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.48 39.99 1.89 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.265 -0.897 . . . . 0.0 109.274 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.569 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -50.5 -53.21 48.08 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.178 -0.951 . . . . 0.0 109.218 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.569 ' HD3' ' CB ' ' A' ' 48' ' ' MET . 36.8 Cg_endo -80.99 41.54 1.17 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.612 2.208 . . . . 0.0 110.404 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.44 ' HB3' HD23 ' A' ' 51' ' ' LEU . 33.8 t0 -111.13 -14.55 13.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.097 -1.002 . . . . 0.0 109.819 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -127.63 -99.24 0.37 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.13 -0.981 . . . . 0.0 109.591 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 57.0 t30 177.78 34.56 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.187 -0.946 . . . . 0.0 109.454 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.428 ' HB1' ' HB3' ' A' ' 58' ' ' ALA . . . -55.74 164.45 1.11 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.23 -22.38 66.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.267 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.465 ' O ' ' SD ' ' A' ' 48' ' ' MET . 0.1 OUTLIER -172.34 -50.19 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.286 -0.884 . . . . 0.0 108.937 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.439 HG23 ' N ' ' A' ' 57' ' ' GLU . 1.8 tt -174.9 -34.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.439 ' N ' HG23 ' A' ' 56' ' ' ILE . 15.9 tt0 -57.85 -66.1 0.53 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.533 -0.73 . . . . 0.0 109.805 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 57' ' ' GLU . . . -42.63 -36.65 1.46 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.354 -0.841 . . . . 0.0 109.751 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.13 -47.95 75.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.135 -0.978 . . . . 0.0 109.772 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.7 -38.02 83.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.989 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.439 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 35.7 mtp180 -74.0 -18.26 60.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 0.0 109.769 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.75 -39.77 30.29 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.125 -0.984 . . . . 0.0 109.672 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.012 HG22 HG22 ' A' ' 40' ' ' VAL . 7.4 mt -65.46 -42.39 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.143 -0.973 . . . . 0.0 109.874 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.495 ' CD ' ' N ' ' A' ' 65' ' ' GLY . 3.0 pp20? -63.35 -47.09 83.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.996 -1.065 . . . . 0.0 109.384 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.495 ' N ' ' CD ' ' A' ' 64' ' ' GLU . . . -65.4 -11.09 51.61 Favored Glycine 0 N--CA 1.478 1.485 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 70' ' ' MET . 86.2 m -81.57 -44.62 17.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.388 -1.066 . . . . 0.0 109.517 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.547 ' HB3' HG21 ' A' ' 74' ' ' VAL . . . -82.35 -16.09 50.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 108.777 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -40.78 65.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.459 -0.775 . . . . 0.0 109.38 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.81 -31.3 14.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.13 -0.981 . . . . 0.0 109.87 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -53.99 -72.95 0.05 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.211 -0.931 . . . . 0.0 109.19 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 72' ' ' ILE . . . -162.48 -87.74 0.07 OUTLIER Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.495 HD13 ' C ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -39.56 152.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.642 -0.916 . . . . 0.0 110.389 -179.526 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.64 135.52 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.547 HG21 ' HB3' ' A' ' 67' ' ' ALA . 2.1 t -108.63 155.39 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.982 -1.074 . . . . 0.0 110.176 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -110.35 -171.37 1.82 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.396 -0.815 . . . . 0.0 109.123 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.9 t70 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.637 -179.928 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.454 ' HG3' ' N ' ' A' ' 2' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.504 ' C ' ' CG ' ' A' ' 3' ' ' PHE . 60.2 p -95.49 85.81 4.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.438 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.529 ' O ' ' CB ' ' A' ' 4' ' ' ILE . 0.8 OUTLIER 64.71 113.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.924 . . . . 0.0 109.132 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.529 ' CB ' ' O ' ' A' ' 3' ' ' PHE . 0.5 OUTLIER 80.46 133.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.455 -0.778 . . . . 0.0 109.176 -179.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.0 m -86.17 -20.5 28.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.906 . . . . 0.0 109.536 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.415 ' O ' ' CB ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -68.18 169.28 10.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.181 -0.949 . . . . 0.0 109.351 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.472 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 0.2 OUTLIER 70.5 63.69 0.47 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.209 -0.932 . . . . 0.0 109.713 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 7' ' ' THR . 35.2 Cg_endo -77.7 148.12 25.4 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.568 2.179 . . . . 0.0 110.48 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.553 ' HG2' ' CG2' ' A' ' 12' ' ' VAL . 35.8 Cg_endo -77.52 147.76 25.59 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.73 2.286 . . . . 0.0 110.37 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.517 ' HA ' HD12 ' A' ' 13' ' ' LEU . . . -52.52 -61.31 2.36 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.294 -0.879 . . . . 0.0 110.129 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -36.4 -40.73 0.25 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.619 -0.676 . . . . 0.0 110.49 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.553 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 72.8 t -74.94 -43.01 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.09 -1.006 . . . . 0.0 109.465 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 10' ' ' ALA . 63.0 mt -56.04 -66.74 0.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.994 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.596 HD13 ' HB2' ' A' ' 67' ' ' ALA . 1.8 pp -57.74 -28.18 63.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.176 -0.953 . . . . 0.0 109.658 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.488 ' N ' ' HG ' ' A' ' 14' ' ' LEU . 57.1 tttt -56.29 -50.81 70.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.546 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -25.54 65.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.686 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.423 ' HB1' ' HE3' ' A' ' 39' ' ' LYS . . . -74.44 -8.84 57.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.201 -0.937 . . . . 0.0 109.58 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.547 ' HB1' HG21 ' A' ' 72' ' ' ILE . . . -93.54 -36.54 12.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.61 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.65 51.61 19.61 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 20' ' ' ILE . 35.0 mt -60.97 -22.74 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.29 -1.123 . . . . 0.0 109.823 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -82.05 121.87 27.1 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.318 -0.864 . . . . 0.0 109.413 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 77.6 p -125.75 179.1 5.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.131 -0.98 . . . . 0.0 109.61 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.38 -105.7 0.78 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 t -112.58 142.68 44.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -1.148 . . . . 0.0 109.378 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 26' ' ' GLU . . . 101.77 170.39 27.64 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 25' ' ' GLY . 61.6 tt0 45.2 85.79 0.16 Allowed Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.225 -1.162 . . . . 0.0 109.073 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.62 163.2 32.09 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.562 2.174 . . . . 0.0 110.423 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -59.85 106.14 0.46 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.309 -0.869 . . . . 0.0 109.465 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -73.23 -166.51 0.33 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.241 -0.912 . . . . 0.0 109.766 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.1 -48.51 17.56 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.272 -0.892 . . . . 0.0 109.709 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.42 129.93 45.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 109.522 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.569 ' CG1' ' CG2' ' A' ' 73' ' ' VAL . 6.3 p -48.74 161.47 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.232 -0.918 . . . . 0.0 109.503 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . -66.58 124.09 21.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.477 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.866 HG22 ' O ' ' A' ' 73' ' ' VAL . 0.9 OUTLIER -101.83 140.04 36.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.419 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 pt -91.69 171.79 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.233 -0.917 . . . . 0.0 109.441 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 mtmt -89.75 151.49 21.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 109.357 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.16 -16.58 64.1 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.206 -0.933 . . . . 0.0 109.303 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -45.69 -41.64 10.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.365 -0.835 . . . . 0.0 109.608 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.471 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.7 OUTLIER -59.76 -64.19 1.04 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 109.367 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.893 HG22 ' CG2' ' A' ' 63' ' ' ILE . 56.1 t -45.74 -23.64 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 0.0 109.973 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -42.79 32.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.118 -0.989 . . . . 0.0 110.162 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -84.6 -6.57 59.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.11 -0.994 . . . . 0.0 110.026 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 39' ' ' LYS . 7.6 mt -93.51 -39.68 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.061 -1.024 . . . . 0.0 109.898 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 48' ' ' MET . . . -77.97 -39.68 41.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.148 -0.97 . . . . 0.0 109.525 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -53.87 -20.59 6.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.272 -0.892 . . . . 0.0 109.77 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 46' ' ' LEU . 9.3 mt -96.01 -30.89 13.33 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.141 -0.975 . . . . 0.0 109.653 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 50' ' ' ASP . 33.3 mmtt -131.39 43.51 3.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.913 . . . . 0.0 109.264 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.565 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -64.03 -52.54 55.32 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.387 -0.821 . . . . 0.0 110.01 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 48' ' ' MET . 35.5 Cg_endo -78.21 -3.03 13.06 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.41 2.074 . . . . 0.0 110.575 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.492 ' C ' HD23 ' A' ' 51' ' ' LEU . 18.3 t70 -62.26 -13.32 26.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.348 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.772 ' N ' HD23 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -139.84 27.81 2.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.397 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 51' ' ' LEU . 20.6 t30 42.33 74.58 0.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.344 -0.848 . . . . 0.0 109.622 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.852 ' CB ' ' HB2' ' A' ' 59' ' ' ALA . . . -77.29 155.33 32.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 0.0 109.504 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -45.49 -35.31 3.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.467 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 m 174.87 -44.67 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.253 -0.904 . . . . 0.0 109.107 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.404 HG23 ' N ' ' A' ' 57' ' ' GLU . 1.5 tt -173.5 -33.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.278 -0.889 . . . . 0.0 109.011 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 58' ' ' ALA . 1.2 tt0 -75.23 -66.41 0.77 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.409 -0.807 . . . . 0.0 110.195 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 57' ' ' GLU . . . -42.49 -40.53 2.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.254 -0.904 . . . . 0.0 110.205 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.852 ' HB2' ' CB ' ' A' ' 53' ' ' ALA . . . -60.41 -47.87 84.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.958 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.6 mtm -59.2 -46.7 87.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 110.186 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.6 mtp-105 -66.58 -19.18 65.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 110.006 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -68.36 -50.84 50.34 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.083 -1.011 . . . . 0.0 109.341 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.893 ' CG2' HG22 ' A' ' 40' ' ' VAL . 6.0 mt -59.73 -35.47 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.219 -0.926 . . . . 0.0 109.607 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.91 -52.3 64.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.086 -1.009 . . . . 0.0 109.061 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -55.59 -16.82 11.88 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 75.7 m -82.29 -52.29 7.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.359 -1.083 . . . . 0.0 109.351 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.596 ' HB2' HD13 ' A' ' 14' ' ' LEU . . . -75.71 -3.73 36.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.308 -0.87 . . . . 0.0 109.322 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -86.87 -48.68 7.98 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.211 -0.931 . . . . 0.0 109.299 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.8 p -81.43 -33.2 32.27 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.265 -0.897 . . . . 0.0 109.65 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -70.5 0.09 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.184 -0.948 . . . . 0.0 109.657 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -160.12 -74.29 0.02 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.547 HG21 ' HB1' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -66.74 -174.98 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -1.16 . . . . 0.0 109.939 -179.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.866 ' O ' HG22 ' A' ' 34' ' ' THR . 0.1 OUTLIER -132.17 132.4 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.34 -0.85 . . . . 0.0 109.22 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.528 ' CG2' ' HB3' ' A' ' 67' ' ' ALA . 27.7 t -81.64 157.48 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.632 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.411 ' N ' HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -115.08 95.06 5.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 109.449 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.518 -179.973 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.294 0.569 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.09 32.25 6.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 109.572 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -111.58 95.57 5.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 109.637 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.695 HG23 ' O ' ' A' ' 4' ' ' ILE . 0.6 OUTLIER -97.12 115.49 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.917 . . . . 0.0 109.332 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.443 HG22 ' H ' ' A' ' 5' ' ' THR . 0.6 OUTLIER -69.71 88.03 0.52 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.517 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.22 74.03 1.16 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.253 -0.904 . . . . 0.0 109.421 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.559 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 53.83 56.39 13.08 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.038 -1.039 . . . . 0.0 109.459 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.637 ' N ' ' CD ' ' A' ' 9' ' ' PRO . 26.0 Cg_endo -69.27 -33.78 17.68 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.1 1.866 . . . . 0.0 111.981 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 8' ' ' PRO . 32.9 Cg_endo -74.29 -41.3 0.93 Allowed 'Trans proline' 0 C--O 1.207 -1.07 0 C-N-CA 121.363 1.375 . . . . 0.0 109.95 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.557 ' C ' ' O ' ' A' ' 9' ' ' PRO . . . -17.63 -66.55 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.191 0.519 . . . . 0.0 111.502 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.66 -51.06 70.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.069 -1.019 . . . . 0.0 109.551 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 9' ' ' PRO . 42.4 t -45.81 -53.36 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.335 -0.853 . . . . 0.0 109.783 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.572 HD23 HG23 ' A' ' 43' ' ' ILE . 8.9 mp -47.17 -70.56 0.09 Allowed 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.331 -0.855 . . . . 0.0 110.15 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.484 ' HA ' HD23 ' A' ' 14' ' ' LEU . 5.4 mt -55.94 -17.23 6.1 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.289 -0.882 . . . . 0.0 110.18 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.83 -38.07 67.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.096 -1.002 . . . . 0.0 109.237 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -79.09 -22.29 45.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.266 -0.896 . . . . 0.0 109.229 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.8 -66.59 0.38 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.219 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.5 -87.53 0.08 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.272 -0.892 . . . . 0.0 109.209 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.08 43.58 0.04 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.0 mm -50.51 -72.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.214 -1.168 . . . . 0.0 109.348 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.461 ' O ' ' OE1' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -80.74 123.66 28.39 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.63 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.3 m -107.89 -174.18 2.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.212 -0.93 . . . . 0.0 109.787 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' ' 24' ' ' SER . . . -67.93 -8.76 54.69 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 2.6 m 73.28 172.51 0.3 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -1.139 . . . . 0.0 109.507 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.511 ' O ' ' HD3' ' A' ' 27' ' ' PRO . . . 90.06 -90.19 1.59 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -112.14 91.83 16.96 Favored Pre-proline 0 C--N 1.306 -1.297 0 O-C-N 121.257 -1.143 . . . . 0.0 109.774 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 25' ' ' GLY . 36.6 Cg_endo -78.4 122.73 5.71 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.583 2.189 . . . . 0.0 110.413 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.422 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 30.4 t-20 -56.5 120.05 7.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.187 -0.946 . . . . 0.0 109.363 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.4 ' O ' ' HB3' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -56.15 99.74 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.282 -0.886 . . . . 0.0 109.704 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 28' ' ' ASN . 5.5 p-10 -178.66 145.31 0.3 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.866 . . . . 0.0 109.408 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.51 -171.93 2.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.153 -0.967 . . . . 0.0 109.647 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 m -65.26 174.21 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.34 -0.85 . . . . 0.0 110.145 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -156.82 171.28 20.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.453 -0.779 . . . . 0.0 109.394 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.79 133.22 34.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 109.575 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.484 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 4.1 pt -107.93 170.88 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 0.0 109.386 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -79.83 147.27 31.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.768 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.18 -6.37 33.92 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.288 -0.882 . . . . 0.0 109.699 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -41.98 -39.88 2.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.33 -0.857 . . . . 0.0 109.945 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -58.25 7.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.148 -0.97 . . . . 0.0 109.693 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.99 HG13 ' HB ' ' A' ' 63' ' ' ILE . 86.1 t -46.73 -27.77 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.303 -0.873 . . . . 0.0 110.024 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -70.92 -46.59 62.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.105 -0.997 . . . . 0.0 109.791 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 43' ' ' ILE . 2.0 tt0 -78.26 -65.4 0.98 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.155 -0.966 . . . . 0.0 109.791 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.572 HG23 HD23 ' A' ' 13' ' ' LEU . 10.8 mt -43.12 -44.8 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.927 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.733 ' HB1' ' HB1' ' A' ' 59' ' ' ALA . . . -64.86 -43.77 91.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.164 -0.96 . . . . 0.0 109.717 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -58.08 -16.49 13.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 109.5 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.42 23.88 2.42 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.29 -0.881 . . . . 0.0 109.499 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.512 ' HD3' ' CB ' ' A' ' 50' ' ' ASP . 0.1 OUTLIER -144.0 18.02 1.77 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.0 109.413 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.553 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -43.73 -54.14 11.18 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.278 -0.889 . . . . 0.0 109.648 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.553 ' HD3' ' CB ' ' A' ' 48' ' ' MET . 36.5 Cg_endo -78.61 73.17 6.03 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.411 2.074 . . . . 0.0 110.438 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.512 ' CB ' ' HD3' ' A' ' 47' ' ' LYS . 36.8 t0 -162.4 -67.89 0.05 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.113 -0.992 . . . . 0.0 109.897 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -114.18 38.7 2.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.139 -0.976 . . . . 0.0 109.868 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 51' ' ' LEU . 4.2 p-10 40.21 28.15 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.479 -0.763 . . . . 0.0 109.916 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.678 ' HB1' ' HB2' ' A' ' 59' ' ' ALA . . . -51.81 124.6 12.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.19 -0.944 . . . . 0.0 109.531 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.458 ' O ' ' CB ' ' A' ' 55' ' ' SER . . . -45.11 -57.92 3.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.939 . . . . 0.0 109.205 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 0.5 OUTLIER 166.32 -45.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.406 -0.809 . . . . 0.0 108.859 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.671 HG22 ' O ' ' A' ' 56' ' ' ILE . 82.5 mt -140.05 7.8 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -104.92 -67.11 0.93 Allowed 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.259 -0.9 . . . . 0.0 109.45 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.09 -37.06 58.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.501 -0.749 . . . . 0.0 109.879 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.733 ' HB1' ' HB1' ' A' ' 44' ' ' ALA . . . -71.08 -31.66 68.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.128 -0.982 . . . . 0.0 109.383 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.498 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -78.64 -39.79 36.05 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.233 -0.917 . . . . 0.0 109.516 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -20.32 62.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.374 -0.829 . . . . 0.0 109.767 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.2 -60.82 2.18 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.179 -0.951 . . . . 0.0 110.075 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.99 ' HB ' HG13 ' A' ' 40' ' ' VAL . 14.9 mt -63.75 -42.75 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.191 -0.943 . . . . 0.0 109.967 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.684 ' HG2' HG21 ' A' ' 74' ' ' VAL . 24.2 tt0 -64.06 -48.52 75.91 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.092 -1.005 . . . . 0.0 109.302 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -67.25 -7.22 43.99 Favored Glycine 0 N--CA 1.478 1.447 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 8.5 m -87.26 -49.53 7.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -1.13 . . . . 0.0 109.46 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -71.49 -36.73 71.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.165 -0.96 . . . . 0.0 109.373 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -64.61 -59.2 4.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.403 -0.811 . . . . 0.0 109.907 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.71 -51.84 68.07 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.244 -0.91 . . . . 0.0 110.045 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.0 -68.88 0.15 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.217 -0.927 . . . . 0.0 109.384 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 72' ' ' ILE . . . -161.96 -88.02 0.07 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.556 HD13 ' C ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -36.39 152.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.884 -0.774 . . . . 0.0 110.279 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.471 ' O ' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -112.88 164.76 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.391 -0.818 . . . . 0.0 108.881 179.527 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.684 HG21 ' HG2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -111.82 -174.55 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.13 -0.981 . . . . 0.0 109.695 -179.583 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 35' ' ' ILE . 0.4 OUTLIER -143.1 151.0 40.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.907 . . . . 0.0 109.267 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.7 t70 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.443 -179.951 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mtt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.9 t -100.41 -22.46 15.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.875 . . . . 0.0 109.573 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.553 ' CG ' ' O ' ' A' ' 3' ' ' PHE . 8.0 p90 -45.47 118.73 1.85 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 0.0 109.631 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.8 tp -54.05 135.05 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.926 . . . . 0.0 109.359 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -64.81 95.74 0.16 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.26 -0.9 . . . . 0.0 109.492 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.467 ' O ' ' O ' ' A' ' 5' ' ' THR . 0.1 OUTLIER 60.78 132.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.296 -0.878 . . . . 0.0 109.493 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.505 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -49.56 173.72 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.31 -0.869 . . . . 0.0 109.669 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' A' ' 7' ' ' THR . 35.7 Cg_endo -78.48 173.72 13.35 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.669 2.246 . . . . 0.0 110.562 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.469 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 35.9 Cg_endo -78.12 115.44 3.75 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.728 2.286 . . . . 0.0 110.398 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.609 ' HA ' HD12 ' A' ' 13' ' ' LEU . . . -47.52 -48.73 27.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.787 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -41.51 -50.58 3.97 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.387 -0.821 . . . . 0.0 109.652 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.408 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 91.5 t -68.34 -36.53 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.69 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.609 HD12 ' HA ' ' A' ' 10' ' ' ALA . 38.4 mt -53.88 -65.85 0.5 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.939 . . . . 0.0 109.57 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 15' ' ' LYS . 1.1 mt -43.18 -48.28 6.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -0.841 . . . . 0.0 109.76 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 14' ' ' LEU . 7.7 ttpt -42.85 -55.18 3.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 109.666 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.33 -43.72 98.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.206 -0.934 . . . . 0.0 109.564 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.592 ' HB1' ' HD3' ' A' ' 39' ' ' LYS . . . -46.63 -35.66 6.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.226 -0.921 . . . . 0.0 109.583 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.63 -66.5 0.86 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.184 -0.947 . . . . 0.0 109.422 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 20' ' ' ILE . . . 114.02 31.55 2.24 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.441 ' C ' ' O ' ' A' ' 19' ' ' GLY . 20.1 mt -42.5 100.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.252 -1.146 . . . . 0.0 109.558 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -91.65 -0.44 57.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.333 -0.854 . . . . 0.0 109.608 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 m -148.66 134.08 18.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.393 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -116.43 -15.36 7.06 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.73 177.24 4.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -1.12 . . . . 0.0 109.545 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 26' ' ' GLU . . . 141.47 -155.94 25.49 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.464 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 25.4 tp10 179.47 65.16 0.13 Allowed Pre-proline 0 N--CA 1.485 1.314 0 O-C-N 121.235 -1.156 . . . . 0.0 109.634 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.464 ' HD3' ' N ' ' A' ' 26' ' ' GLU . 35.2 Cg_endo -78.28 144.67 20.83 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.679 2.252 . . . . 0.0 110.332 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -58.79 -23.55 60.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.153 -0.967 . . . . 0.0 109.515 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' LYS . 6.5 ptp180 -90.43 27.07 1.78 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.214 -0.929 . . . . 0.0 109.881 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.46 ' O ' ' HG2' ' A' ' 27' ' ' PRO . 17.3 t-20 42.2 -93.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.277 -0.889 . . . . 0.0 110.046 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -141.6 105.87 4.81 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.133 -0.979 . . . . 0.0 109.402 -179.662 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.2 t -140.92 109.35 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.162 -0.961 . . . . 0.0 109.524 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -171.29 128.23 0.69 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 0.0 109.296 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.524 HG22 ' CG1' ' A' ' 73' ' ' VAL . 1.8 p -112.96 142.39 45.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 109.738 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.45 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 2.8 pt -98.31 -170.13 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.333 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.466 ' HE2' ' OE2' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -95.1 167.4 11.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.898 . . . . 0.0 109.712 -179.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 1.051 ' O ' HG12 ' A' ' 40' ' ' VAL . 5.5 mtm180 -97.29 -19.25 18.67 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.236 -0.915 . . . . 0.0 109.681 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.466 ' C ' ' O ' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -37.81 -34.9 0.12 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.67 -0.644 . . . . 0.0 109.929 -179.753 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.592 ' HD3' ' HB1' ' A' ' 17' ' ' ALA . 8.5 mttm -72.93 -48.87 33.23 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.344 -0.848 . . . . 0.0 109.623 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 1.051 HG12 ' O ' ' A' ' 37' ' ' ARG . 9.8 p -51.29 -20.07 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 110.174 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -85.94 -62.39 1.53 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.085 -1.01 . . . . 0.0 109.778 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 16.6 pt-20 -50.19 -27.29 5.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.248 -0.908 . . . . 0.0 110.024 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.677 HG22 ' HB2' ' A' ' 47' ' ' LYS . 20.9 mt -96.75 -34.54 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.061 -1.025 . . . . 0.0 109.635 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.829 ' HB2' ' O ' ' A' ' 40' ' ' VAL . . . -47.43 -33.58 6.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.324 -0.86 . . . . 0.0 109.415 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.467 ' HA ' ' SD ' ' A' ' 48' ' ' MET . 2.6 mt-10 -88.46 -35.85 16.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.848 . . . . 0.0 109.268 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.4 mt -91.78 25.11 2.85 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.346 -0.846 . . . . 0.0 109.412 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.677 ' HB2' HG22 ' A' ' 43' ' ' ILE . 14.2 tppt? -143.35 21.47 1.88 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.135 -0.978 . . . . 0.0 109.841 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.467 ' SD ' ' HA ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -114.32 78.49 4.67 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.024 -1.047 . . . . 0.0 109.733 179.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 47' ' ' LYS . 36.1 Cg_endo -78.53 -44.55 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.594 2.196 . . . . 0.0 110.126 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -120.36 1.62 10.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.41 -0.807 . . . . 0.0 109.343 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.544 ' CG ' ' O ' ' A' ' 51' ' ' LEU . 0.7 OUTLIER -116.39 64.99 0.71 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.253 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 53' ' ' ALA . 42.3 t-20 -41.16 -28.69 0.1 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.867 . . . . 0.0 109.673 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.658 ' HB1' ' HB3' ' A' ' 58' ' ' ALA . . . 60.66 142.15 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.457 -0.777 . . . . 0.0 109.556 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -46.51 -61.86 1.62 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.282 -0.886 . . . . 0.0 109.315 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.455 ' O ' HG12 ' A' ' 56' ' ' ILE . 41.1 p -152.19 -49.96 0.11 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.245 -0.91 . . . . 0.0 109.625 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.483 HD13 ' HA ' ' A' ' 56' ' ' ILE . 8.5 mm -154.48 -33.08 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.253 -0.904 . . . . 0.0 109.202 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.74 -59.39 5.29 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.186 -0.946 . . . . 0.0 110.233 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.658 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -50.16 -58.39 5.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.337 -0.852 . . . . 0.0 110.126 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.97 -21.0 63.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.195 -0.941 . . . . 0.0 109.994 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.449 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -77.4 -33.06 55.14 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.171 -0.956 . . . . 0.0 109.83 -179.673 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.14 -13.32 55.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.63 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -80.81 -57.24 3.64 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.249 -0.907 . . . . 0.0 109.956 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.824 ' CG2' HG23 ' A' ' 40' ' ' VAL . 6.5 mt -63.34 -42.17 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.343 -0.848 . . . . 0.0 109.753 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -63.88 -48.39 76.89 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.975 -1.078 . . . . 0.0 108.93 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.39 -12.88 34.28 Favored Glycine 0 N--CA 1.48 1.621 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.491 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 54.2 m -83.78 -51.68 7.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -1.131 . . . . 0.0 109.017 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -68.56 -17.92 64.24 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.328 -0.858 . . . . 0.0 109.193 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.02 -46.59 34.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.339 -0.851 . . . . 0.0 109.682 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.26 -6.14 53.71 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.166 -0.959 . . . . 0.0 109.802 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -99.23 -49.71 4.38 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.078 -1.014 . . . . 0.0 110.361 -179.45 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.1 -134.58 2.21 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.356 -1.402 . . . . 0.0 111.073 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.526 ' C ' HD12 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -52.81 -171.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.589 -0.948 . . . . 0.0 111.114 -178.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.729 HG22 ' H ' ' A' ' 74' ' ' VAL . 3.5 p -110.56 -175.89 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.729 ' H ' HG22 ' A' ' 73' ' ' VAL . 2.0 t -130.68 156.85 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.991 -1.068 . . . . 0.0 109.559 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.466 ' OE2' ' HE2' ' A' ' 36' ' ' LYS . 16.0 pt-20 -131.05 145.33 51.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 0.0 109.505 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 43.9 t0 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.393 -179.996 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.4 m 64.67 39.79 6.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.448 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -162.12 141.45 9.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 109.568 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.738 HD13 ' C ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -117.57 -14.55 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 109.28 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.52 32.82 3.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.282 -0.886 . . . . 0.0 109.313 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.425 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -96.62 151.01 20.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.308 -0.87 . . . . 0.0 109.639 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.482 ' C ' ' HD2' ' A' ' 9' ' ' PRO . 6.7 m -132.44 67.24 78.41 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.886 . . . . 0.0 109.379 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.627 ' N ' ' CD ' ' A' ' 9' ' ' PRO . 30.2 Cg_endo -72.74 -30.36 11.72 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.832 2.355 . . . . 0.0 113.929 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 8' ' ' PRO . 34.4 Cg_endo -75.02 122.8 7.43 Favored 'Trans proline' 0 C--N 1.321 -0.869 0 C-N-CA 121.143 1.229 . . . . 0.0 110.501 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.482 ' HA ' HD12 ' A' ' 13' ' ' LEU . . . -62.96 -41.75 99.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.232 -0.917 . . . . 0.0 109.826 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -36.85 -50.04 0.83 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.55 -0.719 . . . . 0.0 110.427 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.455 ' H ' HG22 ' A' ' 12' ' ' VAL . 2.4 m -72.02 -38.89 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.037 -1.039 . . . . 0.0 109.444 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 10' ' ' ALA . 65.1 mt -54.39 -66.81 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.403 -0.81 . . . . 0.0 109.934 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 18' ' ' ALA . 3.5 pp -52.76 -30.19 31.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 110.294 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.455 ' N ' HD12 ' A' ' 14' ' ' LEU . 19.4 tttt -53.11 -62.38 1.69 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.035 -1.041 . . . . 0.0 110.022 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -69.1 -28.76 66.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.055 -1.028 . . . . 0.0 109.666 -179.732 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.616 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -89.97 5.86 44.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.954 . . . . 0.0 109.701 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.681 ' O ' HD13 ' A' ' 35' ' ' ILE . . . 169.9 62.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.099 -1.0 . . . . 0.0 109.643 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.85 -82.66 0.05 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.1 mm -51.08 -89.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.318 -1.107 . . . . 0.0 109.542 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -71.58 132.24 44.38 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.148 -0.97 . . . . 0.0 109.45 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.9 m -59.48 -49.04 79.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.19 -0.944 . . . . 0.0 109.68 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.15 -77.84 0.35 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 m -44.65 -85.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.209 -1.171 . . . . 0.0 109.331 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 26' ' ' GLU . . . -165.63 99.94 0.17 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 25' ' ' GLY . 23.3 tt0 -43.53 110.53 0.95 Allowed Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.208 -1.172 . . . . 0.0 109.411 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -75.47 168.53 24.31 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.24 1.96 . . . . 0.0 110.113 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -104.34 44.67 1.01 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 109.879 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 30' ' ' ASN . 0.3 OUTLIER -124.36 -160.92 0.96 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.324 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 29' ' ' ARG . 5.7 p30 -44.33 129.44 6.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.16 -0.962 . . . . 0.0 109.455 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.93 160.86 3.26 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.228 -0.92 . . . . 0.0 109.39 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 63.7 t -129.51 131.46 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.579 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.845 ' O ' HG12 ' A' ' 73' ' ' VAL . . . -115.8 51.88 0.92 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.192 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.643 HG22 ' CG1' ' A' ' 73' ' ' VAL . 11.9 p -142.72 164.37 30.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.561 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.681 HD13 ' O ' ' A' ' 18' ' ' ALA . 3.4 pt -150.88 167.03 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 109.522 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -79.71 131.52 35.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.139 -0.976 . . . . 0.0 109.355 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -74.17 -8.01 54.66 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.133 -0.98 . . . . 0.0 109.554 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 37' ' ' ARG . 48.6 t0 -42.78 -33.08 0.69 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.302 -0.874 . . . . 0.0 109.716 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.434 ' HD2' HD11 ' A' ' 43' ' ' ILE . 1.4 mmtt -71.87 -52.82 15.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 109.338 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.937 HG13 ' HB ' ' A' ' 63' ' ' ILE . 57.8 t -48.37 -23.43 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.393 -0.817 . . . . 0.0 109.681 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.81 -44.13 17.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 0.0 109.661 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.42 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 7.4 mm-40 -72.71 -13.55 61.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.222 -0.924 . . . . 0.0 109.849 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.434 HD11 ' HD2' ' A' ' 39' ' ' LYS . 8.0 mt -105.2 -18.5 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.104 -0.997 . . . . 0.0 109.47 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 48' ' ' MET . . . -82.31 -34.98 28.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 109.544 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.27 -22.08 35.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.445 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.421 ' HA ' HD23 ' A' ' 46' ' ' LEU . 4.8 mt -73.4 -44.8 57.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.9 . . . . 0.0 109.445 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -119.58 32.32 6.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.307 -0.87 . . . . 0.0 109.177 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.57 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -48.08 -51.29 49.73 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.384 -0.822 . . . . 0.0 110.007 -179.73 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 48' ' ' MET . 36.4 Cg_endo -80.68 57.62 6.61 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.657 2.238 . . . . 0.0 110.76 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -136.68 4.45 2.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.171 -0.956 . . . . 0.0 109.672 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.616 HD12 ' H ' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -141.71 -91.58 0.14 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.071 -1.018 . . . . 0.0 109.464 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.616 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.4 t30 -176.63 87.09 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.301 -0.875 . . . . 0.0 109.757 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.457 ' CB ' ' HB3' ' A' ' 58' ' ' ALA . . . -120.37 178.69 4.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -0.909 . . . . 0.0 109.303 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -128.99 -38.35 1.65 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.295 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.425 ' O ' HG12 ' A' ' 56' ' ' ILE . 13.6 m -127.61 -63.82 1.01 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.257 -0.902 . . . . 0.0 109.108 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -175.96 -31.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.385 -0.822 . . . . 0.0 108.8 179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.543 ' HA ' ' CG ' ' A' ' 60' ' ' MET . 1.1 tt0 -56.89 -47.94 79.34 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.321 -0.862 . . . . 0.0 109.883 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.457 ' HB3' ' CB ' ' A' ' 53' ' ' ALA . . . -51.63 -43.23 62.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.389 -0.819 . . . . 0.0 110.148 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.01 -61.49 1.76 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.069 -1.019 . . . . 0.0 110.08 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.543 ' CG ' ' HA ' ' A' ' 57' ' ' GLU . 1.7 ppp? -52.86 -19.55 2.61 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.197 -0.94 . . . . 0.0 109.961 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -83.72 -34.88 24.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.175 -0.953 . . . . 0.0 109.599 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -47.41 72.88 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.283 -0.885 . . . . 0.0 109.713 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.937 ' HB ' HG13 ' A' ' 40' ' ' VAL . 8.9 mt -62.99 -40.4 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.938 . . . . 0.0 109.881 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.05 -49.65 73.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.88 -1.137 . . . . 0.0 109.383 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.12 -13.64 28.64 Favored Glycine 0 N--CA 1.479 1.562 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.497 ' O ' ' HB2' ' A' ' 70' ' ' MET . 50.4 m -86.14 -47.42 9.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.389 -1.065 . . . . 0.0 109.918 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -70.21 -19.04 63.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 109.775 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.462 ' CG ' HG23 ' A' ' 73' ' ' VAL . 1.9 ttp180 -79.35 -58.8 3.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.237 -0.914 . . . . 0.0 109.814 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.03 -25.0 63.37 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.23 -0.919 . . . . 0.0 110.329 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.497 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -96.24 -21.86 17.6 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.997 -1.065 . . . . 0.0 110.741 -179.114 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -154.8 -141.97 3.35 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.27 -1.443 . . . . 0.0 110.751 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.587 ' N ' HD12 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -70.81 -174.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.568 -0.96 . . . . 0.0 110.308 -179.315 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.845 HG12 ' O ' ' A' ' 33' ' ' ALA . 1.4 p -90.45 -172.46 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.474 -0.766 . . . . 0.0 108.984 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.667 ' H ' HG22 ' A' ' 73' ' ' VAL . 84.3 t -132.76 135.17 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.079 -1.013 . . . . 0.0 109.729 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 35' ' ' ILE . 22.4 pt-20 -98.65 160.6 14.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 109.26 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 43.6 t0 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.986 -1.006 . . . . 0.0 109.495 -179.957 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.81 38.76 1.66 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 109.4 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -124.66 78.08 1.65 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.298 -0.876 . . . . 0.0 109.396 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.503 ' O ' ' N ' ' A' ' 6' ' ' LYS . 2.9 tp -51.49 -24.15 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.574 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.96 93.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.266 -0.896 . . . . 0.0 109.43 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -135.46 -173.53 3.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 109.471 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.9 m -99.75 115.5 65.54 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.908 . . . . 0.0 109.365 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.71 170.31 19.33 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.34 2.027 . . . . 0.0 110.357 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.441 ' HD2' ' HB ' ' A' ' 12' ' ' VAL . 36.0 Cg_endo -77.77 -162.62 0.18 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.582 2.188 . . . . 0.0 110.559 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -84.02 -68.09 0.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.194 -0.942 . . . . 0.0 109.656 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -40.18 -53.8 2.42 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.422 -0.799 . . . . 0.0 109.973 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.441 ' HB ' ' HD2' ' A' ' 9' ' ' PRO . 48.8 t -60.14 -43.04 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 109.616 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 13' ' ' LEU . 7.9 mt -51.46 -48.13 62.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.214 -0.929 . . . . 0.0 109.789 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.445 ' CD1' HG22 ' A' ' 66' ' ' THR . 8.5 mt -67.4 -27.28 66.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.622 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -69.8 -30.84 68.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.481 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -76.56 -48.3 19.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 0.0 109.489 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.71 37.5 0.96 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.906 . . . . 0.0 109.465 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.768 ' HB1' HG21 ' A' ' 72' ' ' ILE . . . -90.8 -53.24 4.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.427 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 21' ' ' GLU . . . 140.84 -18.49 2.76 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.3 mt -46.86 96.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.318 -1.107 . . . . 0.0 109.532 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.497 ' HG2' ' N ' ' A' ' 22' ' ' SER . 22.9 tt0 -141.97 149.5 40.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.393 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.497 ' N ' ' HG2' ' A' ' 21' ' ' GLU . 39.8 m -54.24 156.59 3.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 109.592 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.24 47.49 0.1 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.35 -159.99 0.63 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -1.139 . . . . 0.0 109.306 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 26' ' ' GLU . . . -179.01 153.63 12.75 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 25' ' ' GLY . 3.6 tt0 45.47 94.23 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.407 -1.055 . . . . 0.0 109.865 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.09 143.52 20.36 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.61 2.207 . . . . 0.0 110.302 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.53 -76.05 0.52 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.205 -0.934 . . . . 0.0 109.62 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.11 -168.09 1.42 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.485 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.2 p-10 -52.88 137.19 32.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.393 -0.817 . . . . 0.0 109.418 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.89 97.46 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.231 -0.918 . . . . 0.0 109.589 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.1 t -58.71 102.73 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.214 -0.929 . . . . 0.0 109.242 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -151.75 125.57 9.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.178 -0.951 . . . . 0.0 109.455 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.2 p -125.81 176.76 6.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.312 -0.867 . . . . 0.0 109.373 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.766 HD12 ' HE2' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -141.1 168.76 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.166 179.77 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.484 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 15.8 ttmt -85.64 171.06 11.96 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.222 -0.924 . . . . 0.0 109.702 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.458 ' HD3' ' OE1' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -72.51 -14.37 61.64 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.34 -0.85 . . . . 0.0 109.474 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 37' ' ' ARG . 4.6 t0 -41.71 -33.64 0.52 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.492 -0.755 . . . . 0.0 109.674 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.766 ' HE2' HD12 ' A' ' 35' ' ' ILE . 1.8 ttpt -69.24 -61.86 1.61 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.191 -0.943 . . . . 0.0 109.442 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.896 HG13 ' HB ' ' A' ' 63' ' ' ILE . 84.8 t -49.69 -20.58 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.885 . . . . 0.0 110.053 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -72.96 -51.34 18.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.023 -1.048 . . . . 0.0 110.369 -179.438 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.478 ' HG3' ' N ' ' A' ' 43' ' ' ILE . 16.8 pt-20 -73.78 -39.2 64.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.02 -1.05 . . . . 0.0 110.476 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.518 ' HB ' HD13 ' A' ' 63' ' ' ILE . 9.6 mt -73.05 -14.44 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.101 -0.999 . . . . 0.0 109.917 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 40' ' ' VAL . . . -92.88 -26.52 17.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.096 -1.002 . . . . 0.0 109.748 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 2.4 pt-20 -96.39 -2.64 45.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.12 -0.987 . . . . 0.0 109.664 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 43' ' ' ILE . 0.3 OUTLIER -73.34 -24.82 60.41 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.235 -0.915 . . . . 0.0 109.744 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.429 ' N ' ' HG ' ' A' ' 46' ' ' LEU . 5.2 ttmt -159.07 58.4 0.42 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.144 -0.972 . . . . 0.0 109.394 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.559 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 1.3 mtp -43.87 -52.87 14.01 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.416 -0.803 . . . . 0.0 110.349 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 48' ' ' MET . 34.0 Cg_endo -77.04 96.26 1.1 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.417 2.078 . . . . 0.0 110.591 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 24.4 t0 178.7 -40.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.366 -0.834 . . . . 0.0 109.38 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.443 ' O ' ' C ' ' A' ' 52' ' ' ASN . 0.5 OUTLIER -107.34 35.84 2.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 109.594 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER 40.56 76.45 0.07 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.459 -0.776 . . . . 0.0 109.755 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.75 139.98 33.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.23 -0.919 . . . . 0.0 109.353 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.94 -47.85 64.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 109.497 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.52 -52.56 0.09 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.245 -0.91 . . . . 0.0 108.851 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.7 tt -175.41 -31.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.303 -0.873 . . . . 0.0 109.242 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -60.2 -53.65 55.22 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.279 -0.888 . . . . 0.0 109.448 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.04 -53.22 44.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.427 -0.795 . . . . 0.0 109.842 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.62 -42.32 61.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.795 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.46 -38.22 90.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.19 -0.943 . . . . 0.0 110.121 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -76.1 -15.99 59.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 109.656 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.61 -59.95 2.57 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.229 -0.92 . . . . 0.0 109.586 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.896 ' HB ' HG13 ' A' ' 40' ' ' VAL . 24.1 mt -57.38 -35.26 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.248 -0.908 . . . . 0.0 109.987 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.458 ' OE1' ' HD3' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -62.29 -51.53 67.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.091 -1.006 . . . . 0.0 109.326 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.81 -9.67 27.99 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 70' ' ' MET . 87.6 m -87.29 -51.17 6.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -1.114 . . . . 0.0 110.026 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -76.69 -14.97 59.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 109.736 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.66 -57.11 3.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.67 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.0 -21.84 62.24 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.284 -0.885 . . . . 0.0 110.172 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -65.08 -65.89 0.61 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.079 -1.013 . . . . 0.0 109.609 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -161.13 -65.96 0.02 OUTLIER Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.267 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.877 HD12 ' N ' ' A' ' 73' ' ' VAL . 1.7 pp -72.62 -179.37 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -1.117 . . . . 0.0 110.513 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.877 ' N ' HD12 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -126.33 151.59 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.583 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.31 168.53 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.146 -0.972 . . . . 0.0 109.588 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.484 ' HG3' ' HA ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -123.75 125.66 45.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.308 -0.87 . . . . 0.0 109.582 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.1 t0 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.52 179.931 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.311 0.577 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.9 m -137.31 -49.39 0.61 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.281 -0.887 . . . . 0.0 109.313 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.64 134.83 54.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 109.353 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.2 mp -137.23 130.97 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.207 -0.933 . . . . 0.0 109.498 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.33 130.95 35.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 109.405 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.73 149.31 41.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.634 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.6 m 63.71 79.02 0.26 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 109.548 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 34.9 Cg_endo -78.27 151.44 26.46 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.571 2.18 . . . . 0.0 110.331 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.473 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 35.4 Cg_endo -77.34 174.1 13.27 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.643 2.229 . . . . 0.0 110.431 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -73.74 -65.04 0.88 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.963 . . . . 0.0 109.822 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.506 ' HA ' ' CE ' ' A' ' 70' ' ' MET . . . -36.69 -39.27 0.2 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.565 -0.709 . . . . 0.0 110.703 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.433 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 38.8 t -75.35 -51.43 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.022 -1.049 . . . . 0.0 109.865 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 13' ' ' LEU . 21.5 mt -51.37 -60.96 2.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.054 -1.028 . . . . 0.0 109.366 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.512 HD13 HG22 ' A' ' 66' ' ' THR . 0.2 OUTLIER -50.06 -40.39 45.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.599 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' LYS . 14.4 mttt -52.89 -65.89 0.48 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 109.196 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.452 ' HA ' HD11 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -44.46 -26.37 0.34 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 108.944 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.726 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -105.22 51.89 0.75 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.454 -0.779 . . . . 0.0 109.34 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' A' ' 17' ' ' ALA . . . 88.75 102.33 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 20' ' ' ILE . . . 168.77 -47.67 0.22 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.476 ' O ' ' O ' ' A' ' 19' ' ' GLY . 1.8 mt -58.7 -120.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.391 -1.064 . . . . 0.0 109.726 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -89.34 88.64 7.57 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 120.7 -1.25 . . . . 0.0 109.442 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.1 m -98.53 8.79 44.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.148 -0.97 . . . . 0.0 109.642 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.1 129.14 1.16 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.0 p 50.94 -168.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.234 -1.156 . . . . 0.0 109.229 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 26' ' ' GLU . . . -158.19 -66.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 25' ' ' GLY . 1.6 pt-20 -43.66 130.48 3.94 Favored Pre-proline 0 C--N 1.305 -1.338 0 O-C-N 121.279 -1.13 . . . . 0.0 109.458 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.75 133.46 11.45 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.491 2.128 . . . . 0.0 110.719 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.67 153.39 35.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.329 -0.857 . . . . 0.0 109.399 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -71.21 -13.13 61.82 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.239 -0.913 . . . . 0.0 109.893 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -110.4 -15.7 13.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.158 -0.963 . . . . 0.0 109.603 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.72 -174.89 5.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.438 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.6 p -46.47 144.03 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 109.576 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.56 -169.43 2.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 0.0 109.656 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.445 ' OG1' ' HA ' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -95.95 171.08 8.85 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.294 -0.879 . . . . 0.0 109.733 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.6 HG21 ' CB ' ' A' ' 18' ' ' ALA . 6.9 pt -85.01 -173.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.374 -0.829 . . . . 0.0 109.91 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -99.3 147.81 24.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 0.0 109.572 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -73.99 -10.13 59.33 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.277 -0.889 . . . . 0.0 109.604 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 37' ' ' ARG . 0.4 OUTLIER -42.6 -51.73 5.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.334 -0.854 . . . . 0.0 109.837 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.465 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -57.32 -45.03 84.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.701 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.942 HG13 ' CG2' ' A' ' 63' ' ' ILE . 75.4 t -56.0 -28.06 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -0.846 . . . . 0.0 110.474 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -75.59 -51.62 12.46 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.986 -1.071 . . . . 0.0 110.072 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -60.97 -29.87 69.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 0.0 110.044 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 39' ' ' LYS . 45.3 mt -83.02 -34.37 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.006 -1.059 . . . . 0.0 109.981 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.03 -9.4 58.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.088 -1.008 . . . . 0.0 109.793 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -99.35 -33.67 10.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.148 -0.97 . . . . 0.0 109.525 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.815 ' O ' HD12 ' A' ' 46' ' ' LEU . 0.7 OUTLIER -77.47 -11.43 59.85 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.225 -0.922 . . . . 0.0 109.998 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -132.08 34.88 3.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 109.673 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.58 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 4.3 ttp -50.57 -48.41 82.18 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.163 -0.961 . . . . 0.0 109.808 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 48' ' ' MET . 35.9 Cg_endo -78.84 82.01 2.62 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.059 1.839 . . . . 0.0 110.168 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -144.57 -46.63 0.25 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -0.945 . . . . 0.0 109.794 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.416 HD13 ' SD ' ' A' ' 62' ' ' MET . 0.5 OUTLIER -117.41 22.29 12.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.212 -0.93 . . . . 0.0 109.681 -179.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 51' ' ' LEU . 3.5 t-20 44.14 72.62 0.18 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.157 -0.964 . . . . 0.0 109.556 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.414 ' HB1' ' HB3' ' A' ' 58' ' ' ALA . . . -100.87 174.05 6.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -0.942 . . . . 0.0 109.325 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.85 -57.69 9.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 0.0 109.521 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.1 m -162.9 -56.6 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.627 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.515 HD13 ' HA ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -157.23 -32.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.251 -0.906 . . . . 0.0 109.064 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -49.55 -65.0 0.64 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.164 -0.96 . . . . 0.0 110.085 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.414 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -53.6 -43.22 68.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.393 -0.817 . . . . 0.0 110.383 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.58 -28.94 68.87 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.024 -1.047 . . . . 0.0 110.15 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -31.3 49.52 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.127 -0.983 . . . . 0.0 109.311 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.429 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -77.32 -16.25 59.02 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.434 -0.791 . . . . 0.0 109.01 179.581 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.416 ' SD ' HD13 ' A' ' 51' ' ' LEU . 3.2 mtp -77.41 -52.06 9.76 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.4 -0.813 . . . . 0.0 109.461 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.942 ' CG2' HG13 ' A' ' 40' ' ' VAL . 2.3 mt -66.07 -45.88 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.762 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.543 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 7.8 pt-20 -64.01 -47.36 80.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.914 -1.116 . . . . 0.0 109.432 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.543 ' N ' ' HG3' ' A' ' 64' ' ' GLU . . . -61.43 -14.78 43.25 Favored Glycine 0 N--CA 1.479 1.53 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.52 ' O ' ' HG2' ' A' ' 70' ' ' MET . 61.0 m -98.02 -20.98 17.06 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.41 -1.053 . . . . 0.0 109.393 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.557 ' HB3' HG21 ' A' ' 74' ' ' VAL . . . -92.07 -9.39 42.87 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.218 -0.926 . . . . 0.0 109.048 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.788 ' CD ' HG13 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -105.36 -49.08 3.53 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.49 -0.757 . . . . 0.0 110.6 -179.362 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 p -75.54 -39.0 58.89 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.215 -0.928 . . . . 0.0 111.729 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.52 ' HG2' ' O ' ' A' ' 66' ' ' THR . 0.2 OUTLIER -81.62 -27.49 34.15 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 120.636 -1.29 . . . . 0.0 111.628 -177.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.504 ' N ' ' HG3' ' A' ' 70' ' ' MET . . . -149.21 -141.24 3.41 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 118.76 -1.686 . . . . 0.0 111.59 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.52 ' N ' HD12 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -52.25 -166.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.869 -0.783 . . . . 0.0 110.717 -178.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.788 HG13 ' CD ' ' A' ' 68' ' ' ARG . 22.4 t -112.14 165.44 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.349 -0.845 . . . . 0.0 109.951 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.557 HG21 ' HB3' ' A' ' 67' ' ' ALA . 98.1 t -124.55 156.66 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.337 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.492 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 14.4 pt-20 -115.59 110.19 18.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -0.943 . . . . 0.0 109.587 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.7 t0 . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.342 179.842 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.652 HG22 ' N ' ' A' ' 3' ' ' PHE . 18.9 m -118.58 -93.42 0.52 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 109.573 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.831 ' C ' HD12 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -107.34 124.24 49.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.18 -0.95 . . . . 0.0 109.68 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.831 HD12 ' C ' ' A' ' 3' ' ' PHE . 3.7 mp -136.69 158.3 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.292 -0.88 . . . . 0.0 109.271 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.76 HG23 ' O ' ' A' ' 5' ' ' THR . 14.2 t -102.66 107.41 18.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.698 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.491 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -80.95 -161.41 0.39 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.211 -0.931 . . . . 0.0 108.856 179.601 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.732 HG22 ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -129.66 52.09 8.68 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 120.989 -1.07 . . . . 0.0 110.15 179.731 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.623 ' N ' ' CD ' ' A' ' 9' ' ' PRO . 28.2 Cg_endo -71.15 -32.07 13.64 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.284 1.99 . . . . 0.0 113.643 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 8' ' ' PRO . 32.8 Cg_endo -75.89 136.13 18.29 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 C-N-CA 121.321 1.347 . . . . 0.0 110.596 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 12' ' ' VAL . . . -54.17 -54.91 33.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.474 -0.766 . . . . 0.0 110.669 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -30.99 -36.84 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.695 -0.628 . . . . 0.0 111.079 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.732 ' CG1' HG22 ' A' ' 7' ' ' THR . 1.2 t -81.33 -53.22 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.964 -1.085 . . . . 0.0 109.706 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.481 HD11 ' O ' ' A' ' 7' ' ' THR . 2.1 mp -46.42 -45.3 17.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.267 -0.896 . . . . 0.0 109.981 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.446 HD22 ' HB2' ' A' ' 67' ' ' ALA . 5.3 mt -67.24 -37.57 83.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.906 . . . . 0.0 110.015 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.99 -33.93 76.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.275 -0.89 . . . . 0.0 110.387 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -92.96 -8.28 43.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.965 -1.084 . . . . 0.0 109.676 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.421 ' HB1' ' CD ' ' A' ' 39' ' ' LYS . . . -76.27 -37.74 57.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 109.643 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.72 -36.53 25.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.899 . . . . 0.0 109.675 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.52 44.11 1.27 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.8 mm -63.73 -10.39 7.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 121.312 -1.111 . . . . 0.0 110.15 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -104.99 -33.07 8.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.033 -1.042 . . . . 0.0 109.807 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.05 -83.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.393 -0.817 . . . . 0.0 109.493 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.56 138.9 8.22 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.19 166.45 10.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -1.154 . . . . 0.0 109.365 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.54 -173.92 0.48 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -46.31 129.79 7.75 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.151 -1.205 . . . . 0.0 109.335 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.89 117.3 4.17 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.443 2.095 . . . . 0.0 110.341 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -151.39 46.28 0.81 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.145 -0.972 . . . . 0.0 109.922 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.44 ' O ' ' C ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -169.45 55.46 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.013 -1.054 . . . . 0.0 110.441 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 29' ' ' ARG . 1.9 p-10 39.69 50.96 2.31 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.36 -0.837 . . . . 0.0 110.3 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.54 104.34 4.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.129 -0.982 . . . . 0.0 109.309 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -171.56 143.21 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.148 -0.97 . . . . 0.0 110.032 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 34' ' ' THR . . . 48.17 74.95 0.15 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.378 -0.826 . . . . 0.0 109.893 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.848 HG22 HG12 ' A' ' 73' ' ' VAL . 16.6 p -160.32 126.35 4.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.395 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.404 HG23 HG13 ' A' ' 72' ' ' ILE . 41.5 pt -86.35 175.18 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.962 . . . . 0.0 109.413 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.74 138.62 45.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.204 -0.935 . . . . 0.0 109.699 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.483 ' NH1' ' OD1' ' A' ' 76' ' ' ASP . 4.6 mtp180 -53.4 -35.7 60.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.34 -0.85 . . . . 0.0 109.457 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.32 -54.54 8.77 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.257 -0.902 . . . . 0.0 109.381 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 40' ' ' VAL . 2.5 mttt -56.9 -55.63 32.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.29 -0.881 . . . . 0.0 109.355 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.845 HG13 HG21 ' A' ' 63' ' ' ILE . 99.2 t -42.32 -29.61 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -0.848 . . . . 0.0 110.171 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -77.66 -44.96 26.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.109 -0.994 . . . . 0.0 110.13 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.404 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 2.7 tp10 -63.48 -61.58 2.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.102 -0.999 . . . . 0.0 109.998 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 19.3 mt -57.47 -31.37 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.321 -0.862 . . . . 0.0 110.242 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 40' ' ' VAL . . . -63.6 -31.65 72.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.112 -0.993 . . . . 0.0 110.024 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -92.68 -65.15 1.02 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.096 -1.003 . . . . 0.0 109.965 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 33.8 mt -53.35 -19.33 3.26 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.24 -0.912 . . . . 0.0 110.204 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.48 ' HD3' HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -116.14 -11.21 11.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.071 -1.018 . . . . 0.0 109.871 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.469 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 0.9 OUTLIER -39.23 99.14 0.19 Allowed Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.6 -0.687 . . . . 0.0 109.927 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 47' ' ' LYS . 36.4 Cg_endo -79.84 -82.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.55 2.167 . . . . 0.0 110.127 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -144.0 -72.96 0.27 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.361 -0.837 . . . . 0.0 109.342 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.824 HD22 ' SD ' ' A' ' 62' ' ' MET . 3.6 mt 54.34 18.19 1.79 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.191 -0.943 . . . . 0.0 109.505 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER 40.34 33.8 0.19 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.449 -0.782 . . . . 0.0 109.792 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.53 154.37 42.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 0.0 109.452 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.23 -26.55 42.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 109.589 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m -158.41 -58.41 0.07 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.165 -0.959 . . . . 0.0 108.88 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.42 HG23 ' N ' ' A' ' 57' ' ' GLU . 1.4 tt -172.51 -33.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.256 -0.903 . . . . 0.0 109.201 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.42 ' N ' HG23 ' A' ' 56' ' ' ILE . 1.3 tt0 -47.97 -60.18 2.8 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.268 -0.895 . . . . 0.0 109.33 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.97 -49.86 29.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.454 -0.779 . . . . 0.0 109.339 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 62' ' ' MET . . . -49.06 -42.09 37.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 109.177 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -37.75 88.47 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.228 -0.92 . . . . 0.0 109.329 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.99 -13.16 62.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 108.914 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.824 ' SD ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -82.63 -51.07 8.09 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.333 -0.855 . . . . 0.0 109.329 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.845 HG21 HG13 ' A' ' 40' ' ' VAL . 4.8 mt -56.35 -42.6 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.895 . . . . 0.0 109.619 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.528 ' CG ' HG21 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -61.55 -53.83 51.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.898 -1.126 . . . . 0.0 109.43 -179.737 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -56.4 -15.57 12.0 Favored Glycine 0 N--CA 1.48 1.618 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 90.5 m -81.71 -59.99 2.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.3 -1.118 . . . . 0.0 109.546 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.709 ' HB1' HD11 ' A' ' 72' ' ' ILE . . . -73.41 -2.78 23.74 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.238 -0.914 . . . . 0.0 109.528 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.526 ' NH1' ' HG3' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -86.56 -50.24 6.98 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.19 -0.944 . . . . 0.0 109.725 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.47 -8.75 34.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.106 -0.996 . . . . 0.0 109.894 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.48 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -71.06 -69.16 0.39 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.064 -1.022 . . . . 0.0 109.086 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -161.44 -79.9 0.03 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.709 HD11 ' HB1' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -57.88 -169.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.464 -1.021 . . . . 0.0 109.995 -179.631 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.848 HG12 HG22 ' A' ' 34' ' ' THR . 0.4 OUTLIER -138.64 169.97 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.4 -0.812 . . . . 0.0 108.884 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.528 HG21 ' CG ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -106.69 151.48 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.027 -1.046 . . . . 0.0 109.425 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -125.22 145.47 49.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.901 . . . . 0.0 109.494 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.483 ' OD1' ' NH1' ' A' ' 37' ' ' ARG . 14.2 t70 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.452 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 71.1 p -69.9 -142.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.27 -0.893 . . . . 0.0 109.246 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -127.76 72.59 1.41 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.959 -1.088 . . . . 0.0 109.641 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.9 tp -98.0 148.88 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.226 -0.921 . . . . 0.0 109.417 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.87 41.74 3.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 109.624 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.95 -171.35 3.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.191 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 44.08 81.21 0.26 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 109.406 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.75 159.66 31.4 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.643 2.229 . . . . 0.0 110.314 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.527 ' O ' HD12 ' A' ' 13' ' ' LEU . 35.3 Cg_endo -77.68 -159.98 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.591 2.194 . . . . 0.0 110.528 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -79.38 -66.99 0.8 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.252 -0.905 . . . . 0.0 110.052 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -37.25 -46.24 0.72 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.51 -0.744 . . . . 0.0 110.187 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.7 t -67.67 -46.78 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.213 -0.929 . . . . 0.0 109.423 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 9' ' ' PRO . 3.3 mt -46.85 -48.93 20.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.433 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.499 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -68.71 -38.48 80.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.594 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.6 -66.02 0.46 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 109.669 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -59.11 -32.93 70.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.152 -0.968 . . . . 0.0 109.739 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 14' ' ' LEU . . . -50.05 -65.1 0.62 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.141 -0.975 . . . . 0.0 109.548 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.48 -29.49 36.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 109.406 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 21' ' ' GLU . . . 81.2 31.82 33.45 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.4 mm -53.55 94.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.196 -1.179 . . . . 0.0 109.769 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 19' ' ' GLY . 40.4 tt0 -121.52 109.23 14.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 109.266 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.3 m -137.12 57.14 1.77 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.328 -0.857 . . . . 0.0 109.536 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.27 -61.13 3.53 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 59.0 m -128.75 -2.08 5.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -1.149 . . . . 0.0 109.583 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.12 67.67 1.21 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -44.7 107.89 0.68 Allowed Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.31 -1.112 . . . . 0.0 109.736 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.96 124.56 7.45 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.439 2.093 . . . . 0.0 110.271 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -129.82 4.26 4.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.322 -0.861 . . . . 0.0 109.56 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.54 113.04 6.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.267 -0.895 . . . . 0.0 109.495 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -153.91 39.56 0.48 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.253 -0.905 . . . . 0.0 109.68 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -55.07 138.94 43.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.177 -0.952 . . . . 0.0 109.153 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.3 t 57.23 99.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.206 -0.933 . . . . 0.0 109.186 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.32 94.37 4.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 0.0 109.616 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.1 p -118.6 148.93 42.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.188 -0.945 . . . . 0.0 109.425 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.765 HG13 HG13 ' A' ' 74' ' ' VAL . 11.6 pt -105.74 -179.09 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.297 -0.877 . . . . 0.0 109.618 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -95.61 146.96 24.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.294 -0.879 . . . . 0.0 109.487 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.9 ppt_? -60.42 -15.44 26.43 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.235 -0.916 . . . . 0.0 109.517 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -47.92 -39.25 18.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.325 -0.859 . . . . 0.0 109.561 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.43 -45.99 90.57 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.314 -0.866 . . . . 0.0 109.52 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.559 HG13 ' HB ' ' A' ' 63' ' ' ILE . 30.4 t -61.79 -12.89 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 0.0 109.48 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.9 -55.15 5.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 109.912 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -72.44 -51.07 21.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.228 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 63.2 mt -57.44 -45.92 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 110.094 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' A' ' 40' ' ' VAL . . . -57.28 -39.18 75.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -0.959 . . . . 0.0 109.981 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.35 -36.78 77.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.125 -0.985 . . . . 0.0 109.831 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mt -87.49 14.89 7.32 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.171 -0.956 . . . . 0.0 109.596 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -134.48 24.38 3.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 0.0 109.264 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.597 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -69.8 -51.01 16.16 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.389 -0.819 . . . . 0.0 109.942 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 48' ' ' MET . 34.1 Cg_endo -77.34 89.1 1.35 Allowed 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.336 2.024 . . . . 0.0 110.647 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -176.69 -62.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.703 HD11 ' HB2' ' A' ' 53' ' ' ALA . 1.5 pp -103.02 -0.75 30.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.387 -0.82 . . . . 0.0 109.22 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 45.95 81.11 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.273 -0.892 . . . . 0.0 109.713 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.703 ' HB2' HD11 ' A' ' 51' ' ' LEU . . . -87.62 163.13 16.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.0 109.277 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -46.45 -56.09 6.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 109.132 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m -160.07 -69.4 0.07 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.276 -0.89 . . . . 0.0 108.678 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -147.0 8.26 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.355 -0.84 . . . . 0.0 109.584 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -92.95 -51.98 4.81 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.111 -0.993 . . . . 0.0 109.483 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.641 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -73.21 -27.81 61.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.361 -0.837 . . . . 0.0 109.543 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.73 -37.61 70.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 109.354 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.64 -50.73 23.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.694 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -61.18 -17.5 53.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.624 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.573 ' SD ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -75.64 -54.75 6.47 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.251 -0.906 . . . . 0.0 110.087 -179.653 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.559 ' HB ' HG13 ' A' ' 40' ' ' VAL . 12.3 mt -56.16 -38.87 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 110.482 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.4 ' C ' ' N ' ' A' ' 66' ' ' THR . 1.7 tt0 -63.11 -60.95 2.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.712 -1.242 . . . . 0.0 109.303 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.74 -16.6 7.71 Favored Glycine 0 N--CA 1.479 1.501 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 33.2 m -74.14 -55.1 6.49 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.234 -1.156 . . . . 0.0 109.272 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -67.76 -14.25 62.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.181 -0.949 . . . . 0.0 109.249 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.403 ' HG2' HG13 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -67.54 -52.29 40.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 0.0 109.803 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.17 -9.92 29.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.206 -0.934 . . . . 0.0 110.49 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.493 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -97.15 -49.85 4.82 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.097 -1.002 . . . . 0.0 110.109 -179.264 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -138.64 -127.02 2.46 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.654 -1.26 . . . . 0.0 110.167 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.525 ' O ' HD12 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -85.69 179.28 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.361 -1.082 . . . . 0.0 109.973 -179.446 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 74' ' ' VAL . 0.2 OUTLIER -94.41 -169.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.917 . . . . 0.0 109.545 179.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.765 HG13 HG13 ' A' ' 35' ' ' ILE . 8.8 t -135.6 167.56 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 0.0 109.525 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.475 ' N ' HG12 ' A' ' 74' ' ' VAL . 5.0 pt-20 -122.01 152.44 39.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.451 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.4 t70 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.455 -179.935 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.74 -35.27 20.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.656 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.499 ' O ' HG13 ' A' ' 4' ' ' ILE . 1.2 t80 59.46 104.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.153 -0.967 . . . . 0.0 109.346 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 3' ' ' PHE . 18.2 mt -146.45 -75.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.281 -0.887 . . . . 0.0 109.412 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.472 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 2.8 t -90.18 178.29 6.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.401 -0.812 . . . . 0.0 109.695 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 5' ' ' THR . 13.2 ttmt 62.77 124.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.407 -0.808 . . . . 0.0 109.513 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.408 ' OG1' ' HG2' ' A' ' 6' ' ' LYS . 1.7 m 66.34 81.71 0.21 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.325 -0.859 . . . . 0.0 109.42 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.404 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 35.1 Cg_endo -77.27 159.85 32.94 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.562 2.175 . . . . 0.0 110.189 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -76.9 -162.11 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.538 2.159 . . . . 0.0 110.332 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.478 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -72.49 -67.25 0.57 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.21 -0.931 . . . . 0.0 110.11 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -33.93 -53.8 0.46 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.761 -0.587 . . . . 0.0 110.663 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 99.4 t -57.31 -50.39 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.089 -1.007 . . . . 0.0 109.783 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 13' ' ' LEU . 39.5 mt -48.18 -68.52 0.18 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.117 -0.99 . . . . 0.0 109.767 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.521 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 6.0 mt -55.67 -20.72 15.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.198 -0.939 . . . . 0.0 109.6 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -61.34 -57.32 12.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.501 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 17' ' ' ALA . 47.0 mmtm -60.22 -25.55 65.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 0.0 109.319 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 14' ' ' LEU . . . -42.92 -35.91 1.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.39 -0.819 . . . . 0.0 109.408 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -102.83 -24.34 13.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.269 -0.894 . . . . 0.0 109.565 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.75 34.95 7.04 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.0 mm -54.43 100.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.249 -1.148 . . . . 0.0 109.746 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -51.23 163.42 0.24 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.872 . . . . 0.0 109.519 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.82 125.33 17.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 109.68 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 163.2 -175.53 39.49 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.1 t -62.09 170.64 2.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -1.118 . . . . 0.0 109.484 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.75 76.89 1.07 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -46.1 127.0 7.29 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.29 -1.124 . . . . 0.0 109.7 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.38 131.46 10.62 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.532 2.155 . . . . 0.0 110.286 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -118.96 -29.16 5.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.117 -0.989 . . . . 0.0 109.539 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.83 138.96 55.15 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.22 -0.925 . . . . 0.0 109.627 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -119.63 21.01 12.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.134 -0.979 . . . . 0.0 109.374 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.95 173.55 3.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.295 -0.878 . . . . 0.0 109.757 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.5 t -126.15 159.61 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.397 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.449 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . -133.22 157.3 45.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.212 -0.93 . . . . 0.0 109.584 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.769 HG22 HG23 ' A' ' 73' ' ' VAL . 11.1 p -126.54 143.5 51.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 109.378 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.077 HD11 HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -112.53 -171.63 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.172 -0.955 . . . . 0.0 109.615 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -100.17 168.69 9.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.386 -0.821 . . . . 0.0 109.931 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.04 -11.22 57.07 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.379 -0.826 . . . . 0.0 110.046 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -51.09 -44.9 61.33 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.135 -0.978 . . . . 0.0 109.776 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.446 ' NZ ' HD23 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -59.77 -34.62 73.23 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.319 -0.863 . . . . 0.0 109.852 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.753 HG13 ' HB ' ' A' ' 63' ' ' ILE . 68.1 t -63.06 -30.59 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 110.017 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -80.73 -23.33 39.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.112 -0.992 . . . . 0.0 110.008 -179.673 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -80.67 -52.6 7.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.971 . . . . 0.0 109.62 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.4 mt -65.99 -36.47 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.663 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.7 -38.71 80.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.212 -0.93 . . . . 0.0 109.636 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -74.52 -27.22 60.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 0.0 109.698 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.03 -0.06 54.61 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.093 -1.005 . . . . 0.0 109.595 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -149.44 47.92 0.96 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.325 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.582 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -62.7 -50.37 78.25 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.273 -0.892 . . . . 0.0 110.033 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 48' ' ' MET . 36.4 Cg_endo -80.7 49.43 3.22 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.711 2.274 . . . . 0.0 110.815 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -123.2 -33.65 3.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.095 -1.003 . . . . 0.0 109.233 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.675 HD11 ' HB2' ' A' ' 53' ' ' ALA . 0.8 OUTLIER -123.86 34.87 4.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -0.885 . . . . 0.0 109.334 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' A' ' 52' ' ' ASN . 29.1 t-20 42.95 38.16 1.33 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.357 -0.84 . . . . 0.0 109.537 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.675 ' HB2' HD11 ' A' ' 51' ' ' LEU . . . -61.54 135.64 57.73 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.187 -0.946 . . . . 0.0 109.318 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.9 -73.41 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.891 . . . . 0.0 109.536 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.461 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -139.08 -51.21 0.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 109.635 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.478 HD13 ' HA ' ' A' ' 56' ' ' ILE . 10.4 mm -157.31 -32.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.385 -0.822 . . . . 0.0 109.371 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.42 -59.12 5.91 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.24 -0.912 . . . . 0.0 110.578 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.9 -50.25 66.79 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.379 -0.826 . . . . 0.0 110.831 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.481 ' HB2' ' CB ' ' A' ' 53' ' ' ALA . . . -66.23 -24.76 66.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.983 -1.073 . . . . 0.0 110.089 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -74.24 -38.06 63.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 109.771 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.08 -13.18 57.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.341 -0.849 . . . . 0.0 109.871 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.05 -53.96 7.56 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.19 -0.944 . . . . 0.0 109.398 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.753 ' HB ' HG13 ' A' ' 40' ' ' VAL . 12.2 mt -64.98 -41.12 91.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.91 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.433 ' HG2' ' CZ ' ' A' ' 68' ' ' ARG . 18.1 tt0 -61.66 -53.35 57.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.04 -1.038 . . . . 0.0 109.722 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.67 -10.66 32.0 Favored Glycine 0 N--CA 1.479 1.537 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 5.0 m -85.12 -44.25 13.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.272 -1.134 . . . . 0.0 109.667 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -72.38 -32.88 66.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -0.932 . . . . 0.0 109.584 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.885 ' HD2' HG12 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -65.35 -55.49 17.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.239 -0.913 . . . . 0.0 110.073 -179.629 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 70' ' ' MET . 0.1 OUTLIER -67.9 -46.45 71.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.965 . . . . 0.0 110.48 -179.275 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.477 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -44.9 -72.02 0.07 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.05 -1.031 . . . . 0.0 109.458 -179.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -162.18 -93.2 0.09 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.077 HD13 HD11 ' A' ' 35' ' ' ILE . 2.2 pp -48.19 178.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.52 -0.988 . . . . 0.0 109.935 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.885 HG12 ' HD2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -122.09 -175.8 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.221 -0.924 . . . . 0.0 109.817 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.8 t -146.53 145.57 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.617 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.68 178.58 5.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 109.376 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.3 t0 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.483 -179.924 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.268 0.556 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.7 t -156.7 24.3 0.33 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.246 -0.909 . . . . 0.0 109.356 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 57.09 92.86 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.332 -0.855 . . . . 0.0 109.685 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.619 HG23 ' O ' ' A' ' 4' ' ' ILE . 1.5 tp -113.02 57.24 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.256 -0.902 . . . . 0.0 109.299 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 4' ' ' ILE . 10.9 t -44.05 161.18 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 109.571 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.8 -152.86 0.46 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.373 -0.829 . . . . 0.0 109.509 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 7' ' ' THR . 3.1 t -63.64 119.33 53.09 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.201 -0.937 . . . . 0.0 109.648 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.504 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 35.1 Cg_endo -78.09 175.18 11.45 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.448 2.099 . . . . 0.0 110.266 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.504 ' HD2' ' HB2' ' A' ' 8' ' ' PRO . 34.5 Cg_endo -76.42 154.58 36.06 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.455 2.103 . . . . 0.0 110.222 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.06 -65.76 0.49 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.337 -0.852 . . . . 0.0 110.837 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.782 ' HB2' ' HE1' ' A' ' 70' ' ' MET . . . -45.35 -65.66 0.51 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.26 -0.9 . . . . 0.0 111.415 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 80.4 t -55.99 -20.62 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.954 -1.091 . . . . 0.0 111.354 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.84 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -87.83 -24.8 23.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.766 -1.209 . . . . 0.0 110.002 -179.418 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 1.011 HD11 HG22 ' A' ' 66' ' ' THR . 10.3 mt -71.26 -50.73 29.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.011 -1.056 . . . . 0.0 109.237 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.511 ' CD ' ' N ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -66.6 -41.43 88.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.207 -0.933 . . . . 0.0 109.169 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.511 ' N ' ' CD ' ' A' ' 15' ' ' LYS . 9.4 tttp -49.93 -36.95 29.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -0.927 . . . . 0.0 109.114 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.428 ' HB1' ' HD3' ' A' ' 39' ' ' LYS . . . -99.81 -75.33 0.57 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.325 -0.859 . . . . 0.0 109.186 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -158.8 85.53 0.83 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.359 -0.838 . . . . 0.0 109.497 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -147.15 -105.84 0.43 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.489 ' HB ' ' HB3' ' A' ' 15' ' ' LYS . 11.7 mt -53.51 -19.18 2.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.29 -1.124 . . . . 0.0 109.479 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 20' ' ' ILE . 3.2 tt0 60.81 111.02 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.296 -0.877 . . . . 0.0 109.32 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.68 135.97 40.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.923 . . . . 0.0 109.433 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 24' ' ' SER . . . 133.12 41.96 0.17 Allowed Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' GLY . 9.5 m -43.89 136.62 3.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.286 -1.126 . . . . 0.0 109.459 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 26' ' ' GLU . . . -162.79 43.9 0.34 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 25' ' ' GLY . 15.0 tt0 49.1 97.21 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.349 -1.089 . . . . 0.0 109.465 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.26 165.68 27.42 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.54 2.16 . . . . 0.0 110.379 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -147.95 -161.79 1.41 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 109.571 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.41 41.52 1.13 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.365 -0.834 . . . . 0.0 108.898 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 31' ' ' LYS . 16.5 p30 -94.82 -145.64 0.26 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.435 -0.791 . . . . 0.0 109.586 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.487 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -71.08 141.65 50.84 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.147 -0.971 . . . . 0.0 110.01 -179.633 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 t -114.59 141.66 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.0 109.309 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.438 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . -97.4 143.26 28.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -0.929 . . . . 0.0 109.608 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.458 ' OG1' ' N ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -106.16 176.39 5.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 109.472 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.458 ' N ' ' OG1' ' A' ' 34' ' ' THR . 12.8 pt -125.94 165.78 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.295 -0.878 . . . . 0.0 109.434 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.8 mtpt -89.53 144.95 25.62 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.336 -0.852 . . . . 0.0 109.293 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -60.77 -13.47 15.33 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.269 -0.894 . . . . 0.0 109.619 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 37' ' ' ARG . 2.5 t0 -42.76 -41.07 3.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.295 -0.878 . . . . 0.0 109.549 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.428 ' HD3' ' HB1' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -71.48 -47.53 54.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -0.857 . . . . 0.0 109.501 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.683 HG22 HG22 ' A' ' 63' ' ' ILE . 75.0 t -53.03 -20.51 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.799 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -81.16 -62.07 1.77 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.94 . . . . 0.0 109.694 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.65 -55.69 23.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.352 -0.842 . . . . 0.0 110.032 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.584 HD13 HD11 ' A' ' 13' ' ' LEU . 74.3 mt -54.24 -58.41 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.916 . . . . 0.0 110.178 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 43' ' ' ILE . . . -42.19 -28.82 0.21 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.223 -0.923 . . . . 0.0 109.77 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -67.03 -51.29 56.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.186 -0.947 . . . . 0.0 109.49 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.5 mt -77.49 -2.24 34.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.875 . . . . 0.0 109.702 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HD3' HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -127.27 23.15 6.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.119 -0.988 . . . . 0.0 109.529 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.617 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 5.5 ttp -69.32 -43.12 23.04 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 110.755 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 48' ' ' MET . 36.2 Cg_endo -79.51 13.7 2.01 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 122.055 1.837 . . . . 0.0 111.194 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.53 -35.46 79.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.97 -1.081 . . . . 0.0 109.412 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.848 HD21 ' SD ' ' A' ' 62' ' ' MET . 0.3 OUTLIER -143.99 23.81 1.69 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -0.87 . . . . 0.0 109.595 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 51' ' ' LEU . 35.3 t-20 44.99 56.69 5.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -0.894 . . . . 0.0 109.626 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 1.021 ' HB1' ' HB3' ' A' ' 58' ' ' ALA . . . -52.56 170.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 109.396 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.27 -44.35 68.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.923 . . . . 0.0 109.367 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.55 -50.81 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.218 -0.926 . . . . 0.0 108.841 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.1 tt -172.53 -31.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 121.207 -0.933 . . . . 0.0 109.518 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -57.2 -45.53 83.69 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.208 -0.932 . . . . 0.0 109.806 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 1.021 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -60.04 -35.84 75.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.337 -0.852 . . . . 0.0 109.813 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.519 ' O ' ' HG3' ' A' ' 62' ' ' MET . . . -63.21 -25.56 68.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.975 . . . . 0.0 109.396 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.421 ' HG3' HG12 ' A' ' 40' ' ' VAL . 1.3 mtt -81.06 -23.54 38.45 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.113 -0.992 . . . . 0.0 108.395 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.05 -22.42 36.39 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.605 -0.685 . . . . 0.0 109.847 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.848 ' SD ' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -82.47 -50.34 8.96 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.894 -1.129 . . . . 0.0 109.425 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.683 HG22 HG22 ' A' ' 40' ' ' VAL . 8.0 mt -57.68 -37.92 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.418 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.39 -50.72 70.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.102 -0.999 . . . . 0.0 109.21 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.77 -12.99 23.11 Favored Glycine 0 N--CA 1.481 1.635 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 1.011 HG22 HD11 ' A' ' 14' ' ' LEU . 54.0 m -82.54 -54.16 5.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -1.15 . . . . 0.0 109.089 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.473 ' HB1' HD11 ' A' ' 72' ' ' ILE . . . -79.21 3.27 18.33 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.374 -0.829 . . . . 0.0 109.261 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.44 -49.91 5.9 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.173 -0.955 . . . . 0.0 109.384 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -21.53 24.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.878 . . . . 0.0 109.877 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.782 ' HE1' ' HB2' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -60.18 -64.34 0.98 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.057 -1.027 . . . . 0.0 109.478 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -159.08 -98.54 0.14 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.765 ' C ' HD12 ' A' ' 72' ' ' ILE . 2.5 pp -53.14 -172.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -1.115 . . . . 0.0 109.692 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.54 176.85 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 109.276 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.435 ' CG2' ' HB3' ' A' ' 67' ' ' ALA . 2.9 t -123.98 151.36 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.337 -0.852 . . . . 0.0 109.476 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.505 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -113.93 65.41 0.66 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.934 . . . . 0.0 109.519 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.6 t0 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.456 179.993 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.404 ' O ' ' HB ' ' A' ' 2' ' ' THR . 9.7 ptt? . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.281 0.562 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.558 HG22 ' H ' ' A' ' 3' ' ' PHE . 8.5 m 66.02 171.53 0.23 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 109.6 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.558 ' H ' HG22 ' A' ' 2' ' ' THR . 0.5 OUTLIER -130.44 97.04 4.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -0.935 . . . . 0.0 109.696 -179.879 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.585 ' N ' HD12 ' A' ' 4' ' ' ILE . 2.0 mp 60.58 168.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 109.047 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.576 ' N ' HG22 ' A' ' 4' ' ' ILE . 3.5 m 63.21 125.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 0.0 109.415 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.524 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -104.32 -160.45 0.77 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.428 -179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.469 ' C ' ' HD2' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -112.05 86.02 7.21 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.247 -0.908 . . . . 0.0 109.523 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.628 ' N ' ' CD ' ' A' ' 9' ' ' PRO . 30.1 Cg_endo -72.18 -30.97 12.56 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.593 2.195 . . . . 0.0 113.647 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 8' ' ' PRO . 34.7 Cg_endo -75.64 127.47 10.28 Favored 'Trans proline' 0 C--N 1.323 -0.816 0 C-N-CA 121.243 1.295 . . . . 0.0 110.535 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -64.46 -43.56 93.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.867 . . . . 0.0 109.956 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 14' ' ' LEU . . . -37.5 -51.66 1.15 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.507 -0.746 . . . . 0.0 110.269 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 9' ' ' PRO . 3.1 m -66.8 -41.04 87.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 121.018 -1.051 . . . . 0.0 109.105 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.518 ' HA ' HD23 ' A' ' 13' ' ' LEU . 9.4 mt -61.86 -15.62 43.85 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.019 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 4.9 mt -77.65 -51.4 10.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 108.778 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -50.43 -34.86 26.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.86 . . . . 0.0 108.968 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.417 ' NZ ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -64.32 -51.33 63.98 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.316 -0.865 . . . . 0.0 109.286 179.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 18' ' ' ALA . . . -61.7 -69.23 0.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 0.0 109.411 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 17' ' ' ALA . . . -45.29 -68.95 0.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.165 -0.959 . . . . 0.0 109.326 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 21' ' ' GLU . . . 61.71 56.91 20.21 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.6 mt -50.01 91.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.24 -1.153 . . . . 0.0 109.594 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.8 tt0 -167.55 69.45 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.905 . . . . 0.0 109.487 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.12 47.68 2.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.167 -0.958 . . . . 0.0 109.297 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.01 -84.34 0.26 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 t -93.44 -165.11 1.27 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -1.162 . . . . 0.0 109.762 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 26' ' ' GLU . . . -134.73 95.58 0.27 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.496 ' HG3' ' HD2' ' A' ' 27' ' ' PRO . 0.5 OUTLIER -43.69 159.19 0.23 Allowed Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.338 -1.095 . . . . 0.0 109.782 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.496 ' HD2' ' HG3' ' A' ' 26' ' ' GLU . 34.8 Cg_endo -78.21 -163.86 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.686 2.258 . . . . 0.0 110.377 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.49 -22.98 15.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.413 -0.805 . . . . 0.0 109.803 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.517 ' CD ' ' OD1' ' A' ' 30' ' ' ASN . 7.1 ptp180 -66.99 -148.74 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.243 -0.911 . . . . 0.0 109.975 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.517 ' OD1' ' CD ' ' A' ' 29' ' ' ARG . 25.3 p-10 -46.64 157.95 0.13 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.27 -0.894 . . . . 0.0 109.786 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.32 106.16 16.18 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.272 -0.893 . . . . 0.0 109.475 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.551 HG22 ' N ' ' A' ' 33' ' ' ALA . 11.6 p -120.43 166.92 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.911 . . . . 0.0 109.418 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.551 ' N ' HG22 ' A' ' 32' ' ' VAL . . . -127.84 103.56 7.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.641 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.413 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 14.6 p -144.73 133.91 22.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.314 -0.866 . . . . 0.0 109.212 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.848 ' CG1' HG13 ' A' ' 74' ' ' VAL . 6.0 pt -90.88 -171.47 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.109 -0.994 . . . . 0.0 109.493 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.469 ' HE3' ' HA ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -97.56 148.21 23.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 109.373 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 38' ' ' ASP . 1.6 mtt180 -75.03 -16.46 60.6 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.278 -0.889 . . . . 0.0 109.458 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 37' ' ' ARG . 5.9 t0 -43.73 -54.33 5.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.453 -0.779 . . . . 0.0 109.468 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.437 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -53.7 -41.18 66.68 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.177 -0.952 . . . . 0.0 109.656 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.687 HG22 ' CG2' ' A' ' 63' ' ' ILE . 75.1 t -57.35 -36.45 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.313 -0.867 . . . . 0.0 109.927 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -29.56 65.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.157 -0.964 . . . . 0.0 110.052 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -80.92 -24.5 38.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.064 -1.022 . . . . 0.0 109.808 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 39' ' ' LYS . 29.6 mt -95.63 -14.59 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.811 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.29 -22.21 13.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.114 -0.991 . . . . 0.0 110.022 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -96.13 -41.12 8.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.096 -1.002 . . . . 0.0 109.759 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.444 ' C ' ' HG2' ' A' ' 47' ' ' LYS . 5.4 mt -84.09 2.8 37.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.15 -0.969 . . . . 0.0 109.662 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.444 ' HG2' ' C ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -139.09 41.43 2.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.151 -0.968 . . . . 0.0 109.458 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.578 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.2 OUTLIER -45.37 -51.57 25.7 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.215 -0.928 . . . . 0.0 109.806 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 48' ' ' MET . 35.4 Cg_endo -78.5 75.66 4.83 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.442 2.095 . . . . 0.0 110.447 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.71 -59.7 0.89 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -0.895 . . . . 0.0 109.678 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.575 HD12 ' HB3' ' A' ' 52' ' ' ASN . 2.3 pp -120.13 -32.88 4.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.143 -0.973 . . . . 0.0 109.991 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.699 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 1.1 t-20 162.41 -90.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.471 -0.768 . . . . 0.0 109.121 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 52' ' ' ASN . . . 76.0 128.82 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.473 -0.767 . . . . 0.0 109.73 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -89.47 -41.45 12.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 109.228 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -158.16 -48.84 0.06 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.417 -0.802 . . . . 0.0 108.854 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.2 tt -177.14 -31.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.317 -0.865 . . . . 0.0 108.985 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.46 -59.87 3.55 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.332 -0.855 . . . . 0.0 110.049 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.94 -30.0 68.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.272 -0.893 . . . . 0.0 110.43 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.55 -33.32 66.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.152 -0.968 . . . . 0.0 109.97 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -50.04 13.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.175 -0.953 . . . . 0.0 110.138 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.7 -17.89 61.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.319 -0.863 . . . . 0.0 109.81 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.92 -55.62 4.67 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.165 -0.959 . . . . 0.0 110.072 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.687 ' CG2' HG22 ' A' ' 40' ' ' VAL . 3.1 mt -51.24 -43.08 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.05 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.479 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 12.3 pt-20 -64.81 -45.62 85.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.869 -1.144 . . . . 0.0 108.867 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.479 ' N ' ' HG3' ' A' ' 64' ' ' GLU . . . -60.26 -14.41 33.16 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 86.7 m -85.73 -60.36 2.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.388 -1.066 . . . . 0.0 109.265 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.463 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -61.86 -13.8 27.76 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.166 -0.959 . . . . 0.0 109.061 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 1.085 ' CG ' HG13 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -77.67 -62.3 1.71 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.329 -0.857 . . . . 0.0 109.269 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.01 -15.48 63.62 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.315 -0.866 . . . . 0.0 109.261 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.413 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.1 OUTLIER -88.4 -34.35 17.58 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.328 -0.858 . . . . 0.0 109.885 -179.754 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -159.64 -102.16 0.18 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.571 ' C ' HD12 ' A' ' 72' ' ' ILE . 1.1 pp -108.16 -169.63 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -1.197 . . . . 0.0 110.103 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 1.085 HG13 ' CG ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -103.92 -176.8 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.392 -0.818 . . . . 0.0 109.517 179.848 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.848 HG13 ' CG1' ' A' ' 35' ' ' ILE . 1.5 t -109.54 -170.15 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.363 -0.836 . . . . 0.0 109.216 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.674 ' H ' HG12 ' A' ' 74' ' ' VAL . 21.9 pt-20 -124.55 177.16 6.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 109.545 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.5 t70 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.461 179.935 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.59 -33.68 2.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.933 . . . . 0.0 109.401 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -158.12 99.85 1.67 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 0.0 109.482 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.442 HG12 ' N ' ' A' ' 5' ' ' THR . 19.2 tt -62.31 164.6 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.198 -0.939 . . . . 0.0 109.534 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.442 ' N ' HG12 ' A' ' 4' ' ' ILE . 6.3 t -85.48 137.24 33.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 109.335 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -137.67 104.05 5.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.236 -0.915 . . . . 0.0 109.379 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.4 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 35.0 p -99.64 136.8 20.21 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.125 -0.985 . . . . 0.0 109.195 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 36.0 Cg_endo -78.75 152.14 25.28 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.416 2.077 . . . . 0.0 110.515 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.9 ' O ' HD12 ' A' ' 13' ' ' LEU . 35.5 Cg_endo -77.97 -165.26 0.32 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.623 2.215 . . . . 0.0 110.081 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -91.7 -65.66 0.99 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.13 -0.981 . . . . 0.0 109.793 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 15' ' ' LYS . . . -41.78 -30.01 0.22 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.014 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.542 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 70.1 t -84.54 -46.46 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.137 -0.977 . . . . 0.0 109.603 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.9 HD12 ' O ' ' A' ' 9' ' ' PRO . 6.3 mt -52.62 -54.72 29.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.586 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.38 -43.98 96.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.312 -0.867 . . . . 0.0 109.531 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 7.9 ttpt -54.18 -30.07 48.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 0.0 109.534 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -45.45 35.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.145 -0.972 . . . . 0.0 109.627 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -102.04 47.5 0.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 109.773 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 17' ' ' ALA . . . 172.17 -42.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.206 -0.934 . . . . 0.0 109.535 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 21' ' ' GLU . . . -48.42 -79.19 0.07 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.535 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.1 mp -42.75 94.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.28 -1.129 . . . . 0.0 109.867 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.1 pt-20 -88.38 -22.28 23.86 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.239 -0.913 . . . . 0.0 109.439 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.7 163.27 13.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -0.81 . . . . 0.0 109.316 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -151.11 -45.91 0.02 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 p -159.49 -176.95 6.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -1.156 . . . . 0.0 109.671 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.97 116.36 0.01 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -47.21 160.23 0.36 Allowed Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 121.23 -1.159 . . . . 0.0 109.489 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.47 167.53 22.69 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.579 2.186 . . . . 0.0 110.449 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -157.03 -61.27 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.378 -0.826 . . . . 0.0 109.209 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -146.97 38.85 1.0 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.297 -0.877 . . . . 0.0 109.567 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -50.12 112.39 0.67 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -0.912 . . . . 0.0 109.13 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -118.88 115.24 23.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.757 -179.629 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 31' ' ' LYS . 52.7 t 58.94 117.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -0.891 . . . . 0.0 109.727 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.44 ' HB2' ' OE1' ' A' ' 21' ' ' GLU . . . -101.81 156.49 17.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 109.237 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.3 p -145.53 152.51 39.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.003 . . . . 0.0 109.689 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.8 pt -115.54 -175.38 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 109.223 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.76 127.6 45.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.0 109.621 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.408 ' NH1' ' HG3' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -56.1 -35.86 67.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.957 . . . . 0.0 109.121 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -49.07 -38.68 25.02 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.471 -0.768 . . . . 0.0 109.61 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -63.96 -45.77 87.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.119 -0.988 . . . . 0.0 109.665 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.723 HG12 ' HB ' ' A' ' 63' ' ' ILE . 1.8 t -68.55 -11.08 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.039 -1.038 . . . . 0.0 109.132 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.45 -47.49 10.59 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.275 -0.89 . . . . 0.0 108.895 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.516 ' O ' HD23 ' A' ' 46' ' ' LEU . 3.1 tt0 -55.44 -33.97 64.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.266 -0.896 . . . . 0.0 109.226 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 12.7 mt -83.36 -22.9 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.379 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.37 -24.54 61.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.913 . . . . 0.0 109.375 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.459 ' HA ' ' SD ' ' A' ' 48' ' ' MET . 31.2 mt-10 -93.47 -35.8 12.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 109.171 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.516 HD23 ' O ' ' A' ' 42' ' ' GLU . 0.5 OUTLIER -66.93 -8.58 30.47 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.332 -0.855 . . . . 0.0 109.795 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HD2' ' O ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -140.86 48.67 1.7 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.206 -0.934 . . . . 0.0 109.61 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.556 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 3.7 tpp -43.42 -52.97 12.35 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.297 -0.877 . . . . 0.0 109.42 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.556 ' HD3' ' CB ' ' A' ' 48' ' ' MET . 36.2 Cg_endo -79.46 86.3 1.7 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.498 2.132 . . . . 0.0 110.131 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -134.66 -60.23 0.79 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.135 -0.978 . . . . 0.0 109.815 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.694 ' C ' HD12 ' A' ' 51' ' ' LEU . 3.9 pp -127.16 -10.69 5.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 110.091 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.672 ' N ' HD12 ' A' ' 51' ' ' LEU . 10.5 t30 164.35 -89.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.318 -0.864 . . . . 0.0 109.024 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.563 ' CB ' ' HB2' ' A' ' 59' ' ' ALA . . . 63.37 72.4 0.48 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.515 -0.74 . . . . 0.0 109.592 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.81 -30.51 57.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.176 -0.953 . . . . 0.0 108.983 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.484 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -164.17 -61.43 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.364 -0.835 . . . . 0.0 109.247 179.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -165.8 -34.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -65.54 -62.82 1.3 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.273 -0.892 . . . . 0.0 110.519 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.95 -38.98 71.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.319 -0.863 . . . . 0.0 110.297 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.563 ' HB2' ' CB ' ' A' ' 53' ' ' ALA . . . -66.3 -70.13 0.26 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.161 -0.962 . . . . 0.0 110.033 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.581 ' HA ' HG12 ' A' ' 63' ' ' ILE . 0.7 OUTLIER -46.68 -28.37 1.47 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.181 -0.949 . . . . 0.0 110.405 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.468 ' HA ' ' OE2' ' A' ' 64' ' ' GLU . 2.3 mmm180 -74.63 -41.28 60.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.975 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.452 ' SD ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -69.49 -47.21 64.61 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.233 -0.917 . . . . 0.0 110.258 -179.3 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.723 ' HB ' HG12 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -52.08 -57.95 3.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.246 -0.909 . . . . 0.0 111.159 -179.421 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.631 ' N ' HD12 ' A' ' 63' ' ' ILE . 9.9 pt-20 -56.44 -55.14 37.34 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 120.946 -1.097 . . . . 0.0 109.519 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.57 -19.41 13.28 Favored Glycine 0 N--CA 1.483 1.778 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.544 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 63.8 m -77.95 -42.82 31.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.473 -1.016 . . . . 0.0 109.119 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -80.72 -1.38 42.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.24 -0.913 . . . . 0.0 108.946 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.98 -55.0 4.46 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.323 -0.861 . . . . 0.0 109.94 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.67 -11.05 43.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.13 -0.981 . . . . 0.0 110.597 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -65.71 -50.35 65.16 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.935 -1.103 . . . . 0.0 110.122 -179.65 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -156.79 -71.56 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.092 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.53 ' C ' HD12 ' A' ' 72' ' ' ILE . 1.0 OUTLIER -98.04 -174.27 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.148 -1.207 . . . . 0.0 109.848 -179.557 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.635 HG22 ' H ' ' A' ' 74' ' ' VAL . 2.3 p -107.98 -179.26 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.465 -0.772 . . . . 0.0 109.043 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.635 ' H ' HG22 ' A' ' 73' ' ' VAL . 0.1 OUTLIER -127.16 159.11 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.989 . . . . 0.0 109.308 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 1.9 pp20? -133.81 157.59 45.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.9 t0 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.5 -179.893 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.28 155.72 50.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 109.52 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.747 ' O ' HG22 ' A' ' 4' ' ' ILE . 62.9 m-85 -81.82 113.89 20.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.193 -0.942 . . . . 0.0 109.39 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 3' ' ' PHE . 1.5 tp 81.03 149.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.547 -0.721 . . . . 0.0 109.411 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 t -156.3 161.9 40.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.227 -0.92 . . . . 0.0 109.708 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.72 178.39 7.96 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.313 -0.867 . . . . 0.0 109.389 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 47.5 88.35 0.11 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 109.518 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.482 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 35.9 Cg_endo -78.65 174.43 12.31 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.665 2.243 . . . . 0.0 110.412 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.718 ' O ' HD12 ' A' ' 13' ' ' LEU . 35.9 Cg_endo -77.36 117.65 4.41 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.555 2.17 . . . . 0.0 110.308 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.691 ' HA ' HD13 ' A' ' 13' ' ' LEU . . . -51.88 -50.65 60.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.305 -0.872 . . . . 0.0 109.995 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -42.57 -50.87 5.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.22 -0.925 . . . . 0.0 109.87 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.457 ' CG2' ' HG2' ' A' ' 9' ' ' PRO . 42.8 t -56.28 -48.83 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 109.973 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.718 HD12 ' O ' ' A' ' 9' ' ' PRO . 4.9 mp -53.25 -58.08 8.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.145 -0.972 . . . . 0.0 109.835 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.59 ' CD2' ' HB2' ' A' ' 67' ' ' ALA . 0.3 OUTLIER -49.06 -33.5 11.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.907 . . . . 0.0 109.604 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -60.9 -62.89 1.53 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 0.0 110.112 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.86 -3.56 29.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.104 -0.997 . . . . 0.0 109.818 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.43 ' HB1' ' NZ ' ' A' ' 39' ' ' LYS . . . -84.57 -25.16 28.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.079 -1.013 . . . . 0.0 109.426 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.82 -73.55 0.1 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.483 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.88 47.89 0.26 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 mt -51.91 -20.77 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.193 -1.18 . . . . 0.0 109.727 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -100.26 136.93 39.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.225 -0.922 . . . . 0.0 109.519 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 p -135.12 -166.88 1.9 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.927 . . . . 0.0 109.72 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.15 -149.39 0.13 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -122.35 -12.55 8.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.335 -1.097 . . . . 0.0 109.517 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 26' ' ' GLU . . . -154.45 55.76 0.42 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.482 ' CG ' ' HD2' ' A' ' 27' ' ' PRO . 27.9 tt0 -44.1 138.97 3.27 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.248 -1.149 . . . . 0.0 109.532 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.482 ' HD2' ' CG ' ' A' ' 26' ' ' GLU . 36.3 Cg_endo -78.41 135.41 13.29 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.596 2.197 . . . . 0.0 110.369 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.418 ' O ' ' O ' ' A' ' 27' ' ' PRO . 27.1 t30 43.69 89.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.22 -0.925 . . . . 0.0 109.336 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.7 ptt-85 -62.11 146.74 49.61 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.281 -0.887 . . . . 0.0 109.713 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.19 -174.45 4.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.366 -0.833 . . . . 0.0 109.245 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.88 118.61 2.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.217 -0.927 . . . . 0.0 109.257 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.632 ' O ' HG13 ' A' ' 32' ' ' VAL . 6.2 p -107.16 38.4 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 109.393 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 34' ' ' THR . . . -132.11 58.69 1.73 Allowed 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.632 -0.668 . . . . 0.0 109.351 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -159.16 150.24 20.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -0.883 . . . . 0.0 109.682 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 35' ' ' ILE . 6.5 pt -145.3 170.3 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.213 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -82.2 142.88 31.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -0.963 . . . . 0.0 109.808 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' A' ' 38' ' ' ASP . 30.0 mtt180 -70.33 -10.41 58.91 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.442 -0.786 . . . . 0.0 109.77 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 37' ' ' ARG . 66.3 t0 -39.5 -50.24 2.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.69 -0.631 . . . . 0.0 109.955 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.43 ' NZ ' ' HB1' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -61.19 -48.24 82.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 0.0 109.726 -179.805 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.78 HG13 ' CG2' ' A' ' 63' ' ' ILE . 46.2 t -45.1 -25.94 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.096 -1.002 . . . . 0.0 109.856 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -84.54 -39.36 18.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.199 -0.938 . . . . 0.0 109.922 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 3.5 tt0 -66.56 -27.87 68.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 0.0 109.924 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.524 HG22 ' HD2' ' A' ' 47' ' ' LYS . 10.7 mt -90.81 -42.41 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.077 -1.015 . . . . 0.0 109.775 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.513 ' HA ' ' CD ' ' A' ' 47' ' ' LYS . . . -56.26 -21.57 24.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.073 -1.017 . . . . 0.0 109.114 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.34 -44.75 12.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.624 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mt -72.21 -10.94 60.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 109.753 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.524 ' HD2' HG22 ' A' ' 43' ' ' ILE . 14.9 ptmt -111.0 29.19 8.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -0.963 . . . . 0.0 110.085 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.58 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -64.88 -51.31 57.87 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.1 -1.0 . . . . 0.0 109.551 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 48' ' ' MET . 36.7 Cg_endo -80.96 57.5 6.56 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.734 2.29 . . . . 0.0 110.605 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.95 -76.67 0.23 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.995 -1.066 . . . . 0.0 109.719 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 51' ' ' LEU . 1.6 pp -89.27 17.99 5.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 109.934 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 52' ' ' ASN . 8.5 t30 45.23 73.08 0.17 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.152 -0.968 . . . . 0.0 109.464 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.522 ' CB ' ' HB2' ' A' ' 59' ' ' ALA . . . -73.88 138.07 44.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.19 -0.944 . . . . 0.0 109.564 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.41 -68.14 0.2 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.951 . . . . 0.0 109.334 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.475 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -143.25 -52.5 0.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.348 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -165.13 -32.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.319 -0.863 . . . . 0.0 108.971 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -60.57 -70.29 0.18 Allowed 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.102 -0.998 . . . . 0.0 110.323 -179.45 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 57' ' ' GLU . . . -42.8 -58.65 2.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 110.007 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.522 ' HB2' ' CB ' ' A' ' 53' ' ' ALA . . . -49.36 -40.02 34.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.215 -0.928 . . . . 0.0 110.186 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.56 -35.67 81.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.168 -0.957 . . . . 0.0 110.207 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -14.81 58.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.12 -0.988 . . . . 0.0 109.677 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.447 ' SD ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -76.79 -57.46 3.84 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.177 -0.952 . . . . 0.0 109.644 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.78 ' CG2' HG13 ' A' ' 40' ' ' VAL . 9.1 mt -61.31 -36.82 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.063 -1.023 . . . . 0.0 109.585 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -63.95 -48.13 77.72 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.076 -1.015 . . . . 0.0 108.972 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.0 -9.39 34.19 Favored Glycine 0 N--CA 1.48 1.601 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 70' ' ' MET . 85.5 m -87.89 -48.2 7.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -1.13 . . . . 0.0 109.752 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.59 ' HB2' ' CD2' ' A' ' 14' ' ' LEU . . . -80.92 -12.13 59.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.127 -0.983 . . . . 0.0 109.622 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.569 ' NH2' ' CG1' ' A' ' 73' ' ' VAL . 0.1 OUTLIER -88.99 -46.0 9.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.176 -0.952 . . . . 0.0 109.435 179.814 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.59 -23.51 42.66 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.362 -0.837 . . . . 0.0 109.91 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.455 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -65.98 -66.01 0.6 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.195 -0.941 . . . . 0.0 109.354 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -161.62 -92.19 0.09 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.753 ' C ' HD12 ' A' ' 72' ' ' ILE . 2.8 pp -48.96 177.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.441 -1.035 . . . . 0.0 110.298 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.569 ' CG1' ' NH2' ' A' ' 68' ' ' ARG . 0.5 OUTLIER -112.26 -171.19 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.394 -0.816 . . . . 0.0 110.014 -179.525 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.552 ' H ' HG12 ' A' ' 73' ' ' VAL . 3.7 t -134.03 163.78 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.076 -1.015 . . . . 0.0 109.767 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -129.76 176.86 7.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.228 -0.92 . . . . 0.0 109.689 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 t70 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.443 179.97 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.452 ' O ' ' CB ' ' A' ' 2' ' ' THR . 24.6 mtt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.26 0.552 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.452 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.2 OUTLIER 72.16 99.22 0.07 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 109.367 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -74.79 84.82 2.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.642 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.3 tt -163.39 152.39 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.352 -0.842 . . . . 0.0 109.306 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.41 99.41 0.41 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.919 . . . . 0.0 109.768 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -137.99 -156.57 0.7 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.882 . . . . 0.0 109.391 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 19.6 p -98.45 139.66 21.31 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.226 -0.921 . . . . 0.0 109.515 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.621 ' HG2' HD11 ' A' ' 13' ' ' LEU . 35.8 Cg_endo -79.12 173.72 13.04 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.607 2.205 . . . . 0.0 110.454 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.548 ' O ' HD12 ' A' ' 13' ' ' LEU . 34.4 Cg_endo -76.64 151.07 32.0 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.726 2.284 . . . . 0.0 110.32 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 13' ' ' LEU . . . -75.76 -64.55 1.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 110.213 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -41.36 -61.46 1.04 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.313 -0.867 . . . . 0.0 110.141 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.543 ' HB ' ' HG2' ' A' ' 9' ' ' PRO . 17.5 t -65.48 -30.01 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 109.852 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.621 HD11 ' HG2' ' A' ' 8' ' ' PRO . 1.1 mt -50.31 -60.54 2.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.078 -1.013 . . . . 0.0 109.581 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.626 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -59.91 -35.43 74.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 109.726 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -50.32 -63.26 1.17 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.879 . . . . 0.0 109.792 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -21.38 60.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 0.0 109.808 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 14' ' ' LEU . . . -54.84 -45.15 74.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 109.798 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.07 -51.05 5.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 0.0 109.453 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.22 46.55 0.86 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.8 mt -56.11 97.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 O-C-N 121.27 -1.135 . . . . 0.0 109.738 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -150.07 -62.1 0.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.287 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 65.22 59.2 0.83 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.547 -0.721 . . . . 0.0 109.677 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.31 -23.89 7.42 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.14 161.59 37.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -1.134 . . . . 0.0 109.426 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.449 ' O ' ' C ' ' A' ' 26' ' ' GLU . . . 67.84 -113.22 5.29 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -39.76 100.59 0.22 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.552 -0.969 . . . . 0.0 109.95 -179.767 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 28' ' ' ASN . 36.2 Cg_endo -79.04 155.8 26.22 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.479 2.119 . . . . 0.0 110.076 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.446 ' O ' ' O ' ' A' ' 27' ' ' PRO . 3.5 t-20 60.54 150.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.275 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.94 137.19 32.55 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.292 -0.88 . . . . 0.0 109.602 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -169.2 29.44 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.927 . . . . 0.0 109.588 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.18 110.06 0.87 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.178 -0.951 . . . . 0.0 109.265 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.57 ' O ' HG13 ' A' ' 32' ' ' VAL . 8.6 p -162.34 39.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 0.0 109.518 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -124.22 177.28 5.92 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.668 -0.645 . . . . 0.0 109.589 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.73 HG22 ' CG1' ' A' ' 73' ' ' VAL . 5.6 p -81.22 -171.66 3.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -0.914 . . . . 0.0 109.55 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.476 ' CG1' HG22 ' A' ' 74' ' ' VAL . 3.3 pt -140.1 -170.08 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.888 . . . . 0.0 109.588 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.4 ptpt -95.11 130.32 41.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.352 -0.843 . . . . 0.0 109.641 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.404 ' O ' ' C ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -67.35 -8.5 33.04 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.223 -0.923 . . . . 0.0 109.655 179.896 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 37' ' ' ARG . 31.9 t70 -42.5 -54.64 3.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.363 -0.836 . . . . 0.0 109.912 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -42.34 90.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 109.809 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.64 HG13 ' HB ' ' A' ' 63' ' ' ILE . 68.2 t -57.38 -21.59 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.193 -0.942 . . . . 0.0 109.717 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.7 ttp85 -84.87 -59.02 2.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.442 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -48.61 -58.18 5.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 109.509 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.479 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 92.2 mt -56.69 -56.21 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 109.571 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -45.59 -25.27 0.44 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.962 . . . . 0.0 109.564 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -75.44 -57.34 3.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.944 . . . . 0.0 109.663 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.578 HD12 ' C ' ' A' ' 46' ' ' LEU . 4.4 pp -70.46 -4.64 23.67 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.122 -0.986 . . . . 0.0 109.867 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.34 5.26 49.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.146 -0.971 . . . . 0.0 109.572 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.587 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -48.39 -50.06 59.63 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 110.199 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 48' ' ' MET . 34.8 Cg_endo -77.47 77.49 3.83 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.258 1.972 . . . . 0.0 110.575 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.704 ' HB3' HD23 ' A' ' 51' ' ' LEU . 7.7 t0 -172.34 -35.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.388 -0.82 . . . . 0.0 109.412 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.704 HD23 ' HB3' ' A' ' 50' ' ' ASP . 0.1 OUTLIER -143.74 16.56 1.79 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.441 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 52' ' ' ASN . 7.3 p-10 40.58 67.7 0.48 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.506 -0.746 . . . . 0.0 109.833 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.753 ' HB1' ' HB3' ' A' ' 58' ' ' ALA . . . -85.37 154.6 21.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 109.549 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -47.65 -51.44 21.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.17 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.12 -52.1 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.368 -0.833 . . . . 0.0 108.931 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.72 HG22 ' O ' ' A' ' 56' ' ' ILE . 20.8 mm -149.99 9.44 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.453 -0.779 . . . . 0.0 109.612 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -97.61 -52.7 3.68 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 120.899 -1.125 . . . . 0.0 109.717 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.753 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -69.51 -43.41 73.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.365 -0.834 . . . . 0.0 109.352 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.67 -24.33 64.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.355 -0.841 . . . . 0.0 109.438 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.43 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -70.66 -38.69 73.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.311 -0.868 . . . . 0.0 109.63 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.51 -14.85 58.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.276 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.37 -60.65 2.28 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.367 -0.833 . . . . 0.0 109.57 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.64 ' HB ' HG13 ' A' ' 40' ' ' VAL . 15.3 mt -59.34 -36.27 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 109.787 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -62.85 -60.02 4.06 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.083 -1.011 . . . . 0.0 109.498 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.414 ' HA2' ' HB2' ' A' ' 68' ' ' ARG . . . -56.52 -15.85 13.5 Favored Glycine 0 N--CA 1.479 1.547 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.746 HG23 ' SD ' ' A' ' 70' ' ' MET . 60.8 m -74.1 -55.86 5.6 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.243 -1.151 . . . . 0.0 109.153 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.473 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -62.2 -27.2 68.81 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.414 ' HB2' ' HA2' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -47.77 -61.81 1.76 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.525 -0.735 . . . . 0.0 109.17 179.302 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.55 -68.58 0.78 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.332 -0.855 . . . . 0.0 110.312 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.746 ' SD ' HG23 ' A' ' 66' ' ' THR . 1.1 mpt? -45.49 -21.02 0.08 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.177 -0.952 . . . . 0.0 111.615 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' A' ' 67' ' ' ALA . . . -150.1 -133.13 2.09 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 118.898 -1.62 . . . . 0.0 110.764 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.506 ' C ' HD12 ' A' ' 72' ' ' ILE . 1.0 OUTLIER -102.81 -170.26 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.529 -0.983 . . . . 0.0 110.215 -179.354 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.73 ' CG1' HG22 ' A' ' 34' ' ' THR . 9.1 p -84.08 165.06 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -0.869 . . . . 0.0 109.85 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.523 HG12 ' N ' ' A' ' 75' ' ' GLU . 54.5 t -124.7 161.95 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.218 -0.926 . . . . 0.0 109.578 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.523 ' N ' HG12 ' A' ' 74' ' ' VAL . 2.3 pp20? -114.51 135.14 54.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 109.38 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.4 179.929 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.6 mtm . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.445 HG23 ' N ' ' A' ' 3' ' ' PHE . 2.2 t -157.13 -42.24 0.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.89 . . . . 0.0 109.63 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.445 ' N ' HG23 ' A' ' 2' ' ' THR . 13.6 t80 -173.88 46.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -0.92 . . . . 0.0 109.342 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.559 HG23 ' O ' ' A' ' 4' ' ' ILE . 2.6 tp -119.69 71.25 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 109.494 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.08 146.76 47.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.221 -0.925 . . . . 0.0 109.564 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.401 ' O ' ' HB ' ' A' ' 7' ' ' THR . 3.9 tptp -60.35 -178.71 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.501 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.454 ' OG1' ' HD2' ' A' ' 8' ' ' PRO . 8.4 t -179.87 146.98 0.45 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.858 . . . . 0.0 109.448 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.454 ' HD2' ' OG1' ' A' ' 7' ' ' THR . 34.8 Cg_endo -77.28 171.47 17.69 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.61 2.207 . . . . 0.0 110.327 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.56 174.47 12.62 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.622 2.215 . . . . 0.0 110.441 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.471 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -67.51 -66.16 0.6 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.244 -0.91 . . . . 0.0 109.883 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.764 ' HB2' ' SD ' ' A' ' 70' ' ' MET . . . -34.51 -67.73 0.13 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.677 -0.639 . . . . 0.0 110.705 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.1 t -49.55 -44.19 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.07 -1.019 . . . . 0.0 109.906 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 14.8 mt -54.13 -69.41 0.12 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.148 -0.97 . . . . 0.0 109.752 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.805 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -48.48 -26.91 2.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.77 -179.801 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -64.58 0.89 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 0.0 109.717 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.4 tptp -56.68 -32.59 65.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -0.942 . . . . 0.0 109.326 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.414 ' HB1' ' HD3' ' A' ' 39' ' ' LYS . . . -105.01 48.62 0.83 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.569 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.805 ' HB2' ' O ' ' A' ' 14' ' ' LEU . . . -133.13 -36.7 1.0 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.14 -0.975 . . . . 0.0 109.532 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.01 63.19 1.91 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 19.8 mm -70.23 -15.28 19.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 O-C-N 121.24 -1.153 . . . . 0.0 109.748 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -97.83 75.38 2.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -0.908 . . . . 0.0 109.817 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 51.09 -157.22 0.11 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.763 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' A' ' 24' ' ' SER . . . -89.18 -82.04 1.31 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 3.6 t 73.78 141.0 0.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.249 -1.148 . . . . 0.0 109.455 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 26' ' ' GLU . . . 101.99 -150.01 18.15 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.438 ' HG3' ' HD2' ' A' ' 27' ' ' PRO . 19.3 tt0 -44.42 136.49 4.19 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.206 -1.173 . . . . 0.0 109.215 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.438 ' HD2' ' HG3' ' A' ' 26' ' ' GLU . 36.3 Cg_endo -78.49 135.12 12.95 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.522 2.148 . . . . 0.0 110.776 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.89 -173.75 2.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.357 -0.839 . . . . 0.0 109.277 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.15 -36.18 14.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.737 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -156.76 81.14 0.95 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.483 -0.76 . . . . 0.0 109.224 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.47 101.07 8.09 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 109.814 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.8 p -152.23 133.36 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.305 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 51.29 43.51 29.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.856 . . . . 0.0 109.625 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.543 ' O ' HG23 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -161.05 179.62 8.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.409 -0.807 . . . . 0.0 109.678 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.608 HG13 HG13 ' A' ' 74' ' ' VAL . 0.8 OUTLIER -159.7 164.0 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.299 -0.876 . . . . 0.0 109.301 179.582 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.5 146.32 31.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 109.707 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.45 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 3.3 ppt_? -64.04 -17.12 63.06 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.353 -0.842 . . . . 0.0 109.791 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 37' ' ' ARG . 11.9 t70 -46.04 -47.87 16.9 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.112 -0.993 . . . . 0.0 109.258 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.433 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -62.71 -44.78 95.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 0.0 109.322 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.648 HG13 ' HB ' ' A' ' 63' ' ' ILE . 47.9 t -53.09 -20.43 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.299 -0.876 . . . . 0.0 109.585 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.24 -52.6 5.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.301 -0.874 . . . . 0.0 109.546 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -59.21 -21.38 59.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.244 -0.91 . . . . 0.0 109.664 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 39' ' ' LYS . 14.2 mt -101.36 -22.0 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.269 -0.895 . . . . 0.0 109.388 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.709 ' HB1' ' HB1' ' A' ' 59' ' ' ALA . . . -83.49 -4.66 58.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.436 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -97.77 -39.65 8.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.156 -0.965 . . . . 0.0 109.529 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.4 mt -91.91 -29.42 16.69 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.158 -0.964 . . . . 0.0 109.5 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.411 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -81.37 -2.44 49.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -0.867 . . . . 0.0 109.542 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.6 ttp -45.22 105.66 0.48 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.199 -0.938 . . . . 0.0 109.321 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HG2' HD21 ' A' ' 51' ' ' LEU . 35.2 Cg_endo -76.85 -69.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.397 2.065 . . . . 0.0 110.66 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.603 ' C ' HD23 ' A' ' 51' ' ' LEU . 2.6 t0 -169.11 34.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.638 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.694 ' N ' HD23 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -102.23 -16.44 16.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.171 -0.956 . . . . 0.0 109.773 -179.734 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 53' ' ' ALA . 10.7 t-20 48.31 69.38 0.55 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.095 -1.003 . . . . 0.0 109.047 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.545 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . . . -43.0 100.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.344 -0.847 . . . . 0.0 109.495 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 52' ' ' ASN . . . -50.35 -31.12 13.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.233 -0.917 . . . . 0.0 109.385 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.511 ' O ' HG12 ' A' ' 56' ' ' ILE . 16.4 m -145.87 -67.71 0.29 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.199 -0.938 . . . . 0.0 109.219 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.516 HD13 ' HA ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -168.28 -30.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.391 -0.818 . . . . 0.0 109.167 -179.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.63 -54.98 30.02 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 120.952 -1.093 . . . . 0.0 109.955 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.545 ' HB3' ' HA ' ' A' ' 53' ' ' ALA . . . -43.8 -72.7 0.05 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.612 -0.68 . . . . 0.0 110.972 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.709 ' HB1' ' HB1' ' A' ' 44' ' ' ALA . . . -52.94 -54.91 27.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.337 -0.852 . . . . 0.0 111.111 -178.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -50.63 -25.83 4.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.077 -1.014 . . . . 0.0 110.815 -178.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -81.56 -32.93 31.98 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.015 -1.053 . . . . 0.0 109.643 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.576 ' SD ' HD11 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -70.57 -54.93 10.15 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.218 -0.927 . . . . 0.0 109.534 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.648 ' HB ' HG13 ' A' ' 40' ' ' VAL . 7.5 mt -67.56 -42.36 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.211 -0.931 . . . . 0.0 109.974 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' A' ' 60' ' ' MET . 2.9 tm-20 -60.11 -54.29 47.73 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.083 -1.011 . . . . 0.0 109.61 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.21 -15.87 31.93 Favored Glycine 0 N--CA 1.479 1.548 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.48 ' O ' ' HB2' ' A' ' 70' ' ' MET . 29.9 m -75.0 -55.05 6.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.282 -1.128 . . . . 0.0 109.001 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.487 ' O ' ' C ' ' A' ' 71' ' ' GLY . . . -64.91 -23.84 67.35 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.003 -1.06 . . . . 0.0 108.493 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.44 -51.53 68.07 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.009 -1.057 . . . . 0.0 109.371 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.46 -53.18 3.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.19 -0.944 . . . . 0.0 110.169 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.764 ' SD ' ' HB2' ' A' ' 11' ' ' ALA . 2.5 mmt -62.64 -23.63 67.18 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.233 -0.917 . . . . 0.0 111.12 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.487 ' C ' ' O ' ' A' ' 67' ' ' ALA . . . -142.85 -123.53 1.82 Allowed Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.586 -1.293 . . . . 0.0 110.372 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.544 ' C ' HD12 ' A' ' 72' ' ' ILE . 1.2 pp -115.4 -174.55 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.188 -1.184 . . . . 0.0 109.894 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 34' ' ' THR . 3.8 t -79.53 157.47 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 109.751 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.608 HG13 HG13 ' A' ' 35' ' ' ILE . 4.9 t -127.61 170.45 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.936 . . . . 0.0 109.594 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.522 ' H ' HG12 ' A' ' 74' ' ' VAL . 2.0 pt-20 -130.21 149.28 51.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.398 -0.814 . . . . 0.0 109.419 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 t70 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.921 -1.038 . . . . 0.0 109.525 -179.939 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttp . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 2' ' ' THR . 2.5 t -169.56 121.83 0.73 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.19 -0.944 . . . . 0.0 109.398 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.422 ' O ' HG13 ' A' ' 4' ' ' ILE . 0.3 OUTLIER 68.91 62.36 0.32 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.356 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 3' ' ' PHE . 26.9 mt -155.61 -66.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.392 -0.818 . . . . 0.0 109.122 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 m -119.62 44.25 2.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.342 -0.849 . . . . 0.0 109.046 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.467 ' O ' ' HB ' ' A' ' 7' ' ' THR . 4.6 mmtt -100.42 163.24 12.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.333 -0.854 . . . . 0.0 109.656 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 6' ' ' LYS . 8.4 m 70.24 123.12 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.336 -0.853 . . . . 0.0 109.62 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.53 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 34.8 Cg_endo -79.38 176.16 9.96 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.621 2.214 . . . . 0.0 110.187 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.53 ' HD2' ' HB2' ' A' ' 8' ' ' PRO . 34.1 Cg_endo -76.48 118.12 4.79 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.419 2.08 . . . . 0.0 110.152 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -54.6 -45.16 73.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -0.872 . . . . 0.0 109.911 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -41.3 -44.52 2.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.008 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.1 t -75.55 -36.91 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.179 -0.951 . . . . 0.0 110.014 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.484 HD11 ' HG2' ' A' ' 8' ' ' PRO . 90.6 mt -57.77 -33.09 68.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.92 . . . . 0.0 110.093 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.1 -36.27 40.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.052 -1.03 . . . . 0.0 109.802 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.68 -13.54 60.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.214 -0.929 . . . . 0.0 109.964 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -92.58 -29.35 16.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.079 -1.013 . . . . 0.0 109.594 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.13 -47.54 79.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.193 -0.942 . . . . 0.0 109.356 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.23 -49.74 8.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 109.351 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.89 81.81 1.24 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 95.5 mt -56.61 -20.13 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.197 -1.178 . . . . 0.0 109.714 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -96.81 36.94 1.34 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 109.629 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 47.15 -149.11 0.14 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.94 . . . . 0.0 109.428 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.3 -149.88 1.83 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.48 15.54 15.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.244 -1.151 . . . . 0.0 109.497 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.456 ' O ' ' HD3' ' A' ' 27' ' ' PRO . . . 163.49 -92.98 0.11 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -40.89 100.89 0.23 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.474 -1.015 . . . . 0.0 109.543 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 25' ' ' GLY . 36.1 Cg_endo -77.95 128.64 9.31 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.483 2.122 . . . . 0.0 110.787 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -94.58 110.93 22.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.326 -0.859 . . . . 0.0 109.163 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.07 120.94 31.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.158 -0.964 . . . . 0.0 110.037 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -166.52 -159.69 0.38 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.339 -0.851 . . . . 0.0 109.252 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -66.08 156.13 34.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.191 -0.943 . . . . 0.0 109.346 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.2 t -52.12 123.18 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.116 -0.99 . . . . 0.0 109.022 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.62 145.69 32.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 109.978 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 73' ' ' VAL . 1.5 p -125.91 169.18 12.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.379 -0.826 . . . . 0.0 109.265 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.554 HG13 HG13 ' A' ' 74' ' ' VAL . 27.3 pt -107.75 169.91 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 109.41 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt -109.9 164.77 12.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.185 -0.947 . . . . 0.0 109.524 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.486 ' HD2' ' CE ' ' A' ' 60' ' ' MET . 0.3 OUTLIER -60.8 -15.52 30.77 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.285 -0.885 . . . . 0.0 109.694 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 37' ' ' ARG . 37.1 t0 -43.63 -55.29 4.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 0.0 109.655 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -61.05 -57.42 12.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.221 -0.925 . . . . 0.0 109.692 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.879 HG13 ' HB ' ' A' ' 63' ' ' ILE . 60.8 t -41.68 -28.68 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.89 . . . . 0.0 110.407 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -74.66 -49.91 19.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.078 -1.014 . . . . 0.0 110.216 -179.447 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -67.73 -21.08 65.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.078 -1.014 . . . . 0.0 110.109 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 19.7 mt -101.33 -13.62 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.457 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.57 ' HB2' ' O ' ' A' ' 40' ' ' VAL . . . -88.15 -14.25 39.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.317 -0.865 . . . . 0.0 109.252 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.67 -52.86 4.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.345 -0.847 . . . . 0.0 109.624 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.2 mt -88.11 32.03 0.77 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -0.944 . . . . 0.0 109.695 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -159.43 23.55 0.19 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.211 -0.931 . . . . 0.0 109.407 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -121.97 85.28 45.47 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.312 -0.867 . . . . 0.0 109.623 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.544 ' HD2' HD23 ' A' ' 51' ' ' LEU . 36.4 Cg_endo -80.42 43.61 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.865 2.376 . . . . 0.0 110.755 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 18.9 t0 53.99 25.63 5.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.062 -1.024 . . . . 0.0 109.23 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 52' ' ' ASN . 1.9 pp -44.44 -39.29 4.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.616 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.557 ' N ' HD12 ' A' ' 51' ' ' LEU . 7.1 t-20 161.47 95.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.636 -0.665 . . . . 0.0 109.21 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.836 ' CB ' ' HB3' ' A' ' 58' ' ' ALA . . . -171.31 139.31 1.3 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.946 . . . . 0.0 109.425 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 53' ' ' ALA . . . -45.09 -59.6 2.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.202 -0.936 . . . . 0.0 109.127 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.8 -65.43 0.1 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.342 -0.849 . . . . 0.0 108.959 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.539 ' O ' ' CG2' ' A' ' 56' ' ' ILE . 2.7 mm -137.82 1.84 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.385 -0.822 . . . . 0.0 108.99 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.32 -57.07 3.22 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.039 -1.038 . . . . 0.0 109.681 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.836 ' HB3' ' CB ' ' A' ' 53' ' ' ALA . . . -64.26 -52.23 59.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.387 -0.821 . . . . 0.0 109.532 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.593 ' H ' ' HB1' ' A' ' 53' ' ' ALA . . . -51.3 -40.96 60.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 109.4 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.486 ' CE ' ' HD2' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -62.56 -37.94 88.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.867 . . . . 0.0 109.671 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.524 ' HA ' ' CG ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -68.05 -16.75 64.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.581 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.404 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -78.56 -53.7 6.93 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.287 -0.883 . . . . 0.0 109.835 -179.724 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.879 ' HB ' HG13 ' A' ' 40' ' ' VAL . 7.8 mt -60.57 -42.3 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.179 -0.951 . . . . 0.0 109.714 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.524 ' CG ' ' HA ' ' A' ' 61' ' ' ARG . 2.0 pp20? -64.25 -44.62 91.23 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.961 -1.087 . . . . 0.0 109.602 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.49 -12.38 55.89 Favored Glycine 0 C--N 1.298 -1.568 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 14.7 m -84.8 -56.11 3.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.401 -1.058 . . . . 0.0 109.644 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.49 ' O ' ' O ' ' A' ' 72' ' ' ILE . . . -64.46 -31.07 72.13 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.93 -1.106 . . . . 0.0 108.75 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -60.13 4.15 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.331 -0.856 . . . . 0.0 109.433 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.51 -56.25 3.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.092 -1.005 . . . . 0.0 109.876 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.45 ' HB2' ' O ' ' A' ' 66' ' ' THR . 9.5 mtp -64.49 -10.01 22.66 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.321 -0.862 . . . . 0.0 111.009 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 67' ' ' ALA . . . -142.94 -130.73 2.48 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.272 -1.442 . . . . 0.0 110.839 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.511 ' C ' HD12 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -101.31 -169.83 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.491 -1.005 . . . . 0.0 110.301 -179.217 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.406 ' O ' ' HB ' ' A' ' 34' ' ' THR . 1.4 t -81.94 145.76 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -0.846 . . . . 0.0 109.69 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.554 HG13 HG13 ' A' ' 35' ' ' ILE . 20.6 t -120.36 147.28 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.407 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 35' ' ' ILE . 12.4 pt-20 -95.27 139.82 31.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.302 -0.874 . . . . 0.0 109.477 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.9 t0 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.438 179.917 . . . . . . . . 0 0 . 1 stop_ save_